data_1q9g_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1q9g _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 12' ' ' SER . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.506 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 . . . . . 0 C--O 1.239 0.547 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.506 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HB2' HD22 ' A' ' 25' ' ' ASN . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 10' ' ' ALA . 47.2 m-80 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 33' ' ' ASP . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 89' ' ' LYS . 0.3 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.47 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . 0.448 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE3' HD11 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.472 HD11 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.46 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.46 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.533 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 66' ' ' THR . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 56' ' ' ASP . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . 0.417 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 42' ' ' SER . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 16' ' ' GLY . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 14' ' ' ALA . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . 0.523 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.463 HD21 ' H ' ' A' ' 38' ' ' GLY . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.463 ' H ' HD21 ' A' ' 37' ' ' LEU . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.226 -0.133 0 CA-C-O 122.083 0.944 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.555 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.403 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.539 HG23 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . 0.539 ' H ' HG23 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.467 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' SER . . . . . 0.416 ' HG ' HG12 ' A' ' 141' ' ' ILE . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . 0.416 HG12 ' HG ' ' A' ' 126' ' ' SER . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' THR . . . . . 0.432 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.4 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.4 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . 0.493 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . 0.411 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 101' ' ' ASP . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . 0.418 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 28.3 t0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 122.508 1.147 . . . . 0.0 114.045 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . 0.581 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.455 ' H ' HG12 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . 0.53 ' H ' HG21 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASN . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' GLU . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . 0.456 HD11 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . 0.456 ' H ' HD11 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . 0.53 HG21 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . 0.477 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . 0.477 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.51 0.195 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 21' ' ' MET . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' GLY . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' ALA . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB3' ' H ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . 0.495 HD22 ' ND2' ' A' ' 60' ' ' ASN . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.495 ' ND2' HD22 ' A' ' 58' ' ' ASN . 1.2 m-20 -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . 0.414 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . 0.409 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . 0.474 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 6.4 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . 0.437 ' CB ' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . 0.409 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . 0.437 ' H ' ' CB ' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . 0.474 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 C--O 1.239 0.545 0 CA-C-O 120.415 0.15 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . 0.405 ' H ' ' CG ' ' A' ' 94' ' ' GLU . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t -156.5 -62.87 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.405 ' CG ' ' H ' ' A' ' 57' ' ' TYR . 1.3 mm-40 59.99 -60.09 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.997 3.319 . . . . 0.0 113.076 -172.512 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.61 151.32 71.56 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.72 85.52 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.389 2.726 . . . . 0.0 109.675 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -149.61 -46.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.511 1.124 . . . . 0.0 109.402 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 63.63 156.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.41 1.484 . . . . 0.0 111.829 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -147.81 -53.07 0.2 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.956 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.5 m120 44.92 76.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.987 0.915 . . . . 0.0 113.07 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -124.51 -68.89 0.83 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.404 ' HB3' ' HE2' ' A' ' 20' ' ' LYS . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.404 ' HE2' ' HB3' ' A' ' 12' ' ' SER . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.49 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m -107.83 -67.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -176.54 -17.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.209 -0.932 . . . . 0.0 113.147 -173.011 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -64.0 -42.84 72.36 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.738 163.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -77.29 173.52 14.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.393 1.89 . . . . 0.0 108.698 167.314 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 t -79.56 55.64 2.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.175 1.79 . . . . 0.0 109.587 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.7 p90 55.49 18.29 2.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.997 1.719 . . . . 0.0 114.316 162.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.71 -53.81 28.32 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.835 2.054 . . . . 0.0 112.762 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -128.21 45.86 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.01 81.98 2.03 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 171.366 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.49 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.501 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t -149.0 90.18 1.73 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -128.65 0.83 5.5 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.271 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 147.32 -69.0 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 130.547 3.539 . . . . 0.0 108.093 -167.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.39 -26.22 63.34 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.103 1.43 . . . . 0.0 112.545 -172.714 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.4 m 62.12 9.95 3.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 173.593 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -146.27 92.98 2.25 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -162.26 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -152.54 -69.28 0.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.134 1.774 . . . . 0.0 108.012 163.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 39.18 65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.128 2.171 . . . . 0.0 110.471 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.83 -55.88 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.935 1.294 . . . . 0.0 109.537 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . 0.42 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.501 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.506 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . 0.413 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m -152.13 110.22 3.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 170.5 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.325 3.05 . . . . 0.0 106.218 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -51.93 142.51 25.61 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.82 1.248 . . . . 0.0 109.923 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.12 -21.14 71.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.976 1.784 . . . . 0.0 111.745 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p -113.67 73.01 0.8 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.704 2.002 . . . . 0.0 106.784 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -45.94 120.3 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.838 1.255 . . . . 0.0 108.752 164.193 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -46.98 63.63 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.687 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.72 66.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.339 2.256 . . . . 0.0 112.261 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.74 141.93 58.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.362 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.506 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . 0.454 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . 0.437 ' HB2' HD22 ' A' ' 25' ' ' ASN . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.437 HD22 ' HB2' ' A' ' 10' ' ' ALA . 47.2 m-80 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.401 ' HG2' HH11 ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.454 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -147.54 -94.85 0.08 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -149.4 -54.88 0.18 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.708 1.603 . . . . 0.0 108.938 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.54 166.27 25.51 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.946 1.698 . . . . 0.0 107.816 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.54 65.04 4.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.62 2.88 . . . . 0.0 111.594 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.7 m -140.27 -71.33 0.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.5 154.24 41.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.488 1.04 . . . . 0.0 109.173 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 153.05 42.16 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.601 1.56 . . . . 0.0 106.858 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -66.5 -59.22 3.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.192 0.905 . . . . 0.0 109.616 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 178.52 90.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.712 0.805 . . . . 0.0 109.59 -164.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.422 ' HG3' ' H ' ' A' ' 33' ' ' ASP . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.422 ' H ' ' HG3' ' A' ' 32' ' ' GLU . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.47 ' ND2' ' H ' ' A' ' 89' ' ' LYS . 0.3 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . 0.438 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.47 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.02 16.3 1.55 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -128.92 75.46 1.65 Allowed 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.813 -1.179 . . . . 0.0 108.498 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 66.44 170.17 0.1 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.716 2.807 . . . . 0.0 113.095 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.34 -17.82 59.44 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.919 1.007 . . . . 0.0 112.259 170.922 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -47.15 -53.74 12.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.445 2.698 . . . . 0.0 111.983 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.4 171.72 13.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.81 0.732 . . . . 0.0 109.297 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -143.76 168.42 19.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.08 -91.22 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.173 0.442 . . . . 0.0 110.96 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -171.75 175.9 3.82 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.706 1.202 . . . . 0.0 108.2 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . 0.438 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.533 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . 0.448 HD21 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . 0.448 ' N ' HD21 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.472 ' HE3' HD11 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.472 HD11 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.46 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.46 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -144.77 35.09 1.14 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -87.71 -88.36 0.14 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -153.63 -59.36 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.584 2.754 . . . . 0.0 109.118 178.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -76.04 11.94 1.61 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.862 2.375 . . . . 0.0 115.362 -167.664 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 p 46.22 36.36 3.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.083 1.753 . . . . 0.0 113.165 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.1 166.61 11.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.913 0.885 . . . . 0.0 110.594 -167.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 67.73 -64.76 0.26 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.646 1.978 . . . . 0.0 111.429 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 39.27 55.83 2.19 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.148 2.179 . . . . 0.0 111.32 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.9 147.62 43.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.482 1.913 . . . . 0.0 108.961 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.533 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.471 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . 0.471 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' SER . . . . . 0.499 ' H ' ' HB ' ' A' ' 66' ' ' THR . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.449 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . 0.417 ' HE ' ' CG ' ' A' ' 56' ' ' ASP . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . 0.417 ' CG ' ' HE ' ' A' ' 50' ' ' ARG . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.449 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' THR . . . . . 0.499 ' HB ' ' H ' ' A' ' 42' ' ' SER . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m 58.34 -6.05 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -82.48 52.94 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.564 2.746 . . . . 0.0 107.446 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -53.37 17.27 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.449 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.79 2.71 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.29 1.993 . . . . 0.0 112.768 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 -51.66 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.917 -1.114 . . . . 0.0 108.195 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.3 t80 62.39 77.77 0.32 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.034 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 139.23 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 1 C-N-CA 133.716 4.806 . . . . 0.0 105.269 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.74 -61.76 1.94 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.517 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -176.52 -69.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.42 ' C ' ' H ' ' A' ' 16' ' ' GLY . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.42 ' H ' ' C ' ' A' ' 14' ' ' ALA . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.523 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . 0.523 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.463 HD21 ' H ' ' A' ' 38' ' ' GLY . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.463 ' H ' HD21 ' A' ' 37' ' ' LEU . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 t -55.33 -70.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -165.76 9.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.058 2.143 . . . . 0.0 109.137 -172.424 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -65.94 -48.3 61.76 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.55 1.14 . . . . 0.0 112.622 -157.487 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.52 13.23 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.234 2.622 . . . . 0.0 114.551 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.39 20.52 0.67 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.359 2.264 . . . . 0.0 110.74 -168.162 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.0 142.67 17.62 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.891 -1.131 . . . . 0.0 110.897 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -73.62 154.96 39.53 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.03 -54.65 44.75 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.343 1.057 . . . . 0.0 111.744 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -177.36 163.06 1.97 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.334 2.654 . . . . 0.0 107.792 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.41 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.41 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -133.11 29.01 4.09 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.03 -52.58 55.17 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.435 -0.791 . . . . 0.0 109.781 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -136.83 161.55 60.98 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.674 1.99 . . . . 0.0 107.632 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 44.78 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.375 3.384 . . . . 0.0 111.725 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.7 m -151.19 -43.39 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.283 1.433 . . . . 0.0 109.281 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.09 109.15 8.32 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.08 121.8 6.42 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.826 0.85 . . . . 0.0 109.035 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -152.49 -176.25 5.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 165.444 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -142.22 72.24 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.712 2.405 . . . . 0.0 108.811 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . 0.465 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.465 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.433 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -150.86 14.2 0.72 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -147.5 5.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.823 1.647 . . . . 0.0 114.197 -166.785 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -143.44 -56.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.782 1.173 . . . . 0.0 112.019 -178.846 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.9 Cg_endo -76.31 -178.08 4.17 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.5 1.571 . . . . 0.0 109.87 166.713 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 p -64.95 28.04 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.129 3.372 . . . . 0.0 115.175 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 75.16 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.814 2.446 . . . . 0.0 109.993 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.65 -69.4 0.85 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 45.09 82.31 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.556 1.142 . . . . 0.0 110.724 -167.732 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -67.91 167.95 12.66 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.433 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.555 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.555 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . 0.403 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.443 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.403 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.539 HG23 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . 0.539 ' H ' HG23 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.467 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' THR . . . . . 0.435 HG23 ' H ' ' A' ' 94' ' ' GLU . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -120.91 23.78 10.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . 0.435 ' H ' HG23 ' A' ' 92' ' ' THR . 4.1 tt0 66.81 74.31 0.34 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.254 1.422 . . . . 0.0 108.507 173.769 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 175.46 -62.07 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 130.899 3.68 . . . . 0.0 107.572 -170.404 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.39 -3.43 12.98 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.846 1.697 . . . . 0.0 114.116 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.1 m 52.16 49.56 20.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.953 1.701 . . . . 0.0 110.051 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -142.44 -63.13 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.534 1.134 . . . . 0.0 108.507 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.13 98.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.442 1.897 . . . . 0.0 109.083 -157.109 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.37 168.41 19.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . 0.467 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' SER . . . . . 0.416 ' HG ' HG12 ' A' ' 141' ' ' ILE . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . 0.416 HG12 ' HG ' ' A' ' 126' ' ' SER . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' THR . . . . . 0.432 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 1.9 pm0 -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . 0.436 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . 0.436 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m -113.06 80.23 1.33 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -148.65 -53.73 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 175.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -91.11 142.87 27.69 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 -11.86 31.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.824 2.349 . . . . 0.0 114.119 -168.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 t -76.62 -12.9 60.08 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.358 -0.839 . . . . 0.0 111.494 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.34 12.71 1.49 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.819 2.047 . . . . 0.0 115.324 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -142.55 109.59 5.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -65.56 0.74 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 55.64 39.55 30.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.022 2.129 . . . . 0.0 112.882 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' MET . . . . . 0.417 ' C ' ' H ' ' A' ' 120' ' ' ASN . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.417 ' H ' ' C ' ' A' ' 118' ' ' MET . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.4 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.4 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.455 HG12 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . 0.493 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . 0.411 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . 0.411 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.418 ' HE3' ' HA ' ' A' ' 101' ' ' ASP . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m -144.72 66.63 1.26 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.52 -63.74 0.18 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -64.4 140.1 97.88 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 123.531 0.732 . . . . 0.0 111.701 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.97 69.7 4.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.849 3.699 . . . . 0.0 110.59 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -162.03 -37.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.098 2.559 . . . . 0.0 107.301 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 p90 40.02 33.81 0.16 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.402 2.681 . . . . 0.0 115.31 165.234 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.95 101.32 4.26 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 163.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -104.34 -27.82 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . 0.418 ' HA ' ' HE3' ' A' ' 89' ' ' LYS . 28.3 t0 28.08 71.59 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 129.191 2.996 . . . . 0.0 114.045 155.69 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.581 ' CG ' ' H ' ' A' ' 125' ' ' PHE . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . 0.581 ' H ' ' CG ' ' A' ' 124' ' ' ASP . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . 0.493 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.455 ' H ' HG12 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . 0.448 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . 0.448 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . 0.419 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.441 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.441 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . 0.419 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.79 -20.05 19.82 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -94.62 -84.03 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 166.98 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 131.533 3.933 . . . . 0.0 108.023 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -59.0 -44.71 32.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 0.0 113.427 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.3 m -42.96 -61.88 1.17 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.166 2.186 . . . . 0.0 112.129 -163.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.11 71.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.16 0.981 . . . . 0.0 108.59 -171.215 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -71.67 81.03 0.84 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.642 -1.286 . . . . 0.0 112.437 -165.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.58 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.791 2.036 . . . . 0.0 111.945 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 166.45 4.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.048 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . 0.53 ' H ' HG21 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . 0.432 ' C ' ' H ' ' A' ' 34' ' ' ASN . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . 0.432 ' H ' ' C ' ' A' ' 32' ' ' GLU . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . 0.456 HD11 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . 0.456 ' H ' HD11 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . 0.53 HG21 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . 0.477 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . 0.408 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . 0.477 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -59.43 -28.8 67.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.15 7.71 3.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.202 1.365 . . . . 0.0 111.779 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.89 -48.27 88.43 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.463 176.954 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.56 7.62 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.995 1.796 . . . . 0.0 113.004 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m 51.8 70.17 0.58 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.325 2.25 . . . . 0.0 111.474 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -139.63 -62.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.582 0.706 . . . . 0.0 110.602 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.39 -164.86 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.175 0.99 . . . . 0.0 109.16 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.0 t30 49.37 48.48 21.12 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.516 1.926 . . . . 0.0 111.807 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.74 -72.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -76.58 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.29 -23.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.658 2.026 . . . . 0.0 113.71 170.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -42.65 -47.53 12.9 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.495 1.518 . . . . 0.0 115.08 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.26 44.07 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.101 1.867 . . . . 0.0 112.509 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 m 52.06 53.89 11.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.539 . . . . 0.0 109.732 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.7 t80 72.09 -49.71 0.69 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.793 2.437 . . . . 0.0 111.829 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mttt 46.85 -95.9 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.365 1.866 . . . . 0.0 109.462 -162.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.14 41.55 5.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.577 1.551 . . . . 0.0 111.441 -172.596 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -117.33 0.97 12.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . 0.414 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' SER . . . . . 0.437 ' H ' ' HB3' ' A' ' 21' ' ' MET . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.469 ' C ' ' H ' ' A' ' 16' ' ' GLY . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . 0.469 ' H ' ' C ' ' A' ' 14' ' ' ALA . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . 0.478 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' MET . . . . . 0.437 ' HB3' ' H ' ' A' ' 12' ' ' SER . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . 0.426 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . 0.495 HD22 ' ND2' ' A' ' 60' ' ' ASN . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.495 ' ND2' HD22 ' A' ' 58' ' ' ASN . 1.2 m-20 -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 95' ' ' TYR . 0.3 OUTLIER 63.36 -68.15 0.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 61.48 -3.28 0.21 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.523 1.929 . . . . 0.0 112.968 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . 0.433 ' H ' ' C ' ' A' ' 93' ' ' THR . 1.5 t80 -70.13 -59.74 4.02 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.402 1.001 . . . . 0.0 110.903 171.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.78 176.73 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 121.441 1.55 . . . . 0.0 111.457 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.6 t -74.8 8.39 2.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.24 110.3 11.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.834 1.652 . . . . 0.0 107.652 -161.251 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.87 132.13 6.42 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -171.798 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 62.97 146.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.742 2.417 . . . . 0.0 111.976 -169.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -143.51 -41.64 0.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.731 1.212 . . . . 0.0 110.382 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . 0.414 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . 0.409 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . 0.474 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 6.4 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . 0.437 ' CB ' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . 0.409 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m -63.78 -99.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -163.13 68.4 0.21 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.27 -57.04 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 127.181 2.193 . . . . 0.0 108.371 171.564 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . 0.413 ' HG2' ' H ' ' A' ' 97' ' ' THR . 72.4 Cg_endo -73.49 -60.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.219 1.471 . . . . 0.0 112.227 -174.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' THR . . . . . 0.413 ' H ' ' HG2' ' A' ' 96' ' ' PRO . 0.8 OUTLIER -160.7 27.21 0.15 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.191 1.397 . . . . 0.0 110.539 -159.524 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -1.1 111.21 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.096 2.958 . . . . 0.0 116.002 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm 61.02 45.34 9.39 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.585 1.154 . . . . 0.0 111.663 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.5 92.85 3.46 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.272 1.429 . . . . 0.0 107.484 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 60.35 102.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.148 2.179 . . . . 0.0 111.83 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . 0.437 ' H ' ' CB ' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . 0.474 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m -132.58 60.1 1.7 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.43 -60.64 0.08 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.0 138.63 83.51 Favored Pre-proline 0 C--O 1.239 0.519 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.53 149.67 88.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.876 2.384 . . . . 0.0 110.594 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m 48.41 68.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -165.632 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -37.25 162.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.14 2.576 . . . . 0.0 113.207 170.853 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.26 70.38 0.65 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -86.68 -56.56 3.35 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.119 -167.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -67.26 129.03 38.59 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.192 0.597 . . . . 0.0 110.756 -170.652 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' H ' HD23 ' A' ' 26' ' ' LEU . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 113' ' ' LEU . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' TYR . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' LYS . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 46' ' ' THR . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 145' ' ' GLY . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 144' ' ' VAL . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 110' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.8 t30 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.536 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 . . . . . 0 C--O 1.239 0.547 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' THR . . . . . 0.464 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 80' ' ' TYR . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.506 HG23 ' HE3' ' A' ' 59' ' ' LYS . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HE3' HG23 ' A' ' 46' ' ' THR . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' HG21 ' A' ' 40' ' ' ILE . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 135' ' ' VAL . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 89' ' ' LYS . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 146' ' ' TYR . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' ASP . . . . . 0.49 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 135' ' ' VAL . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 132' ' ' ILE . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.518 ' H ' HG23 ' A' ' 5' ' ' VAL . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 135' ' ' VAL . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' CA ' ' HB3' ' A' ' 70' ' ' ALA . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.59 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 38' ' ' GLY . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 14' ' ' ALA . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.513 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' HD12 ' A' ' 65' ' ' ILE . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 64' ' ' GLY . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 77' ' ' ALA . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 73' ' ' ILE . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' H ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 72' ' ' ARG . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 ' HA3' ' A' ' 145' ' ' GLY . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.226 -0.133 0 CA-C-O 122.083 0.944 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 145' ' ' GLY . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.609 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.499 ' H ' HG11 ' A' ' 5' ' ' VAL . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 145' ' ' GLY . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 40' ' ' ILE . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 55' ' ' GLY . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 51' ' ' THR . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.401 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.671 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASN . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 113' ' ' LEU . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 80' ' ' TYR . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 91' ' ' GLN . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 59' ' ' LYS . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 6' ' ' THR . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.412 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.542 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 122.508 1.147 . . . . 0.0 114.045 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 80' ' ' TYR . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.602 ' H ' HG11 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 147' ' ' ARG . . . . . 0.468 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 146' ' ' TYR . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.413 HG23 ' CG ' ' A' ' 124' ' ' ASP . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 141' ' ' ILE . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.612 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 79' ' ' ILE . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 73' ' ' ILE . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 121' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 145' ' ' GLY . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 141' ' ' ILE . . . . . 0.433 HG22 ' HA2' ' A' ' 7' ' ' GLY . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 145' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 121' ' ' VAL . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.449 ' H ' HG11 ' A' ' 5' ' ' VAL . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 124' ' ' ASP . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.51 0.195 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 6' ' ' THR . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 137' ' ' VAL . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 137' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 132' ' ' ILE . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG11 ' A' ' 82' ' ' VAL . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HA ' HD13 ' A' ' 113' ' ' LEU . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 40' ' ' ILE . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 79' ' ' ILE . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 6' ' ' THR . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 146' ' ' TYR . . . . . 0.447 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB2' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HB2' HD11 ' A' ' 37' ' ' LEU . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.478 HD13 ' H ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' H ' HG13 ' A' ' 135' ' ' VAL . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 73' ' ' ILE . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 C--O 1.239 0.545 0 CA-C-O 120.415 0.15 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 15' ' ' GLN . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' H ' HD23 ' A' ' 26' ' ' LEU . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.0 m-20 -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 94' ' ' GLU . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 113' ' ' LEU . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t -156.5 -62.87 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' H ' ' A' ' 57' ' ' TYR . 1.3 mm-40 59.99 -60.09 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.997 3.319 . . . . 0.0 113.076 -172.512 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.61 151.32 71.56 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.72 85.52 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.389 2.726 . . . . 0.0 109.675 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -149.61 -46.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.511 1.124 . . . . 0.0 109.402 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 63.63 156.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.41 1.484 . . . . 0.0 111.829 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -147.81 -53.07 0.2 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.956 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.5 m120 44.92 76.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.987 0.915 . . . . 0.0 113.07 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -124.51 -68.89 0.83 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' TYR . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 27.0 p30 -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' LYS . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 46' ' ' THR . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.463 HG23 ' HG2' ' A' ' 96' ' ' PRO . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m -107.83 -67.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -176.54 -17.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.209 -0.932 . . . . 0.0 113.147 -173.011 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -64.0 -42.84 72.36 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.738 163.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HG2' HG23 ' A' ' 92' ' ' THR . 61.0 Cg_endo -77.29 173.52 14.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.393 1.89 . . . . 0.0 108.698 167.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 t -79.56 55.64 2.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.175 1.79 . . . . 0.0 109.587 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.7 p90 55.49 18.29 2.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.997 1.719 . . . . 0.0 114.316 162.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.71 -53.81 28.32 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.835 2.054 . . . . 0.0 112.762 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -128.21 45.86 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.01 81.98 2.03 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 171.366 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 145' ' ' GLY . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 144' ' ' VAL . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.1 mp0 -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t -149.0 90.18 1.73 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -128.65 0.83 5.5 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.271 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 147.32 -69.0 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 130.547 3.539 . . . . 0.0 108.093 -167.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.39 -26.22 63.34 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.103 1.43 . . . . 0.0 112.545 -172.714 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.4 m 62.12 9.95 3.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 173.593 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -146.27 92.98 2.25 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -162.26 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -152.54 -69.28 0.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.134 1.774 . . . . 0.0 108.012 163.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 39.18 65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.128 2.171 . . . . 0.0 110.471 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.83 -55.88 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.935 1.294 . . . . 0.0 109.537 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 60.8 t30 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.536 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m -152.13 110.22 3.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 170.5 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.325 3.05 . . . . 0.0 106.218 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -51.93 142.51 25.61 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.82 1.248 . . . . 0.0 109.923 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.12 -21.14 71.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.976 1.784 . . . . 0.0 111.745 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p -113.67 73.01 0.8 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.704 2.002 . . . . 0.0 106.784 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -45.94 120.3 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.838 1.255 . . . . 0.0 108.752 164.193 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -46.98 63.63 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.687 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.72 66.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.339 2.256 . . . . 0.0 112.261 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.74 141.93 58.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.362 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.464 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 16.0 m120 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.457 HH11 ' HG2' ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 80' ' ' TYR . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.506 HG23 ' HE3' ' A' ' 59' ' ' LYS . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.9 t-20 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HE3' HG23 ' A' ' 46' ' ' THR . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' HG21 ' A' ' 40' ' ' ILE . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 135' ' ' VAL . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -147.54 -94.85 0.08 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -149.4 -54.88 0.18 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.708 1.603 . . . . 0.0 108.938 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.54 166.27 25.51 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.946 1.698 . . . . 0.0 107.816 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.54 65.04 4.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.62 2.88 . . . . 0.0 111.594 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.7 m -140.27 -71.33 0.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.5 154.24 41.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.488 1.04 . . . . 0.0 109.173 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 153.05 42.16 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.601 1.56 . . . . 0.0 106.858 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -66.5 -59.22 3.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.192 0.905 . . . . 0.0 109.616 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 178.52 90.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.712 0.805 . . . . 0.0 109.59 -164.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 89' ' ' LYS . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 146' ' ' TYR . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.02 16.3 1.55 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -128.92 75.46 1.65 Allowed 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.813 -1.179 . . . . 0.0 108.498 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 66.44 170.17 0.1 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.716 2.807 . . . . 0.0 113.095 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.34 -17.82 59.44 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.919 1.007 . . . . 0.0 112.259 170.922 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -47.15 -53.74 12.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.445 2.698 . . . . 0.0 111.983 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.4 171.72 13.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.81 0.732 . . . . 0.0 109.297 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -143.76 168.42 19.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.08 -91.22 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.173 0.442 . . . . 0.0 110.96 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -171.75 175.9 3.82 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.706 1.202 . . . . 0.0 108.2 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 135' ' ' VAL . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 132' ' ' ILE . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.518 ' H ' HG23 ' A' ' 5' ' ' VAL . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 135' ' ' VAL . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' CA ' ' HB3' ' A' ' 70' ' ' ALA . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.59 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 38' ' ' GLY . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -144.77 35.09 1.14 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -87.71 -88.36 0.14 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -153.63 -59.36 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.584 2.754 . . . . 0.0 109.118 178.416 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 88.2 Cg_endo -76.04 11.94 1.61 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.862 2.375 . . . . 0.0 115.362 -167.664 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 p 46.22 36.36 3.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.083 1.753 . . . . 0.0 113.165 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.1 166.61 11.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.913 0.885 . . . . 0.0 110.594 -167.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 67.73 -64.76 0.26 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.646 1.978 . . . . 0.0 111.429 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 39.27 55.83 2.19 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.148 2.179 . . . . 0.0 111.32 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.9 147.62 43.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.482 1.913 . . . . 0.0 108.961 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 14' ' ' ALA . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.513 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 13.0 mm100 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' HD12 ' A' ' 65' ' ' ILE . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 64' ' ' GLY . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 77' ' ' ALA . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 73' ' ' ILE . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m 58.34 -6.05 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -82.48 52.94 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.564 2.746 . . . . 0.0 107.446 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -53.37 17.27 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.449 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.79 2.71 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.29 1.993 . . . . 0.0 112.768 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 -51.66 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.917 -1.114 . . . . 0.0 108.195 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.3 t80 62.39 77.77 0.32 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.034 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 139.23 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 1 C-N-CA 133.716 4.806 . . . . 0.0 105.269 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.74 -61.76 1.94 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.517 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -176.52 -69.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' H ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 63.3 t30 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 72' ' ' ARG . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ILE . . . . . 0.585 HD12 ' H ' ' A' ' 65' ' ' ILE . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 94' ' ' GLU . 6.2 t -55.33 -70.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 93' ' ' THR . 9.2 pt-20 -165.76 9.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.058 2.143 . . . . 0.0 109.137 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -65.94 -48.3 61.76 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.55 1.14 . . . . 0.0 112.622 -157.487 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.52 13.23 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.234 2.622 . . . . 0.0 114.551 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.39 20.52 0.67 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.359 2.264 . . . . 0.0 110.74 -168.162 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.0 142.67 17.62 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.891 -1.131 . . . . 0.0 110.897 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -73.62 154.96 39.53 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.03 -54.65 44.75 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.343 1.057 . . . . 0.0 111.744 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -177.36 163.06 1.97 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.334 2.654 . . . . 0.0 107.792 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 ' HA3' ' A' ' 145' ' ' GLY . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -133.11 29.01 4.09 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.03 -52.58 55.17 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.435 -0.791 . . . . 0.0 109.781 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -136.83 161.55 60.98 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.674 1.99 . . . . 0.0 107.632 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 44.78 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.375 3.384 . . . . 0.0 111.725 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.7 m -151.19 -43.39 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.283 1.433 . . . . 0.0 109.281 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.09 109.15 8.32 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.08 121.8 6.42 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.826 0.85 . . . . 0.0 109.035 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -152.49 -176.25 5.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 165.444 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -142.22 72.24 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.712 2.405 . . . . 0.0 108.811 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 145' ' ' GLY . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.609 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.499 ' H ' HG11 ' A' ' 5' ' ' VAL . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 145' ' ' GLY . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 40' ' ' ILE . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 55' ' ' GLY . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 51' ' ' THR . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -150.86 14.2 0.72 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -147.5 5.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.823 1.647 . . . . 0.0 114.197 -166.785 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 7.9 t80 -143.44 -56.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.782 1.173 . . . . 0.0 112.019 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 41.9 Cg_endo -76.31 -178.08 4.17 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.5 1.571 . . . . 0.0 109.87 166.713 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 p -64.95 28.04 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.129 3.372 . . . . 0.0 115.175 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 75.16 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.814 2.446 . . . . 0.0 109.993 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.65 -69.4 0.85 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 45.09 82.31 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.556 1.142 . . . . 0.0 110.724 -167.732 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -67.91 167.95 12.66 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 7.9 p30 -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.401 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.671 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASN . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 113' ' ' LEU . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 94' ' ' GLU . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -120.91 23.78 10.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 92' ' ' THR . 4.1 tt0 66.81 74.31 0.34 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.254 1.422 . . . . 0.0 108.507 173.769 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 175.46 -62.07 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 130.899 3.68 . . . . 0.0 107.572 -170.404 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.39 -3.43 12.98 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.846 1.697 . . . . 0.0 114.116 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.1 m 52.16 49.56 20.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.953 1.701 . . . . 0.0 110.051 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -142.44 -63.13 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.534 1.134 . . . . 0.0 108.507 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.13 98.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.442 1.897 . . . . 0.0 109.083 -157.109 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.37 168.41 19.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 80' ' ' TYR . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 91' ' ' GLN . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 59' ' ' LYS . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m -113.06 80.23 1.33 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -148.65 -53.73 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 175.079 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -91.11 142.87 27.69 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 -11.86 31.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.824 2.349 . . . . 0.0 114.119 -168.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 t -76.62 -12.9 60.08 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.358 -0.839 . . . . 0.0 111.494 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.34 12.71 1.49 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.819 2.047 . . . . 0.0 115.324 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -142.55 109.59 5.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -71.68 -65.56 0.74 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 55.64 39.55 30.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.022 2.129 . . . . 0.0 112.882 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 6' ' ' THR . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.412 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.542 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.451 HD13 ' H ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m -144.72 66.63 1.26 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.52 -63.74 0.18 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -64.4 140.1 97.88 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 123.531 0.732 . . . . 0.0 111.701 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.97 69.7 4.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.849 3.699 . . . . 0.0 110.59 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -162.03 -37.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.098 2.559 . . . . 0.0 107.301 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 p90 40.02 33.81 0.16 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.402 2.681 . . . . 0.0 115.31 165.234 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.95 101.32 4.26 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 163.734 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -104.34 -27.82 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t0 28.08 71.59 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 129.191 2.996 . . . . 0.0 114.045 155.69 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 80' ' ' TYR . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.602 ' H ' HG11 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 147' ' ' ARG . . . . . 0.468 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 146' ' ' TYR . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.413 HG23 ' CG ' ' A' ' 124' ' ' ASP . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 141' ' ' ILE . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.612 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 79' ' ' ILE . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 73' ' ' ILE . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.79 -20.05 19.82 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -94.62 -84.03 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 166.98 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 131.533 3.933 . . . . 0.0 108.023 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -59.0 -44.71 32.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 0.0 113.427 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.3 m -42.96 -61.88 1.17 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.166 2.186 . . . . 0.0 112.129 -163.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.11 71.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.16 0.981 . . . . 0.0 108.59 -171.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -71.67 81.03 0.84 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.642 -1.286 . . . . 0.0 112.437 -165.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.58 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.791 2.036 . . . . 0.0 111.945 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 166.45 4.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.048 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.0 m-20 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 121' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 145' ' ' GLY . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 141' ' ' ILE . . . . . 0.433 HG22 ' HA2' ' A' ' 7' ' ' GLY . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 121' ' ' VAL . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.449 ' H ' HG11 ' A' ' 5' ' ' VAL . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 12.1 m120 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -59.43 -28.8 67.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.15 7.71 3.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.202 1.365 . . . . 0.0 111.779 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.89 -48.27 88.43 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.463 176.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.56 7.62 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.995 1.796 . . . . 0.0 113.004 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m 51.8 70.17 0.58 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.325 2.25 . . . . 0.0 111.474 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -139.63 -62.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.582 0.706 . . . . 0.0 110.602 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.39 -164.86 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.175 0.99 . . . . 0.0 109.16 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.0 t30 49.37 48.48 21.12 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.516 1.926 . . . . 0.0 111.807 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.74 -72.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 124' ' ' ASP . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -76.58 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.29 -23.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.658 2.026 . . . . 0.0 113.71 170.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -42.65 -47.53 12.9 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.495 1.518 . . . . 0.0 115.08 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.26 44.07 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.101 1.867 . . . . 0.0 112.509 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 m 52.06 53.89 11.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.539 . . . . 0.0 109.732 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.7 t80 72.09 -49.71 0.69 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.793 2.437 . . . . 0.0 111.829 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mttt 46.85 -95.9 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.365 1.866 . . . . 0.0 109.462 -162.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.14 41.55 5.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.577 1.551 . . . . 0.0 111.441 -172.596 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -117.33 0.97 12.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 6' ' ' THR . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 132' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 137' ' ' VAL . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 137' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 132' ' ' ILE . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG11 ' A' ' 82' ' ' VAL . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HA ' HD13 ' A' ' 113' ' ' LEU . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 40' ' ' ILE . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.36 -68.15 0.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 61.48 -3.28 0.21 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.523 1.929 . . . . 0.0 112.968 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -70.13 -59.74 4.02 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.402 1.001 . . . . 0.0 110.903 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.78 176.73 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 121.441 1.55 . . . . 0.0 111.457 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.6 t -74.8 8.39 2.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.24 110.3 11.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.834 1.652 . . . . 0.0 107.652 -161.251 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.87 132.13 6.42 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -171.798 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 62.97 146.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.742 2.417 . . . . 0.0 111.976 -169.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -143.51 -41.64 0.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.731 1.212 . . . . 0.0 110.382 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 79' ' ' ILE . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 6' ' ' THR . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 146' ' ' TYR . . . . . 0.447 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.0 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB2' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HB2' HD11 ' A' ' 37' ' ' LEU . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.478 HD13 ' H ' ' A' ' 73' ' ' ILE . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m -63.78 -99.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -163.13 68.4 0.21 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.27 -57.04 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 127.181 2.193 . . . . 0.0 108.371 171.564 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.49 -60.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.219 1.471 . . . . 0.0 112.227 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.7 27.21 0.15 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.191 1.397 . . . . 0.0 110.539 -159.524 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -1.1 111.21 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.096 2.958 . . . . 0.0 116.002 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm 61.02 45.34 9.39 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.585 1.154 . . . . 0.0 111.663 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.5 92.85 3.46 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.272 1.429 . . . . 0.0 107.484 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 60.35 102.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.148 2.179 . . . . 0.0 111.83 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 14.8 t30 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' H ' HG13 ' A' ' 135' ' ' VAL . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 16.5 t-20 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 73' ' ' ILE . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m -132.58 60.1 1.7 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.43 -60.64 0.08 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.0 138.63 83.51 Favored Pre-proline 0 C--O 1.239 0.519 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.53 149.67 88.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.876 2.384 . . . . 0.0 110.594 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m 48.41 68.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -165.632 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -37.25 162.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.14 2.576 . . . . 0.0 113.207 170.853 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.26 70.38 0.65 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -86.68 -56.56 3.35 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.119 -167.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -67.26 129.03 38.59 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.192 0.597 . . . . 0.0 110.756 -170.652 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 28.4 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 15' ' ' GLN . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.424 ' H ' HD23 ' A' ' 26' ' ' LEU . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 113' ' ' LEU . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t . . . . . 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 . . . . . 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' TYR . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' LYS . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 46' ' ' THR . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m . . . . . 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 . . . . . 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 145' ' ' GLY . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 144' ' ' VAL . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t . . . . . 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.467 0.378 0 N-CA-C 109.537 -0.542 . . . . 0.0 109.537 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.481 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.536 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m . . . . . 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 . . . . . 0 C--O 1.239 0.547 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . 0.464 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.561 HD21 ' HB2' ' A' ' 10' ' ' ALA . 47.2 m-80 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 80' ' ' TYR . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.506 HG23 ' HE3' ' A' ' 59' ' ' LYS . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HE3' HG23 ' A' ' 46' ' ' THR . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' HG21 ' A' ' 40' ' ' ILE . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 135' ' ' VAL . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p . . . . . 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 . . . . . 0 CA--C 1.532 0.26 0 CA-C-O 118.714 -0.66 . . . . 0.0 109.59 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 89' ' ' LYS . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 146' ' ' TYR . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 89' ' ' LYS . 0.3 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.449 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 . . . . . 0 N--CA 1.467 0.413 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . 0.49 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 135' ' ' VAL . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 132' ' ' ILE . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.518 ' H ' HG23 ' A' ' 5' ' ' VAL . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 135' ' ' VAL . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.506 ' CA ' ' HB3' ' A' ' 70' ' ' ALA . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.59 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 38' ' ' GLY . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t . . . . . 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 . . . . . 0 N--CA 1.45 -0.428 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 14' ' ' ALA . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.513 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' HD12 ' A' ' 65' ' ' ILE . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 64' ' ' GLY . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 77' ' ' ALA . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 73' ' ' ILE . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m . . . . . 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 . . . . . 0 C--O 1.231 0.131 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' H ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 72' ' ' ARG . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 6.2 t . . . . . 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 . . . . . 0 C--O 1.238 0.499 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 ' HA3' ' A' ' 145' ' ' GLY . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m . . . . . 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 . . . . . 0 C--O 1.226 -0.133 0 CA-C-O 122.083 0.944 . . . . 0.0 108.811 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 145' ' ' GLY . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.609 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.499 ' H ' HG11 ' A' ' 5' ' ' VAL . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 145' ' ' GLY . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 40' ' ' ILE . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 55' ' ' GLY . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 51' ' ' THR . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t . . . . . 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 . . . . . 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.401 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.671 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 113' ' ' LEU . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER . . . . . 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--O 1.234 0.258 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 80' ' ' TYR . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 1.9 pm0 -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 91' ' ' GLN . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 59' ' ' LYS . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 N--CA 1.47 0.537 0 N-CA-C 112.882 0.697 . . . . 0.0 112.882 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 6' ' ' THR . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.412 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.583 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.542 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m . . . . . 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t0 . . . . . 0 C--O 1.233 0.194 0 CA-C-O 122.508 1.147 . . . . 0.0 114.045 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.498 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 80' ' ' TYR . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.602 ' H ' HG11 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . 0.468 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 146' ' ' TYR . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.413 HG23 ' CG ' ' A' ' 124' ' ' ASP . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 141' ' ' ILE . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.612 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 79' ' ' ILE . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 73' ' ' ILE . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 145' ' ' GLY . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . 0.433 HG22 ' HA2' ' A' ' 7' ' ' GLY . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 121' ' ' VAL . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.449 ' H ' HG11 ' A' ' 5' ' ' VAL . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . 0.497 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m . . . . . 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 124' ' ' ASP . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 . . . . . 0 CA--C 1.535 0.372 0 CA-C-O 120.51 0.195 . . . . 0.0 111.007 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 6' ' ' THR . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 137' ' ' VAL . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 132' ' ' ILE . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG11 ' A' ' 82' ' ' VAL . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . 0.507 HD21 ' ND2' ' A' ' 60' ' ' ASN . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.507 ' ND2' HD21 ' A' ' 58' ' ' ASN . 1.2 m-20 -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HA ' HD13 ' A' ' 113' ' ' LEU . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 40' ' ' ILE . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 . . . . . 0 N--CA 1.463 0.207 0 CA-C-O 120.928 0.394 . . . . 0.0 110.382 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 79' ' ' ILE . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 6' ' ' THR . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . 0.447 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . 0.46 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 6.4 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB2' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . 0.407 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HB2' HD11 ' A' ' 37' ' ' LEU . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m . . . . . 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 . . . . . 0 N--CA 1.465 0.28 0 CA-C-O 121.458 0.647 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . 0.46 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.499 ' H ' HG13 ' A' ' 135' ' ' VAL . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 73' ' ' ILE . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m . . . . . 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 . . . . . 0 C--O 1.239 0.545 0 CA-C-O 120.415 0.15 . . . . 0.0 110.756 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 15' ' ' GLN . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.825 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 5.0 t -150.02 151.46 33.32 Favored 'General case' 0 C--O 1.235 0.333 0 O-C-N 121.611 -0.68 . . . . 0.0 110.529 162.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -130.79 106.49 8.49 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 126.589 1.956 . . . . 0.0 108.867 172.094 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 52.5 m -63.2 133.74 54.8 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 106.79 -1.559 . . . . 0.0 106.79 159.355 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.2 m -133.24 137.31 53.62 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 173.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 12.6 t -137.59 163.38 31.36 Favored 'General case' 0 C--O 1.237 0.446 0 O-C-N 121.603 -0.686 . . . . 0.0 109.463 -166.934 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.57 84.27 0.15 Allowed Glycine 0 C--N 1.334 0.431 0 N-CA-C 108.869 -1.692 . . . . 0.0 108.869 -170.69 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.04 165.57 26.91 Favored Glycine 0 N--CA 1.444 -0.783 0 C-N-CA 124.651 1.12 . . . . 0.0 112.894 -175.558 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -96.29 158.88 15.24 Favored 'General case' 0 C--O 1.239 0.504 0 C-N-CA 125.018 1.327 . . . . 0.0 110.508 -173.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -118.43 116.89 27.63 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 125.301 1.441 . . . . 0.0 108.676 173.599 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -110.15 139.71 45.01 Favored 'General case' 0 C--O 1.236 0.385 0 C-N-CA 124.764 1.226 . . . . 0.0 108.137 175.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.4 t -140.75 113.85 8.46 Favored 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 119.085 0.857 . . . . 0.0 110.069 155.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -123.13 150.2 43.55 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 108.128 -1.064 . . . . 0.0 108.128 178.459 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -144.11 150.63 38.42 Favored 'General case' 0 N--CA 1.445 -0.676 0 C-N-CA 123.857 0.863 . . . . 0.0 109.567 -165.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 18.5 mm-40 -66.15 68.92 0.05 Allowed 'General case' 0 CA--C 1.54 0.574 0 C-N-CA 126.763 2.025 . . . . 0.0 111.501 173.362 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.07 -11.5 1.05 Allowed Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 126.251 1.881 . . . . 0.0 111.881 176.076 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 2.8 mm-40 -151.11 96.34 2.3 Favored 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 124.629 1.172 . . . . 0.0 107.97 179.254 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 61.8 mtt -84.82 68.19 10.38 Favored 'General case' 0 C--O 1.239 0.544 0 C-N-CA 125.068 1.347 . . . . 0.0 107.876 173.572 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 77.2 m-20 -66.95 95.97 0.4 Allowed 'General case' 0 CA--C 1.52 -0.197 0 C-N-CA 126.783 2.033 . . . . 0.0 109.73 172.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 13.0 mttt -56.19 152.12 11.33 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 122.988 0.515 . . . . 0.0 110.003 -174.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -61.14 86.67 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 126.004 1.722 . . . . 0.0 109.94 171.973 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -115.07 43.55 1.67 Allowed Glycine 0 CA--C 1.519 0.319 0 N-CA-C 107.737 -2.145 . . . . 0.0 107.737 175.309 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -158.42 166.21 34.17 Favored Glycine 0 N--CA 1.443 -0.839 0 N-CA-C 110.0 -1.24 . . . . 0.0 110.0 -177.365 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -119.15 174.5 6.29 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 127.064 2.146 . . . . 0.0 108.61 -177.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 7.2 p30 -123.85 163.51 21.1 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 158.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.424 HD23 ' H ' ' A' ' 27' ' ' LYS . 0.4 OUTLIER -143.26 171.2 14.43 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 159.248 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.424 ' H ' HD23 ' A' ' 26' ' ' LEU . 86.2 mttt -143.78 162.84 35.0 Favored 'General case' 0 C--O 1.24 0.597 0 N-CA-C 107.258 -1.386 . . . . 0.0 107.258 171.712 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 34.8 t80 -138.04 139.98 39.85 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.383 1.073 . . . . 0.0 108.517 167.406 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -139.22 130.65 27.03 Favored 'General case' 0 C--O 1.228 -0.039 0 C-N-CA 125.236 1.415 . . . . 0.0 107.313 174.96 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.6 p90 -98.42 151.08 20.95 Favored 'General case' 0 C--O 1.238 0.468 0 N-CA-C 106.479 -1.675 . . . . 0.0 106.479 164.244 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 24.8 pt-20 -88.01 140.39 29.54 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 106.391 -1.707 . . . . 0.0 106.391 153.685 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -76.03 132.84 40.38 Favored 'General case' 0 N--CA 1.453 -0.313 0 N-CA-C 107.062 -1.459 . . . . 0.0 107.062 172.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 5.5 t0 -74.57 0.59 14.44 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.391 -0.818 . . . . 0.0 112.108 -174.342 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -126.95 2.49 6.59 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 125.84 1.656 . . . . 0.0 112.173 179.209 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.7 m -157.75 155.14 26.34 Favored Pre-proline 0 N--CA 1.465 0.317 0 CA-C-N 120.65 1.568 . . . . 0.0 110.619 174.825 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 89.6 Cg_endo -74.21 29.6 0.33 Allowed 'Trans proline' 0 CA--C 1.544 1.021 0 C-N-CA 123.71 2.94 . . . . 0.0 112.967 176.637 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 57.3 tp -70.61 155.24 40.99 Favored 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 125.416 1.486 . . . . 0.0 110.296 178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -143.19 -178.54 19.11 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.299 -1.52 . . . . 0.0 109.299 153.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.5 m -131.83 162.44 39.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 N-CA-C 106.281 -1.748 . . . . 0.0 106.281 164.615 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.5 pp -135.49 155.67 37.18 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 156.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -158.62 109.12 0.39 Allowed Glycine 0 N--CA 1.441 -0.999 0 N-CA-C 104.48 -3.448 . . . . 0.0 104.48 171.489 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.7 p -80.22 153.91 28.26 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 108.151 -1.055 . . . . 0.0 108.151 167.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 82.9 m-85 -126.21 141.05 52.08 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 106.113 -1.81 . . . . 0.0 106.113 159.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 42.0 p -127.43 145.6 50.77 Favored 'General case' 0 C--N 1.325 -0.474 0 C-N-CA 125.088 1.355 . . . . 0.0 107.904 174.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 54.0 t80 -143.24 107.03 4.64 Favored 'General case' 0 C--O 1.232 0.139 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 169.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.2 t -103.76 141.45 36.06 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 108.811 -0.811 . . . . 0.0 108.811 174.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 18.0 tt0 -143.07 145.96 33.36 Favored 'General case' 0 N--CA 1.45 -0.441 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 170.297 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 9.3 tmtt? -145.09 114.2 6.98 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 105.456 -2.053 . . . . 0.0 105.456 163.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -66.05 139.42 58.19 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 118.074 -0.965 . . . . 0.0 109.393 -176.666 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.02 109.72 9.17 Favored 'General case' 0 C--N 1.347 0.499 0 CA-C-N 120.178 1.354 . . . . 0.0 110.836 -171.27 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 10.2 t -126.03 -160.45 0.98 Allowed 'General case' 0 C--O 1.24 0.595 0 C-N-CA 126.488 1.915 . . . . 0.0 107.103 153.299 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 127.86 -6.94 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 130.235 3.414 . . . . 0.0 113.623 158.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 9.8 m -84.41 -86.4 0.12 Allowed 'General case' 0 CA--C 1.538 0.508 0 CA-C-N 120.513 1.506 . . . . 0.0 107.016 165.095 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 8.2 t -131.16 -5.72 3.87 Favored 'General case' 0 CA--C 1.539 0.556 0 CA-C-N 119.914 1.234 . . . . 0.0 113.726 178.335 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 120.41 73.0 0.34 Allowed Glycine 0 C--N 1.337 0.632 0 N-CA-C 109.55 -1.42 . . . . 0.0 109.55 -172.797 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.7 t0 -122.34 100.31 6.88 Favored 'General case' 0 N--CA 1.464 0.262 0 C-N-CA 125.244 1.418 . . . . 0.0 108.251 175.357 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . 0.448 ' H ' ' CG ' ' A' ' 94' ' ' GLU . 10.9 m-30 -62.8 124.47 21.12 Favored 'General case' 0 N--CA 1.468 0.462 0 CA-C-N 121.197 1.817 . . . . 0.0 107.142 -177.379 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.2 m-80 -120.35 60.41 0.88 Allowed 'General case' 0 C--O 1.235 0.302 0 N-CA-C 105.381 -2.081 . . . . 0.0 105.381 170.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 41.8 mttm -75.5 139.87 42.47 Favored 'General case' 0 C--N 1.343 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 -179.625 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.9 p30 -154.04 176.41 12.25 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 107.136 -1.431 . . . . 0.0 107.136 159.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 21.5 mt-30 -142.04 153.56 44.31 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.555 -2.387 . . . . 0.0 104.555 173.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.9 m-85 -127.4 129.28 47.26 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 105.815 -1.92 . . . . 0.0 105.815 161.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 17.8 p90 -141.75 146.62 36.21 Favored 'General case' 0 N--CA 1.447 -0.616 0 C-N-CA 126.007 1.723 . . . . 0.0 106.627 177.292 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -130.71 89.16 0.29 Allowed Glycine 0 C--N 1.334 0.464 0 C-N-CA 123.989 0.804 . . . . 0.0 111.522 -171.089 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 44.0 mm -71.4 109.04 3.34 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.246 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 -178.834 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 61.6 m -110.9 133.56 53.27 Favored 'General case' 0 N--CA 1.447 -0.604 0 C-N-CA 124.8 1.24 . . . . 0.0 107.887 -174.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.34 145.67 24.76 Favored 'General case' 0 C--O 1.236 0.379 0 CA-C-N 119.065 0.848 . . . . 0.0 112.715 179.085 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.49 167.93 22.65 Favored Glycine 0 CA--C 1.537 1.418 0 C-N-CA 127.783 2.611 . . . . 0.0 110.216 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo -71.32 -169.56 0.42 Allowed 'Trans proline' 0 CA--C 1.541 0.868 0 C-N-CA 123.495 2.797 . . . . 0.0 111.669 174.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.25 133.76 50.16 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 126.441 1.896 . . . . 0.0 106.533 170.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 32.2 t80 -100.29 149.68 23.35 Favored 'General case' 0 C--O 1.238 0.472 0 CA-C-O 121.262 0.553 . . . . 0.0 110.443 -179.531 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.5 tpt180 -98.43 102.61 14.41 Favored 'General case' 0 N--CA 1.454 -0.247 0 N-CA-C 106.845 -1.539 . . . . 0.0 106.845 177.837 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 19.8 mt -69.33 -71.88 0.15 Allowed 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 C-N-CA 124.829 1.252 . . . . 0.0 109.066 -173.705 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 11.2 t30 -156.56 -74.15 0.1 Allowed 'General case' 0 N--CA 1.463 0.212 0 C-N-CA 123.794 0.837 . . . . 0.0 108.898 -168.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.0 p-10 -126.9 -155.61 0.7 Allowed 'General case' 0 N--CA 1.467 0.398 0 C-N-CA 127.227 2.211 . . . . 0.0 107.414 173.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.9 m0 -63.18 77.28 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 126.605 1.962 . . . . 0.0 114.644 -158.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -161.08 152.41 19.0 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 127.097 2.159 . . . . 0.0 107.137 179.751 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 68.7 m -149.49 129.24 13.26 Favored 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 162.61 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.537 HG22 ' CD1' ' A' ' 113' ' ' LEU . 2.5 pp -126.18 146.93 31.16 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 N-CA-C 105.435 -2.061 . . . . 0.0 105.435 174.497 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.73 124.31 9.05 Favored 'General case' 0 N--CA 1.449 -0.505 0 N-CA-C 107.806 -1.183 . . . . 0.0 107.806 159.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -68.12 139.27 33.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 107.589 -2.204 . . . . 0.0 107.589 164.709 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 9.7 m -133.3 174.55 13.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 C-N-CA 125.319 1.448 . . . . 0.0 108.564 -174.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.8 m -95.21 160.62 2.73 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.377 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 169.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -144.8 169.13 26.7 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 107.023 -2.431 . . . . 0.0 107.023 165.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 16.1 m -142.65 121.15 8.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 N-CA-C 105.649 -1.982 . . . . 0.0 105.649 170.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.71 110.26 1.04 Allowed Glycine 0 C--N 1.323 -0.143 0 N-CA-C 108.509 -1.836 . . . . 0.0 108.509 -173.33 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.2 t80 -145.44 167.24 23.42 Favored 'General case' 0 C--O 1.235 0.314 0 CA-C-N 118.028 0.914 . . . . 0.0 110.795 174.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -74.7 176.66 48.31 Favored Glycine 0 CA--C 1.527 0.799 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 172.433 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 24.5 tttm -149.4 -175.6 5.06 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.664 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 56.52 -161.74 0.19 Allowed 'General case' 0 C--O 1.238 0.454 0 C-N-CA 124.092 0.957 . . . . 0.0 110.538 -178.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 16.5 pt20 -156.66 -178.51 7.41 Favored 'General case' 0 C--O 1.236 0.356 0 O-C-N 121.165 -0.959 . . . . 0.0 110.65 -173.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 49.4 m -127.91 117.37 21.65 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.911 -1.885 . . . . 0.0 105.911 176.063 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 14.9 t -156.5 -62.87 0.1 Allowed 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 174.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.448 ' CG ' ' H ' ' A' ' 57' ' ' TYR . 1.3 mm-40 59.99 -60.09 0.06 Allowed 'General case' 0 N--CA 1.467 0.38 0 C-N-CA 129.997 3.319 . . . . 0.0 113.076 -172.512 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 6.4 m-85 -60.61 151.32 71.56 Favored Pre-proline 0 CA--C 1.537 0.463 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 174.674 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 60.1 Cg_endo -68.72 85.52 0.48 Allowed 'Trans proline' 0 N--CA 1.455 -0.761 0 C-N-CA 123.389 2.726 . . . . 0.0 109.675 -179.034 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 35.4 m -149.61 -46.16 0.13 Allowed 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.511 1.124 . . . . 0.0 109.402 -174.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.1 m-85 63.63 156.64 0.07 Allowed 'General case' 0 CA--C 1.537 0.442 0 C-N-CA 125.41 1.484 . . . . 0.0 111.829 -169.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 2.8 tttp -147.81 -53.07 0.2 Allowed 'General case' 0 CA--C 1.52 -0.211 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.956 -172.343 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 16.5 m120 44.92 76.13 0.09 Allowed 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.987 0.915 . . . . 0.0 113.07 158.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 25.6 t0 -124.51 -68.89 0.83 Allowed 'General case' 0 N--CA 1.466 0.366 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 174.612 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.9 m -82.36 94.11 7.32 Favored 'General case' 0 CA--C 1.538 0.497 0 N-CA-C 109.775 -0.454 . . . . 0.0 109.775 -174.417 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 25.9 t -169.5 76.06 0.09 Allowed 'General case' 0 N--CA 1.465 0.296 0 N-CA-C 107.151 -1.425 . . . . 0.0 107.151 171.987 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 22.5 t0 -166.38 128.8 1.89 Allowed 'General case' 0 N--CA 1.47 0.539 0 CA-C-N 119.469 1.031 . . . . 0.0 109.474 176.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 2.8 p90 -47.72 140.48 6.31 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 124.495 1.118 . . . . 0.0 113.97 -163.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -95.91 -152.11 28.79 Favored Glycine 0 C--N 1.335 0.521 0 N-CA-C 108.951 -1.66 . . . . 0.0 108.951 175.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -130.96 141.04 50.23 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 170.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 47.8 t -142.68 163.52 32.6 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 125.196 1.399 . . . . 0.0 108.444 175.367 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -146.38 153.21 40.24 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 166.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -138.47 -171.88 12.35 Favored Glycine 0 N--CA 1.45 -0.432 0 N-CA-C 109.392 -1.483 . . . . 0.0 109.392 -177.443 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -137.04 146.65 45.48 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.174 -0.676 . . . . 0.0 109.174 166.665 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -91.81 110.8 3.92 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.097 -2.401 . . . . 0.0 107.097 167.965 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.537 ' CD1' HG22 ' A' ' 79' ' ' ILE . 2.5 mm? -115.51 138.87 50.59 Favored 'General case' 0 C--O 1.234 0.246 0 N-CA-C 104.752 -2.314 . . . . 0.0 104.752 164.617 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -147.21 112.66 5.6 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.518 -0.919 . . . . 0.0 108.518 -170.548 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -127.87 146.04 50.75 Favored 'General case' 0 C--O 1.236 0.358 0 C-N-CA 123.532 0.733 . . . . 0.0 111.068 -170.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 28.5 m120 -133.95 101.02 12.86 Favored Pre-proline 0 C--O 1.233 0.195 0 C-N-CA 124.408 1.083 . . . . 0.0 108.637 -174.543 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -79.79 -22.7 7.45 Favored 'Trans proline' 0 N--CA 1.455 -0.75 0 C-N-CA 121.382 1.388 . . . . 0.0 111.66 172.066 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 6.0 tpp -154.46 -176.09 5.72 Favored 'General case' 0 C--N 1.343 0.324 0 CA-C-N 119.479 1.036 . . . . 0.0 109.734 -160.856 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -112.48 5.92 18.28 Favored 'General case' 0 CA--C 1.537 0.476 0 C-N-CA 128.187 2.595 . . . . 0.0 109.5 -165.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -147.42 20.24 1.2 Allowed 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 126.067 1.747 . . . . 0.0 109.709 165.478 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 6.8 t -139.25 127.56 27.53 Favored 'Isoleucine or valine' 0 C--O 1.234 0.254 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 176.622 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -142.8 142.91 31.97 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 105.999 -1.852 . . . . 0.0 105.999 168.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.5 pt? -142.46 146.89 35.25 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 108.208 -1.034 . . . . 0.0 108.208 178.566 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 4.2 p-10 -149.31 154.86 39.63 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 106.419 -1.697 . . . . 0.0 106.419 -172.026 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -148.82 124.76 10.63 Favored 'General case' 0 N--CA 1.446 -0.646 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -164.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.5 m -130.91 157.37 43.11 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.014 0.925 . . . . 0.0 109.046 167.436 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -137.32 136.74 38.25 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 127.186 2.194 . . . . 0.0 105.762 178.936 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -136.83 145.12 44.08 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 126.008 1.723 . . . . 0.0 108.962 176.159 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -131.98 141.93 49.44 Favored 'General case' 0 C--O 1.235 0.294 0 C-N-CA 124.007 0.923 . . . . 0.0 109.311 173.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 39.6 m -133.7 160.23 38.16 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.825 1.65 . . . . 0.0 109.175 177.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 80.9 mtt180 -129.11 96.74 4.41 Favored 'General case' 0 N--CA 1.462 0.163 0 N-CA-C 107.973 -1.121 . . . . 0.0 107.973 -179.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.0 mp -99.25 101.56 12.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 106.472 -1.677 . . . . 0.0 106.472 -178.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 64.6 mtp180 48.88 50.89 16.92 Favored 'General case' 0 N--CA 1.471 0.616 0 C-N-CA 123.681 0.792 . . . . 0.0 111.799 177.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.7 m 60.36 16.13 6.01 Favored 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 125.185 1.394 . . . . 0.0 113.308 178.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.9 t -81.05 118.05 28.16 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.635 0 N-CA-C 103.907 -2.627 . . . . 0.0 103.907 166.204 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 33.2 t70 -67.96 131.01 44.7 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 118.254 -0.879 . . . . 0.0 108.701 169.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 16.8 t -129.52 147.11 33.32 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 C-N-CA 124.826 1.251 . . . . 0.0 107.741 -179.651 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.96 139.89 12.72 Favored Glycine 0 C--N 1.334 0.457 0 N-CA-C 109.31 -1.516 . . . . 0.0 109.31 170.266 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 56.0 m -140.72 128.06 21.15 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 124.785 1.234 . . . . 0.0 107.723 170.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -142.43 157.67 44.52 Favored 'General case' 0 C--O 1.239 0.55 0 N-CA-C 107.297 -1.372 . . . . 0.0 107.297 166.772 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.7 pt -124.04 131.41 72.95 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.497 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 171.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -145.34 160.27 41.79 Favored 'General case' 0 C--O 1.24 0.556 0 C-N-CA 124.272 1.029 . . . . 0.0 108.364 171.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 173.07 -169.23 42.37 Favored Glycine 0 N--CA 1.451 -0.352 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 -178.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.42 138.7 19.67 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.481 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 177.35 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -135.65 -122.0 2.16 Favored Glycine 0 C--N 1.33 0.223 0 N-CA-C 109.324 -1.511 . . . . 0.0 109.324 175.198 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 66.9 m-85 -146.05 176.52 9.65 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 125.666 1.587 . . . . 0.0 109.336 -168.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -143.92 107.66 4.66 Favored 'General case' 0 N--CA 1.466 0.36 0 O-C-N 120.523 -1.361 . . . . 0.0 112.303 -172.048 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 42.9 m-85 . . . . . 0 C--O 1.252 1.187 0 C-N-CA 124.992 1.317 . . . . 0.0 109.556 176.315 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.526 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.4 p -141.16 145.75 36.1 Favored 'General case' 0 C--O 1.237 0.409 0 N-CA-C 109.124 -0.695 . . . . 0.0 109.124 172.843 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 17.7 m -113.37 123.32 49.83 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.437 1.113 . . . . 0.0 109.532 162.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.3 m -141.28 94.47 2.7 Favored 'General case' 0 N--CA 1.444 -0.759 0 N-CA-C 102.818 -3.03 . . . . 0.0 102.818 -172.753 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.405 HG12 ' O ' ' A' ' 146' ' ' TYR . 5.5 p -91.3 139.45 17.7 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 -166.723 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 1.5 p -143.01 120.65 11.8 Favored 'General case' 0 N--CA 1.45 -0.456 0 C-N-CA 125.279 1.432 . . . . 0.0 107.691 -159.372 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 163.81 175.69 34.96 Favored Glycine 0 CA--C 1.521 0.427 0 CA-C-O 121.998 0.777 . . . . 0.0 112.565 176.547 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 154.67 -162.06 30.56 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 108.711 -1.756 . . . . 0.0 108.711 -170.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -93.17 155.21 17.61 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 122.896 0.479 . . . . 0.0 111.37 -169.518 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.01 142.37 51.23 Favored 'General case' 0 N--CA 1.446 -0.626 0 CA-C-N 114.368 -1.287 . . . . 0.0 108.454 153.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 5.2 pt20 -101.14 158.65 15.87 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 106.675 -1.602 . . . . 0.0 106.675 160.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 18.8 m -111.7 151.49 28.84 Favored 'General case' 0 N--CA 1.449 -0.497 0 N-CA-C 109.932 -0.396 . . . . 0.0 109.932 178.47 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -133.91 144.84 49.1 Favored 'General case' 0 C--O 1.236 0.352 0 C-N-CA 125.047 1.339 . . . . 0.0 107.694 -173.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.98 162.88 39.49 Favored 'General case' 0 C--O 1.235 0.29 0 CA-C-N 120.231 1.378 . . . . 0.0 111.257 171.25 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -62.32 44.59 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 130.924 3.69 . . . . 0.0 115.586 175.639 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 163.58 -18.17 0.13 Allowed Glycine 0 CA--C 1.527 0.795 0 O-C-N 120.975 -1.078 . . . . 0.0 111.468 177.521 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 48.3 mt-30 -141.18 96.01 2.93 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.653 -0.869 . . . . 0.0 108.653 161.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -68.25 1.07 3.14 Favored 'General case' 0 N--CA 1.467 0.379 0 C-N-CA 124.859 1.264 . . . . 0.0 113.129 166.203 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -107.44 94.7 5.23 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.486 1.514 . . . . 0.0 109.161 166.618 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.7 mtpt -127.1 145.07 50.87 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 105.183 -2.154 . . . . 0.0 105.183 163.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 6.0 tmm? -91.87 156.06 17.76 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 178.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -129.48 -96.57 0.8 Allowed Glycine 0 N--CA 1.443 -0.856 0 N-CA-C 105.744 -2.942 . . . . 0.0 105.744 -166.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 147.31 -145.71 14.71 Favored Glycine 0 N--CA 1.446 -0.643 0 N-CA-C 108.817 -1.713 . . . . 0.0 108.817 177.8 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 52.1 t80 -109.49 147.89 32.13 Favored 'General case' 0 C--O 1.237 0.436 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -171.682 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 30.4 m120 -113.03 111.23 21.8 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 125.4 1.48 . . . . 0.0 107.067 -178.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -84.98 142.88 29.31 Favored 'General case' 0 CA--C 1.535 0.367 0 N-CA-C 106.777 -1.564 . . . . 0.0 106.777 169.156 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HE3' ' OD1' ' A' ' 124' ' ' ASP . 66.4 mttm -140.41 156.94 46.21 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 107.262 -1.384 . . . . 0.0 107.262 166.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -142.68 136.93 29.52 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 123.934 0.894 . . . . 0.0 109.392 -176.894 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 5.4 tpt180 -123.14 135.32 54.3 Favored 'General case' 0 N--CA 1.466 0.359 0 C-N-CA 123.785 0.834 . . . . 0.0 110.081 -175.951 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 9.2 m-85 -114.1 157.4 22.62 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 124.95 1.3 . . . . 0.0 109.541 173.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 3.1 tt0 -129.08 115.21 17.39 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.786 1.235 . . . . 0.0 108.274 170.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -81.3 166.92 20.07 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-O 121.581 0.705 . . . . 0.0 109.391 164.015 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 23.0 m-20 -109.72 -3.94 16.44 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 125.244 1.418 . . . . 0.0 110.311 174.5 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 20.3 p30 -155.53 13.0 0.35 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.059 1.744 . . . . 0.0 111.716 -151.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 9.2 t -144.87 108.32 4.67 Favored Pre-proline 0 C--O 1.235 0.335 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 174.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 78.5 Cg_endo -78.12 60.77 7.51 Favored 'Trans proline' 0 CA--C 1.539 0.757 0 C-N-CA 124.338 3.358 . . . . 0.0 110.916 -170.763 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 15.2 tp -150.21 155.92 40.63 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.724 2.01 . . . . 0.0 106.946 -162.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -130.93 178.66 17.56 Favored Glycine 0 N--CA 1.454 -0.151 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 163.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 71.4 t -136.61 158.05 37.11 Favored 'Isoleucine or valine' 0 C--O 1.237 0.399 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 -176.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 10.5 tp -135.41 149.1 28.35 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.49 0 N-CA-C 106.188 -1.782 . . . . 0.0 106.188 164.329 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -140.41 117.04 1.23 Allowed Glycine 0 N--CA 1.446 -0.65 0 N-CA-C 104.431 -3.468 . . . . 0.0 104.431 165.795 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 25.5 t -124.8 154.42 40.99 Favored 'General case' 0 C--O 1.238 0.473 0 C-N-CA 123.885 0.874 . . . . 0.0 109.9 -176.629 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 53.1 m-85 -140.48 141.08 35.43 Favored 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 126.987 2.115 . . . . 0.0 107.064 -174.919 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 84.8 m -128.32 132.96 48.63 Favored 'General case' 0 C--O 1.232 0.177 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 169.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.46 157.22 16.68 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 123.226 0.61 . . . . 0.0 110.392 173.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.406 HG22 ' H ' ' A' ' 48' ' ' LYS . 4.3 m -116.35 147.45 41.58 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 150.643 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.4 tt0 -144.41 50.75 1.29 Allowed 'General case' 0 CA--C 1.531 0.241 0 CA-C-N 119.401 1.0 . . . . 0.0 110.067 154.757 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.406 ' H ' HG22 ' A' ' 46' ' ' THR . 9.2 tmtm? -67.74 112.96 5.12 Favored 'General case' 0 CA--C 1.516 -0.365 0 O-C-N 120.843 -1.161 . . . . 0.0 108.31 -172.46 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 3.0 p -71.88 126.35 29.52 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -177.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.6 tpt180 -135.0 123.27 23.05 Favored 'General case' 0 N--CA 1.45 -0.432 0 N-CA-C 107.494 -1.298 . . . . 0.0 107.494 160.021 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -150.49 93.69 2.01 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 105.515 -2.031 . . . . 0.0 105.515 178.095 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -80.99 -103.74 0.03 OUTLIER 'General case' 0 CA--C 1.535 0.4 0 C-N-CA 123.722 0.809 . . . . 0.0 109.052 170.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 48.5 m -144.72 91.03 2.12 Favored 'General case' 0 N--CA 1.452 -0.357 0 C-N-CA 124.578 1.151 . . . . 0.0 108.329 175.729 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 5.4 p 62.07 22.51 13.16 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.588 1.955 . . . . 0.0 113.503 171.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -136.05 -71.27 0.06 OUTLIER Glycine 0 C--N 1.333 0.41 0 N-CA-C 109.63 -1.388 . . . . 0.0 109.63 -179.725 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.9 m-20 -83.05 91.52 7.21 Favored 'General case' 0 N--CA 1.467 0.406 0 N-CA-C 105.051 -2.203 . . . . 0.0 105.051 -178.618 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -131.05 111.3 11.89 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.465 1.506 . . . . 0.0 108.439 -171.1 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 33.5 t-20 -67.98 130.46 43.02 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 123.501 0.72 . . . . 0.0 109.224 172.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 12.0 tptp -142.37 172.77 12.23 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 128.045 2.538 . . . . 0.0 106.675 164.975 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 69.74 -175.85 0.2 Allowed 'General case' 0 C--O 1.237 0.436 0 C-N-CA 124.681 1.192 . . . . 0.0 109.728 -174.753 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 pt20 -149.77 173.86 13.25 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 109.874 -179.122 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 15.1 t80 -81.44 159.84 24.17 Favored 'General case' 0 C--O 1.235 0.327 0 O-C-N 121.902 -0.499 . . . . 0.0 110.698 178.81 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -137.47 117.94 13.81 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 166.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.12 121.69 1.67 Allowed Glycine 0 CA--C 1.521 0.41 0 N-CA-C 108.122 -1.991 . . . . 0.0 108.122 -179.56 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 pt -137.48 109.67 6.86 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.194 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 177.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -104.92 128.02 52.99 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 126.907 2.083 . . . . 0.0 107.211 177.52 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -138.51 153.83 48.77 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.855 1.262 . . . . 0.0 110.085 -176.211 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 178.52 171.51 41.88 Favored Glycine 0 CA--C 1.528 0.854 0 N-CA-C 111.373 -0.691 . . . . 0.0 111.373 176.907 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_endo -76.17 174.81 12.21 Favored 'Trans proline' 0 N--CA 1.451 -1.001 0 C-N-CA 122.563 2.175 . . . . 0.0 109.743 165.449 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -107.14 128.22 54.2 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 106.249 -1.759 . . . . 0.0 106.249 160.097 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -79.93 155.68 27.6 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 166.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 22.5 ttm180 -132.84 114.82 14.53 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 176.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 5.4 mp -82.27 -94.8 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 51.4 t30 -163.99 53.76 0.15 Allowed 'General case' 0 CA--C 1.529 0.16 0 N-CA-C 106.92 -1.511 . . . . 0.0 106.92 -172.325 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 7.7 t70 -174.9 172.41 2.91 Favored 'General case' 0 C--O 1.239 0.506 0 C-N-CA 127.813 2.445 . . . . 0.0 105.614 -174.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.4 OUTLIER -72.6 7.56 1.83 Allowed 'General case' 0 C--N 1.324 -0.538 0 C-N-CA 127.424 2.29 . . . . 0.0 114.297 173.024 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -74.27 155.66 38.02 Favored 'General case' 0 C--O 1.238 0.484 0 O-C-N 121.733 -0.605 . . . . 0.0 109.574 -173.177 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 67.0 m -118.92 166.62 12.61 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 126.23 1.812 . . . . 0.0 108.406 173.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 7.1 tp -144.89 164.83 12.7 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 CA-C-O 122.113 0.959 . . . . 0.0 112.055 -174.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.498 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 36.6 p90 -105.68 169.12 8.66 Favored 'General case' 0 N--CA 1.446 -0.657 0 C-N-CA 127.684 2.394 . . . . 0.0 109.865 178.927 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 129.61 31.17 0.62 Allowed Glycine 0 CA--C 1.534 1.221 0 C-N-CA 125.044 1.307 . . . . 0.0 109.868 -157.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 16.4 t -105.19 143.65 16.12 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.533 0 N-CA-C 105.043 -2.206 . . . . 0.0 105.043 -179.326 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 3.4 m -139.88 156.81 25.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.501 0 N-CA-C 108.237 -1.023 . . . . 0.0 108.237 -176.168 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -165.12 169.02 39.53 Favored Glycine 0 N--CA 1.442 -0.927 0 N-CA-C 110.694 -0.962 . . . . 0.0 110.694 -177.562 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.8 p -74.09 151.48 7.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.505 0 C-N-CA 125.324 1.45 . . . . 0.0 109.311 169.445 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.8 127.08 7.52 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 106.358 -2.697 . . . . 0.0 106.358 153.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 54.4 t80 -149.83 153.79 37.35 Favored 'General case' 0 C--N 1.332 -0.184 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 173.468 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.23 165.3 13.05 Favored Glycine 0 C--N 1.331 0.303 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 167.059 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 41.2 mtpt -136.57 139.28 42.05 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 107.028 -1.471 . . . . 0.0 107.028 -173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 36.2 p90 -164.76 166.85 19.52 Favored 'General case' 0 N--CA 1.466 0.328 0 C-N-CA 123.608 0.763 . . . . 0.0 110.254 -175.491 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 48.0 tt0 68.3 -60.49 0.42 Allowed 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 128.346 2.658 . . . . 0.0 112.813 175.316 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.463 HG23 ' HG2' ' A' ' 96' ' ' PRO . 99.1 m -85.16 135.08 34.12 Favored 'General case' 0 N--CA 1.445 -0.686 0 N-CA-C 106.458 -1.682 . . . . 0.0 106.458 162.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 56.4 m -107.83 -67.55 0.96 Allowed 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.084 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.8 tt0 -176.54 -17.62 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.372 0 O-C-N 121.209 -0.932 . . . . 0.0 113.147 -173.011 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 31.5 m-85 -64.0 -42.84 72.36 Favored Pre-proline 0 CA--C 1.543 0.681 0 CA-C-O 117.7 -1.143 . . . . 0.0 112.738 163.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.463 ' HG2' HG23 ' A' ' 92' ' ' THR . 61.0 Cg_endo -77.29 173.52 14.2 Favored 'Trans proline' 0 C--N 1.352 0.739 0 CA-C-N 122.393 1.89 . . . . 0.0 108.698 167.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 t -79.56 55.64 2.02 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 126.175 1.79 . . . . 0.0 109.587 -173.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 8.7 p90 55.49 18.29 2.61 Favored 'General case' 0 CA--C 1.546 0.8 0 C-N-CA 125.997 1.719 . . . . 0.0 114.316 162.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.7 mttt -50.71 -53.81 28.32 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 126.835 2.054 . . . . 0.0 112.762 -173.026 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -128.21 45.86 2.68 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 -176.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 23.5 t70 -126.01 81.98 2.03 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 106.327 -1.731 . . . . 0.0 106.327 171.366 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 8.7 t -139.37 144.0 37.99 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 125.077 1.351 . . . . 0.0 107.863 -177.103 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -128.0 102.06 6.58 Favored 'General case' 0 C--N 1.329 -0.289 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 -157.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -167.42 165.12 15.05 Favored 'General case' 0 N--CA 1.469 0.496 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 171.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 54.4 p90 -75.78 167.1 22.52 Favored 'General case' 0 C--O 1.238 0.489 0 CA-C-O 122.404 1.097 . . . . 0.0 110.726 177.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -134.15 178.33 18.46 Favored Glycine 0 CA--C 1.529 0.957 0 N-CA-C 107.34 -2.304 . . . . 0.0 107.34 147.115 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -87.07 151.47 23.21 Favored 'General case' 0 C--O 1.238 0.45 0 C-N-CA 124.203 1.001 . . . . 0.0 108.87 176.156 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.7 m -130.96 171.01 13.69 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 125.21 1.404 . . . . 0.0 110.22 172.293 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 10.6 t80 -147.63 152.41 37.83 Favored 'General case' 0 C--O 1.235 0.315 0 C-N-CA 127.712 2.405 . . . . 0.0 105.595 173.146 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -139.11 109.29 0.64 Allowed Glycine 0 C--N 1.337 0.593 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 176.42 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -53.17 143.42 18.09 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 118.56 1.18 . . . . 0.0 110.934 -177.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -126.94 74.69 0.42 Allowed Glycine 0 C--N 1.339 0.732 0 N-CA-C 109.849 -1.3 . . . . 0.0 109.849 -174.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -126.34 140.66 52.33 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 107.132 -1.432 . . . . 0.0 107.132 -178.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 37.2 tt0 -145.94 134.98 22.67 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 108.172 -1.047 . . . . 0.0 108.172 -171.121 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -93.12 171.71 8.77 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 124.589 1.156 . . . . 0.0 107.943 173.368 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 27.6 m-80 -62.46 119.04 46.56 Favored Pre-proline 0 C--O 1.235 0.319 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 174.041 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 72.3 Cg_endo -69.15 167.63 23.08 Favored 'Trans proline' 0 N--CA 1.457 -0.63 0 C-N-CA 122.621 2.214 . . . . 0.0 110.474 176.111 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 14.3 tmm? -142.44 167.91 20.97 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.093 0.957 . . . . 0.0 108.707 171.752 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -85.25 44.04 1.06 Allowed 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 128.349 2.66 . . . . 0.0 108.152 -167.053 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -165.58 -49.06 0.03 OUTLIER 'General case' 0 CA--C 1.505 -0.769 0 O-C-N 120.955 -1.091 . . . . 0.0 109.481 171.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.8 m -138.19 153.19 26.5 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.954 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 178.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -144.49 172.22 13.26 Favored 'General case' 0 N--CA 1.438 -1.036 0 C-N-CA 126.418 1.887 . . . . 0.0 107.623 176.197 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -130.56 115.34 16.64 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 179.994 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' OD1' ' HE3' ' A' ' 27' ' ' LYS . 0.9 OUTLIER -105.65 151.31 24.55 Favored 'General case' 0 C--N 1.324 -0.515 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 153.716 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 71.9 t80 -133.12 114.58 14.05 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 174.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 t -129.2 149.85 50.83 Favored 'General case' 0 N--CA 1.443 -0.822 0 N-CA-C 106.804 -1.554 . . . . 0.0 106.804 -176.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 32.7 t80 -140.72 104.66 4.76 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 103.587 -2.746 . . . . 0.0 103.587 176.386 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -99.09 116.0 30.31 Favored 'General case' 0 N--CA 1.444 -0.751 0 N-CA-C 104.409 -2.441 . . . . 0.0 104.409 -176.906 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -131.32 120.13 22.72 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -170.691 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 67.2 m -114.37 148.18 38.04 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 125.838 1.655 . . . . 0.0 107.42 177.087 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 66.6 mtp85 -128.46 117.51 21.46 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 105.157 -2.164 . . . . 0.0 105.157 -178.82 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.2 mp -117.26 91.15 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.462 0.14 0 N-CA-C 106.643 -1.614 . . . . 0.0 106.643 -175.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.5 tmt_? 65.32 -64.16 0.18 Allowed 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 130.195 3.398 . . . . 0.0 112.78 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -140.83 -0.24 1.53 Allowed 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 125.185 1.394 . . . . 0.0 111.185 168.903 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.5 t -81.99 142.07 14.2 Favored 'Isoleucine or valine' 0 C--O 1.241 0.611 0 N-CA-C 106.73 -1.581 . . . . 0.0 106.73 -177.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 37.8 p-10 -102.26 131.07 49.05 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 125.714 1.606 . . . . 0.0 109.137 175.542 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 20.7 t -143.13 64.37 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.406 0 N-CA-C 105.993 -1.854 . . . . 0.0 105.993 -173.282 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -80.9 145.52 25.98 Favored Glycine 0 CA--C 1.523 0.554 0 N-CA-C 108.028 -2.029 . . . . 0.0 108.028 167.71 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -140.62 120.2 13.27 Favored 'General case' 0 C--O 1.24 0.555 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 171.325 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.9 OUTLIER -84.03 140.08 32.09 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 107.078 -1.453 . . . . 0.0 107.078 169.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 66.0 mt -111.7 132.84 59.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 107.201 -1.407 . . . . 0.0 107.201 -176.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.22 106.61 18.31 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 104.712 -2.329 . . . . 0.0 104.712 168.114 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -96.07 93.03 1.48 Allowed Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 106.488 -2.645 . . . . 0.0 106.488 177.471 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 145' ' ' GLY . 3.4 t -131.04 172.72 15.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 107.408 -1.33 . . . . 0.0 107.408 -179.194 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.43 ' H ' HG12 ' A' ' 144' ' ' VAL . . . 139.95 173.9 13.49 Favored Glycine 0 CA--C 1.519 0.325 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 -175.669 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.405 ' O ' HG12 ' A' ' 5' ' ' VAL . 7.7 p90 -97.73 161.7 13.63 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 122.546 1.165 . . . . 0.0 109.771 -174.817 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 74.7 ttt180 -89.91 143.37 26.84 Favored 'General case' 0 C--N 1.323 -0.552 0 N-CA-C 106.678 -1.601 . . . . 0.0 106.678 164.147 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 9.2 p90 . . . . . 0 C--O 1.25 1.114 0 N-CA-C 105.644 -1.984 . . . . 0.0 105.644 162.276 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 56.6 m -144.85 146.85 32.25 Favored 'General case' 0 N--CA 1.472 0.654 0 CA-C-N 118.743 0.701 . . . . 0.0 110.386 -169.277 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.0 m -111.44 107.18 16.31 Favored 'General case' 0 N--CA 1.452 -0.334 0 CA-C-O 122.96 1.362 . . . . 0.0 108.895 -176.189 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.3 p -93.24 112.64 24.63 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 125.281 1.432 . . . . 0.0 107.658 -176.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 29.6 m -128.52 105.33 13.0 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 N-CA-C 107.082 -1.451 . . . . 0.0 107.082 -163.28 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 9.6 t -121.57 164.58 17.03 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 124.539 1.136 . . . . 0.0 108.435 -176.733 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.7 -176.08 36.09 Favored Glycine 0 N--CA 1.446 -0.667 0 C-N-CA 125.909 1.718 . . . . 0.0 109.845 168.695 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -153.65 47.57 0.54 Allowed Glycine 0 N--CA 1.446 -0.657 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 176.803 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 11.2 t80 -90.74 110.84 22.03 Favored 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 -178.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -132.3 172.99 11.73 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 125.056 1.342 . . . . 0.0 107.861 175.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -120.8 164.25 16.9 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.232 -1.025 . . . . 0.0 108.232 160.514 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 65.0 m -135.72 151.93 50.66 Favored 'General case' 0 N--CA 1.448 -0.567 0 C-N-CA 127.38 2.272 . . . . 0.0 106.791 167.391 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -125.76 172.18 10.04 Favored 'General case' 0 C--O 1.237 0.437 0 C-N-CA 125.438 1.495 . . . . 0.0 109.515 -169.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -130.7 130.27 43.63 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.1 0.96 . . . . 0.0 109.018 174.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 57.9 tt0 68.62 -70.77 0.13 Allowed 'General case' 0 C--O 1.236 0.37 0 C-N-CA 128.217 2.607 . . . . 0.0 111.779 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -131.94 -92.7 0.56 Allowed Glycine 0 N--CA 1.452 -0.299 0 N-CA-C 108.03 -2.028 . . . . 0.0 108.03 -178.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -146.78 95.03 2.52 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 105.577 -2.009 . . . . 0.0 105.577 -179.3 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -164.96 19.62 0.05 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-O 120.959 0.409 . . . . 0.0 110.786 -174.006 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -145.04 149.41 35.05 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 107.186 -1.413 . . . . 0.0 107.186 -176.415 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 70.3 tttt -138.52 92.93 2.67 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 179.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.5 ptt? -137.61 159.31 42.32 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 125.925 1.69 . . . . 0.0 107.941 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -170.42 -148.37 5.93 Favored Glycine 0 N--CA 1.447 -0.603 0 N-CA-C 106.061 -2.815 . . . . 0.0 106.061 173.76 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -177.5 -121.52 0.69 Allowed Glycine 0 N--CA 1.451 -0.366 0 N-CA-C 107.176 -2.37 . . . . 0.0 107.176 179.475 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -149.07 165.84 30.5 Favored 'General case' 0 CA--C 1.535 0.377 0 C-N-CA 126.405 1.882 . . . . 0.0 107.597 173.845 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 22.9 t30 -138.19 148.94 45.35 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 126.288 1.835 . . . . 0.0 108.267 169.924 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -139.38 119.75 13.87 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.932 1.293 . . . . 0.0 108.58 -177.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -92.45 173.43 7.8 Favored 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 122.9 0.48 . . . . 0.0 111.454 -177.796 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -140.73 140.21 34.81 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 161.553 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -127.4 150.99 49.38 Favored 'General case' 0 C--O 1.233 0.223 0 N-CA-C 106.064 -1.828 . . . . 0.0 106.064 155.375 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.6 t80 -130.85 118.11 20.28 Favored 'General case' 0 N--CA 1.45 -0.469 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 -172.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 46.1 mt-10 -129.82 113.35 14.57 Favored 'General case' 0 CA--C 1.515 -0.368 0 N-CA-C 108.875 -0.787 . . . . 0.0 108.875 -177.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 44.8 tp10 -123.65 123.32 40.29 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -175.321 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 25.9 t0 33.51 66.33 0.24 Allowed 'General case' 0 N--CA 1.468 0.455 0 C-N-CA 126.355 1.862 . . . . 0.0 112.249 -155.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 42.6 m-80 53.55 39.03 29.49 Favored 'General case' 0 C--O 1.236 0.375 0 CA-C-N 113.603 -1.635 . . . . 0.0 110.707 160.257 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 34.2 p -64.72 137.28 97.09 Favored Pre-proline 0 C--O 1.24 0.572 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.832 -163.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -69.79 -34.27 14.82 Favored 'Trans proline' 0 N--CA 1.46 -0.491 0 C-N-CA 122.432 2.088 . . . . 0.0 110.144 176.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -80.07 119.22 22.58 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.426 -1.694 . . . . 0.0 106.426 170.779 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -117.17 165.73 12.45 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 109.0 -1.64 . . . . 0.0 109.0 169.239 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.8 t -102.9 158.34 4.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.512 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 175.504 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 70.4 mt -132.73 147.9 31.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 104.413 -2.44 . . . . 0.0 104.413 169.612 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.65 157.29 23.58 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 108.754 -1.738 . . . . 0.0 108.754 153.168 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 19.5 p -126.15 134.11 51.4 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 107.294 -1.372 . . . . 0.0 107.294 157.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 44.3 m-85 -134.76 109.67 8.72 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 104.897 -2.26 . . . . 0.0 104.897 173.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.4 t -127.63 151.62 48.71 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.189 0.996 . . . . 0.0 109.196 -176.042 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -126.5 156.74 40.25 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 125.34 1.456 . . . . 0.0 108.495 178.67 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 11.6 m -126.22 157.94 36.95 Favored 'General case' 0 CA--C 1.532 0.281 0 N-CA-C 107.552 -1.277 . . . . 0.0 107.552 169.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -123.7 4.72 8.85 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 123.868 0.867 . . . . 0.0 113.246 -167.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -66.93 128.07 34.95 Favored 'General case' 0 C--O 1.234 0.238 0 O-C-N 121.519 -0.738 . . . . 0.0 109.587 -173.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 25.5 p -112.33 152.43 28.57 Favored 'General case' 0 C--N 1.325 -0.46 0 N-CA-C 107.636 -1.246 . . . . 0.0 107.636 176.201 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -118.52 119.26 33.99 Favored 'General case' 0 CA--C 1.513 -0.451 0 N-CA-C 107.948 -1.13 . . . . 0.0 107.948 177.538 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 52.4 m -149.61 125.24 10.37 Favored 'General case' 0 C--N 1.322 -0.628 0 N-CA-C 105.159 -2.163 . . . . 0.0 105.159 170.386 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -87.58 -96.26 0.09 Allowed 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 106.167 -1.79 . . . . 0.0 106.167 161.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 68.7 m -142.31 91.55 2.34 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 107.624 -1.25 . . . . 0.0 107.624 162.133 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 44.7 m 53.2 34.64 17.99 Favored 'General case' 0 CA--C 1.543 0.684 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -134.32 -25.86 0.57 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.98 -1.455 . . . . 0.0 115.949 175.046 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -121.48 109.0 14.3 Favored 'General case' 0 C--O 1.24 0.57 0 CA-C-N 120.49 2.145 . . . . 0.0 105.808 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -131.31 107.76 9.18 Favored 'General case' 0 N--CA 1.467 0.413 0 CA-C-N 120.298 1.408 . . . . 0.0 111.471 177.757 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -138.45 159.81 41.14 Favored 'General case' 0 C--O 1.232 0.152 0 CA-C-O 121.201 0.524 . . . . 0.0 111.399 163.054 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 26.3 tptt -84.23 127.32 33.88 Favored 'General case' 0 C--O 1.238 0.461 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 163.794 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -106.08 81.5 1.64 Allowed 'General case' 0 C--O 1.234 0.289 0 CA-C-N 120.324 1.42 . . . . 0.0 107.337 176.243 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.8 pt20 -113.32 153.25 28.78 Favored 'General case' 0 N--CA 1.445 -0.694 0 CA-C-N 113.878 -1.51 . . . . 0.0 107.85 -171.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -139.99 136.18 33.49 Favored 'General case' 0 C--N 1.326 -0.455 0 N-CA-C 105.522 -2.029 . . . . 0.0 105.522 174.727 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -141.92 148.39 38.6 Favored 'General case' 0 N--CA 1.449 -0.481 0 N-CA-C 105.336 -2.098 . . . . 0.0 105.336 170.517 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -161.57 169.77 37.14 Favored Glycine 0 CA--C 1.519 0.334 0 N-CA-C 108.092 -2.003 . . . . 0.0 108.092 -173.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.9 mp -141.3 134.17 30.13 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.185 0 N-CA-C 105.076 -2.194 . . . . 0.0 105.076 -178.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 36.4 p -120.92 134.51 55.3 Favored 'General case' 0 N--CA 1.447 -0.613 0 N-CA-C 106.654 -1.61 . . . . 0.0 106.654 170.452 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -148.14 167.1 25.91 Favored 'General case' 0 C--N 1.327 -0.381 0 O-C-N 120.7 -1.25 . . . . 0.0 107.752 168.188 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 162.61 168.51 24.64 Favored Glycine 0 CA--C 1.53 0.996 0 N-CA-C 110.526 -1.03 . . . . 0.0 110.526 173.854 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_endo -72.21 95.63 0.77 Allowed 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 124.619 3.546 . . . . 0.0 109.819 -178.211 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.91 145.66 24.55 Favored 'General case' 0 N--CA 1.451 -0.409 0 O-C-N 121.776 -0.578 . . . . 0.0 109.636 -175.629 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 53.3 p90 -148.7 156.56 42.55 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 109.703 -0.48 . . . . 0.0 109.703 178.06 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 57.0 mtt180 -93.7 138.56 31.79 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 162.919 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 6.9 mt -52.9 -58.16 3.27 Favored 'Isoleucine or valine' 0 C--O 1.233 0.199 0 N-CA-C 106.942 -1.503 . . . . 0.0 106.942 176.332 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -165.05 -64.52 0.03 OUTLIER 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 159.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -40.05 -82.69 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 127.454 2.301 . . . . 0.0 111.883 -163.349 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 54.8 p-90 -165.57 20.02 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.36 0 C-N-CA 124.038 0.935 . . . . 0.0 111.871 -176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -118.38 121.43 40.33 Favored 'General case' 0 C--O 1.237 0.405 0 C-N-CA 123.363 0.665 . . . . 0.0 109.404 -179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 72.3 m -72.31 154.06 41.16 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 125.361 1.464 . . . . 0.0 110.41 172.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 26.8 mm -120.89 164.4 17.49 Favored 'Isoleucine or valine' 0 C--O 1.236 0.395 0 C-N-CA 126.653 1.981 . . . . 0.0 109.292 179.163 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.481 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 14.6 p90 -104.83 161.13 14.44 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 124.649 1.179 . . . . 0.0 111.676 174.703 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -178.24 30.12 0.07 OUTLIER Glycine 0 CA--C 1.529 0.967 0 C-N-CA 126.189 1.852 . . . . 0.0 109.86 169.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 22.4 m -104.45 161.94 4.55 Favored 'Isoleucine or valine' 0 C--O 1.238 0.471 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 -176.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.3 m -139.36 135.96 40.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.376 0 C-N-CA 125.542 1.537 . . . . 0.0 108.919 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.61 -176.02 15.57 Favored Glycine 0 CA--C 1.523 0.557 0 C-N-CA 125.876 1.703 . . . . 0.0 110.371 172.741 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 17.4 m -144.89 150.45 16.11 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.522 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 -175.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -103.18 135.87 12.56 Favored Glycine 0 N--CA 1.445 -0.739 0 N-CA-C 106.307 -2.717 . . . . 0.0 106.307 159.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 47.4 p90 -116.31 150.41 37.69 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 154.45 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -147.11 176.49 25.94 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 110.629 -0.988 . . . . 0.0 110.629 -178.548 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 13.5 mptt 56.7 172.6 0.04 OUTLIER 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 126.369 1.868 . . . . 0.0 111.197 -164.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 83.5 t80 -161.19 -75.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 124.405 1.082 . . . . 0.0 110.405 173.065 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -85.79 149.49 25.23 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 122.951 0.5 . . . . 0.0 110.561 -171.161 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.4 p -123.25 96.51 5.02 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.585 -0.894 . . . . 0.0 108.585 -167.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.1 t -149.0 90.18 1.73 Allowed 'General case' 0 N--CA 1.44 -0.949 0 N-CA-C 103.973 -2.602 . . . . 0.0 103.973 -177.172 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -128.65 0.83 5.5 Favored 'General case' 0 CA--C 1.537 0.462 0 CA-C-N 114.363 -1.29 . . . . 0.0 111.271 177.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.3 m-85 147.32 -69.0 0.0 OUTLIER Pre-proline 0 N--CA 1.47 0.547 0 C-N-CA 130.547 3.539 . . . . 0.0 108.093 -167.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -64.39 -26.22 63.34 Favored 'Trans proline' 0 C--N 1.352 0.754 0 CA-C-N 121.103 1.43 . . . . 0.0 112.545 -172.714 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.4 m 62.12 9.95 3.43 Favored 'General case' 0 CA--C 1.55 0.945 0 C-N-CA 124.327 1.051 . . . . 0.0 112.433 173.593 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -146.27 92.98 2.25 Favored 'General case' 0 C--O 1.238 0.456 0 O-C-N 121.293 -0.88 . . . . 0.0 110.948 -162.26 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 83.4 mttt -152.54 -69.28 0.16 Allowed 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.134 1.774 . . . . 0.0 108.012 163.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.2 m120 39.18 65.87 0.62 Allowed 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 127.128 2.171 . . . . 0.0 110.471 -161.424 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -151.83 -55.88 0.14 Allowed 'General case' 0 N--CA 1.467 0.378 0 C-N-CA 124.935 1.294 . . . . 0.0 109.537 -178.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 24.5 m -76.37 94.16 3.58 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 123.178 0.591 . . . . 0.0 110.042 -170.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 51.0 m -86.22 175.04 8.7 Favored 'General case' 0 CA--C 1.543 0.705 0 C-N-CA 124.941 1.296 . . . . 0.0 108.453 161.689 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -119.5 145.58 46.19 Favored 'General case' 0 N--CA 1.468 0.445 0 C-N-CA 125.567 1.547 . . . . 0.0 108.432 176.272 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 19.6 p90 -147.61 154.63 40.9 Favored 'General case' 0 N--CA 1.469 0.49 0 N-CA-C 114.725 1.38 . . . . 0.0 114.725 -167.24 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -164.4 174.79 40.49 Favored Glycine 0 CA--C 1.533 1.217 0 C-N-CA 126.765 2.126 . . . . 0.0 110.251 -177.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 35.1 t80 -137.74 123.26 19.67 Favored 'General case' 0 C--O 1.232 0.154 0 C-N-CA 127.382 2.273 . . . . 0.0 107.356 -165.707 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 10.7 m -137.83 137.56 38.27 Favored 'General case' 0 C--O 1.233 0.199 0 C-N-CA 125.342 1.457 . . . . 0.0 108.678 -175.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 32.1 p90 -150.14 166.58 29.38 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 125.417 1.487 . . . . 0.0 110.361 -167.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . 0.443 ' HA2' ' CD1' ' A' ' 80' ' ' TYR . . . 103.02 -125.72 8.59 Favored Glycine 0 C--N 1.334 0.449 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 169.037 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 61.45 20.69 11.4 Favored 'General case' 0 CA--C 1.543 0.709 0 N-CA-C 115.576 1.695 . . . . 0.0 115.576 163.437 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.481 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . -104.1 40.58 2.4 Favored Glycine 0 C--N 1.338 0.682 0 CA-C-O 118.367 -1.241 . . . . 0.0 113.127 -165.626 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -113.9 140.4 48.4 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-N 119.975 1.888 . . . . 0.0 107.044 -168.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 68.7 mt-30 -145.83 148.46 32.93 Favored 'General case' 0 N--CA 1.464 0.243 0 C-N-CA 124.202 1.001 . . . . 0.0 109.119 -176.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.6 m-85 -107.6 172.7 6.68 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 127.804 2.442 . . . . 0.0 109.53 -179.111 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 16.1 p-10 -56.05 107.73 0.98 Allowed Pre-proline 0 CA--C 1.544 0.722 0 C-N-CA 124.831 1.252 . . . . 0.0 108.575 173.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -79.7 98.81 1.16 Allowed 'Trans proline' 0 N--CA 1.454 -0.806 0 C-N-CA 123.228 2.619 . . . . 0.0 108.359 -174.771 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 15.6 ptt? -149.76 170.97 17.5 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.364 1.066 . . . . 0.0 109.29 -177.989 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 69.65 41.29 1.25 Allowed 'General case' 0 C--N 1.325 -0.467 0 C-N-CA 126.771 2.028 . . . . 0.0 108.684 177.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 48.26 37.9 9.24 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 127.395 2.278 . . . . 0.0 112.392 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 20.4 m -131.41 162.41 39.4 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.575 0 C-N-CA 124.95 1.3 . . . . 0.0 108.381 161.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -99.81 161.41 13.63 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 107.159 -1.422 . . . . 0.0 107.159 149.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 18.5 mt -133.73 114.92 13.96 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 104.661 -2.348 . . . . 0.0 104.661 179.236 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -110.22 168.27 9.57 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 106.825 -1.546 . . . . 0.0 106.825 175.352 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 59.3 t80 -138.29 122.97 18.66 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 158.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 69.1 m -144.77 122.05 11.57 Favored 'General case' 0 N--CA 1.446 -0.636 0 N-CA-C 107.16 -1.422 . . . . 0.0 107.16 -173.461 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 7.5 t80 -136.91 139.78 41.84 Favored 'General case' 0 C--N 1.333 -0.111 0 N-CA-C 104.99 -2.226 . . . . 0.0 104.99 177.444 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -136.89 148.13 46.86 Favored 'General case' 0 C--O 1.239 0.519 0 C-N-CA 124.088 0.955 . . . . 0.0 109.857 -179.179 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -131.84 106.93 8.4 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 124.252 1.021 . . . . 0.0 110.582 -176.456 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 3.3 m -111.92 137.0 50.5 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 107.419 -1.326 . . . . 0.0 107.419 164.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -127.33 97.06 4.77 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 105.452 -2.055 . . . . 0.0 105.452 176.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 5.6 mt -82.89 88.13 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.322 0 N-CA-C 106.207 -1.775 . . . . 0.0 106.207 -177.71 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 5.8 mtt-85 65.17 -70.14 0.09 Allowed 'General case' 0 N--CA 1.475 0.81 0 C-N-CA 127.689 2.396 . . . . 0.0 112.967 175.885 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.0 t -144.52 17.31 1.67 Allowed 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 126.191 1.797 . . . . 0.0 110.131 -179.809 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 43.5 t -100.25 148.81 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 C-N-CA 125.687 1.595 . . . . 0.0 106.699 169.495 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 22.3 t0 -113.89 133.29 55.53 Favored 'General case' 0 N--CA 1.464 0.267 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 173.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 53.0 t -132.56 105.39 8.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.827 -1.546 . . . . 0.0 106.827 177.295 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -97.99 115.58 5.31 Favored Glycine 0 N--CA 1.446 -0.649 0 C-N-CA 125.549 1.547 . . . . 0.0 110.177 -178.262 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 49.1 p -128.79 120.25 26.0 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 106.934 -1.506 . . . . 0.0 106.934 -175.673 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 40.1 p90 -143.17 146.27 33.56 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 167.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 79.3 mt -96.06 151.23 4.05 Favored 'Isoleucine or valine' 0 C--O 1.237 0.407 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 177.058 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -93.54 114.37 26.72 Favored 'General case' 0 C--O 1.234 0.24 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 164.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -62.15 109.03 2.32 Favored Glycine 0 CA--C 1.524 0.613 0 N-CA-C 109.675 -1.37 . . . . 0.0 109.675 169.392 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -154.7 163.67 1.6 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.529 0 C-N-CA 129.37 3.068 . . . . 0.0 104.329 159.241 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 178.46 -116.48 0.53 Allowed Glycine 0 C--N 1.335 0.489 0 CA-C-N 120.146 1.339 . . . . 0.0 110.796 169.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 91.8 m-85 -141.19 176.98 8.4 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 125.281 1.433 . . . . 0.0 107.777 179.6 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -130.29 147.92 52.06 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 120.815 1.643 . . . . 0.0 112.093 167.827 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 50.3 m-85 . . . . . 0 C--O 1.247 0.958 0 N-CA-C 104.6 -2.37 . . . . 0.0 104.6 168.631 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.626 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -145.65 161.12 40.6 Favored 'General case' 0 C--O 1.238 0.474 0 CA-C-N 118.369 0.531 . . . . 0.0 109.813 174.391 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 27.9 t -133.59 123.32 24.91 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.705 -1.961 . . . . 0.0 105.705 175.474 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -141.16 144.83 35.04 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 119.18 0.9 . . . . 0.0 109.018 179.696 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 5.0 p -89.82 148.15 4.74 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 CA-C-O 122.1 0.952 . . . . 0.0 108.803 -173.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 27.7 m -145.71 118.03 8.44 Favored 'General case' 0 N--CA 1.444 -0.726 0 N-CA-C 104.606 -2.368 . . . . 0.0 104.606 157.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.536 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 163.14 164.65 18.68 Favored Glycine 0 CA--C 1.525 0.67 0 C-N-CA 123.764 0.697 . . . . 0.0 112.125 -179.435 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.97 -116.35 0.71 Allowed Glycine 0 N--CA 1.441 -1.012 0 N-CA-C 109.423 -1.471 . . . . 0.0 109.423 177.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -143.15 148.08 35.98 Favored 'General case' 0 C--O 1.239 0.553 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 -175.884 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -124.7 172.91 8.91 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.507 1.123 . . . . 0.0 110.308 179.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 16.3 pt20 -147.85 140.5 24.65 Favored 'General case' 0 N--CA 1.452 -0.33 0 O-C-N 122.21 -0.306 . . . . 0.0 110.905 173.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 m -131.88 136.94 47.81 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 105.837 -1.912 . . . . 0.0 105.837 171.554 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.5 t0 -103.56 170.62 7.83 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.86 138.0 50.73 Favored 'General case' 0 CA--C 1.514 -0.434 0 O-C-N 120.377 -1.452 . . . . 0.0 109.403 -176.421 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 72.0 mt-30 66.83 -62.83 0.29 Allowed 'General case' 0 C--N 1.328 -0.34 0 C-N-CA 128.297 2.639 . . . . 0.0 112.267 -179.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -140.56 -95.79 0.28 Allowed Glycine 0 N--CA 1.449 -0.444 0 C-N-CA 126.619 2.057 . . . . 0.0 108.776 -174.754 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 16.9 pt20 -151.21 101.05 2.82 Favored 'General case' 0 C--O 1.236 0.343 0 CA-C-N 118.348 1.074 . . . . 0.0 111.499 172.589 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 6.2 ttm -155.39 7.32 0.25 Allowed 'General case' 0 CA--C 1.549 0.907 0 C-N-CA 124.555 1.142 . . . . 0.0 113.507 169.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.0 m-80 -136.16 147.72 47.84 Favored 'General case' 0 N--CA 1.452 -0.329 0 O-C-N 119.289 -2.132 . . . . 0.0 109.373 -160.811 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mtpt -128.62 77.05 1.75 Allowed 'General case' 0 C--N 1.329 -0.316 0 N-CA-C 107.505 -1.294 . . . . 0.0 107.505 177.584 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 40.9 ttp -78.68 118.87 21.17 Favored 'General case' 0 CA--C 1.518 -0.263 0 N-CA-C 108.776 -0.824 . . . . 0.0 108.776 178.663 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.44 -171.8 44.2 Favored Glycine 0 N--CA 1.444 -0.823 0 N-CA-C 111.125 -0.79 . . . . 0.0 111.125 178.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.33 -163.32 30.04 Favored Glycine 0 CA--C 1.527 0.822 0 C-N-CA 130.002 3.668 . . . . 0.0 105.361 -171.817 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -98.56 110.49 23.07 Favored 'General case' 0 C--O 1.234 0.269 0 N-CA-C 105.72 -1.955 . . . . 0.0 105.72 -169.763 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -97.37 136.01 38.44 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 106.932 -1.507 . . . . 0.0 106.932 -176.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -134.82 144.83 47.83 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 169.273 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.1 ttpp -92.41 175.74 6.73 Favored 'General case' 0 C--O 1.239 0.516 0 N-CA-C 106.163 -1.791 . . . . 0.0 106.163 163.05 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 46.5 t80 -131.63 127.25 36.63 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 106.272 -1.751 . . . . 0.0 106.272 158.327 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 15.3 ttt-85 -104.52 143.63 32.77 Favored 'General case' 0 CA--C 1.509 -0.628 0 CA-C-N 119.72 1.146 . . . . 0.0 107.953 176.508 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 8.5 t80 -139.16 150.88 46.13 Favored 'General case' 0 N--CA 1.44 -0.926 0 N-CA-C 104.826 -2.287 . . . . 0.0 104.826 166.931 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -120.16 113.27 20.2 Favored 'General case' 0 N--CA 1.452 -0.338 0 N-CA-C 105.597 -2.001 . . . . 0.0 105.597 177.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 59.5 mm-40 -65.11 155.6 34.31 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 178.057 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -99.6 -18.25 17.43 Favored 'General case' 0 C--N 1.323 -0.552 0 C-N-CA 125.018 1.327 . . . . 0.0 110.584 -175.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -136.9 -31.73 0.83 Allowed 'General case' 0 N--CA 1.464 0.231 0 C-N-CA 125.629 1.572 . . . . 0.0 112.369 -172.558 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 26.4 m -71.52 129.36 88.79 Favored Pre-proline 0 CA--C 1.538 0.507 0 CA-C-N 118.88 0.764 . . . . 0.0 109.553 165.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -84.46 46.11 1.86 Allowed 'Trans proline' 0 CA--C 1.537 0.645 1 C-N-CA 125.307 4.005 . . . . 0.0 109.647 173.078 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 31.7 tp -149.09 131.23 15.42 Favored 'General case' 0 C--O 1.233 0.232 0 N-CA-C 107.782 -1.192 . . . . 0.0 107.782 -165.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -88.9 -163.11 39.12 Favored Glycine 0 CA--C 1.526 0.74 0 N-CA-C 111.8 -0.52 . . . . 0.0 111.8 178.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 66.3 t -144.65 137.64 22.41 Favored 'Isoleucine or valine' 0 C--O 1.239 0.551 0 C-N-CA 124.744 1.218 . . . . 0.0 109.0 168.346 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.4 tt -140.58 120.66 12.95 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.351 0 O-C-N 121.21 -0.931 . . . . 0.0 110.184 173.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -161.54 146.53 12.31 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 109.019 -1.633 . . . . 0.0 109.019 155.563 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.6 t -111.21 151.22 28.5 Favored 'General case' 0 C--O 1.242 0.673 0 N-CA-C 107.113 -1.44 . . . . 0.0 107.113 167.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 40.2 p90 -88.92 144.39 26.23 Favored 'General case' 0 C--O 1.239 0.505 0 N-CA-C 106.368 -1.715 . . . . 0.0 106.368 150.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 43.6 m -129.35 128.55 43.32 Favored 'General case' 0 CA--C 1.535 0.4 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 167.727 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -116.11 153.7 31.29 Favored 'General case' 0 C--O 1.231 0.115 0 CA-C-N 119.988 1.267 . . . . 0.0 109.949 -178.696 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.3 m -103.89 135.46 45.39 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 177.798 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 6.9 pt-20 -140.8 88.96 2.22 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.161 0.984 . . . . 0.0 109.981 177.156 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -132.49 141.13 48.66 Favored 'General case' 0 CA--C 1.517 -0.292 0 O-C-N 120.744 -1.222 . . . . 0.0 111.647 171.185 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.4 p -131.78 154.73 48.79 Favored 'General case' 0 C--N 1.321 -0.636 0 C-N-CA 126.961 2.105 . . . . 0.0 107.824 175.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -133.67 98.97 4.34 Favored 'General case' 0 N--CA 1.463 0.189 0 CA-C-N 119.838 1.199 . . . . 0.0 109.466 171.88 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -93.84 115.52 27.92 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 177.196 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 71.13 105.22 0.06 Allowed 'General case' 0 CA--C 1.53 0.193 0 C-N-CA 127.424 2.29 . . . . 0.0 112.16 174.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 30.0 t 156.62 -78.5 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.135 0 C-N-CA 130.574 3.549 . . . . 0.0 105.514 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 4.1 p -83.18 -47.71 11.29 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.626 1.97 . . . . 0.0 111.426 176.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 64.63 69.37 1.35 Allowed Glycine 0 C--N 1.338 0.674 0 N-CA-C 107.478 -2.249 . . . . 0.0 107.478 -152.131 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 11.4 p-10 -121.56 91.9 3.62 Favored 'General case' 0 C--N 1.329 -0.288 0 O-C-N 121.133 -1.216 . . . . 0.0 108.811 152.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -90.21 75.85 6.92 Favored 'General case' 0 CA--C 1.532 0.251 0 N-CA-C 106.191 -1.781 . . . . 0.0 106.191 -178.056 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.9 t-20 172.55 163.67 0.12 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 128.328 2.651 . . . . 0.0 107.059 -176.958 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.5 mttt -159.18 155.37 27.0 Favored 'General case' 0 CA--C 1.519 -0.225 0 C-N-CA 125.25 1.42 . . . . 0.0 107.288 158.512 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.483 ' H ' ' HA ' ' A' ' 91' ' ' GLN . 28.9 m120 35.51 -144.14 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 127.776 2.431 . . . . 0.0 111.636 165.2 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.6 tp60 -155.49 158.22 38.17 Favored 'General case' 0 CA--C 1.533 0.306 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 166.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 55.0 p90 -72.87 115.35 12.07 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 169.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.44 118.71 12.77 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 104.507 -2.405 . . . . 0.0 104.507 161.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.41 89.16 0.13 Allowed Glycine 0 N--CA 1.448 -0.54 0 N-CA-C 106.305 -2.718 . . . . 0.0 106.305 177.7 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.3 mp -124.04 116.95 49.42 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.341 0 N-CA-C 102.93 -2.989 . . . . 0.0 102.93 177.334 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 41.5 p -136.65 143.54 43.53 Favored 'General case' 0 C--O 1.241 0.614 0 C-N-CA 124.2 1.0 . . . . 0.0 108.657 178.105 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -158.97 158.31 33.01 Favored 'General case' 0 C--O 1.238 0.48 0 C-N-CA 123.434 0.694 . . . . 0.0 110.015 172.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 167.2 176.14 37.81 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 110.215 -1.154 . . . . 0.0 110.215 165.395 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 41.8 Cg_endo -70.78 126.65 12.84 Favored 'Trans proline' 0 N--CA 1.447 -1.209 0 C-N-CA 121.648 1.565 . . . . 0.0 110.023 -177.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -94.94 138.73 32.3 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 156.766 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -116.22 155.22 28.71 Favored 'General case' 0 C--O 1.238 0.463 0 C-N-CA 126.489 1.916 . . . . 0.0 109.586 -175.672 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.2 ttp-105 -145.04 128.67 17.14 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.567 1.547 . . . . 0.0 109.504 -174.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.6 mp -92.73 -54.02 7.84 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 C-N-CA 124.748 1.219 . . . . 0.0 108.428 179.222 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 77.4 m-20 -129.21 -97.13 0.38 Allowed 'General case' 0 CA--C 1.53 0.184 0 N-CA-C 104.985 -2.228 . . . . 0.0 104.985 175.698 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 5.8 p-10 -145.73 0.68 0.87 Allowed 'General case' 0 CA--C 1.542 0.666 0 C-N-CA 127.252 2.221 . . . . 0.0 112.04 173.234 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 4.4 p90 -119.33 40.22 3.39 Favored 'General case' 0 N--CA 1.465 0.324 0 C-N-CA 125.329 1.452 . . . . 0.0 112.541 -171.012 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -139.21 174.12 10.84 Favored 'General case' 0 CA--C 1.53 0.177 0 C-N-CA 124.732 1.213 . . . . 0.0 109.981 166.998 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 33.3 t -147.62 152.13 37.38 Favored 'General case' 0 C--O 1.239 0.534 0 N-CA-C 106.881 -1.526 . . . . 0.0 106.881 152.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 30.4 mm -125.88 147.4 30.64 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.588 1.555 . . . . 0.0 107.033 -175.262 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 21.7 p90 -105.66 174.75 5.75 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 127.405 2.282 . . . . 0.0 110.72 -169.498 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 119.81 70.12 0.32 Allowed Glycine 0 C--N 1.335 0.524 0 C-N-CA 124.475 1.036 . . . . 0.0 110.654 176.324 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 32.7 m -123.22 153.18 28.43 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.139 0 N-CA-C 108.411 -0.959 . . . . 0.0 108.411 170.241 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 29.9 m -95.15 165.65 1.92 Allowed 'Isoleucine or valine' 0 C--O 1.236 0.369 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 172.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -155.12 179.9 30.79 Favored Glycine 0 N--CA 1.446 -0.678 0 N-CA-C 111.137 -0.785 . . . . 0.0 111.137 167.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -151.99 148.96 14.17 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 N-CA-C 106.937 -1.505 . . . . 0.0 106.937 -179.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -121.89 158.52 16.6 Favored Glycine 0 C--O 1.24 0.501 0 N-CA-C 108.39 -1.884 . . . . 0.0 108.39 157.979 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 15.7 t80 -136.44 116.35 13.2 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.83 -1.174 . . . . 0.0 107.83 178.354 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.3 105.39 3.28 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 108.899 -1.68 . . . . 0.0 108.899 177.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.3 tmtm? -110.02 -165.98 1.05 Allowed 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 107.276 -1.379 . . . . 0.0 107.276 164.261 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 39.99 -90.31 0.01 OUTLIER 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 128.42 2.688 . . . . 0.0 113.144 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.483 ' HA ' ' H ' ' A' ' 60' ' ' ASN . 32.4 tt0 76.89 -53.0 0.57 Allowed 'General case' 0 C--O 1.226 -0.169 0 C-N-CA 125.645 1.578 . . . . 0.0 111.846 172.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 82.6 p -134.4 146.78 50.18 Favored 'General case' 0 N--CA 1.45 -0.454 0 CA-C-N 120.023 1.283 . . . . 0.0 107.701 165.579 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 4.7 m -152.13 110.22 3.7 Favored 'General case' 0 CA--C 1.531 0.237 0 N-CA-C 105.963 -1.866 . . . . 0.0 105.963 177.944 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 170.5 -60.05 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.957 0 C-N-CA 129.325 3.05 . . . . 0.0 106.218 171.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 28.4 m-85 -51.93 142.51 25.61 Favored Pre-proline 0 CA--C 1.534 0.345 0 C-N-CA 124.82 1.248 . . . . 0.0 109.923 -177.989 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -62.12 -21.14 71.96 Favored 'Trans proline' 0 CA--C 1.537 0.63 0 C-N-CA 121.976 1.784 . . . . 0.0 111.745 174.5 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 23.7 p -113.67 73.01 0.8 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.704 2.002 . . . . 0.0 106.784 172.164 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 13.7 m-85 -45.94 120.3 2.63 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 124.838 1.255 . . . . 0.0 108.752 164.193 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -70.13 -46.98 63.63 Favored 'General case' 0 C--N 1.339 0.127 0 CA-C-O 117.968 -1.015 . . . . 0.0 109.687 -173.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 33.72 66.34 0.25 Allowed 'General case' 0 N--CA 1.469 0.481 0 C-N-CA 127.339 2.256 . . . . 0.0 112.261 178.578 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 48.2 t0 -62.74 141.93 58.37 Favored 'General case' 0 C--O 1.239 0.547 0 CA-C-N 115.565 -0.743 . . . . 0.0 109.362 178.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 t -77.58 94.58 4.38 Favored 'General case' 0 N--CA 1.452 -0.338 0 CA-C-O 122.012 0.911 . . . . 0.0 108.673 -164.482 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 2.4 p -120.19 35.4 4.87 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.166 0.987 . . . . 0.0 109.911 -166.119 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.6 p30 -124.92 176.15 6.83 Favored 'General case' 0 C--O 1.233 0.234 0 N-CA-C 113.941 1.089 . . . . 0.0 113.941 -167.66 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.4 t80 49.19 62.82 2.41 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 126.914 2.086 . . . . 0.0 110.375 -174.26 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -77.57 168.45 54.38 Favored Glycine 0 CA--C 1.531 1.04 0 CA-C-N 114.964 -1.016 . . . . 0.0 112.174 176.825 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -138.68 99.21 3.75 Favored 'General case' 0 C--O 1.236 0.347 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 174.405 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 7.2 t -119.84 168.95 10.59 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 123.688 0.795 . . . . 0.0 109.924 -171.581 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.9 p90 -135.64 151.65 50.44 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 107.982 -1.118 . . . . 0.0 107.982 168.502 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -127.58 172.96 18.77 Favored Glycine 0 CA--C 1.521 0.408 0 N-CA-C 109.42 -1.472 . . . . 0.0 109.42 174.763 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -122.2 178.09 5.07 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.119 0.568 . . . . 0.0 111.431 -173.359 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.48 86.3 0.14 Allowed Glycine 0 C--N 1.338 0.656 0 N-CA-C 108.615 -1.794 . . . . 0.0 108.615 168.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -115.41 158.36 22.6 Favored 'General case' 0 CA--C 1.52 -0.2 0 N-CA-C 107.931 -1.136 . . . . 0.0 107.931 -179.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 7.8 pt20 -104.9 154.66 19.78 Favored 'General case' 0 C--O 1.236 0.385 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 -175.92 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -114.56 172.26 7.14 Favored 'General case' 0 C--N 1.323 -0.577 0 C-N-CA 126.382 1.873 . . . . 0.0 108.721 179.074 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 18.6 m-20 -57.94 159.28 10.77 Favored Pre-proline 0 C--O 1.236 0.37 0 O-C-N 122.055 -0.403 . . . . 0.0 111.072 174.828 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 13.7 Cg_endo -61.35 151.67 77.82 Favored 'Trans proline' 0 N--CA 1.454 -0.818 0 C-N-CA 121.565 1.51 . . . . 0.0 110.716 174.952 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 16.3 mtt -129.79 -179.97 5.5 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 126.633 1.973 . . . . 0.0 107.016 167.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 5.5 mp0 -70.44 -34.14 72.12 Favored 'General case' 0 N--CA 1.467 0.414 0 O-C-N 121.523 -0.736 . . . . 0.0 111.315 -157.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -162.52 25.11 0.1 Allowed 'General case' 0 C--N 1.334 -0.102 0 C-N-CA 124.036 0.934 . . . . 0.0 111.712 178.427 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 4.3 m -129.34 166.4 26.97 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.954 -1.128 . . . . 0.0 107.954 -179.908 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -116.24 137.01 52.5 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 105.193 -2.151 . . . . 0.0 105.193 173.141 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.0 mm? -112.11 118.07 34.38 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 104.732 -2.321 . . . . 0.0 104.732 175.426 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 11.4 t70 -121.94 115.3 22.32 Favored 'General case' 0 C--N 1.328 -0.366 0 N-CA-C 105.742 -1.948 . . . . 0.0 105.742 -178.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -100.1 114.0 27.04 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 106.895 -1.52 . . . . 0.0 106.895 -160.182 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 10.9 t -141.94 162.15 36.2 Favored 'General case' 0 C--O 1.239 0.507 0 CA-C-O 122.021 0.915 . . . . 0.0 108.678 -176.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 45.1 p90 -149.7 162.23 40.64 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.497 2.319 . . . . 0.0 105.777 179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -138.09 164.16 29.81 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 120.821 -0.352 . . . . 0.0 111.087 162.588 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 91.2 mt-30 -132.83 107.81 8.58 Favored 'General case' 0 C--O 1.238 0.464 0 C-N-CA 125.084 1.354 . . . . 0.0 109.61 -176.369 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 65.8 m -110.78 159.45 17.63 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.158 0.583 . . . . 0.0 110.379 175.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.7 ptt180 -146.38 98.0 3.01 Favored 'General case' 0 N--CA 1.462 0.175 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 175.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -136.31 93.25 1.09 Allowed 'Isoleucine or valine' 0 C--O 1.222 -0.379 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -178.549 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.01 40.25 31.94 Favored 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 124.146 0.978 . . . . 0.0 110.965 -177.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 36.0 m 57.07 16.03 2.7 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 124.813 1.245 . . . . 0.0 113.914 -173.627 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 41.3 t -82.32 141.69 14.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.554 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 163.298 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 88.86 -60.62 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 131.238 3.815 . . . . 0.0 111.071 166.406 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 66.9 t 75.45 -69.55 0.15 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.598 0 C-N-CA 126.155 1.782 . . . . 0.0 112.68 160.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -142.21 152.06 23.39 Favored Glycine 0 CA--C 1.524 0.631 0 C-N-CA 126.902 2.192 . . . . 0.0 108.381 169.331 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 51.8 m -140.6 151.25 44.51 Favored 'General case' 0 C--N 1.323 -0.544 0 O-C-N 120.531 -1.57 . . . . 0.0 108.641 177.858 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.9 p90 -138.8 130.14 27.12 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 106.65 -1.611 . . . . 0.0 106.65 -176.355 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 41.9 mt -120.51 133.67 66.45 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 106.15 -1.796 . . . . 0.0 106.15 -166.135 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.83 151.78 21.61 Favored 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 174.377 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.536 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -133.63 97.83 0.32 Allowed Glycine 0 N--CA 1.443 -0.855 0 N-CA-C 107.857 -2.097 . . . . 0.0 107.857 172.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.0 m -139.97 165.65 21.47 Favored 'Isoleucine or valine' 0 C--O 1.234 0.245 0 CA-C-N 119.425 1.613 . . . . 0.0 108.71 168.029 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 161.87 -96.35 0.14 Allowed Glycine 0 C--O 1.227 -0.319 0 N-CA-C 107.249 -2.34 . . . . 0.0 107.249 177.251 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -145.14 150.56 36.99 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.845 1.823 . . . . 0.0 110.923 178.252 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? -123.82 153.46 40.99 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 125.733 1.613 . . . . 0.0 107.023 173.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 49.4 m-85 . . . . . 0 C--O 1.249 1.052 0 N-CA-C 104.455 -2.424 . . . . 0.0 104.455 -175.219 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.606 0 CA-C-O 119.294 -0.384 . . . . 0.0 111.056 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.464 ' H ' ' HB3' ' A' ' 31' ' ' GLU . 36.9 p -134.8 164.89 26.54 Favored 'General case' 0 C--O 1.239 0.534 0 C-N-CA 124.557 1.143 . . . . 0.0 109.233 -169.374 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 12.4 m -143.48 117.25 9.29 Favored 'General case' 0 C--N 1.341 0.213 0 CA-C-N 119.04 0.837 . . . . 0.0 110.917 -178.308 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 5.3 m -60.14 136.45 58.03 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.086 1.355 . . . . 0.0 108.151 169.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.6 m -130.38 125.66 59.79 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 126.543 1.937 . . . . 0.0 108.582 -179.168 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 77.7 p -145.46 157.65 43.97 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 122.872 0.469 . . . . 0.0 111.241 -172.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -153.31 127.41 2.18 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 108.539 -1.825 . . . . 0.0 108.539 175.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -150.27 154.2 25.52 Favored Glycine 0 CA--C 1.521 0.437 0 N-CA-C 109.654 -1.378 . . . . 0.0 109.654 -177.23 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -92.11 135.46 33.96 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 108.423 -0.955 . . . . 0.0 108.423 -176.205 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.561 ' HB2' HD21 ' A' ' 25' ' ' ASN . . . -95.1 118.26 31.6 Favored 'General case' 0 C--O 1.238 0.458 0 C-N-CA 123.895 0.878 . . . . 0.0 108.794 -177.718 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 2.2 mt-30 -113.81 126.68 55.47 Favored 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 125.035 1.334 . . . . 0.0 107.834 -178.452 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 69.0 p -140.07 151.59 45.5 Favored 'General case' 0 C--O 1.237 0.415 0 CA-C-N 118.403 0.547 . . . . 0.0 109.703 164.28 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.5 t0 -138.53 114.3 9.89 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 178.012 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -79.6 158.46 27.09 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.172 0.989 . . . . 0.0 109.616 -170.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.4 mt-30 50.65 -76.94 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 126.183 1.793 . . . . 0.0 113.78 176.066 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -132.4 -89.13 0.42 Allowed Glycine 0 CA--C 1.528 0.868 0 C-N-CA 127.175 2.322 . . . . 0.0 108.67 167.495 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 57.7 mt-30 -146.85 95.81 2.64 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 126.354 1.862 . . . . 0.0 110.172 -177.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 2.1 mtt -151.51 -4.3 0.28 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.345 1.458 . . . . 0.0 112.21 171.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.3 m-80 -81.25 170.47 16.04 Favored 'General case' 0 N--CA 1.443 -0.786 0 C-N-CA 127.211 2.204 . . . . 0.0 107.407 175.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 65.1 tttt -138.89 99.59 3.82 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 165.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -66.67 153.32 43.48 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 175.137 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 176.83 112.17 0.31 Allowed Glycine 0 N--CA 1.445 -0.714 0 N-CA-C 105.469 -3.053 . . . . 0.0 105.469 176.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -178.16 145.38 6.92 Favored Glycine 0 N--CA 1.452 -0.279 0 CA-C-N 118.873 1.336 . . . . 0.0 110.967 -173.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -99.84 173.66 6.58 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 124.95 1.3 . . . . 0.0 107.719 -179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.561 HD21 ' HB2' ' A' ' 10' ' ' ALA . 47.2 m-80 -136.79 163.14 31.33 Favored 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 124.781 1.232 . . . . 0.0 108.076 177.383 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -133.99 135.15 43.26 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 103.496 -2.779 . . . . 0.0 103.496 164.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 66.0 mttm -137.73 140.56 40.76 Favored 'General case' 0 CA--C 1.514 -0.431 0 N-CA-C 103.71 -2.7 . . . . 0.0 103.71 159.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 23.0 p90 -136.22 139.98 43.17 Favored 'General case' 0 C--N 1.322 -0.624 0 N-CA-C 106.408 -1.701 . . . . 0.0 106.408 174.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.457 ' HG2' HH11 ' A' ' 29' ' ' ARG . 53.2 ttp85 -106.53 158.77 16.68 Favored 'General case' 0 C--O 1.236 0.355 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 175.114 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -122.09 157.27 31.81 Favored 'General case' 0 C--O 1.238 0.453 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 161.794 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.464 ' HB3' ' H ' ' A' ' 2' ' ' THR . 2.5 tp10 -137.01 137.9 39.92 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 126.858 2.063 . . . . 0.0 105.637 -171.796 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -129.35 178.51 6.4 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 124.546 1.139 . . . . 0.0 110.969 -166.791 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -127.0 93.43 3.76 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 103.589 -2.745 . . . . 0.0 103.589 169.335 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.1 m-20 -167.36 -56.12 0.03 OUTLIER 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 126.192 1.797 . . . . 0.0 106.248 167.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 17.0 m -145.56 156.69 52.81 Favored Pre-proline 0 C--O 1.238 0.484 0 C-N-CA 122.976 0.511 . . . . 0.0 110.42 -178.414 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 61.6 Cg_endo -72.47 86.87 0.97 Allowed 'Trans proline' 0 N--CA 1.457 -0.622 0 C-N-CA 124.1 3.2 . . . . 0.0 109.607 173.07 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.412 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -145.1 155.12 43.14 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 126.646 1.978 . . . . 0.0 105.71 -179.724 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.412 ' H ' HD13 ' A' ' 37' ' ' LEU . . . -156.16 158.83 28.93 Favored Glycine 0 CA--C 1.522 0.482 0 N-CA-C 108.083 -2.007 . . . . 0.0 108.083 167.586 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 96.1 t -113.91 133.22 60.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.399 0 CA-C-O 118.426 -0.797 . . . . 0.0 109.454 -165.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.461 HG21 ' CE2' ' A' ' 80' ' ' TYR . 31.7 mm -126.78 109.89 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 N-CA-C 107.094 -1.447 . . . . 0.0 107.094 171.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -86.62 -178.11 49.39 Favored Glycine 0 N--CA 1.447 -0.582 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 167.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.3 t -122.63 140.06 53.25 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 108.719 -0.845 . . . . 0.0 108.719 -174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 83.7 t80 -143.81 114.25 7.51 Favored 'General case' 0 N--CA 1.442 -0.837 0 N-CA-C 106.26 -1.755 . . . . 0.0 106.26 165.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 6.7 t -126.11 137.36 53.6 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.272 1.029 . . . . 0.0 108.387 172.866 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 27.6 t80 -143.24 136.52 28.14 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.574 1.15 . . . . 0.0 108.374 -178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.506 HG23 ' HE3' ' A' ' 59' ' ' LYS . 13.7 t -130.67 159.44 37.21 Favored 'General case' 0 C--O 1.235 0.335 0 CA-C-O 122.229 1.014 . . . . 0.0 111.763 179.288 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? -132.62 123.11 25.77 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 125.079 1.352 . . . . 0.0 107.679 176.281 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -159.52 113.93 2.35 Favored 'General case' 0 CA--C 1.514 -0.43 0 N-CA-C 104.341 -2.466 . . . . 0.0 104.341 159.471 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.0 m -113.4 154.75 26.43 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 123.612 0.765 . . . . 0.0 109.955 -176.203 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -105.24 121.39 43.76 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.027 -1.471 . . . . 0.0 107.027 166.457 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 7.8 p -139.84 110.78 6.87 Favored 'General case' 0 C--N 1.322 -0.604 0 N-CA-C 104.203 -2.517 . . . . 0.0 104.203 158.459 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 60.76 54.44 3.58 Favored 'General case' 0 C--N 1.344 0.339 0 C-N-CA 124.357 1.063 . . . . 0.0 111.25 -179.55 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 34.3 t -110.04 -90.44 0.47 Allowed 'General case' 0 C--O 1.233 0.232 0 N-CA-C 105.258 -2.127 . . . . 0.0 105.258 165.64 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -131.43 28.02 4.69 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 123.844 0.858 . . . . 0.0 111.005 -176.155 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 69.23 1.72 28.96 Favored Glycine 0 C--N 1.346 1.136 0 O-C-N 122.026 -0.421 . . . . 0.0 112.098 -176.712 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -84.47 91.22 7.78 Favored 'General case' 0 N--CA 1.435 -1.198 0 C-N-CA 128.893 2.877 . . . . 0.0 106.998 -165.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -55.79 125.21 20.32 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 106.342 -1.725 . . . . 0.0 106.342 -179.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.3 t30 -90.61 -179.36 5.53 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 119.635 -0.826 . . . . 0.0 111.342 -162.027 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.506 ' HE3' HG23 ' A' ' 46' ' ' THR . 33.8 pttt -45.08 134.71 5.9 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.622 1.169 . . . . 0.0 110.004 169.617 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -81.6 -72.1 0.45 Allowed 'General case' 0 C--N 1.326 -0.444 0 N-CA-C 107.556 -1.276 . . . . 0.0 107.556 175.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.5 pm0 -132.29 166.86 20.94 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.832 0.853 . . . . 0.0 110.696 176.458 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 24.5 m-85 -129.62 118.14 21.5 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 105.36 -2.089 . . . . 0.0 105.36 154.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -135.04 116.89 15.12 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 104.75 -2.315 . . . . 0.0 104.75 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -100.77 154.31 19.26 Favored Glycine 0 CA--C 1.52 0.366 0 N-CA-C 107.844 -2.102 . . . . 0.0 107.844 171.567 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 38.3 mm -121.63 107.36 19.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 N-CA-C 104.255 -2.498 . . . . 0.0 104.255 173.17 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 22.0 p -140.35 147.25 39.55 Favored 'General case' 0 N--CA 1.443 -0.812 0 C-N-CA 124.339 1.056 . . . . 0.0 108.178 -170.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -145.85 168.34 21.03 Favored 'General case' 0 N--CA 1.447 -0.584 0 C-N-CA 125.037 1.335 . . . . 0.0 108.347 -178.68 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 161.97 102.11 0.17 Allowed Glycine 0 N--CA 1.449 -0.447 0 N-CA-C 106.245 -2.742 . . . . 0.0 106.245 -178.228 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 17.1 Cg_endo -59.64 154.38 49.19 Favored 'Trans proline' 0 N--CA 1.452 -0.967 0 CA-C-N 119.392 1.596 . . . . 0.0 111.458 -178.515 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -89.95 133.61 34.69 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 125.965 1.706 . . . . 0.0 107.86 -176.393 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.74 101.28 12.95 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 117.243 -1.783 . . . . 0.0 107.619 -165.577 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 5.1 ttp85 -64.83 110.5 2.44 Favored 'General case' 0 N--CA 1.468 0.474 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 178.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 83.1 mt -110.23 -30.26 2.38 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.421 0 C-N-CA 123.996 0.918 . . . . 0.0 108.676 175.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.4 t30 48.96 64.66 1.63 Allowed 'General case' 0 C--O 1.238 0.476 0 C-N-CA 126.108 1.763 . . . . 0.0 110.71 178.075 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 13.6 t70 -153.47 -83.7 0.08 Allowed 'General case' 0 C--O 1.234 0.286 0 C-N-CA 119.738 -0.785 . . . . 0.0 112.479 -171.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 6.2 p-90 -90.68 -70.6 0.67 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 106.573 -1.64 . . . . 0.0 106.573 170.668 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -141.12 -168.37 2.6 Favored 'General case' 0 C--O 1.236 0.368 0 C-N-CA 126.518 1.927 . . . . 0.0 107.957 -178.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 22.3 p -134.13 156.13 48.84 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 156.245 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -120.39 156.46 23.39 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.609 0 C-N-CA 128.588 2.755 . . . . 0.0 109.095 176.698 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.461 ' CE2' HG21 ' A' ' 40' ' ' ILE . 3.2 p90 -149.95 124.6 9.75 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.19 1.396 . . . . 0.0 107.863 171.647 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.29 109.64 1.54 Allowed Glycine 0 C--N 1.332 0.327 0 N-CA-C 109.419 -1.472 . . . . 0.0 109.419 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 8.8 m -103.6 155.8 5.5 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.555 0 CA-C-N 117.328 0.564 . . . . 0.0 112.278 -164.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 12.9 m -151.63 164.33 2.38 Favored 'Isoleucine or valine' 0 C--O 1.236 0.353 0 C-N-CA 127.052 2.141 . . . . 0.0 109.879 -171.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 161.71 -102.86 0.21 Allowed Glycine 0 C--N 1.334 0.434 0 N-CA-C 109.768 -1.333 . . . . 0.0 109.768 171.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 14.7 p -144.53 150.21 16.64 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.401 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 169.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -111.67 141.13 16.49 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 107.95 -2.06 . . . . 0.0 107.95 166.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -143.16 150.33 39.26 Favored 'General case' 0 C--O 1.233 0.198 0 CA-C-O 122.123 0.964 . . . . 0.0 109.447 179.752 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 139.49 167.51 10.99 Favored Glycine 0 CA--C 1.524 0.624 0 C-N-CA 127.37 2.414 . . . . 0.0 107.747 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.459 ' HE2' HG21 ' A' ' 135' ' ' VAL . 23.9 tttt -168.31 175.96 6.16 Favored 'General case' 0 CA--C 1.531 0.238 0 C-N-CA 125.008 1.323 . . . . 0.0 107.962 169.298 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 -85.01 154.34 22.17 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 156.59 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -160.31 110.58 1.82 Allowed 'General case' 0 N--CA 1.465 0.305 0 CA-C-O 117.681 -1.152 . . . . 0.0 108.843 -174.246 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 12.1 t -128.71 150.92 50.06 Favored 'General case' 0 C--O 1.233 0.221 0 CA-C-N 119.472 1.033 . . . . 0.0 109.043 171.326 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 18.1 p -147.54 -94.85 0.08 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 126.161 1.784 . . . . 0.0 107.111 166.485 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 14.1 tt0 -149.4 -54.88 0.18 Allowed 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.708 1.603 . . . . 0.0 108.938 -174.578 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -139.54 166.27 25.51 Favored Pre-proline 0 CA--C 1.539 0.53 0 C-N-CA 125.946 1.698 . . . . 0.0 107.816 -175.254 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -73.54 65.04 4.67 Favored 'Trans proline' 0 CA--C 1.541 0.825 0 C-N-CA 123.62 2.88 . . . . 0.0 111.594 175.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 69.7 m -140.27 -71.33 0.38 Allowed 'General case' 0 C--O 1.235 0.316 0 N-CA-C 106.957 -1.497 . . . . 0.0 106.957 168.809 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -67.5 154.24 41.86 Favored 'General case' 0 CA--C 1.533 0.297 0 CA-C-N 119.488 1.04 . . . . 0.0 109.173 169.786 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.56 153.05 42.16 Favored 'General case' 0 N--CA 1.465 0.276 0 C-N-CA 125.601 1.56 . . . . 0.0 106.858 173.662 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 32.0 t30 -66.5 -59.22 3.85 Favored 'General case' 0 N--CA 1.464 0.271 0 CA-C-N 119.192 0.905 . . . . 0.0 109.616 179.011 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 16.2 t0 178.52 90.67 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.26 0 C-N-CA 123.712 0.805 . . . . 0.0 109.59 -164.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 3.2 p -139.54 165.19 27.89 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.036 0.935 . . . . 0.0 113.212 -177.262 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.2 t 69.77 89.09 0.1 Allowed 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.209 2.604 . . . . 0.0 108.202 -172.537 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -134.98 168.45 19.08 Favored 'General case' 0 C--O 1.238 0.489 0 N-CA-C 106.686 -1.598 . . . . 0.0 106.686 169.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -97.18 142.48 29.04 Favored 'General case' 0 C--O 1.237 0.411 0 N-CA-C 107.224 -1.399 . . . . 0.0 107.224 164.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -123.49 167.47 15.75 Favored Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.076 -2.009 . . . . 0.0 108.076 154.14 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -112.91 145.71 40.26 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 106.984 -1.487 . . . . 0.0 106.984 173.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 96.7 p -123.97 148.66 46.76 Favored 'General case' 0 CA--C 1.532 0.266 0 O-C-N 124.734 1.271 . . . . 0.0 110.907 162.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 7.0 t80 -148.3 142.37 25.97 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.35 1.86 . . . . 0.0 106.343 166.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -168.0 173.42 42.89 Favored Glycine 0 CA--C 1.525 0.716 0 N-CA-C 107.752 -2.139 . . . . 0.0 107.752 177.479 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -129.12 89.11 2.81 Favored 'General case' 0 C--O 1.239 0.535 0 C-N-CA 123.785 0.834 . . . . 0.0 110.17 -170.301 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -90.91 -165.93 40.49 Favored Glycine 0 CA--C 1.524 0.633 0 C-N-CA 125.25 1.405 . . . . 0.0 111.102 173.27 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -168.87 174.71 6.3 Favored 'General case' 0 C--N 1.321 -0.635 0 C-N-CA 129.709 3.203 . . . . 0.0 106.011 -170.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 52.3 mt-30 -145.68 135.53 23.51 Favored 'General case' 0 C--O 1.235 0.293 0 N-CA-C 106.77 -1.567 . . . . 0.0 106.77 165.878 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -135.15 161.28 35.8 Favored 'General case' 0 C--O 1.237 0.397 0 CA-C-N 118.353 0.524 . . . . 0.0 110.019 -177.796 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 26.6 m120 -135.01 99.93 12.13 Favored Pre-proline 0 CA--C 1.533 0.326 0 N-CA-C 106.973 -1.492 . . . . 0.0 106.973 177.174 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 90.8 Cg_endo -85.72 -18.41 3.78 Favored 'Trans proline' 0 CA--C 1.533 0.447 0 C-N-CA 122.178 1.919 . . . . 0.0 111.858 176.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 81.8 mtp -139.85 -176.2 4.49 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.35 2.66 . . . . 0.0 105.554 176.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.4 mt-10 -103.94 -3.7 24.37 Favored 'General case' 0 CA--C 1.539 0.522 0 O-C-N 121.602 -0.686 . . . . 0.0 110.633 168.241 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 12.9 m120 -110.56 -16.45 13.65 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 124.588 1.155 . . . . 0.0 111.982 -174.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 29.5 m -133.6 139.04 49.71 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.737 0 N-CA-C 105.819 -1.919 . . . . 0.0 105.819 161.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -108.33 174.87 5.68 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.202 1.401 . . . . 0.0 109.185 162.694 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -126.64 116.03 20.38 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.326 1.45 . . . . 0.0 107.42 179.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -126.42 128.13 46.51 Favored 'General case' 0 N--CA 1.468 0.439 0 C-N-CA 124.469 1.107 . . . . 0.0 109.177 179.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 28.1 t80 -150.08 122.67 8.56 Favored 'General case' 0 N--CA 1.452 -0.355 0 C-N-CA 124.043 0.937 . . . . 0.0 108.733 -179.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 73.7 m -133.24 159.27 40.69 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 162.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 10.8 t80 -149.84 115.45 5.55 Favored 'General case' 0 CA--C 1.514 -0.404 0 N-CA-C 105.005 -2.22 . . . . 0.0 105.005 -177.894 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -127.83 166.11 18.86 Favored 'General case' 0 N--CA 1.447 -0.622 0 C-N-CA 126.225 1.81 . . . . 0.0 107.649 -160.78 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -131.01 118.15 20.2 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 106.344 -1.725 . . . . 0.0 106.344 178.076 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 27.8 m -111.43 105.22 13.76 Favored 'General case' 0 N--CA 1.445 -0.706 0 N-CA-C 103.825 -2.657 . . . . 0.0 103.825 162.153 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 41.7 mtm180 -96.21 117.45 30.78 Favored 'General case' 0 CA--C 1.505 -0.786 0 N-CA-C 105.698 -1.964 . . . . 0.0 105.698 163.054 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -124.43 97.25 4.37 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 104.822 -2.288 . . . . 0.0 104.822 163.897 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 31.1 ttm180 57.32 46.03 19.15 Favored 'General case' 0 N--CA 1.47 0.565 0 CA-C-O 121.139 0.495 . . . . 0.0 111.612 172.092 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 49.8 m 59.79 9.9 1.85 Allowed 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 126.816 2.047 . . . . 0.0 114.757 -176.608 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.459 HG21 ' HE2' ' A' ' 89' ' ' LYS . 47.1 t -86.58 148.13 4.88 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.691 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 165.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 3.4 t70 77.07 -56.04 0.54 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 130.382 3.473 . . . . 0.0 112.974 170.073 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.8 t 78.89 -67.42 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 C-N-CA 127.556 2.342 . . . . 0.0 112.511 155.639 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.06 143.67 13.6 Favored Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.569 -2.612 . . . . 0.0 106.569 177.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 26.1 p -135.7 120.48 18.45 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 107.205 -1.405 . . . . 0.0 107.205 -171.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 7.1 p90 -119.26 124.67 47.28 Favored 'General case' 0 C--O 1.237 0.431 0 N-CA-C 108.496 -0.928 . . . . 0.0 108.496 -174.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -135.24 110.92 12.62 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.606 0 N-CA-C 107.255 -1.387 . . . . 0.0 107.255 -170.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.65 161.22 39.71 Favored 'General case' 0 C--O 1.241 0.643 0 C-N-CA 123.731 0.812 . . . . 0.0 108.914 179.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 174.38 -143.56 7.01 Favored Glycine 0 N--CA 1.448 -0.557 0 N-CA-C 110.972 -0.851 . . . . 0.0 110.972 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 19.3 m -136.62 -174.87 1.14 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 126.844 2.058 . . . . 0.0 107.901 -173.836 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -172.01 -151.17 7.64 Favored Glycine 0 N--CA 1.439 -1.136 0 N-CA-C 106.386 -2.686 . . . . 0.0 106.386 177.008 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.4 m-85 -140.35 176.43 8.78 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 127.319 2.247 . . . . 0.0 106.976 176.902 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.5 ttm-85 -114.79 153.17 30.85 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 106.892 -1.521 . . . . 0.0 106.892 154.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.253 1.287 0 N-CA-C 107.22 -1.4 . . . . 0.0 107.22 159.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.547 0 CA-C-O 119.088 -0.482 . . . . 0.0 110.151 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.3 m -150.78 151.43 32.33 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 108.768 -0.827 . . . . 0.0 108.768 176.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.8 m -110.93 159.08 18.04 Favored 'General case' 0 N--CA 1.451 -0.382 0 C-N-CA 125.314 1.446 . . . . 0.0 111.012 174.257 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 74.6 m -136.55 103.98 5.42 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 105.787 -1.931 . . . . 0.0 105.787 -179.573 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.518 HG23 ' H ' ' A' ' 146' ' ' TYR . 6.4 m -100.89 139.51 22.01 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 N-CA-C 107.574 -1.269 . . . . 0.0 107.574 175.994 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 70.5 p -147.15 119.16 8.19 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 123.057 0.543 . . . . 0.0 109.953 -163.231 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -131.13 97.47 0.36 Allowed Glycine 0 CA--C 1.524 0.653 0 C-N-CA 126.165 1.841 . . . . 0.0 108.823 176.542 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -114.24 -168.46 16.26 Favored Glycine 0 CA--C 1.522 0.503 0 C-N-CA 126.977 2.227 . . . . 0.0 109.115 167.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -112.55 140.2 47.51 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.342 -1.355 . . . . 0.0 107.342 172.37 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -127.28 146.71 50.34 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.778 1.231 . . . . 0.0 110.428 173.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -144.36 164.94 29.33 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 126.629 1.972 . . . . 0.0 109.256 -177.7 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.2 p -131.86 123.52 27.67 Favored 'General case' 0 C--O 1.24 0.595 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 174.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.3 t0 -133.8 170.87 14.95 Favored 'General case' 0 C--N 1.326 -0.432 0 C-N-CA 124.05 0.94 . . . . 0.0 108.621 177.248 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 161.12 42.66 Favored 'General case' 0 C--O 1.238 0.461 0 C-N-CA 124.845 1.258 . . . . 0.0 107.875 173.571 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 54.5 tt0 -70.56 82.07 0.59 Allowed 'General case' 0 C--O 1.234 0.245 0 N-CA-C 108.484 -0.932 . . . . 0.0 108.484 167.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 176.48 -134.12 2.49 Favored Glycine 0 N--CA 1.436 -1.361 0 N-CA-C 105.798 -2.921 . . . . 0.0 105.798 -174.32 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.7 tm0? -150.33 96.45 2.4 Favored 'General case' 0 N--CA 1.444 -0.757 0 N-CA-C 105.054 -2.202 . . . . 0.0 105.054 -171.306 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -158.95 -5.67 0.07 Allowed 'General case' 0 CA--C 1.543 0.691 0 N-CA-C 113.933 1.086 . . . . 0.0 113.933 -177.153 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -39.18 120.42 1.01 Allowed 'General case' 0 C--O 1.24 0.598 0 C-N-CA 130.626 3.57 . . . . 0.0 113.105 -161.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 25.9 mttm -129.33 152.46 48.86 Favored 'General case' 0 C--N 1.331 -0.202 0 C-N-CA 127.115 2.166 . . . . 0.0 110.594 174.352 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 13.8 ttt -137.65 84.28 2.04 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 125.406 1.482 . . . . 0.0 107.861 -176.382 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -52.7 -72.9 0.45 Allowed Glycine 0 C--N 1.336 0.557 0 C-N-CA 125.593 1.568 . . . . 0.0 114.44 -171.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 159.83 -97.33 0.16 Allowed Glycine 0 N--CA 1.448 -0.553 0 N-CA-C 108.74 -1.744 . . . . 0.0 108.74 -165.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -146.88 174.27 11.65 Favored 'General case' 0 C--O 1.241 0.606 0 CA-C-N 119.189 1.494 . . . . 0.0 110.341 -171.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 36.6 p30 -115.69 161.53 18.57 Favored 'General case' 0 CA--C 1.532 0.255 0 C-N-CA 124.978 1.311 . . . . 0.0 109.218 167.418 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -138.4 119.16 14.12 Favored 'General case' 0 C--O 1.236 0.395 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 -177.017 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 15.6 ttmm -104.34 145.19 30.6 Favored 'General case' 0 C--O 1.235 0.322 0 C-N-CA 124.847 1.259 . . . . 0.0 108.794 -177.862 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 10.5 t80 -144.81 136.43 25.52 Favored 'General case' 0 C--O 1.235 0.331 0 N-CA-C 108.472 -0.936 . . . . 0.0 108.472 174.222 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 6.4 ptm180 -120.58 163.56 17.82 Favored 'General case' 0 CA--C 1.508 -0.636 0 C-N-CA 126.525 1.93 . . . . 0.0 108.228 175.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 7.9 t80 -135.53 108.39 7.57 Favored 'General case' 0 N--CA 1.443 -0.792 0 N-CA-C 106.258 -1.756 . . . . 0.0 106.258 160.411 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 5.7 tm-20 -115.15 122.2 45.35 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 103.762 -2.681 . . . . 0.0 103.762 178.276 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.4 tp10 -141.06 179.35 6.79 Favored 'General case' 0 C--O 1.239 0.521 0 N-CA-C 105.257 -2.127 . . . . 0.0 105.257 179.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 15.6 t70 -76.83 -55.9 5.07 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 118.537 -1.265 . . . . 0.0 109.394 156.286 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 10.9 m120 -75.51 -40.41 57.11 Favored 'General case' 0 N--CA 1.463 0.221 0 C-N-CA 123.202 0.601 . . . . 0.0 112.357 -163.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 68.2 m -84.15 113.95 51.41 Favored Pre-proline 0 CA--C 1.534 0.362 0 N-CA-C 106.996 -1.483 . . . . 0.0 106.996 168.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_endo -63.67 144.67 90.05 Favored 'Trans proline' 0 N--CA 1.456 -0.723 0 C-N-CA 121.848 1.698 . . . . 0.0 110.529 -175.161 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 tm? -74.11 145.18 44.54 Favored 'General case' 0 N--CA 1.457 -0.088 0 N-CA-C 107.317 -1.364 . . . . 0.0 107.317 172.469 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . 158.72 12.58 0.04 OUTLIER Glycine 0 CA--C 1.527 0.82 0 CA-C-O 118.597 -1.113 . . . . 0.0 111.911 -167.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 16.1 m -135.64 140.11 45.11 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 CA-C-N 119.291 1.545 . . . . 0.0 110.239 -165.647 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.589 HD11 ' HB2' ' A' ' 70' ' ' ALA . 0.2 OUTLIER -136.3 150.61 27.83 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 105.137 -2.171 . . . . 0.0 105.137 154.079 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.86 127.07 7.26 Favored Glycine 0 C--O 1.237 0.287 0 N-CA-C 106.058 -2.817 . . . . 0.0 106.058 160.736 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.1 t -123.97 123.89 41.39 Favored 'General case' 0 C--N 1.332 -0.194 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -123.13 131.78 53.82 Favored 'General case' 0 C--O 1.235 0.304 0 C-N-CA 124.869 1.268 . . . . 0.0 107.967 178.457 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 24.0 m -129.51 151.86 49.68 Favored 'General case' 0 CA--C 1.535 0.381 0 N-CA-C 107.965 -1.124 . . . . 0.0 107.965 164.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 40.4 p90 -128.53 157.81 40.15 Favored 'General case' 0 N--CA 1.466 0.375 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 171.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.21 158.43 26.01 Favored 'General case' 0 N--CA 1.465 0.309 0 CA-C-N 119.117 0.872 . . . . 0.0 109.519 171.06 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.3 tt0 -154.43 107.25 2.83 Favored 'General case' 0 CA--C 1.532 0.257 0 N-CA-C 105.047 -2.205 . . . . 0.0 105.047 -179.173 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.9 mmtt -175.9 146.85 0.74 Allowed 'General case' 0 N--CA 1.476 0.84 0 CA-C-N 120.09 1.313 . . . . 0.0 112.552 166.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -98.43 156.96 16.5 Favored 'General case' 0 C--N 1.323 -0.58 0 C-N-CA 127.207 2.203 . . . . 0.0 108.96 162.474 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.9 tpm_? -128.29 99.72 5.54 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 103.25 -2.87 . . . . 0.0 103.25 170.187 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 4.1 t -157.66 -179.29 8.01 Favored 'General case' 0 CA--C 1.534 0.358 0 CA-C-N 118.725 0.693 . . . . 0.0 111.489 -167.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 89.03 57.23 0.01 OUTLIER 'General case' 0 C--O 1.236 0.382 1 C-N-CA 131.881 4.072 . . . . 0.0 109.181 177.005 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 62.3 m -146.49 -66.04 0.29 Allowed 'General case' 0 N--CA 1.453 -0.32 0 C-N-CA 124.626 1.17 . . . . 0.0 109.131 166.012 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.8 m -125.68 12.87 8.01 Favored 'General case' 0 N--CA 1.468 0.455 0 CA-C-N 119.425 1.011 . . . . 0.0 113.706 -159.829 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 83.31 68.39 1.43 Allowed Glycine 0 C--N 1.337 0.619 0 N-CA-C 106.605 -2.598 . . . . 0.0 106.605 -172.135 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 42.4 m-20 -113.71 91.31 3.59 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 106.861 -1.533 . . . . 0.0 106.861 -172.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -95.14 116.21 28.43 Favored 'General case' 0 N--CA 1.451 -0.4 0 N-CA-C 107.048 -1.464 . . . . 0.0 107.048 164.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 9.5 p30 -138.54 148.05 43.79 Favored 'General case' 0 N--CA 1.444 -0.756 0 C-N-CA 125.189 1.396 . . . . 0.0 107.678 164.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 2.1 mtpm? -153.99 166.04 34.25 Favored 'General case' 0 C--N 1.321 -0.649 0 C-N-CA 128.49 2.716 . . . . 0.0 104.09 163.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.449 ' ND2' ' H ' ' A' ' 89' ' ' LYS . 0.3 OUTLIER 168.97 115.97 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 101.948 -3.353 . . . . 0.0 101.948 -157.872 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -126.89 137.72 53.2 Favored 'General case' 0 CA--C 1.518 -0.275 0 CA-C-N 119.93 1.241 . . . . 0.0 108.947 177.366 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 57.8 m-85 -75.13 126.37 30.88 Favored 'General case' 0 N--CA 1.446 -0.667 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 176.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 38.0 m-85 -135.99 117.45 14.76 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 106.283 -1.747 . . . . 0.0 106.283 160.588 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -112.06 170.23 13.5 Favored Glycine 0 N--CA 1.448 -0.542 0 N-CA-C 108.686 -1.766 . . . . 0.0 108.686 168.153 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -119.99 145.69 25.89 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.537 0 N-CA-C 103.994 -2.595 . . . . 0.0 103.994 162.695 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 73.3 p -124.92 132.72 53.25 Favored 'General case' 0 C--N 1.323 -0.566 0 N-CA-C 105.755 -1.943 . . . . 0.0 105.755 179.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.34 138.59 15.69 Favored 'General case' 0 C--O 1.235 0.319 0 CA-C-N 120.552 1.524 . . . . 0.0 112.929 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 156.34 166.96 16.96 Favored Glycine 0 CA--C 1.527 0.814 0 C-N-CA 124.775 1.178 . . . . 0.0 110.672 171.498 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 73.7 Cg_endo -69.24 149.76 70.59 Favored 'Trans proline' 0 N--CA 1.45 -1.055 0 C-N-CA 122.002 1.802 . . . . 0.0 111.044 178.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.589 ' HB2' HD11 ' A' ' 40' ' ' ILE . . . -124.0 176.47 6.33 Favored 'General case' 0 N--CA 1.464 0.247 0 O-C-N 123.956 0.785 . . . . 0.0 111.418 172.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -89.3 107.62 19.16 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 109.551 -0.537 . . . . 0.0 109.551 -176.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.85 90.32 0.13 Allowed 'General case' 0 C--N 1.342 0.267 0 N-CA-C 106.049 -1.834 . . . . 0.0 106.049 147.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 28.3 mm -67.14 152.67 9.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.209 -2.515 . . . . 0.0 104.209 151.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 7.3 m120 -71.39 -90.17 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 108.029 -1.1 . . . . 0.0 108.029 170.156 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -147.79 83.96 1.53 Allowed 'General case' 0 N--CA 1.462 0.136 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 -167.948 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 91.3 m95 -159.09 -51.71 0.06 Allowed 'General case' 0 N--CA 1.464 0.273 0 C-N-CA 128.108 2.563 . . . . 0.0 106.87 179.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -146.55 -169.41 3.27 Favored 'General case' 0 C--O 1.232 0.152 0 C-N-CA 126.357 1.863 . . . . 0.0 107.506 170.415 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 5.2 p -148.83 138.67 22.08 Favored 'General case' 0 C--O 1.237 0.422 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 149.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -136.6 157.81 36.97 Favored 'Isoleucine or valine' 0 C--O 1.237 0.396 0 CA-C-N 118.715 0.688 . . . . 0.0 109.764 -174.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.17 165.48 26.55 Favored 'General case' 0 C--O 1.234 0.278 0 C-N-CA 124.423 1.089 . . . . 0.0 108.068 172.525 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -159.21 104.44 0.25 Allowed Glycine 0 N--CA 1.447 -0.572 0 N-CA-C 105.137 -3.185 . . . . 0.0 105.137 176.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.1 -178.11 1.84 Allowed 'Isoleucine or valine' 0 CA--C 1.537 0.476 0 C-N-CA 125.157 1.383 . . . . 0.0 108.997 -176.134 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.0 t -132.76 130.97 59.49 Favored 'Isoleucine or valine' 0 C--O 1.24 0.57 0 N-CA-C 106.325 -1.731 . . . . 0.0 106.325 -174.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -133.48 -179.07 16.01 Favored Glycine 0 N--CA 1.448 -0.552 0 CA-C-O 122.42 1.011 . . . . 0.0 111.827 -178.085 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 8.6 p -141.94 151.53 18.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 C-N-CA 125.512 1.525 . . . . 0.0 108.001 -167.933 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.58 158.0 22.01 Favored Glycine 0 CA--C 1.522 0.491 0 N-CA-C 108.229 -1.948 . . . . 0.0 108.229 160.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 33.1 t80 -144.09 116.93 8.77 Favored 'General case' 0 C--N 1.324 -0.503 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.888 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . 0.49 ' H ' ' HA ' ' A' ' 104' ' ' ASP . . . -79.91 151.99 34.41 Favored Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.686 -1.366 . . . . 0.0 109.686 178.42 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.449 ' H ' ' ND2' ' A' ' 60' ' ' ASN . 31.1 tptt -145.66 96.5 2.82 Favored 'General case' 0 N--CA 1.452 -0.353 0 N-CA-C 107.367 -1.346 . . . . 0.0 107.367 -173.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 22.3 p90 -57.42 137.5 56.1 Favored 'General case' 0 N--CA 1.454 -0.257 0 C-N-CA 123.29 0.636 . . . . 0.0 110.361 179.574 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -119.24 62.68 0.8 Allowed 'General case' 0 CA--C 1.539 0.543 0 C-N-CA 124.081 0.952 . . . . 0.0 109.191 170.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 52.4 m -65.97 107.26 1.81 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 130.214 3.406 . . . . 0.0 106.239 175.166 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -145.02 16.3 1.55 Allowed 'General case' 0 CA--C 1.544 0.749 0 N-CA-C 113.174 0.805 . . . . 0.0 113.174 -170.151 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.4 mm-40 -128.92 75.46 1.65 Allowed 'General case' 0 C--O 1.233 0.212 0 O-C-N 120.813 -1.179 . . . . 0.0 108.498 172.869 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 89.3 m-85 66.44 170.17 0.1 Allowed Pre-proline 0 CA--C 1.537 0.459 0 C-N-CA 128.716 2.807 . . . . 0.0 113.095 166.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_endo -62.34 -17.82 59.44 Favored 'Trans proline' 0 CA--C 1.537 0.665 0 CA-C-N 119.919 1.007 . . . . 0.0 112.259 170.922 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.9 m -47.15 -53.74 12.29 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 128.445 2.698 . . . . 0.0 111.983 -178.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -143.4 171.72 13.75 Favored 'General case' 0 N--CA 1.452 -0.34 0 CA-C-N 118.81 0.732 . . . . 0.0 109.297 174.227 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 32.4 mttm -143.76 168.42 19.96 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 107.284 -1.376 . . . . 0.0 107.284 -171.134 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -70.08 -91.22 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.654 0 CA-C-N 118.173 0.442 . . . . 0.0 110.96 176.73 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 34.4 t0 -171.75 175.9 3.82 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 124.706 1.202 . . . . 0.0 108.2 -173.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -136.02 98.14 3.8 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 120.421 1.464 . . . . 0.0 110.11 -177.557 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.3 m -152.24 136.89 16.94 Favored 'General case' 0 C--O 1.233 0.23 0 N-CA-C 107.774 -1.195 . . . . 0.0 107.774 174.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . 0.49 ' HA ' ' H ' ' A' ' 88' ' ' GLY . 27.6 p-10 -167.04 176.36 6.96 Favored 'General case' 0 C--N 1.327 -0.412 0 C-N-CA 127.878 2.471 . . . . 0.0 109.329 -179.898 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER 57.76 66.93 1.03 Allowed 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.954 1.302 . . . . 0.0 110.513 -171.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -87.5 175.91 46.1 Favored Glycine 0 CA--C 1.527 0.826 0 O-C-N 121.187 -0.946 . . . . 0.0 111.182 174.412 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 26.5 m-85 -126.96 148.76 50.06 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 126.601 1.96 . . . . 0.0 108.11 169.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 11.1 t -140.96 143.85 34.77 Favored 'General case' 0 C--O 1.24 0.564 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 171.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 36.7 t80 -152.95 130.93 11.78 Favored 'General case' 0 C--O 1.237 0.428 0 N-CA-C 108.929 -0.767 . . . . 0.0 108.929 -177.497 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 141.1 -157.36 25.98 Favored Glycine 0 N--CA 1.448 -0.546 0 N-CA-C 108.469 -1.852 . . . . 0.0 108.469 -177.209 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -165.91 -84.61 0.02 OUTLIER 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 106.543 -1.651 . . . . 0.0 106.543 168.21 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.459 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 154.62 169.67 19.56 Favored Glycine 0 N--CA 1.443 -0.881 0 N-CA-C 108.812 -1.715 . . . . 0.0 108.812 -172.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.459 HD22 ' C ' ' A' ' 112' ' ' GLY . 3.9 mm? -135.79 152.16 50.82 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 106.161 -1.792 . . . . 0.0 106.161 -172.171 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 8.1 pt20 -126.12 159.7 32.16 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 108.113 -1.069 . . . . 0.0 108.113 171.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 13.4 m-85 -92.76 172.39 8.38 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.992 0.901 . . . . 0.0 109.229 163.753 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 8.2 p-10 -63.5 104.11 0.47 Allowed Pre-proline 0 N--CA 1.451 -0.398 0 C-N-CA 128.398 2.679 . . . . 0.0 110.059 -177.269 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.4 Cg_endo -77.9 110.96 3.02 Favored 'Trans proline' 0 N--CA 1.447 -1.211 0 C-N-CA 123.375 2.716 . . . . 0.0 110.42 -167.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 22.3 ttt -158.49 138.09 11.88 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 106.118 -1.808 . . . . 0.0 106.118 175.233 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 121.69 29.59 0.0 OUTLIER 'General case' 0 N--CA 1.48 1.048 0 C-N-CA 130.441 3.497 . . . . 0.0 110.304 164.863 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.4 m120 62.4 33.8 16.03 Favored 'General case' 0 N--CA 1.466 0.351 0 C-N-CA 124.469 1.108 . . . . 0.0 110.057 -166.214 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 m -144.6 167.41 11.19 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.488 0 C-N-CA 126.06 1.744 . . . . 0.0 109.948 175.108 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -147.34 119.34 8.2 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 128.614 2.766 . . . . 0.0 105.752 165.27 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -87.3 116.27 25.28 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 106.926 -1.509 . . . . 0.0 106.926 -176.908 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 13.2 t70 -127.51 131.39 50.11 Favored 'General case' 0 C--O 1.234 0.275 0 C-N-CA 125.009 1.323 . . . . 0.0 109.834 -169.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 -131.15 150.83 51.97 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 125.245 1.418 . . . . 0.0 109.433 179.813 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 40.4 t -145.37 142.34 29.28 Favored 'General case' 0 C--O 1.239 0.521 0 C-N-CA 127.156 2.182 . . . . 0.0 106.452 171.216 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -145.7 122.61 11.32 Favored 'General case' 0 C--O 1.239 0.539 0 N-CA-C 104.893 -2.262 . . . . 0.0 104.893 173.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.3 mt-10 -132.17 153.47 50.52 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 177.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 25.7 pt20 -117.27 143.96 45.35 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.065 -1.087 . . . . 0.0 108.065 176.18 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -140.7 152.98 45.76 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.969 1.307 . . . . 0.0 108.186 -179.025 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 11.8 ttt85 -144.28 96.62 2.91 Favored 'General case' 0 CA--C 1.514 -0.421 0 N-CA-C 105.451 -2.055 . . . . 0.0 105.451 169.042 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.575 ' O ' HG22 ' A' ' 135' ' ' VAL . 4.2 mp -88.03 110.9 21.5 Favored 'Isoleucine or valine' 0 CA--C 1.518 -0.28 0 N-CA-C 104.946 -2.242 . . . . 0.0 104.946 174.465 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.9 ttt180 75.71 -65.11 0.34 Allowed 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 128.154 2.582 . . . . 0.0 111.215 174.705 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.42 -3.65 0.1 Allowed 'General case' 0 N--CA 1.444 -0.745 0 C-N-CA 128.993 2.917 . . . . 0.0 109.313 -169.871 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.575 HG22 ' O ' ' A' ' 132' ' ' ILE . 24.6 m -102.71 105.84 18.89 Favored 'Isoleucine or valine' 0 C--N 1.345 0.409 0 CA-C-N 119.636 1.107 . . . . 0.0 109.257 -167.098 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.8 m-20 -82.49 81.7 8.21 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 -173.164 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 95.1 t -86.54 140.2 16.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.392 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 178.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -139.33 115.02 1.06 Allowed Glycine 0 C--O 1.236 0.242 0 N-CA-C 107.972 -2.051 . . . . 0.0 107.972 172.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 19.6 m -83.13 138.1 33.81 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 107.355 -1.35 . . . . 0.0 107.355 176.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 8.9 p-90 -130.59 133.95 46.6 Favored 'General case' 0 N--CA 1.441 -0.883 0 N-CA-C 105.315 -2.106 . . . . 0.0 105.315 174.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.7 mp -131.73 125.29 55.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 N-CA-C 104.398 -2.445 . . . . 0.0 104.398 174.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -133.78 142.54 47.95 Favored 'General case' 0 C--N 1.324 -0.541 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 173.522 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -174.19 -170.07 37.06 Favored Glycine 0 N--CA 1.447 -0.608 0 C-N-CA 120.807 -0.711 . . . . 0.0 112.382 -166.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 20.9 m -127.44 -176.15 1.46 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.432 0 C-N-CA 127.275 2.23 . . . . 0.0 107.642 178.835 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -167.16 -145.37 4.46 Favored Glycine 0 C--O 1.226 -0.355 0 N-CA-C 108.401 -1.88 . . . . 0.0 108.401 -168.003 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.518 ' H ' HG23 ' A' ' 5' ' ' VAL . 94.7 m-85 -150.46 164.87 34.83 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 128.032 2.533 . . . . 0.0 105.834 166.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 8.6 ttm180 -92.39 137.86 32.01 Favored 'General case' 0 C--O 1.235 0.326 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 168.601 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.0 m-85 . . . . . 0 C--O 1.247 0.973 0 N-CA-C 107.786 -1.19 . . . . 0.0 107.786 164.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.602 0 N-CA-C 107.999 -1.111 . . . . 0.0 107.999 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 12.9 p -144.82 148.14 33.67 Favored 'General case' 0 C--O 1.237 0.442 0 CA-C-N 119.612 1.096 . . . . 0.0 110.178 -169.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 2.2 m -132.04 106.2 7.87 Favored 'General case' 0 C--N 1.333 -0.109 0 C-N-CA 124.122 0.969 . . . . 0.0 110.543 -170.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.8 p -82.86 116.32 22.13 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.017 1.327 . . . . 0.0 107.751 169.466 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.513 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 8.0 p -100.22 175.78 0.85 Allowed 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 125.017 1.327 . . . . 0.0 109.51 177.465 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -134.32 167.51 20.58 Favored 'General case' 0 CA--C 1.536 0.425 0 O-C-N 120.91 -1.119 . . . . 0.0 110.088 164.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -178.41 107.38 0.23 Allowed Glycine 0 N--CA 1.448 -0.536 0 N-CA-C 106.093 -2.803 . . . . 0.0 106.093 -175.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -160.97 -154.27 7.33 Favored Glycine 0 N--CA 1.451 -0.313 0 N-CA-C 109.62 -1.392 . . . . 0.0 109.62 -172.643 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -132.92 130.17 39.28 Favored 'General case' 0 CA--C 1.509 -0.62 0 N-CA-C 109.012 -0.736 . . . . 0.0 109.012 177.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.11 157.02 16.07 Favored 'General case' 0 N--CA 1.44 -0.927 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 165.032 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -149.28 134.82 18.55 Favored 'General case' 0 N--CA 1.448 -0.565 0 N-CA-C 106.022 -1.844 . . . . 0.0 106.022 172.378 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 3.6 t -139.69 152.01 46.35 Favored 'General case' 0 N--CA 1.445 -0.718 0 N-CA-C 107.94 -1.133 . . . . 0.0 107.94 167.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 2.9 p30 -117.91 161.87 19.06 Favored 'General case' 0 C--N 1.321 -0.648 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 157.958 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.463 ' HB1' HG11 ' A' ' 135' ' ' VAL . . . -95.27 128.64 42.27 Favored 'General case' 0 N--CA 1.445 -0.677 0 N-CA-C 105.46 -2.052 . . . . 0.0 105.46 165.362 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 39.1 tt0 66.76 -62.26 0.3 Allowed 'General case' 0 CA--C 1.539 0.554 0 C-N-CA 127.307 2.243 . . . . 0.0 112.259 176.047 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -170.93 -52.68 0.04 OUTLIER Glycine 0 CA--C 1.522 0.476 0 N-CA-C 109.65 -1.38 . . . . 0.0 109.65 176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 50.2 mt-30 -141.5 96.11 2.93 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 124.706 1.202 . . . . 0.0 107.827 172.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -122.3 -59.08 1.67 Allowed 'General case' 0 C--N 1.332 -0.19 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 168.66 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 5.1 p30 -157.52 160.79 38.58 Favored 'General case' 0 C--O 1.235 0.321 0 C-N-CA 127.192 2.197 . . . . 0.0 107.164 176.366 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 38.4 tttp -110.79 85.53 2.13 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 107.703 -1.221 . . . . 0.0 107.703 -163.363 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 53.8 mtm -72.53 149.4 44.11 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.845 0.831 . . . . 0.0 109.14 -179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 171.9 165.69 29.45 Favored Glycine 0 N--CA 1.445 -0.703 0 N-CA-C 106.001 -2.84 . . . . 0.0 106.001 -177.773 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 178.47 -124.8 0.94 Allowed Glycine 0 N--CA 1.452 -0.266 0 N-CA-C 108.944 -1.663 . . . . 0.0 108.944 -175.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -142.53 154.01 44.1 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 118.002 0.901 . . . . 0.0 110.073 167.254 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . 0.499 HD22 ' N ' ' A' ' 26' ' ' LEU . 0.2 OUTLIER -116.01 140.48 49.22 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 173.097 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . 0.499 ' N ' HD22 ' A' ' 25' ' ' ASN . 1.8 tm? -119.96 135.38 54.93 Favored 'General case' 0 C--N 1.332 -0.172 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 163.449 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.536 ' HE3' HD13 ' A' ' 40' ' ' ILE . 1.8 ttmp? -138.6 137.92 37.4 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 105.07 -2.196 . . . . 0.0 105.07 173.164 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 5.0 p90 -141.76 141.43 33.22 Favored 'General case' 0 C--O 1.233 0.218 0 C-N-CA 125.175 1.39 . . . . 0.0 107.791 -175.775 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 65.8 ttt180 -113.09 144.98 41.7 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 169.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -121.85 116.61 24.74 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 126.29 1.836 . . . . 0.0 106.776 175.289 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.2 tt0 -129.91 112.31 13.41 Favored 'General case' 0 N--CA 1.465 0.299 0 C-N-CA 124.768 1.227 . . . . 0.0 110.037 -171.847 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 mt-10 -82.17 103.3 11.68 Favored 'General case' 0 C--O 1.231 0.127 0 N-CA-C 109.192 -0.67 . . . . 0.0 109.192 171.988 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 6.0 t70 28.38 88.22 0.01 OUTLIER 'General case' 0 C--O 1.237 0.399 0 C-N-CA 129.983 3.313 . . . . 0.0 113.116 -179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 71.2 m-80 56.36 45.42 22.85 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-N 114.069 -1.423 . . . . 0.0 109.887 171.658 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 1.4 t -65.02 134.09 95.95 Favored Pre-proline 0 N--CA 1.446 -0.645 0 C-N-CA 124.73 1.212 . . . . 0.0 108.011 177.735 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -71.5 -13.04 30.04 Favored 'Trans proline' 0 N--CA 1.453 -0.898 0 C-N-CA 121.893 1.728 . . . . 0.0 111.812 167.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 60.1 tp -76.48 152.81 35.99 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.758 1.223 . . . . 0.0 110.403 168.192 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.506 ' CA ' ' HB3' ' A' ' 70' ' ' ALA . . . -151.4 169.09 30.97 Favored Glycine 0 C--N 1.334 0.43 0 O-C-N 121.567 -0.708 . . . . 0.0 111.666 154.557 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 60.1 t -141.82 137.29 31.22 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 C-N-CA 126.783 2.033 . . . . 0.0 105.777 -176.571 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.536 HD13 ' HE3' ' A' ' 27' ' ' LYS . 2.9 pp -140.3 160.82 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.394 0 C-N-CA 127.292 2.237 . . . . 0.0 108.593 169.281 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.55 171.91 22.73 Favored Glycine 0 CA--C 1.533 1.196 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 162.432 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . 0.59 ' H ' ' HB ' ' A' ' 66' ' ' THR . 50.7 m -125.59 153.53 43.57 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 126.567 1.947 . . . . 0.0 107.702 168.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 98.0 m-85 -144.12 132.14 21.62 Favored 'General case' 0 C--O 1.232 0.134 0 N-CA-C 107.735 -1.209 . . . . 0.0 107.735 178.639 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 41.8 m -109.08 116.44 31.96 Favored 'General case' 0 C--O 1.233 0.185 0 C-N-CA 123.92 0.888 . . . . 0.0 108.765 -178.465 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 68.1 t80 -94.83 143.24 26.61 Favored 'General case' 0 CA--C 1.532 0.253 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 162.619 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 5.3 m -135.68 136.65 41.08 Favored 'General case' 0 CA--C 1.535 0.372 0 CA-C-N 119.269 0.94 . . . . 0.0 109.537 173.705 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 4.8 mm-40 -83.48 157.15 22.52 Favored 'General case' 0 CA--C 1.532 0.276 0 C-N-CA 124.37 1.068 . . . . 0.0 109.928 173.843 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.1 114.43 3.93 Favored 'General case' 0 C--O 1.236 0.385 0 O-C-N 121.861 -0.525 . . . . 0.0 110.141 -178.128 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 5.1 t -130.36 127.52 39.57 Favored 'General case' 0 CA--C 1.535 0.376 0 C-N-CA 123.694 0.798 . . . . 0.0 111.625 -174.4 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.4 ptt-85 -71.25 101.12 2.25 Favored 'General case' 0 C--N 1.343 0.302 0 C-N-CA 128.484 2.714 . . . . 0.0 110.649 178.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 5.5 t -129.27 18.37 5.94 Favored 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.276 1.831 . . . . 0.0 113.137 -168.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.81 -4.75 9.93 Favored 'General case' 0 CA--C 1.542 0.638 0 O-C-N 120.478 -1.389 . . . . 0.0 113.461 168.242 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.4 t 69.9 -31.55 0.22 Allowed 'General case' 0 CA--C 1.538 0.486 0 C-N-CA 127.551 2.34 . . . . 0.0 112.491 -169.173 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -64.99 -47.05 78.92 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 120.022 1.283 . . . . 0.0 109.4 179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 111.25 71.5 0.63 Allowed Glycine 0 N--CA 1.446 -0.682 0 N-CA-C 106.506 -2.638 . . . . 0.0 106.506 -158.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 53.7 t0 -119.75 112.57 19.43 Favored 'General case' 0 C--N 1.332 -0.176 0 C-N-CA 126.03 1.732 . . . . 0.0 106.688 169.806 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -57.25 102.45 0.09 Allowed 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 119.706 1.139 . . . . 0.0 110.31 176.427 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 67.9 m-20 -73.16 103.05 3.77 Favored 'General case' 0 C--O 1.234 0.279 0 N-CA-C 104.657 -2.349 . . . . 0.0 104.657 158.114 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 mttt -77.47 159.04 29.67 Favored 'General case' 0 N--CA 1.464 0.269 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 158.082 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 38.8 t-20 -175.01 107.94 0.1 Allowed 'General case' 0 C--O 1.222 -0.349 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 161.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.3 tt0 -147.15 128.93 15.26 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 121.006 1.73 . . . . 0.0 110.555 174.539 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -80.7 158.86 25.44 Favored 'General case' 0 N--CA 1.466 0.355 0 N-CA-C 107.942 -1.133 . . . . 0.0 107.942 170.61 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -142.27 116.29 9.37 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 106.198 -1.779 . . . . 0.0 106.198 167.056 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -105.83 169.73 16.27 Favored Glycine 0 N--CA 1.465 0.578 0 CA-C-N 119.532 1.06 . . . . 0.0 113.008 -162.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -150.2 138.87 14.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 135.539 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.59 ' HB ' ' H ' ' A' ' 42' ' ' SER . 7.7 m -128.47 128.02 43.59 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 179.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.33 178.68 4.38 Favored 'General case' 0 CA--C 1.537 0.455 0 CA-C-O 120.915 0.388 . . . . 0.0 110.579 174.029 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -163.18 56.28 0.29 Allowed Glycine 0 N--CA 1.451 -0.335 0 CA-C-O 117.327 -1.818 . . . . 0.0 113.349 171.486 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -64.64 97.26 0.26 Allowed 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 122.945 2.43 . . . . 0.0 110.938 -179.288 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.506 ' HB3' ' CA ' ' A' ' 38' ' ' GLY . . . -90.18 131.59 35.93 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 176.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -129.43 108.27 10.14 Favored 'General case' 0 N--CA 1.449 -0.509 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 176.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 25.3 mtp180 -63.89 149.08 47.9 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 163.285 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 4.8 mp -80.39 -108.5 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.913 0 N-CA-C 105.102 -2.184 . . . . 0.0 105.102 170.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -132.15 25.26 4.56 Favored 'General case' 0 N--CA 1.473 0.687 0 O-C-N 120.433 -1.417 . . . . 0.0 108.836 -174.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.1 t0 -160.45 -170.72 2.89 Favored 'General case' 0 N--CA 1.449 -0.506 0 C-N-CA 127.11 2.164 . . . . 0.0 106.097 -177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 18.3 p-90 -94.4 95.32 8.79 Favored 'General case' 0 CA--C 1.541 0.603 0 O-C-N 120.367 -1.458 . . . . 0.0 110.972 -179.243 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -130.75 174.93 9.47 Favored 'General case' 0 N--CA 1.468 0.435 0 C-N-CA 125.249 1.42 . . . . 0.0 110.279 163.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 50.6 m -131.41 164.93 24.63 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 125.514 1.526 . . . . 0.0 107.909 163.386 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 6.7 tp -139.16 159.38 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.523 0 C-N-CA 123.969 0.908 . . . . 0.0 109.746 -169.056 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 55.5 p90 -104.86 174.95 5.66 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 126.647 1.979 . . . . 0.0 109.159 172.339 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 133.71 35.2 0.28 Allowed Glycine 0 CA--C 1.529 0.913 0 C-N-CA 124.687 1.137 . . . . 0.0 110.415 -165.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -105.05 143.76 15.85 Favored 'Isoleucine or valine' 0 C--O 1.232 0.161 0 C-N-CA 124.067 0.947 . . . . 0.0 109.399 -172.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.0 t -96.66 149.81 4.68 Favored 'Isoleucine or valine' 0 C--O 1.236 0.359 0 N-CA-C 106.75 -1.574 . . . . 0.0 106.75 173.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -164.82 164.31 36.89 Favored Glycine 0 CA--C 1.532 1.138 0 C-N-CA 126.265 1.888 . . . . 0.0 110.0 173.763 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.3 m -139.87 151.0 21.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 O-C-N 121.713 -0.875 . . . . 0.0 110.547 -170.462 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -130.27 104.76 0.62 Allowed Glycine 0 C--O 1.224 -0.496 0 N-CA-C 109.776 -1.33 . . . . 0.0 109.776 170.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -113.66 123.9 51.01 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 106.603 -1.628 . . . . 0.0 106.603 178.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -97.82 -175.1 33.64 Favored Glycine 0 CA--C 1.53 0.989 0 CA-C-N 117.764 0.256 . . . . 0.0 113.211 -175.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.71 146.42 25.11 Favored 'General case' 0 N--CA 1.466 0.331 0 O-C-N 121.676 -0.896 . . . . 0.0 110.056 161.75 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -146.48 164.72 31.63 Favored 'General case' 0 N--CA 1.462 0.156 0 C-N-CA 126.048 1.739 . . . . 0.0 108.625 172.096 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -166.36 157.96 13.43 Favored 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 124.341 1.056 . . . . 0.0 109.466 163.739 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 3.4 t -97.94 125.45 42.86 Favored 'General case' 0 C--O 1.236 0.371 0 C-N-CA 126.468 1.907 . . . . 0.0 108.197 174.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 11.2 t -144.77 35.09 1.14 Allowed 'General case' 0 C--N 1.319 -0.738 0 C-N-CA 125.784 1.634 . . . . 0.0 108.565 -179.997 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 81.4 tt0 -87.71 -88.36 0.14 Allowed 'General case' 0 N--CA 1.448 -0.534 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 178.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.532 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 0.9 OUTLIER -153.63 -59.36 0.02 OUTLIER Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 128.584 2.754 . . . . 0.0 109.118 178.416 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.532 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 88.2 Cg_endo -76.04 11.94 1.61 Allowed 'Trans proline' 0 CA--C 1.542 0.908 0 C-N-CA 122.862 2.375 . . . . 0.0 115.362 -167.664 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 15.4 p 46.22 36.36 3.2 Favored 'General case' 0 CA--C 1.542 0.663 0 C-N-CA 126.083 1.753 . . . . 0.0 113.165 176.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -97.1 166.61 11.51 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 123.913 0.885 . . . . 0.0 110.594 -167.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 10.4 mmpt? 67.73 -64.76 0.26 Allowed 'General case' 0 N--CA 1.47 0.536 0 C-N-CA 126.646 1.978 . . . . 0.0 111.429 -174.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.0 t-20 39.27 55.83 2.19 Favored 'General case' 0 C--O 1.237 0.438 0 C-N-CA 127.148 2.179 . . . . 0.0 111.32 -177.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -73.9 147.62 43.02 Favored 'General case' 0 N--CA 1.45 -0.428 0 C-N-CA 126.482 1.913 . . . . 0.0 108.961 179.086 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 32.1 m -138.47 118.25 13.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 105.988 -1.856 . . . . 0.0 105.988 173.111 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 4.4 m -66.14 152.46 44.72 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-O 121.806 0.812 . . . . 0.0 110.281 169.869 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -106.97 177.48 4.85 Favored 'General case' 0 N--CA 1.447 -0.616 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 164.453 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 40.0 p90 -53.68 144.58 17.44 Favored 'General case' 0 C--O 1.237 0.434 0 CA-C-O 122.07 0.938 . . . . 0.0 109.765 165.087 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -124.58 157.55 18.91 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 106.322 -2.711 . . . . 0.0 106.322 160.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 74.4 t80 -131.09 128.1 39.52 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 107.052 -1.462 . . . . 0.0 107.052 -170.384 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 24.7 p -138.0 107.85 6.3 Favored 'General case' 0 N--CA 1.45 -0.458 0 N-CA-C 108.663 -0.865 . . . . 0.0 108.663 -173.338 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.42 58.11 Favored 'General case' 0 CA--C 1.53 0.2 0 N-CA-C 106.186 -1.783 . . . . 0.0 106.186 170.124 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -102.77 -152.05 23.72 Favored Glycine 0 CA--C 1.528 0.884 0 N-CA-C 110.014 -1.235 . . . . 0.0 110.014 177.213 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -142.43 169.6 17.28 Favored 'General case' 0 CA--C 1.538 0.506 0 CA-C-N 118.634 1.217 . . . . 0.0 110.831 166.318 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -140.62 55.12 0.63 Allowed Glycine 0 C--N 1.347 1.163 0 CA-C-N 118.909 0.777 . . . . 0.0 113.29 -179.794 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.4 mp -122.0 144.74 48.71 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.819 1.309 . . . . 0.0 109.476 -175.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 3.5 pp0? -134.34 138.25 44.78 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 108.927 -0.768 . . . . 0.0 108.927 175.316 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -139.87 105.21 5.05 Favored 'General case' 0 CA--C 1.517 -0.289 0 N-CA-C 107.902 -1.148 . . . . 0.0 107.902 173.609 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -143.13 144.95 30.77 Favored Pre-proline 0 C--N 1.329 -0.293 0 CA-C-N 118.642 0.656 . . . . 0.0 110.589 -172.448 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 95.7 Cg_endo -78.81 -19.77 10.87 Favored 'Trans proline' 0 N--CA 1.454 -0.823 0 C-N-CA 123.017 2.478 . . . . 0.0 113.34 -179.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 26.1 mtt -151.48 177.65 10.09 Favored 'General case' 0 C--N 1.337 0.059 0 N-CA-C 106.909 -1.515 . . . . 0.0 106.909 176.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.8 mt-10 -75.5 -34.09 60.81 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 164.593 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -61.63 -20.8 63.77 Favored 'General case' 0 C--N 1.345 0.386 0 CA-C-O 117.844 -1.074 . . . . 0.0 111.604 -176.1 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 31.0 m -133.96 109.37 12.76 Favored 'Isoleucine or valine' 0 C--N 1.34 0.188 0 N-CA-C 107.422 -1.325 . . . . 0.0 107.422 159.927 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -101.71 135.47 43.19 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.615 -1.254 . . . . 0.0 107.615 -179.921 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 13.3 mt -130.64 115.72 17.1 Favored 'General case' 0 C--O 1.237 0.434 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -173.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -136.97 151.41 48.97 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -165.747 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 65.6 m-85 -131.05 124.0 29.91 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.022 1.329 . . . . 0.0 109.806 -155.402 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 3.8 t -145.83 142.38 28.79 Favored 'General case' 0 C--O 1.238 0.487 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 167.301 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 12.8 p90 -140.56 136.72 33.12 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.162 -1.421 . . . . 0.0 107.162 170.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -137.01 120.6 17.2 Favored 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 125.46 1.504 . . . . 0.0 108.512 -167.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 39.2 mt-30 -110.97 109.6 19.79 Favored 'General case' 0 N--CA 1.467 0.425 0 CA-C-N 119.811 1.187 . . . . 0.0 109.227 170.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 47.9 m -88.09 157.72 18.78 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 123.759 0.824 . . . . 0.0 108.884 163.009 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 59.8 mtt180 -134.76 121.83 21.27 Favored 'General case' 0 CA--C 1.512 -0.501 0 N-CA-C 107.282 -1.377 . . . . 0.0 107.282 167.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.6 mp -115.0 98.84 7.43 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.396 0 N-CA-C 105.472 -2.048 . . . . 0.0 105.472 -176.56 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 22.9 ttm105 53.65 60.58 3.59 Favored 'General case' 0 CA--C 1.533 0.295 0 C-N-CA 124.095 0.958 . . . . 0.0 111.755 172.821 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 17.1 m 53.02 41.95 32.2 Favored 'General case' 0 C--O 1.238 0.492 0 C-N-CA 124.58 1.152 . . . . 0.0 113.062 -179.01 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.463 HG11 ' HB1' ' A' ' 14' ' ' ALA . 73.3 t -126.43 120.03 55.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.406 0 N-CA-C 105.007 -2.22 . . . . 0.0 105.007 163.151 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 15.8 m-20 -64.88 135.95 56.31 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 125.16 1.384 . . . . 0.0 108.565 170.042 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 49.0 t -136.83 95.78 1.31 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.319 0 N-CA-C 106.3 -1.741 . . . . 0.0 106.3 169.245 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -107.45 126.4 8.36 Favored Glycine 0 C--N 1.333 0.376 0 N-CA-C 109.405 -1.478 . . . . 0.0 109.405 -178.124 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 27.6 m -126.83 146.36 50.29 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 108.011 -1.107 . . . . 0.0 108.011 -175.836 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 43.5 m95 -142.27 142.55 32.59 Favored 'General case' 0 CA--C 1.512 -0.515 0 N-CA-C 106.719 -1.586 . . . . 0.0 106.719 -176.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 3.8 mp -123.7 127.35 73.87 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.523 0 N-CA-C 106.431 -1.692 . . . . 0.0 106.431 177.514 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.88 150.03 36.34 Favored 'General case' 0 N--CA 1.445 -0.684 0 N-CA-C 107.024 -1.473 . . . . 0.0 107.024 168.336 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -178.4 -124.02 0.84 Allowed Glycine 0 N--CA 1.45 -0.423 0 N-CA-C 109.692 -1.363 . . . . 0.0 109.692 166.324 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.6 m -147.17 -175.35 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.451 0 C-N-CA 127.139 2.176 . . . . 0.0 107.913 -175.75 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -161.89 -172.4 29.24 Favored Glycine 0 N--CA 1.447 -0.612 0 N-CA-C 108.699 -1.76 . . . . 0.0 108.699 -179.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.513 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 79.8 m-85 -142.02 175.27 9.86 Favored 'General case' 0 C--N 1.326 -0.42 0 C-N-CA 125.803 1.641 . . . . 0.0 108.675 177.039 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 34.7 ttt-85 -87.35 146.9 25.71 Favored 'General case' 0 C--O 1.233 0.222 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 178.708 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 1.2 m-85 . . . . . 0 C--O 1.244 0.794 0 C-N-CA 126.175 1.79 . . . . 0.0 108.022 -166.737 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.491 ' HA ' ' HB3' ' A' ' 31' ' ' GLU . . . . . . . . 0 N--CA 1.47 0.546 0 CA-C-O 119.163 -0.446 . . . . 0.0 110.857 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 91.7 m -150.2 111.53 4.42 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.293 -1.373 . . . . 0.0 107.293 172.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 74.5 m -78.81 159.0 28.06 Favored 'General case' 0 C--O 1.233 0.228 0 CA-C-N 119.068 0.849 . . . . 0.0 110.439 174.232 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 15.7 p -138.91 110.19 6.92 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 126.309 1.844 . . . . 0.0 106.492 -178.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.3 m -128.43 99.55 5.1 Favored 'Isoleucine or valine' 0 C--O 1.225 -0.195 0 CA-C-N 119.2 0.909 . . . . 0.0 108.565 -179.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 2.0 p -116.11 170.43 8.51 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 125.315 1.446 . . . . 0.0 108.335 -178.256 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -162.52 112.12 0.5 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 106.589 -2.605 . . . . 0.0 106.589 -177.745 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -142.95 170.81 25.13 Favored Glycine 0 N--CA 1.446 -0.64 0 N-CA-C 109.985 -1.246 . . . . 0.0 109.985 -177.036 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -129.92 144.42 51.31 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 177.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -129.5 167.16 18.28 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.498 -1.297 . . . . 0.0 107.498 170.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -132.52 140.24 48.25 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 106.592 -1.633 . . . . 0.0 106.592 172.835 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 20.0 m -84.9 152.39 23.58 Favored 'General case' 0 N--CA 1.449 -0.487 0 O-C-N 124.99 1.431 . . . . 0.0 109.624 171.151 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.27 171.93 13.76 Favored 'General case' 0 C--N 1.324 -0.533 0 C-N-CA 126.508 1.923 . . . . 0.0 107.087 158.309 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -141.16 162.48 35.39 Favored 'General case' 0 C--O 1.24 0.594 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 161.24 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -74.76 73.64 2.06 Favored 'General case' 0 CA--C 1.54 0.567 0 C-N-CA 123.902 0.881 . . . . 0.0 109.222 178.24 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 149.73 -19.03 1.12 Allowed Glycine 0 CA--C 1.532 1.106 0 C-N-CA 126.757 2.122 . . . . 0.0 112.946 175.268 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -147.6 106.73 3.87 Favored 'General case' 0 N--CA 1.466 0.355 0 CA-C-N 119.496 1.648 . . . . 0.0 108.454 175.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 33.4 ttm -77.2 64.02 2.54 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 126.314 1.846 . . . . 0.0 108.85 177.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 66.6 m-80 -69.51 91.67 0.59 Allowed 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 -177.858 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 24.5 mtmt -63.6 136.78 57.77 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 107.495 -1.298 . . . . 0.0 107.495 179.815 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 31.7 ttm -136.93 161.83 34.95 Favored 'General case' 0 C--N 1.319 -0.747 0 C-N-CA 125.632 1.573 . . . . 0.0 107.943 -171.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -164.26 160.47 33.47 Favored Glycine 0 CA--C 1.519 0.319 0 N-CA-C 109.122 -1.591 . . . . 0.0 109.122 174.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -174.98 -108.15 0.22 Allowed Glycine 0 C--N 1.334 0.462 0 CA-C-O 117.721 -1.599 . . . . 0.0 113.142 171.513 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -164.96 119.18 1.3 Allowed 'General case' 0 C--O 1.234 0.262 0 CA-C-N 118.896 1.348 . . . . 0.0 108.31 173.37 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.37 131.1 41.85 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 105.328 -2.101 . . . . 0.0 105.328 168.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.65 126.0 18.75 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 104.008 -2.59 . . . . 0.0 104.008 -178.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.51 160.01 29.29 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-N 117.914 0.324 . . . . 0.0 110.369 176.297 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.2 t80 -138.08 131.36 30.44 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 107.229 -1.397 . . . . 0.0 107.229 -177.344 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 78.5 ttt180 -100.38 116.85 33.32 Favored 'General case' 0 CA--C 1.521 -0.158 0 N-CA-C 105.399 -2.074 . . . . 0.0 105.399 168.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 12.1 t80 -99.35 109.57 22.17 Favored 'General case' 0 CA--C 1.516 -0.335 0 N-CA-C 104.803 -2.295 . . . . 0.0 104.803 164.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . 0.491 ' HB3' ' HA ' ' A' ' 1' ' ' ALA . 10.4 tt0 -88.3 116.92 26.85 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 107.034 -1.469 . . . . 0.0 107.034 171.791 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 93.0 mt-10 -70.47 161.39 30.65 Favored 'General case' 0 N--CA 1.452 -0.337 0 O-C-N 121.673 -0.642 . . . . 0.0 109.445 167.531 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 81.9 m-20 -90.0 30.4 1.08 Allowed 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 124.582 1.153 . . . . 0.0 110.952 173.829 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -153.38 -59.25 0.13 Allowed 'General case' 0 N--CA 1.462 0.146 0 C-N-CA 125.322 1.449 . . . . 0.0 111.318 -178.318 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 m -65.47 119.52 60.49 Favored Pre-proline 0 CA--C 1.541 0.624 0 CA-C-N 119.498 1.045 . . . . 0.0 110.365 -175.338 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 66.5 Cg_endo -80.13 -2.89 12.36 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 123.212 2.608 . . . . 0.0 113.524 -176.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 2.7 pp -102.04 150.19 23.49 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 163.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -99.78 163.93 19.63 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 109.904 -1.279 . . . . 0.0 109.904 176.399 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 3.1 t -102.03 153.01 5.3 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 106.47 -1.678 . . . . 0.0 106.47 172.104 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 32.1 mm -127.28 147.2 32.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.451 0 N-CA-C 106.063 -1.828 . . . . 0.0 106.063 167.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -136.44 127.01 3.98 Favored Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 105.986 -2.846 . . . . 0.0 105.986 163.941 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.9 t -125.8 155.22 41.42 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 126.643 1.977 . . . . 0.0 106.942 169.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 73.4 m-85 -114.43 157.49 22.83 Favored 'General case' 0 C--O 1.234 0.254 0 N-CA-C 108.606 -0.887 . . . . 0.0 108.606 173.839 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 21.6 m -115.82 115.45 26.3 Favored 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 105.958 -1.867 . . . . 0.0 105.958 -176.898 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.465 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 28.6 p90 -90.83 152.46 20.76 Favored 'General case' 0 C--O 1.236 0.35 0 CA-C-N 119.587 1.085 . . . . 0.0 110.039 -176.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 92.3 m -140.7 122.23 15.11 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -123.58 140.29 53.15 Favored 'General case' 0 C--O 1.237 0.443 0 C-N-CA 123.503 0.721 . . . . 0.0 109.892 176.728 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.66 114.39 6.05 Favored 'General case' 0 N--CA 1.465 0.288 0 C-N-CA 125.159 1.383 . . . . 0.0 107.327 175.483 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 7.3 m -79.5 142.44 35.79 Favored 'General case' 0 C--O 1.235 0.341 0 N-CA-C 107.727 -1.212 . . . . 0.0 107.727 156.76 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 5.0 tpt180 -125.91 -179.73 4.82 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 125.172 1.389 . . . . 0.0 107.414 169.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.4 p -80.27 -54.05 6.09 Favored 'General case' 0 C--N 1.321 -0.64 0 C-N-CA 124.314 1.045 . . . . 0.0 111.376 -171.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 90.37 -9.09 0.33 Allowed 'General case' 0 N--CA 1.471 0.593 0 C-N-CA 128.409 2.684 . . . . 0.0 113.01 171.352 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 15.5 m -73.91 -74.75 0.17 Allowed 'General case' 0 N--CA 1.45 -0.442 0 C-N-CA 122.849 0.459 . . . . 0.0 110.002 -173.484 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 36.8 m -85.57 -0.88 56.31 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 114.272 1.212 . . . . 0.0 114.272 -168.426 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 122.84 20.37 2.83 Favored Glycine 0 C--N 1.341 0.831 0 CA-C-N 119.362 0.983 . . . . 0.0 113.607 176.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -119.49 94.08 4.29 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 106.857 -1.534 . . . . 0.0 106.857 174.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 30.3 t80 -124.29 157.78 34.11 Favored 'General case' 0 C--O 1.236 0.346 0 C-N-CA 125.328 1.451 . . . . 0.0 108.872 -173.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.9 t-20 -132.03 117.23 18.1 Favored 'General case' 0 CA--C 1.52 -0.203 0 CA-C-N 119.053 0.842 . . . . 0.0 111.692 166.793 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 25.8 mmtt -130.73 115.91 17.29 Favored 'General case' 0 N--CA 1.45 -0.461 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 155.361 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.5 p-10 -147.32 -173.14 4.18 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 105.626 -1.99 . . . . 0.0 105.626 152.471 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.6 mp0 -125.04 162.91 23.51 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 105.033 -2.21 . . . . 0.0 105.033 163.172 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.465 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 38.0 p90 -73.74 158.56 34.4 Favored 'General case' 0 N--CA 1.451 -0.394 0 C-N-CA 119.153 -1.019 . . . . 0.0 109.962 168.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -141.27 126.24 18.25 Favored 'General case' 0 N--CA 1.45 -0.443 0 N-CA-C 106.549 -1.648 . . . . 0.0 106.549 164.381 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . 0.43 ' C ' HD12 ' A' ' 65' ' ' ILE . . . -150.92 156.19 26.54 Favored Glycine 0 C--N 1.333 0.379 0 N-CA-C 110.721 -0.951 . . . . 0.0 110.721 165.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.43 HD12 ' C ' ' A' ' 64' ' ' GLY . 3.3 mp -134.96 128.76 50.27 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.808 -1.923 . . . . 0.0 105.808 -179.233 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 19.2 m -104.24 145.73 29.8 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 125.119 1.368 . . . . 0.0 109.244 173.706 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -141.5 159.23 42.65 Favored 'General case' 0 N--CA 1.451 -0.389 0 C-N-CA 125.795 1.638 . . . . 0.0 107.989 165.448 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 138.82 161.83 8.91 Favored Glycine 0 CA--C 1.529 0.934 0 C-N-CA 123.086 0.374 . . . . 0.0 112.349 164.593 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo -76.71 143.63 24.03 Favored 'Trans proline' 0 N--CA 1.451 -1.011 0 C-N-CA 122.639 2.226 . . . . 0.0 112.769 -165.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.24 122.57 33.28 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 166.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -79.54 113.72 17.9 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.812 2.045 . . . . 0.0 107.196 172.809 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.9 ptt85 -71.55 148.51 46.63 Favored 'General case' 0 C--O 1.234 0.243 0 N-CA-C 109.166 -0.679 . . . . 0.0 109.166 179.675 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.619 HG21 ' HB3' ' A' ' 77' ' ' ALA . 13.1 mm -137.49 150.25 25.76 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 N-CA-C 105.932 -1.877 . . . . 0.0 105.932 168.409 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.8 t-20 -123.32 44.33 2.71 Favored 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 126.031 1.732 . . . . 0.0 108.384 177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . 0.424 ' H ' HG22 ' A' ' 73' ' ' ILE . 9.2 t0 -154.01 53.17 0.69 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 124.0 0.92 . . . . 0.0 109.231 -167.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 93.6 m95 42.18 47.2 3.97 Favored 'General case' 0 CA--C 1.544 0.72 0 C-N-CA 127.211 2.204 . . . . 0.0 113.41 -178.214 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . 0.619 ' HB3' HG21 ' A' ' 73' ' ' ILE . . . -156.89 164.24 38.28 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 125.795 1.638 . . . . 0.0 108.028 178.238 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 9.3 m -150.38 152.23 34.05 Favored 'General case' 0 N--CA 1.47 0.53 0 O-C-N 120.255 -1.528 . . . . 0.0 109.497 159.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 38.2 mt -121.37 147.11 25.47 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 -173.693 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.6 m-85 -132.65 124.25 27.9 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 106.338 -1.727 . . . . 0.0 106.338 173.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -121.19 87.15 0.4 Allowed Glycine 0 CA--C 1.507 -0.436 0 N-CA-C 105.464 -3.054 . . . . 0.0 105.464 177.257 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 19.2 m -127.92 -177.99 2.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.47 0 O-C-N 124.613 0.831 . . . . 0.0 109.499 -164.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -134.51 141.38 43.57 Favored 'Isoleucine or valine' 0 CA--C 1.517 -0.309 0 N-CA-C 107.843 -1.169 . . . . 0.0 107.843 167.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . 0.501 ' H ' ' HB2' ' A' ' 109' ' ' TYR . . . -130.63 161.06 23.31 Favored Glycine 0 N--CA 1.438 -1.199 0 N-CA-C 105.932 -2.867 . . . . 0.0 105.932 161.889 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 10.8 p -145.99 137.11 19.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 179.094 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.93 129.63 8.06 Favored Glycine 0 N--CA 1.449 -0.473 0 N-CA-C 107.652 -2.179 . . . . 0.0 107.652 178.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 23.3 p90 -114.74 148.87 37.73 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.096 0.959 . . . . 0.0 109.178 173.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -133.27 93.16 0.26 Allowed Glycine 0 C--N 1.334 0.459 0 N-CA-C 109.201 -1.56 . . . . 0.0 109.201 -172.449 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 49.1 mttm -90.69 84.31 5.87 Favored 'General case' 0 CA--C 1.519 -0.245 0 N-CA-C 105.586 -2.005 . . . . 0.0 105.586 178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.4 p90 -82.78 151.19 26.23 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 108.545 -0.909 . . . . 0.0 108.545 173.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 20.9 mm-40 -102.82 151.68 22.14 Favored 'General case' 0 C--O 1.235 0.334 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 168.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.3 m -124.89 96.93 5.06 Favored 'General case' 0 C--N 1.325 -0.462 0 N-CA-C 105.59 -2.004 . . . . 0.0 105.59 169.252 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.266 89.5 m 58.34 -6.05 0.05 OUTLIER 'General case' 0 CA--C 1.548 0.877 0 C-N-CA 126.835 2.054 . . . . 0.0 114.873 -175.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 5.0 mm-40 -82.48 52.94 2.18 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 128.564 2.746 . . . . 0.0 107.446 176.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -68.5 -53.37 17.27 Favored Pre-proline 0 N--CA 1.451 -0.419 0 CA-C-O 116.944 -1.503 . . . . 0.0 111.449 -176.338 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -79.79 2.71 8.18 Favored 'Trans proline' 0 CA--C 1.541 0.85 0 C-N-CA 122.29 1.993 . . . . 0.0 112.768 173.923 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -99.67 -51.66 3.68 Favored 'General case' 0 CA--C 1.532 0.274 0 O-C-N 120.917 -1.114 . . . . 0.0 108.195 178.838 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 28.3 t80 62.39 77.77 0.32 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 125.092 1.357 . . . . 0.0 112.034 171.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 87.0 tttt 139.23 80.17 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.28 1 C-N-CA 133.716 4.806 . . . . 0.0 105.269 176.493 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -49.74 -61.76 1.94 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 118.605 -0.712 . . . . 0.0 111.517 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 14.3 t70 -176.52 -69.18 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.186 0 N-CA-C 108.784 -0.821 . . . . 0.0 108.784 175.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.6 m -70.06 97.29 1.15 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 126.112 1.765 . . . . 0.0 108.71 -165.25 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 39.5 t -128.21 97.02 4.62 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 106.363 -1.717 . . . . 0.0 106.363 -172.457 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -138.26 177.8 7.6 Favored 'General case' 0 C--O 1.241 0.622 0 C-N-CA 124.037 0.935 . . . . 0.0 109.418 179.908 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.1 p90 -127.4 160.08 32.51 Favored 'General case' 0 CA--C 1.529 0.146 0 C-N-CA 124.783 1.233 . . . . 0.0 110.534 -172.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -118.2 123.95 5.9 Favored Glycine 0 N--CA 1.446 -0.697 0 N-CA-C 106.323 -2.711 . . . . 0.0 106.323 172.495 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.7 m-85 -71.94 135.76 46.59 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 104.688 -2.338 . . . . 0.0 104.688 167.346 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 80.7 p -142.82 70.01 1.32 Allowed 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . 0.501 ' HB2' ' H ' ' A' ' 84' ' ' GLY . 0.1 OUTLIER -168.35 -163.37 0.46 Allowed 'General case' 0 C--O 1.237 0.429 0 C-N-CA 128.562 2.745 . . . . 0.0 105.901 168.681 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 156.24 -81.11 0.17 Allowed Glycine 0 C--N 1.334 0.449 0 N-CA-C 107.992 -2.043 . . . . 0.0 107.992 -177.167 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -139.2 113.7 9.04 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 125.886 1.674 . . . . 0.0 106.886 175.105 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -141.58 144.14 14.02 Favored Glycine 0 C--N 1.335 0.48 0 N-CA-C 108.614 -1.794 . . . . 0.0 108.614 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 5.0 mp -141.49 -179.7 6.3 Favored 'General case' 0 CA--C 1.532 0.286 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -172.68 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 53.7 tt0 -146.18 150.94 36.81 Favored 'General case' 0 C--O 1.238 0.455 0 O-C-N 120.755 -1.216 . . . . 0.0 108.347 166.602 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 87.5 m-85 -134.0 144.77 48.93 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 125.624 1.57 . . . . 0.0 107.457 177.183 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -137.95 100.2 8.94 Favored Pre-proline 0 C--O 1.235 0.332 0 N-CA-C 106.12 -1.807 . . . . 0.0 106.12 173.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 96.2 Cg_endo -74.04 -9.78 22.36 Favored 'Trans proline' 0 N--CA 1.453 -0.864 0 C-N-CA 121.558 1.505 . . . . 0.0 110.992 173.887 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 5.0 mtt -136.9 174.32 10.75 Favored 'General case' 0 N--CA 1.446 -0.648 0 C-N-CA 125.876 1.67 . . . . 0.0 108.649 -175.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -89.39 -27.87 20.15 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 125.992 1.717 . . . . 0.0 108.533 164.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 5.7 t-20 -109.17 12.75 24.82 Favored 'General case' 0 N--CA 1.453 -0.299 0 O-C-N 120.493 -1.38 . . . . 0.0 111.843 -176.319 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 1.2 t -150.49 133.42 6.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.253 -2.129 . . . . 0.0 105.253 171.229 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -133.91 154.36 51.12 Favored 'General case' 0 CA--C 1.518 -0.262 0 C-N-CA 126.032 1.733 . . . . 0.0 107.024 168.36 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -152.45 147.71 26.58 Favored 'General case' 0 CA--C 1.518 -0.256 0 C-N-CA 123.893 0.877 . . . . 0.0 109.198 177.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -142.8 167.9 20.98 Favored 'General case' 0 C--O 1.239 0.508 0 C-N-CA 121.359 -0.136 . . . . 0.0 111.311 177.444 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -132.79 140.52 48.05 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 127.898 2.479 . . . . 0.0 104.925 164.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 46.0 t -145.7 157.02 43.99 Favored 'General case' 0 N--CA 1.443 -0.818 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 168.366 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 17.8 t80 -130.15 136.73 49.6 Favored 'General case' 0 N--CA 1.449 -0.503 0 N-CA-C 108.224 -1.028 . . . . 0.0 108.224 176.134 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -131.08 111.8 12.32 Favored 'General case' 0 N--CA 1.444 -0.749 0 C-N-CA 125.108 1.363 . . . . 0.0 107.454 -177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 6.2 tm0? -99.63 113.56 26.07 Favored 'General case' 0 CA--C 1.519 -0.227 0 N-CA-C 106.294 -1.743 . . . . 0.0 106.294 -176.117 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.4 p -120.51 159.2 25.66 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 121.351 0.596 . . . . 0.0 109.744 -169.308 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 62.6 mtt-85 -119.44 111.31 17.97 Favored 'General case' 0 CA--C 1.511 -0.539 0 N-CA-C 105.859 -1.904 . . . . 0.0 105.859 172.442 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 49.6 mm -125.35 126.43 70.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 N-CA-C 105.6 -2.0 . . . . 0.0 105.6 -170.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 35.5 ttt180 54.91 44.87 27.63 Favored 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 123.857 0.863 . . . . 0.0 110.162 172.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 10.1 t 68.48 -11.34 0.4 Allowed 'General case' 0 CA--C 1.542 0.647 0 C-N-CA 126.879 2.071 . . . . 0.0 113.964 -177.561 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 20.2 m -99.73 150.72 5.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.398 0 O-C-N 120.404 -1.435 . . . . 0.0 111.246 -175.595 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -54.04 142.19 25.88 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 123.999 0.919 . . . . 0.0 109.139 165.639 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 94.6 t -143.0 156.07 17.45 Favored 'Isoleucine or valine' 0 C--O 1.239 0.527 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 167.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -122.66 152.77 16.88 Favored Glycine 0 N--CA 1.448 -0.554 0 C-N-CA 126.325 1.917 . . . . 0.0 109.324 172.927 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 5.3 m -139.55 133.0 30.19 Favored 'General case' 0 N--CA 1.447 -0.597 0 N-CA-C 105.415 -2.069 . . . . 0.0 105.415 165.022 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -139.68 110.28 6.7 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 126.186 1.794 . . . . 0.0 106.311 -169.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 33.3 mt -82.12 129.73 36.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 108.218 -1.03 . . . . 0.0 108.218 -176.078 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -135.71 146.55 47.84 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 106.641 -1.614 . . . . 0.0 106.641 163.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . 150.96 -175.28 29.99 Favored Glycine 0 C--O 1.24 0.505 0 N-CA-C 112.45 -0.26 . . . . 0.0 112.45 -177.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -142.0 156.95 20.13 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 C-N-CA 126.889 2.076 . . . . 0.0 109.663 -169.03 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -157.17 -131.41 1.33 Allowed Glycine 0 N--CA 1.443 -0.838 0 N-CA-C 107.659 -2.177 . . . . 0.0 107.659 169.88 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 7.2 m-85 -145.58 177.09 9.13 Favored 'General case' 0 C--O 1.236 0.37 0 C-N-CA 126.595 1.958 . . . . 0.0 110.195 -168.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 6.5 ttp180 -141.83 112.03 6.93 Favored 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 112.692 0.626 . . . . 0.0 112.692 175.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 . . . . . 0 C--O 1.249 1.063 0 N-CA-C 105.561 -2.014 . . . . 0.0 105.561 168.998 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.631 0 CA-C-O 118.491 -0.766 . . . . 0.0 110.857 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 11.6 t -150.81 165.72 32.68 Favored 'General case' 0 C--O 1.238 0.465 0 C-N-CA 125.062 1.345 . . . . 0.0 109.931 -166.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 26.0 m -136.83 106.8 6.28 Favored 'General case' 0 CA--C 1.534 0.352 0 C-N-CA 124.525 1.13 . . . . 0.0 109.952 174.663 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.4 m -71.24 116.64 11.79 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 162.59 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 2.6 p -110.38 131.39 61.59 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.369 0 C-N-CA 126.202 1.801 . . . . 0.0 108.256 170.71 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 54.7 p -128.43 -178.67 4.66 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 119.157 0.889 . . . . 0.0 111.776 -164.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 175.43 -177.16 47.38 Favored Glycine 0 N--CA 1.446 -0.652 0 C-N-CA 126.441 1.972 . . . . 0.0 108.996 -175.664 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 136.8 151.93 6.11 Favored Glycine 0 CA--C 1.528 0.845 0 N-CA-C 109.623 -1.391 . . . . 0.0 109.623 -175.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -104.85 116.86 32.71 Favored 'General case' 0 C--O 1.237 0.446 0 C-N-CA 124.703 1.201 . . . . 0.0 108.091 -168.246 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.82 170.82 9.17 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 123.842 0.857 . . . . 0.0 110.05 -171.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -152.46 157.05 40.62 Favored 'General case' 0 C--O 1.232 0.183 0 N-CA-C 109.37 -0.604 . . . . 0.0 109.37 159.409 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 13.5 m -134.67 114.85 13.15 Favored 'General case' 0 N--CA 1.446 -0.668 0 N-CA-C 103.991 -2.596 . . . . 0.0 103.991 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.1 t0 -128.18 171.68 11.71 Favored 'General case' 0 N--CA 1.468 0.441 0 C-N-CA 123.965 0.906 . . . . 0.0 109.229 -175.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -121.19 130.78 53.87 Favored 'General case' 0 C--N 1.331 -0.209 0 C-N-CA 125.148 1.379 . . . . 0.0 108.678 -175.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 55.8 mt-30 57.68 -2.14 0.07 Allowed 'General case' 0 CA--C 1.543 0.696 0 C-N-CA 126.011 1.724 . . . . 0.0 114.602 -175.24 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 126.39 -51.79 0.83 Allowed Glycine 0 N--CA 1.446 -0.692 0 C-N-CA 126.944 2.211 . . . . 0.0 108.749 -178.047 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 4.6 pt20 -150.95 97.88 2.52 Favored 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.585 1.154 . . . . 0.0 110.138 -176.368 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -145.29 -34.1 0.34 Allowed 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 124.196 0.998 . . . . 0.0 110.339 159.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 80.1 m-20 -128.22 93.48 3.67 Favored 'General case' 0 CA--C 1.52 -0.189 0 CA-C-N 120.41 1.459 . . . . 0.0 109.232 -176.257 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -73.28 90.95 1.66 Allowed 'General case' 0 C--O 1.232 0.173 0 N-CA-C 107.512 -1.292 . . . . 0.0 107.512 172.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 21.6 ptt? -124.09 151.8 43.45 Favored 'General case' 0 C--N 1.332 -0.196 0 C-N-CA 125.166 1.387 . . . . 0.0 108.169 170.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 150.5 162.59 10.68 Favored Glycine 0 C--N 1.333 0.39 0 N-CA-C 111.0 -0.84 . . . . 0.0 111.0 -174.426 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -155.37 -130.99 1.38 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.368 -1.493 . . . . 0.0 109.368 -177.682 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 55.2 p90 -114.18 174.32 6.0 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.37 1.068 . . . . 0.0 109.961 -177.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p30 -127.84 161.08 29.86 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 125.253 1.421 . . . . 0.0 108.314 175.209 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.1 tm? -159.05 115.93 2.71 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.066 -1.827 . . . . 0.0 106.066 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 4.4 pttp -119.73 176.28 5.46 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 118.817 0.735 . . . . 0.0 109.256 169.343 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -120.42 142.68 48.99 Favored 'General case' 0 C--N 1.32 -0.686 0 C-N-CA 125.728 1.611 . . . . 0.0 108.133 175.731 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 3.0 ttt180 -132.49 144.01 50.15 Favored 'General case' 0 C--O 1.233 0.21 0 C-N-CA 119.286 -0.965 . . . . 0.0 108.63 153.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 27.7 t80 -142.95 157.43 44.57 Favored 'General case' 0 C--N 1.323 -0.561 0 N-CA-C 105.031 -2.211 . . . . 0.0 105.031 166.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 30.9 tt0 -115.16 125.1 53.03 Favored 'General case' 0 C--O 1.231 0.12 0 N-CA-C 108.304 -0.999 . . . . 0.0 108.304 171.847 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.507 ' HG2' ' H ' ' A' ' 33' ' ' ASP . 6.8 tt0 -142.46 177.91 7.95 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 124.21 1.004 . . . . 0.0 108.419 167.623 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . 0.507 ' H ' ' HG2' ' A' ' 32' ' ' GLU . 6.2 m-20 -91.69 -13.84 31.04 Favored 'General case' 0 C--O 1.234 0.237 0 C-N-CA 124.91 1.284 . . . . 0.0 113.228 -164.345 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 12.5 m120 -124.77 -6.05 7.45 Favored 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 124.833 1.253 . . . . 0.0 111.259 -178.491 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 14.4 t -77.64 152.72 80.83 Favored Pre-proline 0 C--O 1.236 0.394 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 163.727 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.57 163.33 35.37 Favored 'Trans proline' 0 CA--C 1.54 0.778 0 C-N-CA 121.574 1.516 . . . . 0.0 110.314 164.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.543 HD11 ' HB2' ' A' ' 72' ' ' ARG . 2.6 tm? -91.49 155.75 18.19 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 125.659 1.583 . . . . 0.0 111.103 -167.032 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.544 ' HA3' ' HB3' ' A' ' 70' ' ' ALA . . . 35.26 73.95 0.09 OUTLIER Glycine 0 C--N 1.337 0.61 0 C-N-CA 129.107 3.241 . . . . 0.0 113.683 173.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 12.4 m -99.95 151.23 5.05 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-O 122.318 1.056 . . . . 0.0 108.486 -164.115 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.4 pp -140.14 152.02 21.74 Favored 'Isoleucine or valine' 0 C--O 1.236 0.377 0 C-N-CA 125.916 1.687 . . . . 0.0 106.541 -177.793 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.2 108.7 0.4 Allowed Glycine 0 CA--C 1.521 0.467 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 33.3 t -68.32 129.37 39.73 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 174.174 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -144.14 113.47 6.96 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 171.346 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 32.5 p -127.89 152.67 47.56 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 126.457 1.903 . . . . 0.0 110.127 -176.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 6.7 t80 -136.82 156.81 48.01 Favored 'General case' 0 C--O 1.233 0.229 0 N-CA-C 107.897 -1.149 . . . . 0.0 107.897 171.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 57.7 p -136.47 155.98 49.23 Favored 'General case' 0 C--O 1.235 0.329 0 CA-C-N 118.469 0.577 . . . . 0.0 109.856 174.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -158.37 10.03 0.15 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 124.33 1.052 . . . . 0.0 112.182 -178.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 46.8 mmtt -66.16 134.9 53.72 Favored 'General case' 0 N--CA 1.468 0.457 0 O-C-N 119.546 -1.971 . . . . 0.0 110.459 -178.161 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 28.2 p -70.14 155.43 40.64 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 123.529 0.732 . . . . 0.0 110.097 174.084 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -127.15 -178.85 4.58 Favored 'General case' 0 C--N 1.334 -0.075 0 C-N-CA 125.302 1.441 . . . . 0.0 108.822 162.829 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 30.9 p -46.4 -49.02 18.55 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 126.894 2.078 . . . . 0.0 112.038 -158.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 56.95 19.98 5.0 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 126.15 1.78 . . . . 0.0 112.463 173.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 5.8 p -112.8 -60.7 1.84 Allowed 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 125.412 1.485 . . . . 0.0 109.553 -164.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 6.6 t -87.55 -8.57 56.17 Favored 'General case' 0 CA--C 1.539 0.536 0 CA-C-O 117.236 -1.364 . . . . 0.0 111.977 175.134 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 132.9 -20.05 4.34 Favored Glycine 0 CA--C 1.529 0.935 0 CA-C-N 120.333 1.424 . . . . 0.0 113.632 177.7 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.7 t70 -71.19 89.76 0.87 Allowed 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.499 1.52 . . . . 0.0 106.947 174.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 2.0 t80 -115.39 78.84 1.21 Allowed 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 105.581 -2.007 . . . . 0.0 105.581 -167.567 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -85.63 118.6 25.24 Favored 'General case' 0 CA--C 1.515 -0.366 0 N-CA-C 108.684 -0.858 . . . . 0.0 108.684 -174.522 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.9 ptpt -123.63 145.61 48.81 Favored 'General case' 0 C--N 1.329 -0.318 0 N-CA-C 105.881 -1.896 . . . . 0.0 105.881 159.957 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -179.33 168.3 1.49 Allowed 'General case' 0 C--O 1.238 0.463 0 C-N-CA 123.77 0.828 . . . . 0.0 110.024 159.324 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 4.1 pm0 -113.73 129.48 56.57 Favored 'General case' 0 N--CA 1.442 -0.831 0 C-N-CA 127.889 2.476 . . . . 0.0 105.091 170.195 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 10.1 t80 -75.36 155.88 36.03 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 107.819 -1.178 . . . . 0.0 107.819 168.808 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -141.09 150.9 43.5 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 104.416 -2.439 . . . . 0.0 104.416 163.024 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -153.09 89.69 0.13 Allowed Glycine 0 N--CA 1.446 -0.669 0 N-CA-C 107.726 -2.15 . . . . 0.0 107.726 178.088 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . 0.585 ' H ' HD12 ' A' ' 65' ' ' ILE . 2.9 mp -71.1 114.24 8.85 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.588 0 N-CA-C 105.291 -2.114 . . . . 0.0 105.291 179.769 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.408 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 29.1 m -133.88 139.75 46.4 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 125.487 1.515 . . . . 0.0 107.611 178.406 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -149.23 169.05 21.64 Favored 'General case' 0 N--CA 1.446 -0.626 0 C-N-CA 124.473 1.109 . . . . 0.0 109.126 174.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.78 123.04 0.66 Allowed Glycine 0 CA--C 1.529 0.934 0 N-CA-C 106.767 -2.533 . . . . 0.0 106.767 167.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 93.9 Cg_endo -71.98 153.69 57.95 Favored 'Trans proline' 0 N--CA 1.459 -0.52 0 CA-C-N 120.039 1.92 . . . . 0.0 108.859 174.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.544 ' HB3' ' HA3' ' A' ' 38' ' ' GLY . . . -89.85 174.12 7.87 Favored 'General case' 0 C--O 1.233 0.229 0 CA-C-N 119.615 1.098 . . . . 0.0 108.107 -179.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -122.86 127.98 49.74 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 107.138 -1.43 . . . . 0.0 107.138 178.256 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.543 ' HB2' HD11 ' A' ' 37' ' ' LEU . 0.7 OUTLIER -115.87 101.63 8.96 Favored 'General case' 0 N--CA 1.466 0.358 0 C-N-CA 124.261 1.024 . . . . 0.0 109.518 -170.917 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -132.03 14.65 1.72 Allowed 'Isoleucine or valine' 0 CA--C 1.536 0.44 0 C-N-CA 125.625 1.57 . . . . 0.0 110.765 -170.158 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -140.61 -177.95 5.29 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 125.188 1.395 . . . . 0.0 109.179 -171.498 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 8.3 t0 -57.62 -51.44 69.48 Favored 'General case' 0 N--CA 1.466 0.353 0 C-N-CA 124.309 1.044 . . . . 0.0 109.874 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 85.5 m95 -152.54 3.18 0.34 Allowed 'General case' 0 CA--C 1.54 0.569 0 N-CA-C 113.789 1.033 . . . . 0.0 113.789 174.259 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -76.81 119.61 20.82 Favored 'General case' 0 C--O 1.236 0.374 0 CA-C-N 119.528 1.058 . . . . 0.0 109.034 172.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.42 122.15 15.35 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 125.776 1.631 . . . . 0.0 106.872 168.434 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -144.16 152.26 15.8 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.419 0 C-N-CA 126.219 1.808 . . . . 0.0 107.859 -178.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 74.1 t80 -151.35 162.55 40.72 Favored 'General case' 0 N--CA 1.467 0.379 0 CA-C-N 118.968 0.803 . . . . 0.0 111.116 173.912 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -89.67 144.29 17.68 Favored Glycine 0 CA--C 1.528 0.9 0 C-N-CA 125.145 1.355 . . . . 0.0 110.967 172.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 21.1 m -132.92 177.92 6.43 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.567 0 C-N-CA 124.99 1.316 . . . . 0.0 110.342 -169.591 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.408 ' O ' ' HA ' ' A' ' 66' ' ' THR . 2.7 m -137.58 131.1 43.39 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.422 0 C-N-CA 125.258 1.423 . . . . 0.0 109.736 -175.848 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -118.2 167.84 13.01 Favored Glycine 0 CA--C 1.527 0.815 0 C-N-CA 124.735 1.159 . . . . 0.0 111.446 174.969 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 44.9 t -128.45 149.83 33.61 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.321 0 N-CA-C 106.815 -1.55 . . . . 0.0 106.815 169.076 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.75 136.78 13.46 Favored Glycine 0 N--CA 1.452 -0.246 0 N-CA-C 105.708 -2.957 . . . . 0.0 105.708 166.669 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 32.3 t80 -143.51 153.75 42.92 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 123.968 0.907 . . . . 0.0 108.626 175.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 84.12 -163.51 39.67 Favored Glycine 0 C--N 1.332 0.356 0 C-N-CA 124.229 0.919 . . . . 0.0 110.899 161.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 4.3 ttpt 63.76 153.03 0.04 OUTLIER 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 125.225 1.41 . . . . 0.0 110.071 -164.505 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 54.9 p90 -145.67 -36.34 0.28 Allowed 'General case' 0 C--O 1.222 -0.386 0 CA-C-O 117.712 -1.137 . . . . 0.0 111.054 -171.107 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 62.3 tt0 66.59 -65.46 0.2 Allowed 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 125.017 1.327 . . . . 0.0 113.475 177.709 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 66.2 m -105.69 105.64 15.77 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 107.351 -1.352 . . . . 0.0 107.351 174.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . 0.465 HG23 ' H ' ' A' ' 94' ' ' GLU . 6.2 t -55.33 -70.72 0.1 Allowed 'General case' 0 CA--C 1.536 0.424 0 C-N-CA 126.51 1.924 . . . . 0.0 110.702 -177.147 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.465 ' H ' HG23 ' A' ' 93' ' ' THR . 9.2 pt-20 -165.76 9.59 0.03 OUTLIER 'General case' 0 CA--C 1.542 0.659 0 C-N-CA 127.058 2.143 . . . . 0.0 109.137 -172.424 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -65.94 -48.3 61.76 Favored Pre-proline 0 CA--C 1.537 0.45 0 C-N-CA 124.55 1.14 . . . . 0.0 112.622 -157.487 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_exo -68.52 13.23 0.21 Allowed 'Trans proline' 0 CA--C 1.54 0.8 0 C-N-CA 123.234 2.622 . . . . 0.0 114.551 172.632 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER 79.39 20.52 0.67 Allowed 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 127.359 2.264 . . . . 0.0 110.74 -168.162 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -157.0 142.67 17.62 Favored 'General case' 0 C--O 1.235 0.312 0 O-C-N 120.891 -1.131 . . . . 0.0 110.897 -179.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.0 ptmt -73.62 154.96 39.53 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.031 0.932 . . . . 0.0 112.088 171.278 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -59.03 -54.65 44.75 Favored 'General case' 0 N--CA 1.467 0.418 0 C-N-CA 124.343 1.057 . . . . 0.0 111.744 176.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 37.9 p-10 -177.36 163.06 1.97 Allowed 'General case' 0 C--O 1.238 0.499 0 C-N-CA 128.334 2.654 . . . . 0.0 107.792 172.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.1 p -78.1 138.92 39.0 Favored 'General case' 0 CA--C 1.538 0.496 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.397 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 58.4 m -76.23 147.36 38.39 Favored 'General case' 0 C--O 1.234 0.248 0 CA-C-O 121.488 0.661 . . . . 0.0 110.523 177.61 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -136.13 176.97 8.21 Favored 'General case' 0 C--N 1.323 -0.571 0 C-N-CA 128.363 2.665 . . . . 0.0 107.781 -177.539 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 11.1 p90 -92.87 95.02 9.26 Favored 'General case' 0 CA--C 1.532 0.278 0 N-CA-C 107.339 -1.356 . . . . 0.0 107.339 170.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -82.03 146.3 25.22 Favored Glycine 0 CA--C 1.527 0.839 0 N-CA-C 109.886 -1.286 . . . . 0.0 109.886 -178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 31.0 m-85 -97.76 121.5 39.74 Favored 'General case' 0 CA--C 1.532 0.287 0 O-C-N 121.313 -1.11 . . . . 0.0 113.102 -163.223 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.8 m -115.36 154.36 29.33 Favored 'General case' 0 C--O 1.234 0.251 0 C-N-CA 123.737 0.815 . . . . 0.0 110.395 169.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -155.98 134.45 11.63 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 104.465 -2.42 . . . . 0.0 104.465 -179.249 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -158.33 -160.37 10.24 Favored Glycine 0 CA--C 1.522 0.499 0 N-CA-C 109.467 -1.453 . . . . 0.0 109.467 -169.981 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -143.68 158.93 43.31 Favored 'General case' 0 N--CA 1.457 -0.114 0 CA-C-N 117.862 0.831 . . . . 0.0 110.078 174.132 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -117.61 117.74 3.87 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 108.186 -1.966 . . . . 0.0 108.186 177.319 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -116.03 141.57 47.94 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 126.932 2.093 . . . . 0.0 107.395 -168.268 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -140.03 115.24 9.81 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 119.164 0.893 . . . . 0.0 111.942 -177.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -93.08 172.43 8.31 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 123.141 0.576 . . . . 0.0 110.089 166.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 14.4 t30 -62.6 123.04 77.61 Favored Pre-proline 0 CA--C 1.539 0.534 0 CA-C-O 117.809 -1.091 . . . . 0.0 110.532 172.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 12.9 Cg_exo -67.25 132.66 28.26 Favored 'Trans proline' 0 CA--C 1.541 0.874 0 C-N-CA 122.818 2.346 . . . . 0.0 111.484 170.968 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 17.9 ttm -163.79 -177.51 5.18 Favored 'General case' 0 CA--C 1.535 0.404 0 C-N-CA 126.084 1.754 . . . . 0.0 107.215 160.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER 68.7 20.2 8.26 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 125.279 1.431 . . . . 0.0 110.658 170.481 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 78.6 m-20 41.3 50.02 3.42 Favored 'General case' 0 N--CA 1.454 -0.238 0 C-N-CA 127.102 2.161 . . . . 0.0 111.694 -163.375 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.8 m -144.3 112.91 1.71 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.764 -1.569 . . . . 0.0 106.764 167.349 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -72.51 138.46 46.99 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 106.025 -1.842 . . . . 0.0 106.025 161.865 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -100.99 115.05 29.56 Favored 'General case' 0 C--O 1.237 0.419 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 176.838 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.6 t70 -158.69 84.94 0.83 Allowed 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 106.336 -1.728 . . . . 0.0 106.336 -167.728 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 8.0 t80 -99.07 143.31 29.49 Favored 'General case' 0 C--O 1.236 0.353 0 N-CA-C 107.571 -1.27 . . . . 0.0 107.571 -172.166 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 58.6 m -145.94 137.74 25.1 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 121.686 0.755 . . . . 0.0 110.369 171.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 16.2 t80 -144.05 128.53 18.0 Favored 'General case' 0 C--O 1.238 0.482 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 -178.736 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 pm0 -136.88 163.79 29.83 Favored 'General case' 0 N--CA 1.451 -0.388 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 171.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.5 tt0 -125.23 148.79 48.5 Favored 'General case' 0 N--CA 1.452 -0.374 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 -179.369 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 45.2 t -140.5 159.53 41.99 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 125.76 1.624 . . . . 0.0 107.35 -162.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 99.5 mtt180 -136.28 107.65 6.87 Favored 'General case' 0 CA--C 1.513 -0.448 0 C-N-CA 123.859 0.863 . . . . 0.0 108.736 174.171 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 38.9 mm -86.68 96.14 5.28 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 N-CA-C 105.82 -1.918 . . . . 0.0 105.82 176.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 6.0 ttt-85 70.81 -71.97 0.12 Allowed 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 127.833 2.453 . . . . 0.0 109.439 -177.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 19.7 m -145.32 4.99 1.07 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.201 2.201 . . . . 0.0 111.38 171.928 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 98.8 t -85.26 122.58 38.46 Favored 'Isoleucine or valine' 0 CA--C 1.522 -0.121 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -179.35 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.8 m-20 -69.83 135.93 50.19 Favored 'General case' 0 C--O 1.237 0.41 0 N-CA-C 108.308 -0.997 . . . . 0.0 108.308 175.249 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 54.8 t -137.82 150.88 25.32 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 125.235 1.414 . . . . 0.0 108.031 173.003 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.34 152.1 23.08 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 173.315 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.2 t -129.23 152.23 49.04 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 107.259 -1.386 . . . . 0.0 107.259 174.111 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 1.5 p90 -135.95 138.5 42.39 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 124.491 1.116 . . . . 0.0 108.03 173.412 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 21.6 mt -131.79 111.83 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.373 0 N-CA-C 104.696 -2.335 . . . . 0.0 104.696 172.884 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.93 106.39 18.38 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 106.447 -1.686 . . . . 0.0 106.447 177.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -54.57 119.18 11.32 Favored Glycine 0 N--CA 1.449 -0.476 0 C-N-CA 124.134 0.873 . . . . 0.0 111.52 178.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 3.3 m -137.63 178.2 4.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 C-N-CA 127.81 2.444 . . . . 0.0 106.364 153.593 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 176.97 -125.65 1.04 Allowed Glycine 0 C--O 1.226 -0.405 0 N-CA-C 108.651 -1.78 . . . . 0.0 108.651 -179.589 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 81.2 m-85 -146.96 177.07 9.43 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 127.913 2.485 . . . . 0.0 106.792 176.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 4.9 tmt_? -126.22 126.58 44.28 Favored 'General case' 0 N--CA 1.465 0.282 0 O-C-N 120.77 -1.207 . . . . 0.0 109.253 170.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 52.6 p90 . . . . . 0 C--O 1.248 1.015 0 C-N-CA 123.693 0.797 . . . . 0.0 109.552 166.931 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.403 0 N-CA-C 108.154 -1.054 . . . . 0.0 108.154 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.2 m -150.51 113.96 4.92 Favored 'General case' 0 N--CA 1.451 -0.377 0 N-CA-C 103.855 -2.646 . . . . 0.0 103.855 177.064 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -126.44 132.68 51.42 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -156.574 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 41.0 p -121.6 164.12 17.81 Favored 'General case' 0 C--N 1.329 -0.3 0 O-C-N 121.146 -0.971 . . . . 0.0 110.719 -166.191 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.609 HG21 ' HA3' ' A' ' 145' ' ' GLY . 6.0 p -91.4 167.81 1.59 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.498 0 C-N-CA 123.719 0.808 . . . . 0.0 108.939 179.193 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 55.4 m -149.4 126.73 11.46 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 120.587 -1.321 . . . . 0.0 107.68 166.062 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -78.61 169.92 54.53 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.952 -0.859 . . . . 0.0 110.952 169.137 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -151.11 34.34 0.92 Allowed Glycine 0 CA--C 1.52 0.356 0 C-N-CA 124.82 1.2 . . . . 0.0 111.16 -178.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -94.94 130.69 41.46 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 174.111 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -140.13 176.09 9.04 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 126.844 2.058 . . . . 0.0 109.533 -177.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 7.2 tt0 -125.74 143.51 51.02 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 106.725 -1.583 . . . . 0.0 106.725 168.356 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.1 m -107.44 115.17 29.69 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 159.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 7.0 p30 -111.48 171.1 7.68 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.921 1.288 . . . . 0.0 107.564 161.4 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.92 157.27 43.0 Favored 'General case' 0 C--O 1.238 0.469 0 O-C-N 121.249 -0.907 . . . . 0.0 109.099 173.894 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 46.7 mt-30 60.26 -72.5 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.272 0 C-N-CA 126.57 1.948 . . . . 0.0 110.122 -166.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -139.97 -85.2 0.11 Allowed Glycine 0 N--CA 1.45 -0.429 0 N-CA-C 107.674 -2.17 . . . . 0.0 107.674 172.608 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.6 pp0? -150.91 106.44 3.37 Favored 'General case' 0 N--CA 1.461 0.094 0 CA-C-N 117.969 0.885 . . . . 0.0 109.763 178.296 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.6 tmt? -144.08 -78.08 0.21 Allowed 'General case' 0 C--O 1.236 0.38 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 -172.604 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 14.0 p-10 -56.86 142.31 41.56 Favored 'General case' 0 N--CA 1.438 -1.059 0 N-CA-C 106.683 -1.599 . . . . 0.0 106.683 152.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 43.1 mttt -121.81 158.04 29.75 Favored 'General case' 0 C--N 1.314 -0.94 0 CA-C-N 111.91 -2.404 . . . . 0.0 104.886 155.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 18.9 mmt -137.38 160.54 38.8 Favored 'General case' 0 C--N 1.317 -0.826 0 N-CA-C 104.886 -2.265 . . . . 0.0 104.886 165.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -136.38 177.02 19.95 Favored Glycine 0 N--CA 1.448 -0.55 0 N-CA-C 107.872 -2.091 . . . . 0.0 107.872 153.943 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -167.24 164.91 38.25 Favored Glycine 0 N--CA 1.441 -0.969 0 N-CA-C 109.212 -1.555 . . . . 0.0 109.212 -173.414 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 77.5 m-85 -124.48 110.08 14.06 Favored 'General case' 0 C--O 1.24 0.603 0 C-N-CA 125.159 1.384 . . . . 0.0 107.77 175.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 2.0 m-20 -111.76 163.29 14.32 Favored 'General case' 0 C--N 1.326 -0.422 0 N-CA-C 106.466 -1.679 . . . . 0.0 106.466 168.733 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -142.32 141.63 32.4 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 177.875 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 13.3 mtpt -135.58 154.47 51.34 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 125.809 1.644 . . . . 0.0 107.408 -178.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -128.4 140.39 51.87 Favored 'General case' 0 C--N 1.326 -0.425 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -171.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 2.8 mmm-85 -138.45 109.43 6.76 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 123.649 0.78 . . . . 0.0 109.163 -173.519 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -113.96 149.59 35.04 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 106.987 -1.486 . . . . 0.0 106.987 168.27 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 52.0 mt-10 -90.93 146.93 23.48 Favored 'General case' 0 C--O 1.238 0.472 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 151.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 -81.16 179.11 8.0 Favored 'General case' 0 C--N 1.329 -0.326 0 C-N-CA 124.933 1.293 . . . . 0.0 108.69 158.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -114.22 23.77 12.57 Favored 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 124.377 1.071 . . . . 0.0 109.312 -170.317 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -141.21 -83.23 0.21 Allowed 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.001 0.92 . . . . 0.0 109.358 -174.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 3.2 m -90.93 137.7 26.56 Favored Pre-proline 0 CA--C 1.535 0.396 0 CA-C-N 119.005 0.821 . . . . 0.0 109.373 173.024 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_endo -73.38 116.67 4.78 Favored 'Trans proline' 0 N--CA 1.453 -0.877 0 C-N-CA 122.985 2.457 . . . . 0.0 108.946 169.365 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 40.8 tp -141.44 156.62 45.76 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 126.747 2.019 . . . . 0.0 106.961 -179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -121.47 173.71 15.73 Favored Glycine 0 N--CA 1.459 0.216 0 O-C-N 121.462 -0.774 . . . . 0.0 111.599 173.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -138.28 128.8 35.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 107.273 -1.381 . . . . 0.0 107.273 173.548 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 2.0 mp -134.23 113.57 17.66 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.304 0 C-N-CA 126.741 2.016 . . . . 0.0 106.151 175.007 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -160.42 123.85 1.27 Allowed Glycine 0 C--N 1.336 0.53 0 N-CA-C 108.001 -2.04 . . . . 0.0 108.001 167.238 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 10.0 p -116.83 153.45 32.47 Favored 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 118.777 1.288 . . . . 0.0 110.157 -176.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 68.0 m-85 -102.87 120.79 41.23 Favored 'General case' 0 CA--C 1.521 -0.156 0 C-N-CA 124.94 1.296 . . . . 0.0 108.166 179.686 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 50.7 p -92.15 139.25 30.81 Favored 'General case' 0 C--O 1.239 0.516 0 CA-C-N 119.241 0.928 . . . . 0.0 109.175 -166.825 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -142.84 146.13 33.85 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 171.512 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.5 m -143.83 160.08 41.4 Favored 'General case' 0 C--O 1.241 0.652 0 O-C-N 121.181 -0.95 . . . . 0.0 109.425 164.934 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 2.0 mp0 -110.96 109.51 19.67 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 124.721 1.208 . . . . 0.0 109.851 171.984 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -68.0 141.1 56.34 Favored 'General case' 0 C--O 1.237 0.402 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 161.692 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 22.8 m -130.61 136.73 49.15 Favored 'General case' 0 C--N 1.325 -0.458 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 138.319 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 63.1 mtt180 -131.37 151.2 51.75 Favored 'General case' 0 C--O 1.236 0.343 0 N-CA-C 107.372 -1.344 . . . . 0.0 107.372 136.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 9.0 t 153.44 92.74 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 131.021 3.729 . . . . 0.0 105.405 -178.346 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -148.97 86.32 1.5 Allowed 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 108.572 -0.899 . . . . 0.0 108.572 171.498 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 51.0 m 45.32 58.8 3.91 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 126.704 2.002 . . . . 0.0 111.412 -177.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -163.58 -33.33 0.04 OUTLIER 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 125.379 1.472 . . . . 0.0 109.752 177.738 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.16 12.8 83.99 Favored Glycine 0 CA--C 1.531 1.049 0 C-N-CA 123.624 0.631 . . . . 0.0 114.47 172.361 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 24.2 t0 -75.13 94.57 2.94 Favored 'General case' 0 CA--C 1.517 -0.289 0 CA-C-N 119.028 1.414 . . . . 0.0 107.724 169.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 83.1 m-85 -76.97 79.58 3.51 Favored 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.279 -1.008 . . . . 0.0 108.279 167.327 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.9 t30 -64.77 88.3 0.06 Allowed 'General case' 0 N--CA 1.468 0.465 0 C-N-CA 123.222 0.609 . . . . 0.0 110.084 178.047 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 40.3 tttm -77.62 115.7 17.59 Favored 'General case' 0 CA--C 1.521 -0.144 0 N-CA-C 107.759 -1.2 . . . . 0.0 107.759 -173.488 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 11.5 p30 -146.11 161.47 40.09 Favored 'General case' 0 C--O 1.239 0.533 0 N-CA-C 107.626 -1.25 . . . . 0.0 107.626 169.499 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.8 pm0 -154.94 145.68 22.4 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.475 1.91 . . . . 0.0 107.225 172.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -88.91 104.86 17.34 Favored 'General case' 0 C--O 1.234 0.264 0 C-N-CA 124.305 1.042 . . . . 0.0 109.062 -176.851 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 t80 -120.37 118.01 29.25 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 108.823 -0.806 . . . . 0.0 108.823 -178.249 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.52 167.03 31.38 Favored Glycine 0 CA--C 1.523 0.546 0 C-N-CA 124.209 0.909 . . . . 0.0 111.335 179.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 5.1 mp -142.83 125.05 12.97 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.709 -1.96 . . . . 0.0 105.709 178.621 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.2 t -125.39 147.18 49.27 Favored 'General case' 0 N--CA 1.441 -0.906 0 C-N-CA 128.71 2.804 . . . . 0.0 106.354 171.735 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -144.37 153.11 41.62 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 125.06 1.344 . . . . 0.0 108.957 179.391 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.63 169.75 24.32 Favored Glycine 0 CA--C 1.525 0.699 0 N-CA-C 111.204 -0.758 . . . . 0.0 111.204 160.529 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.431 ' HD2' ' CE2' ' A' ' 80' ' ' TYR . 42.2 Cg_endo -86.05 -167.79 0.41 Allowed 'Trans proline' 0 N--CA 1.45 -1.057 0 C-N-CA 123.151 2.567 . . . . 0.0 112.008 178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -127.91 159.92 33.43 Favored 'General case' 0 C--O 1.237 0.414 0 N-CA-C 109.094 -0.706 . . . . 0.0 109.094 152.428 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -136.12 129.95 32.58 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 124.584 1.154 . . . . 0.0 109.509 -166.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.9 mmt85 -63.65 116.73 5.95 Favored 'General case' 0 N--CA 1.468 0.442 0 C-N-CA 124.909 1.283 . . . . 0.0 109.627 178.1 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 51.4 mm -74.88 -32.18 27.27 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-O 118.125 -0.94 . . . . 0.0 111.068 -176.348 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 154.73 77.67 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 130.058 3.343 . . . . 0.0 108.455 175.277 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 12.8 t70 51.94 6.6 0.04 OUTLIER 'General case' 0 N--CA 1.479 1.014 0 C-N-CA 128.809 2.844 . . . . 0.0 117.159 171.354 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 7.8 p-90 -120.61 -28.09 4.99 Favored 'General case' 0 CA--C 1.535 0.392 0 O-C-N 120.887 -1.133 . . . . 0.0 112.155 -173.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -158.81 164.57 35.66 Favored 'General case' 0 C--O 1.24 0.59 0 C-N-CA 126.651 1.98 . . . . 0.0 108.206 175.281 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 54.7 m -142.54 106.35 4.69 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.911 1.684 . . . . 0.0 107.806 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.01 168.4 17.77 Favored 'Isoleucine or valine' 0 C--O 1.236 0.36 0 C-N-CA 122.714 0.406 . . . . 0.0 111.005 -175.436 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.431 ' CE2' ' HD2' ' A' ' 69' ' ' PRO . 1.0 OUTLIER -150.64 175.38 11.99 Favored 'General case' 0 N--CA 1.451 -0.39 0 C-N-CA 125.152 1.381 . . . . 0.0 109.575 168.976 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -129.12 130.09 6.31 Favored Glycine 0 CA--C 1.523 0.557 0 N-CA-C 106.929 -2.468 . . . . 0.0 106.929 154.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 30.2 m -104.0 176.9 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 126.221 1.808 . . . . 0.0 108.163 175.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 13.0 m -137.94 130.2 40.16 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.383 0 CA-C-N 118.613 0.642 . . . . 0.0 110.205 -174.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -138.92 177.57 20.12 Favored Glycine 0 C--O 1.239 0.432 0 C-N-CA 124.85 1.214 . . . . 0.0 111.756 -173.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.4 p -130.91 150.21 34.37 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 125.89 1.676 . . . . 0.0 106.92 177.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.76 103.97 1.32 Allowed Glycine 0 N--CA 1.446 -0.65 1 N-CA-C 102.423 -4.271 . . . . 0.0 102.423 158.737 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -106.53 115.82 30.87 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 104.333 -2.469 . . . . 0.0 104.333 179.459 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -81.07 172.72 54.31 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 110.202 -1.159 . . . . 0.0 110.202 175.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 14.5 mtmt -126.95 -179.51 4.87 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 148.916 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -150.91 160.17 44.08 Favored 'General case' 0 C--N 1.32 -0.701 0 C-N-CA 125.321 1.448 . . . . 0.0 107.379 -164.265 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 2.5 mt-30 -172.15 116.97 0.36 Allowed 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 105.964 -1.865 . . . . 0.0 105.964 161.154 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 20.9 m -104.89 119.84 39.99 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.75 -1.944 . . . . 0.0 105.75 165.649 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 1.3 m -133.11 29.01 4.09 Favored 'General case' 0 CA--C 1.534 0.343 0 N-CA-C 108.955 -0.758 . . . . 0.0 108.955 -179.477 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 27.3 tt0 -65.03 -52.58 55.17 Favored 'General case' 0 CA--C 1.53 0.208 0 O-C-N 121.435 -0.791 . . . . 0.0 109.781 -171.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 76.6 m-85 -136.83 161.55 60.98 Favored Pre-proline 0 C--O 1.238 0.498 0 C-N-CA 126.674 1.99 . . . . 0.0 107.632 -178.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 94.3 Cg_endo -74.32 44.78 1.09 Allowed 'Trans proline' 0 CA--C 1.543 0.956 0 C-N-CA 124.375 3.384 . . . . 0.0 111.725 177.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 16.7 m -151.19 -43.39 0.12 Allowed 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 125.283 1.433 . . . . 0.0 109.281 -178.6 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -75.09 109.15 8.32 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 107.82 -1.178 . . . . 0.0 107.82 -176.511 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 7.3 ptmt -153.08 121.8 6.42 Favored 'General case' 0 CA--C 1.522 -0.128 0 C-N-CA 123.826 0.85 . . . . 0.0 109.035 -177.586 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 47.3 p30 -152.49 -176.25 5.63 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 165.444 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.5 p-10 -142.22 72.24 1.37 Allowed 'General case' 0 C--N 1.32 -0.69 0 C-N-CA 127.712 2.405 . . . . 0.0 108.811 -176.599 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -139.18 132.01 29.21 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 124.92 1.288 . . . . 0.0 108.109 177.439 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 57.7 m -154.97 -89.66 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.195 0 N-CA-C 107.274 -1.38 . . . . 0.0 107.274 168.208 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -122.84 145.82 48.1 Favored 'General case' 0 N--CA 1.467 0.392 0 CA-C-N 119.519 1.054 . . . . 0.0 108.66 178.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 25.0 t80 -168.75 144.77 3.54 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 126.949 2.1 . . . . 0.0 105.663 173.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 131.91 177.73 15.08 Favored Glycine 0 C--N 1.336 0.551 0 N-CA-C 109.845 -1.302 . . . . 0.0 109.845 170.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 17.5 p90 -122.79 149.58 43.95 Favored 'General case' 0 C--O 1.235 0.331 0 CA-C-N 118.719 1.26 . . . . 0.0 111.06 -165.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -129.97 169.43 15.26 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 124.194 0.997 . . . . 0.0 110.924 179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -152.25 153.94 34.75 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 126.416 1.886 . . . . 0.0 106.977 -172.289 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 116.0 -149.79 18.75 Favored Glycine 0 CA--C 1.52 0.362 0 N-CA-C 110.134 -1.186 . . . . 0.0 110.134 167.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 49.88 55.58 9.2 Favored 'General case' 0 CA--C 1.541 0.61 0 N-CA-C 115.842 1.793 . . . . 0.0 115.842 159.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -146.0 63.68 0.45 Allowed Glycine 0 C--N 1.339 0.723 0 CA-C-O 119.056 -0.858 . . . . 0.0 111.394 173.856 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -147.08 176.72 9.73 Favored 'General case' 0 C--O 1.234 0.264 0 CA-C-N 119.414 1.607 . . . . 0.0 113.137 -173.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 13.0 pt20 -125.29 140.27 52.97 Favored 'General case' 0 CA--C 1.521 -0.163 0 C-N-CA 124.708 1.203 . . . . 0.0 109.733 -178.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -93.45 172.29 8.37 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.186 -1.042 . . . . 0.0 108.186 162.655 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -56.66 122.57 52.15 Favored Pre-proline 0 CA--C 1.541 0.611 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.559 -177.528 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 63.4 Cg_endo -74.67 121.92 7.02 Favored 'Trans proline' 0 N--CA 1.459 -0.515 0 C-N-CA 123.252 2.635 . . . . 0.0 110.113 -179.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 20.3 mmt -97.93 -176.68 3.52 Favored 'General case' 0 CA--C 1.532 0.283 0 C-N-CA 125.765 1.626 . . . . 0.0 110.655 -169.209 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -46.73 -51.98 14.98 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 129.792 3.237 . . . . 0.0 110.173 -164.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.5 m120 -146.33 32.15 0.99 Allowed 'General case' 0 N--CA 1.45 -0.451 0 C-N-CA 123.768 0.827 . . . . 0.0 111.297 -175.086 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.507 HG12 ' H ' ' A' ' 145' ' ' GLY . 16.0 m -149.25 165.91 3.6 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.383 0 C-N-CA 124.712 1.205 . . . . 0.0 108.63 173.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.91 143.07 49.14 Favored 'General case' 0 C--O 1.238 0.475 0 N-CA-C 106.712 -1.588 . . . . 0.0 106.712 164.443 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.6 mm? -109.31 139.69 43.93 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 -174.464 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -113.01 168.89 9.33 Favored 'General case' 0 C--N 1.322 -0.599 0 C-N-CA 125.238 1.415 . . . . 0.0 108.877 -179.376 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -144.48 114.06 7.15 Favored 'General case' 0 N--CA 1.451 -0.394 0 N-CA-C 107.198 -1.408 . . . . 0.0 107.198 145.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 75.4 m -120.62 116.32 25.1 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 177.888 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.1 t80 -134.07 115.07 13.86 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 127.347 2.259 . . . . 0.0 105.247 -176.131 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -132.36 163.61 28.33 Favored 'General case' 0 CA--C 1.536 0.414 0 C-N-CA 126.561 1.945 . . . . 0.0 108.46 -174.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -131.52 127.11 36.58 Favored 'General case' 0 CA--C 1.528 0.108 0 C-N-CA 125.097 1.359 . . . . 0.0 108.418 176.341 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 35.7 m -96.72 109.45 22.1 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.084 -1.08 . . . . 0.0 108.084 167.253 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 63.5 ttt180 -81.86 114.92 20.8 Favored 'General case' 0 C--O 1.235 0.31 0 N-CA-C 108.221 -1.029 . . . . 0.0 108.221 172.76 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 42.1 mm -110.93 158.69 11.33 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.614 1.966 . . . . 0.0 107.895 -172.956 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.91 84.37 0.0 OUTLIER 'General case' 0 CA--C 1.544 0.741 0 C-N-CA 128.22 2.608 . . . . 0.0 112.08 -178.612 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 3.8 m 52.96 37.67 25.13 Favored 'General case' 0 CA--C 1.533 0.311 0 C-N-CA 125.461 1.504 . . . . 0.0 113.299 -168.2 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.0 t -134.74 150.09 29.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 106.193 -1.78 . . . . 0.0 106.193 162.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -108.86 152.04 25.44 Favored 'General case' 0 C--N 1.325 -0.471 0 O-C-N 120.588 -1.32 . . . . 0.0 108.174 161.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 24.4 t -141.47 138.81 32.61 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.833 0 N-CA-C 105.287 -2.116 . . . . 0.0 105.287 -174.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -100.32 152.73 19.27 Favored Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 108.106 -1.998 . . . . 0.0 108.106 172.022 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 14.8 t -139.47 138.78 36.7 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.65 -1.981 . . . . 0.0 105.65 156.814 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 70.1 p-90 -143.65 155.58 44.28 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 170.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 65.0 mt -124.56 158.27 31.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.436 0 N-CA-C 107.204 -1.406 . . . . 0.0 107.204 -178.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -117.06 158.34 24.34 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 123.714 0.805 . . . . 0.0 109.833 175.42 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -118.97 116.48 3.37 Favored Glycine 0 N--CA 1.449 -0.487 0 N-CA-C 109.434 -1.466 . . . . 0.0 109.434 -178.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 15.7 m -138.36 176.91 5.91 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.528 0 C-N-CA 126.307 1.843 . . . . 0.0 107.135 165.866 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.609 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.81 -100.86 0.24 Allowed Glycine 0 CA--C 1.531 1.038 0 CA-C-O 117.355 -1.803 . . . . 0.0 113.409 160.401 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.499 ' H ' HG11 ' A' ' 5' ' ' VAL . 46.0 m-85 -145.69 142.34 28.91 Favored 'General case' 0 N--CA 1.471 0.599 0 CA-C-N 119.414 1.607 . . . . 0.0 112.632 -178.216 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.65 111.73 24.09 Favored 'General case' 0 N--CA 1.466 0.339 0 C-N-CA 125.922 1.689 . . . . 0.0 109.398 179.88 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--O 1.238 0.465 0 N-CA-C 105.379 -2.082 . . . . 0.0 105.379 173.542 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 120.996 0.427 . . . . 0.0 110.451 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 59.4 m -132.4 105.67 7.42 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 107.521 -1.289 . . . . 0.0 107.521 -156.097 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.8 m -77.84 126.13 30.38 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 177.231 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 88.2 m -139.46 139.09 36.93 Favored 'General case' 0 CA--C 1.506 -0.72 0 N-CA-C 104.45 -2.426 . . . . 0.0 104.45 -170.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.426 HG21 ' HA3' ' A' ' 145' ' ' GLY . 7.1 p -88.87 153.07 3.26 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 C-N-CA 118.335 -1.346 . . . . 0.0 107.481 -164.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 28.7 m -141.82 121.93 13.79 Favored 'General case' 0 N--CA 1.444 -0.771 0 N-CA-C 107.988 -1.115 . . . . 0.0 107.988 152.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 170.86 173.03 37.7 Favored Glycine 0 N--CA 1.451 -0.344 0 N-CA-C 109.758 -1.337 . . . . 0.0 109.758 167.473 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.19 -91.23 0.11 Allowed Glycine 0 N--CA 1.441 -1.01 0 N-CA-C 108.455 -1.858 . . . . 0.0 108.455 174.768 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -150.49 157.87 43.5 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 123.32 0.648 . . . . 0.0 110.207 -173.143 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -142.24 159.81 41.48 Favored 'General case' 0 C--O 1.238 0.457 0 C-N-CA 125.77 1.628 . . . . 0.0 107.864 170.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 9.0 mt-30 -145.95 152.87 40.11 Favored 'General case' 0 C--O 1.239 0.513 0 C-N-CA 126.693 1.997 . . . . 0.0 106.399 167.615 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 2.0 t -139.86 151.19 45.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 124.735 1.214 . . . . 0.0 107.964 156.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . 0.451 ' OD1' ' HE2' ' A' ' 20' ' ' LYS . 45.8 m-20 -104.87 172.26 6.88 Favored 'General case' 0 C--O 1.237 0.404 0 C-N-CA 127.6 2.36 . . . . 0.0 107.686 166.206 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -129.41 118.01 21.49 Favored 'General case' 0 C--O 1.233 0.204 0 N-CA-C 107.788 -1.19 . . . . 0.0 107.788 164.161 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.5 tm0? 61.8 -31.19 0.08 Allowed 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 128.094 2.558 . . . . 0.0 114.559 -176.472 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 155.53 -57.57 0.39 Allowed Glycine 0 CA--C 1.525 0.698 0 C-N-CA 126.525 2.012 . . . . 0.0 108.22 177.587 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -138.05 108.03 6.35 Favored 'General case' 0 C--O 1.233 0.215 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 161.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -147.94 -45.89 0.16 Allowed 'General case' 0 C--N 1.328 -0.353 0 O-C-N 121.732 -0.605 . . . . 0.0 109.728 165.021 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.4 p30 -145.34 168.44 20.49 Favored 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 126.179 1.791 . . . . 0.0 106.673 163.009 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.451 ' HE2' ' OD1' ' A' ' 13' ' ' ASP . 91.2 mttt -134.34 156.1 49.08 Favored 'General case' 0 C--O 1.238 0.456 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 170.204 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -130.37 112.4 13.24 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 105.466 -2.05 . . . . 0.0 105.466 168.502 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -147.51 163.54 28.75 Favored Glycine 0 CA--C 1.52 0.376 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 178.062 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 154.21 -149.58 21.0 Favored Glycine 0 N--CA 1.448 -0.541 0 N-CA-C 108.544 -1.822 . . . . 0.0 108.544 -174.058 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -98.58 141.72 31.06 Favored 'General case' 0 C--O 1.237 0.408 0 N-CA-C 106.253 -1.758 . . . . 0.0 106.253 -173.413 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.1 t-20 -116.86 115.39 25.43 Favored 'General case' 0 CA--C 1.515 -0.374 0 N-CA-C 106.293 -1.743 . . . . 0.0 106.293 167.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -115.25 114.58 25.39 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 171.232 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.549 ' HE3' HD11 ' A' ' 40' ' ' ILE . 43.9 mtpt -104.09 173.87 6.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 106.101 -1.814 . . . . 0.0 106.101 173.465 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 71.0 t80 -151.23 140.94 21.79 Favored 'General case' 0 C--O 1.238 0.48 0 N-CA-C 106.835 -1.543 . . . . 0.0 106.835 171.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -135.77 156.1 49.33 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 109.114 -0.698 . . . . 0.0 109.114 170.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 2.8 t80 -144.71 147.75 33.37 Favored 'General case' 0 N--CA 1.451 -0.42 0 N-CA-C 106.382 -1.71 . . . . 0.0 106.382 171.761 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 15.4 pt-20 -99.25 153.51 18.88 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 168.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -70.94 167.2 19.59 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 166.296 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -105.29 1.66 28.22 Favored 'General case' 0 CA--C 1.534 0.337 0 C-N-CA 122.972 0.509 . . . . 0.0 111.964 -170.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -144.84 -59.68 0.36 Allowed 'General case' 0 CA--C 1.53 0.192 0 C-N-CA 127.676 2.391 . . . . 0.0 108.072 -178.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 54.3 m -64.95 139.24 97.74 Favored Pre-proline 0 C--O 1.238 0.461 0 N-CA-C 108.306 -0.998 . . . . 0.0 108.306 173.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_endo -78.79 51.26 3.74 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 123.21 2.607 . . . . 0.0 110.391 172.404 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 6.5 tp -111.98 156.21 22.5 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.763 2.025 . . . . 0.0 108.956 -174.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -147.26 178.02 25.16 Favored Glycine 0 N--CA 1.452 -0.236 0 N-CA-C 110.565 -1.014 . . . . 0.0 110.565 164.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 45.9 t -125.18 161.33 29.51 Favored 'Isoleucine or valine' 0 C--O 1.24 0.563 0 C-N-CA 126.805 2.042 . . . . 0.0 107.377 -178.028 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.549 HD11 ' HE3' ' A' ' 27' ' ' LYS . 0.0 OUTLIER -140.36 158.67 25.25 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.372 0 N-CA-C 108.741 -0.837 . . . . 0.0 108.741 160.197 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -150.55 136.09 5.48 Favored Glycine 0 CA--C 1.529 0.958 0 N-CA-C 109.035 -1.626 . . . . 0.0 109.035 159.697 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 8.5 t -120.73 154.15 36.0 Favored 'General case' 0 N--CA 1.465 0.318 0 C-N-CA 128.697 2.799 . . . . 0.0 110.807 -177.695 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 6.6 m-85 -143.03 157.52 44.46 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 126.179 1.792 . . . . 0.0 109.715 176.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.2 m -127.27 153.11 46.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 126.195 1.798 . . . . 0.0 108.215 177.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -111.87 158.21 19.7 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.782 0.833 . . . . 0.0 109.827 164.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.4 t -133.94 144.7 48.97 Favored 'General case' 0 C--O 1.235 0.342 0 O-C-N 120.833 -1.167 . . . . 0.0 109.83 151.754 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -67.67 150.21 49.02 Favored 'General case' 0 CA--C 1.541 0.634 0 N-CA-C 108.061 -1.088 . . . . 0.0 108.061 168.703 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 27.1 pttt -105.06 113.11 26.51 Favored 'General case' 0 N--CA 1.466 0.372 0 O-C-N 120.897 -1.127 . . . . 0.0 107.965 -177.392 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 26.9 m -102.85 155.64 18.2 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-O 121.664 0.745 . . . . 0.0 109.777 -175.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 45.5 mtm105 -136.05 99.94 4.28 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.992 2.117 . . . . 0.0 107.132 -167.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.471 HG23 ' H ' ' A' ' 55' ' ' GLY . 61.0 m 61.73 127.5 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 125.241 1.416 . . . . 0.0 112.637 -168.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -145.32 11.62 1.33 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 125.667 1.587 . . . . 0.0 111.553 164.288 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 65.4 m -149.46 -78.17 0.14 Allowed 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 127.48 2.312 . . . . 0.0 107.358 173.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 17.6 m -152.07 77.21 1.2 Allowed 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 119.724 1.147 . . . . 0.0 110.022 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . 0.471 ' H ' HG23 ' A' ' 51' ' ' THR . . . 73.68 16.46 79.14 Favored Glycine 0 CA--C 1.532 1.136 0 O-C-N 121.353 -0.842 . . . . 0.0 112.2 177.563 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 21.0 p-10 -81.61 91.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.447 0 C-N-CA 126.313 1.845 . . . . 0.0 106.331 173.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 3.9 m-85 -70.94 124.07 23.5 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 172.085 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 3.4 t30 -79.15 57.65 2.3 Favored 'General case' 0 C--O 1.238 0.477 0 C-N-CA 117.524 -1.67 . . . . 0.0 107.528 157.401 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 32.8 tttp -76.64 114.36 15.29 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 102.599 -3.112 . . . . 0.0 102.599 163.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.2 t-20 -166.19 -173.22 2.51 Favored 'General case' 0 C--N 1.319 -0.74 0 N-CA-C 105.947 -1.871 . . . . 0.0 105.947 -178.847 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 15.2 tp60 -132.64 164.11 27.42 Favored 'General case' 0 N--CA 1.444 -0.773 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 177.634 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -74.19 144.43 44.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 149.681 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -141.59 116.72 10.0 Favored 'General case' 0 N--CA 1.444 -0.732 0 N-CA-C 103.133 -2.914 . . . . 0.0 103.133 157.64 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -143.07 117.46 1.11 Allowed Glycine 0 N--CA 1.449 -0.464 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -179.169 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -129.06 137.61 56.7 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 N-CA-C 107.487 -1.301 . . . . 0.0 107.487 179.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 64.0 p -140.53 147.47 39.56 Favored 'General case' 0 C--O 1.235 0.336 0 N-CA-C 108.169 -1.049 . . . . 0.0 108.169 -178.305 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -155.3 154.29 31.87 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 118.356 0.526 . . . . 0.0 109.597 167.66 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.34 138.89 2.54 Favored Glycine 0 CA--C 1.531 1.076 0 N-CA-C 109.371 -1.492 . . . . 0.0 109.371 161.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -78.0 153.93 29.18 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 CA-C-N 119.496 1.648 . . . . 0.0 111.719 -176.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.69 163.22 14.59 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 125.804 1.642 . . . . 0.0 110.357 173.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 81.0 t80 -155.65 130.39 9.17 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 123.506 0.722 . . . . 0.0 109.332 -179.327 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.7 ttm105 -63.91 125.81 25.62 Favored 'General case' 0 N--CA 1.469 0.513 0 N-CA-C 106.418 -1.697 . . . . 0.0 106.418 169.363 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . 0.251 9.4 pt -76.4 -70.05 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.535 0.375 0 N-CA-C 109.237 -0.653 . . . . 0.0 109.237 175.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -157.93 -2.9 0.09 Allowed 'General case' 0 CA--C 1.539 0.535 0 N-CA-C 112.972 0.73 . . . . 0.0 112.972 -174.041 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 55.2 t0 -142.59 23.11 1.97 Allowed 'General case' 0 CA--C 1.542 0.651 0 O-C-N 121.482 -0.761 . . . . 0.0 111.238 -139.506 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.7 m95 51.86 12.03 0.17 Allowed 'General case' 0 N--CA 1.477 0.91 0 C-N-CA 126.118 1.767 . . . . 0.0 112.785 -163.229 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -106.46 117.88 35.19 Favored 'General case' 0 N--CA 1.439 -1.024 0 C-N-CA 126.901 2.08 . . . . 0.0 106.44 -178.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 18.0 m -104.28 129.42 52.12 Favored 'General case' 0 N--CA 1.446 -0.656 0 N-CA-C 107.125 -1.435 . . . . 0.0 107.125 173.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 2.3 pp -126.86 160.07 35.78 Favored 'Isoleucine or valine' 0 C--O 1.233 0.237 0 N-CA-C 108.961 -0.755 . . . . 0.0 108.961 179.733 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.464 ' CD2' ' HA3' ' A' ' 112' ' ' GLY . 0.1 OUTLIER -149.91 167.34 26.91 Favored 'General case' 0 N--CA 1.446 -0.627 0 C-N-CA 128.524 2.73 . . . . 0.0 106.88 175.875 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -149.32 98.78 0.19 Allowed Glycine 0 C--N 1.329 0.175 0 N-CA-C 105.917 -2.873 . . . . 0.0 105.917 177.523 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 33.9 m -104.05 169.52 2.11 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-N 117.58 0.69 . . . . 0.0 109.323 -163.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 2.6 t -95.08 151.98 3.75 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 106.56 -1.644 . . . . 0.0 106.56 174.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -153.1 154.96 25.84 Favored Glycine 0 N--CA 1.447 -0.611 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 168.002 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 6.7 m -137.46 147.26 26.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 N-CA-C 106.434 -1.691 . . . . 0.0 106.434 169.266 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.57 121.38 3.44 Favored Glycine 0 N--CA 1.45 -0.402 0 N-CA-C 108.914 -1.674 . . . . 0.0 108.914 -176.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 25.1 t80 -95.6 160.19 14.62 Favored 'General case' 0 CA--C 1.541 0.597 0 C-N-CA 124.259 1.024 . . . . 0.0 110.393 -170.542 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 152.63 133.09 1.87 Allowed Glycine 0 CA--C 1.53 0.976 0 CA-C-N 119.221 0.919 . . . . 0.0 112.703 167.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 18.0 tptt -153.05 151.53 30.33 Favored 'General case' 0 N--CA 1.465 0.285 0 C-N-CA 125.136 1.374 . . . . 0.0 109.912 176.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 48.6 p90 -73.36 164.53 26.54 Favored 'General case' 0 C--O 1.238 0.459 0 CA-C-O 121.188 0.518 . . . . 0.0 110.399 164.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -133.42 103.16 5.82 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 124.895 1.278 . . . . 0.0 108.368 -164.871 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 88.9 m -86.18 101.93 13.45 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 126.484 1.914 . . . . 0.0 108.998 -175.885 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 8.9 t -150.86 14.2 0.72 Allowed 'General case' 0 CA--C 1.543 0.708 0 CA-C-O 118.002 -0.999 . . . . 0.0 113.596 -169.02 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 17.1 tt0 -147.5 5.81 0.82 Allowed 'General case' 0 N--CA 1.474 0.76 0 CA-C-N 120.823 1.647 . . . . 0.0 114.197 -166.785 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . 0.405 ' H ' ' HD2' ' A' ' 96' ' ' PRO . 7.9 t80 -143.44 -56.54 0.02 OUTLIER Pre-proline 0 CA--C 1.535 0.376 0 CA-C-N 119.782 1.173 . . . . 0.0 112.019 -178.846 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . 0.405 ' HD2' ' H ' ' A' ' 95' ' ' TYR . 41.9 Cg_endo -76.31 -178.08 4.17 Favored 'Trans proline' 0 N--CA 1.456 -0.726 0 CA-C-N 121.5 1.571 . . . . 0.0 109.87 166.713 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.5 p -64.95 28.04 0.02 OUTLIER 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 130.129 3.372 . . . . 0.0 115.175 -177.691 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 10.9 t80 75.16 129.35 0.04 OUTLIER 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 127.814 2.446 . . . . 0.0 109.993 178.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.65 -69.4 0.85 Allowed 'General case' 0 CA--C 1.519 -0.249 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 174.059 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 36.1 t-20 45.09 82.31 0.03 OUTLIER 'General case' 0 C--O 1.238 0.498 0 C-N-CA 124.556 1.142 . . . . 0.0 110.724 -167.732 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.6 t0 -67.91 167.95 12.66 Favored 'General case' 0 C--O 1.239 0.502 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.64 164.81 9.1 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 124.313 1.045 . . . . 0.0 110.086 173.016 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.4 p -56.5 125.99 24.54 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 156.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 14.4 m-20 -101.27 128.37 47.44 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 173.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -94.59 158.89 15.33 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 123.131 0.572 . . . . 0.0 109.701 177.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -115.74 -173.6 17.44 Favored Glycine 0 CA--C 1.529 0.938 0 N-CA-C 109.254 -1.539 . . . . 0.0 109.254 160.025 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -134.21 126.19 29.37 Favored 'General case' 0 C--O 1.238 0.47 0 N-CA-C 107.791 -1.189 . . . . 0.0 107.791 166.415 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 2.2 p -142.14 179.51 6.86 Favored 'General case' 0 CA--C 1.54 0.571 0 C-N-CA 124.189 0.996 . . . . 0.0 110.451 -178.486 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -145.37 168.68 19.93 Favored 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 125.012 1.325 . . . . 0.0 108.564 -169.842 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -144.03 111.51 0.63 Allowed Glycine 0 CA--C 1.521 0.459 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -171.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -63.17 118.67 8.25 Favored 'General case' 0 N--CA 1.452 -0.364 0 C-N-CA 124.662 1.185 . . . . 0.0 108.504 169.531 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.464 ' HA3' ' CD2' ' A' ' 80' ' ' TYR . . . -113.44 97.19 0.85 Allowed Glycine 0 C--N 1.335 0.492 0 N-CA-C 110.257 -1.137 . . . . 0.0 110.257 179.448 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.1 mp -142.33 163.29 33.24 Favored 'General case' 0 C--O 1.233 0.237 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 -176.692 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 10.0 tt0 -132.06 103.81 6.47 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 105.591 -2.004 . . . . 0.0 105.591 174.828 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -125.99 105.36 8.84 Favored 'General case' 0 CA--C 1.514 -0.409 0 N-CA-C 104.961 -2.237 . . . . 0.0 104.961 -179.591 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -127.13 100.81 26.39 Favored Pre-proline 0 N--CA 1.452 -0.35 0 C-N-CA 123.985 0.914 . . . . 0.0 108.777 -172.738 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 66.3 Cg_endo -78.45 27.38 0.5 Allowed 'Trans proline' 0 CA--C 1.54 0.794 0 C-N-CA 122.605 2.203 . . . . 0.0 110.929 163.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 53.2 mtp -127.44 170.39 12.6 Favored 'General case' 0 N--CA 1.432 -1.359 0 N-CA-C 104.443 -2.429 . . . . 0.0 104.443 170.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.9 tp10 -125.15 -17.54 5.69 Favored 'General case' 0 C--N 1.318 -0.767 0 CA-C-O 121.81 0.814 . . . . 0.0 109.765 -150.512 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -133.59 0.98 3.35 Favored 'General case' 0 C--O 1.222 -0.393 0 C-N-CA 126.174 1.79 . . . . 0.0 110.064 175.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 54.9 t -116.5 150.16 18.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.222 0 C-N-CA 126.664 1.985 . . . . 0.0 105.76 175.582 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -122.37 138.96 54.35 Favored 'General case' 0 C--O 1.236 0.36 0 N-CA-C 108.241 -1.022 . . . . 0.0 108.241 169.438 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -113.89 128.55 56.45 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 126.02 1.728 . . . . 0.0 107.868 -174.564 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -134.79 153.55 51.98 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 126.839 2.056 . . . . 0.0 107.681 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.8 p90 -149.8 114.63 5.34 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.682 1.193 . . . . 0.0 108.935 -173.307 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.5 m -102.79 141.24 35.93 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 162.157 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -135.69 108.97 7.79 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.368 -1.345 . . . . 0.0 107.368 172.015 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -98.65 158.07 15.85 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.279 1.038 . . . . 0.0 109.247 -178.901 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -132.03 136.57 47.34 Favored 'General case' 0 N--CA 1.447 -0.582 0 N-CA-C 105.608 -1.997 . . . . 0.0 105.608 157.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -140.78 158.56 43.79 Favored 'General case' 0 N--CA 1.448 -0.548 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 156.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 18.0 ttt180 -134.28 97.17 3.77 Favored 'General case' 0 CA--C 1.516 -0.334 0 N-CA-C 106.412 -1.699 . . . . 0.0 106.412 -179.332 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.8 mp -84.13 103.69 11.64 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 105.294 -2.113 . . . . 0.0 105.294 176.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.1 ttt-85 70.31 -80.57 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 128.346 2.658 . . . . 0.0 109.662 173.306 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 14.0 t -145.61 28.74 1.16 Allowed 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.349 1.06 . . . . 0.0 108.716 172.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 19.4 m -117.87 103.49 14.86 Favored 'Isoleucine or valine' 0 C--O 1.231 0.13 0 N-CA-C 107.754 -1.202 . . . . 0.0 107.754 167.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 5.4 p-10 -63.46 122.42 16.21 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 163.04 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 62.1 t -126.89 104.75 13.1 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.521 0 N-CA-C 102.932 -2.988 . . . . 0.0 102.932 172.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -128.92 114.57 1.79 Allowed Glycine 0 C--N 1.335 0.526 0 N-CA-C 108.764 -1.735 . . . . 0.0 108.764 -179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 13.9 t -99.53 154.82 17.95 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 125.154 1.381 . . . . 0.0 109.343 -171.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.1 OUTLIER -116.6 157.12 25.83 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 161.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 67.1 mt -133.88 144.63 35.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 N-CA-C 105.219 -2.141 . . . . 0.0 105.219 172.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -134.75 118.14 16.75 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 124.209 1.004 . . . . 0.0 109.11 -177.961 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -87.08 117.35 4.67 Favored Glycine 0 CA--C 1.524 0.628 0 CA-C-O 118.422 -1.21 . . . . 0.0 110.167 176.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 47.2 t -126.37 160.32 34.16 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.689 0 CA-C-N 118.611 1.205 . . . . 0.0 107.93 163.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.426 ' HA3' HG21 ' A' ' 5' ' ' VAL . . . 144.03 -139.16 8.48 Favored Glycine 0 CA--C 1.523 0.592 0 N-CA-C 108.581 -1.807 . . . . 0.0 108.581 -174.776 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.401 ' N ' HG11 ' A' ' 5' ' ' VAL . 0.3 OUTLIER -126.51 150.69 48.61 Favored 'General case' 0 C--N 1.342 0.257 0 CA-C-N 119.866 1.833 . . . . 0.0 113.189 -168.082 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.29 124.05 44.66 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 107.881 -1.155 . . . . 0.0 107.881 -179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.855 0 C-N-CA 128.589 2.756 . . . . 0.0 105.992 -170.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.472 0.645 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.9 m -144.33 122.93 12.5 Favored 'General case' 0 C--O 1.242 0.663 0 O-C-N 123.601 0.563 . . . . 0.0 110.043 -166.236 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 70.7 m -130.1 105.33 7.87 Favored 'General case' 0 C--N 1.342 0.276 0 CA-C-O 121.37 0.605 . . . . 0.0 110.512 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.671 ' H ' ' HD2' ' A' ' 29' ' ' ARG . 7.6 m -95.54 141.65 28.81 Favored 'General case' 0 C--O 1.238 0.45 0 N-CA-C 105.702 -1.962 . . . . 0.0 105.702 163.107 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 6.1 m -125.95 157.04 36.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.533 0 C-N-CA 126.817 2.047 . . . . 0.0 106.092 168.929 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 15.3 t -154.68 149.87 27.03 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.915 0.886 . . . . 0.0 108.939 -171.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -156.36 110.5 0.45 Allowed Glycine 0 N--CA 1.451 -0.331 0 N-CA-C 109.004 -1.639 . . . . 0.0 109.004 -166.48 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -169.66 -174.74 38.23 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 108.528 -1.829 . . . . 0.0 108.528 -174.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 24.9 m-85 -109.11 125.44 52.15 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.214 -0.661 . . . . 0.0 109.214 -156.854 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.85 125.72 39.7 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 106.943 -1.502 . . . . 0.0 106.943 -175.71 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 4.7 mt-30 -99.48 124.66 44.84 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 125.544 1.538 . . . . 0.0 108.02 -175.668 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 50.9 p -96.95 115.7 27.9 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.211 -1.774 . . . . 0.0 106.211 163.709 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 11.1 t0 -125.3 170.76 11.0 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-O 118.741 -0.647 . . . . 0.0 109.38 179.296 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.4 165.14 32.96 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 119.631 1.105 . . . . 0.0 113.185 -172.761 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.65 -25.64 28.09 Favored 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 128.233 2.613 . . . . 0.0 112.006 175.961 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -125.82 112.41 1.65 Allowed Glycine 0 N--CA 1.445 -0.7 0 N-CA-C 106.374 -2.69 . . . . 0.0 106.374 174.636 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 14.9 pt20 -48.79 95.11 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 127.586 2.354 . . . . 0.0 109.698 177.995 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.5 ttm 179.49 28.25 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 125.404 1.482 . . . . 0.0 110.945 -170.778 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 10.2 m-80 -129.93 138.57 50.96 Favored 'General case' 0 C--O 1.234 0.258 0 N-CA-C 105.969 -1.863 . . . . 0.0 105.969 171.826 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 62.5 tttp -126.16 142.57 51.47 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 125.118 1.367 . . . . 0.0 107.418 -174.297 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 3.0 ptt? -73.69 142.58 46.39 Favored 'General case' 0 C--N 1.328 -0.343 0 C-N-CA 123.512 0.725 . . . . 0.0 112.216 -169.69 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -158.35 61.91 0.32 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 109.193 -1.563 . . . . 0.0 109.193 179.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -161.36 173.86 37.83 Favored Glycine 0 N--CA 1.447 -0.583 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -174.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -140.35 174.46 10.49 Favored 'General case' 0 N--CA 1.451 -0.411 0 C-N-CA 126.373 1.869 . . . . 0.0 108.423 -176.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 28.1 m120 -129.17 164.22 23.85 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 125.778 1.631 . . . . 0.0 110.029 -172.107 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -157.02 152.79 27.0 Favored 'General case' 0 CA--C 1.539 0.551 0 C-N-CA 124.004 0.922 . . . . 0.0 109.826 173.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 8.5 mtpt -122.01 143.75 49.31 Favored 'General case' 0 CA--C 1.516 -0.332 0 C-N-CA 125.105 1.362 . . . . 0.0 108.377 169.158 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.8 t80 -141.31 108.85 5.59 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.384 -1.71 . . . . 0.0 106.384 177.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.671 ' HD2' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -115.84 156.11 26.68 Favored 'General case' 0 C--O 1.236 0.35 0 O-C-N 121.917 -0.489 . . . . 0.0 111.321 -175.987 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 5.9 t80 -122.67 122.86 39.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 107.519 -1.289 . . . . 0.0 107.519 173.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 16.9 tp10 -87.42 118.87 27.16 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.305 -2.109 . . . . 0.0 105.305 164.397 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 5.4 tt0 -104.96 174.79 5.73 Favored 'General case' 0 N--CA 1.452 -0.356 0 N-CA-C 107.623 -1.251 . . . . 0.0 107.623 172.217 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -135.58 58.97 1.74 Allowed 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 107.035 -1.468 . . . . 0.0 107.035 -167.126 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 4.1 m-20 -161.99 -69.87 0.06 Allowed 'General case' 0 CA--C 1.52 -0.204 0 C-N-CA 126.217 1.807 . . . . 0.0 106.719 174.859 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 73.0 m -79.95 135.08 55.61 Favored Pre-proline 0 N--CA 1.449 -0.51 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -179.713 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -75.2 39.46 0.6 Allowed 'Trans proline' 0 CA--C 1.544 0.983 0 C-N-CA 123.681 2.921 . . . . 0.0 110.437 166.607 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.1 pp -127.6 148.44 50.36 Favored 'General case' 0 CA--C 1.513 -0.469 0 C-N-CA 125.252 1.421 . . . . 0.0 108.121 179.288 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -122.88 -169.62 13.37 Favored Glycine 0 N--CA 1.45 -0.388 0 N-CA-C 110.441 -1.064 . . . . 0.0 110.441 178.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 5.2 t -130.53 149.32 33.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 -178.632 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 88.1 mt -139.99 151.2 21.72 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.327 0 C-N-CA 126.873 2.069 . . . . 0.0 106.508 -179.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -153.08 110.87 0.47 Allowed Glycine 0 CA--C 1.531 1.056 0 N-CA-C 109.118 -1.593 . . . . 0.0 109.118 163.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 50.5 m -67.42 121.93 16.84 Favored 'General case' 0 C--O 1.236 0.354 0 N-CA-C 108.247 -1.02 . . . . 0.0 108.247 167.184 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 1.3 m-85 -123.59 139.89 53.55 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.062 0.945 . . . . 0.0 110.194 -177.803 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 12.5 t -128.17 152.73 47.69 Favored 'General case' 0 C--O 1.237 0.398 0 C-N-CA 126.295 1.838 . . . . 0.0 110.539 -173.505 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . 0.401 ' HA ' ' CG ' ' A' ' 62' ' ' TYR . 31.8 m-85 -124.6 141.72 51.89 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 126.192 1.797 . . . . 0.0 107.54 168.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 52.8 m -142.0 140.23 32.61 Favored 'General case' 0 N--CA 1.465 0.277 0 CA-C-N 119.355 0.979 . . . . 0.0 109.592 175.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -148.9 154.47 39.48 Favored 'General case' 0 C--O 1.24 0.557 0 CA-C-N 118.043 0.383 . . . . 0.0 110.142 164.162 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.66 114.4 1.83 Allowed 'General case' 0 C--O 1.235 0.312 0 C-N-CA 123.229 0.612 . . . . 0.0 111.602 174.434 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -68.42 115.23 7.6 Favored 'General case' 0 C--O 1.242 0.689 0 C-N-CA 123.052 0.541 . . . . 0.0 109.976 163.54 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.8 mmp_? -119.92 166.76 12.9 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 107.542 -1.281 . . . . 0.0 107.542 155.266 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 15.3 t 145.19 128.53 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.349 1 C-N-CA 132.69 4.396 . . . . 0.0 106.031 -177.136 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -131.1 3.49 4.36 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 125.425 1.49 . . . . 0.0 111.544 175.129 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 32.5 t 136.31 -70.49 0.0 OUTLIER 'General case' 0 C--O 1.232 0.172 0 C-N-CA 131.3 3.84 . . . . 0.0 106.564 173.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 1.2 m -48.1 -54.83 11.89 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 125.943 1.697 . . . . 0.0 112.49 -154.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 153.82 47.88 0.02 OUTLIER Glycine 0 C--O 1.22 -0.753 0 N-CA-C 106.854 -2.498 . . . . 0.0 106.854 -171.398 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 9.6 p-10 -119.71 91.62 3.59 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.898 1.279 . . . . 0.0 107.84 -163.47 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 96.0 m-85 -124.11 158.68 31.7 Favored 'General case' 0 C--O 1.235 0.315 0 N-CA-C 107.656 -1.239 . . . . 0.0 107.656 -175.503 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 16.7 t-20 -124.36 74.43 1.31 Allowed 'General case' 0 N--CA 1.468 0.456 0 N-CA-C 108.139 -1.06 . . . . 0.0 108.139 167.446 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.489 ' HA ' ' HE2' ' A' ' 59' ' ' LYS . 4.1 mmpt? -80.3 119.43 23.02 Favored 'General case' 0 CA--C 1.507 -0.681 0 N-CA-C 108.351 -0.981 . . . . 0.0 108.351 -171.146 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 2.7 p30 -148.59 153.0 37.73 Favored 'General case' 0 N--CA 1.442 -0.835 0 N-CA-C 107.551 -1.278 . . . . 0.0 107.551 -179.904 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -121.5 146.05 47.32 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 106.774 -1.565 . . . . 0.0 106.774 169.265 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.401 ' CG ' ' HA ' ' A' ' 45' ' ' TYR . 26.3 p90 -74.03 129.41 37.81 Favored 'General case' 0 N--CA 1.446 -0.674 0 CA-C-O 121.573 0.701 . . . . 0.0 109.609 178.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 33.8 m-85 -140.86 117.97 11.25 Favored 'General case' 0 N--CA 1.448 -0.572 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 163.048 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -128.99 108.14 0.87 Allowed Glycine 0 N--CA 1.446 -0.645 0 N-CA-C 105.677 -2.969 . . . . 0.0 105.677 164.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 3.4 mm -119.55 110.98 31.1 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 -176.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 3.0 p -128.0 140.52 51.92 Favored 'General case' 0 N--CA 1.441 -0.898 0 C-N-CA 126.826 2.05 . . . . 0.0 107.903 -172.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -160.22 156.8 27.14 Favored 'General case' 0 C--O 1.235 0.306 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 168.001 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 170.69 165.63 28.34 Favored Glycine 0 CA--C 1.531 1.047 0 N-CA-C 108.661 -1.776 . . . . 0.0 108.661 172.951 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -69.57 125.95 12.85 Favored 'Trans proline' 0 N--CA 1.455 -0.759 0 C-N-CA 122.787 2.325 . . . . 0.0 108.8 179.42 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.13 129.9 36.36 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 108.234 -1.024 . . . . 0.0 108.234 -178.013 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -85.37 121.43 28.09 Favored 'General case' 0 C--O 1.238 0.484 0 N-CA-C 106.653 -1.61 . . . . 0.0 106.653 172.482 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 15.2 ttp180 -69.22 143.36 53.99 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.72 -0.613 . . . . 0.0 109.427 176.449 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.729 HG22 ' H ' ' A' ' 74' ' ' ASN . 20.1 mm -72.35 -153.14 0.01 OUTLIER 'Isoleucine or valine' 0 CA--C 1.548 0.875 0 N-CA-C 105.332 -2.099 . . . . 0.0 105.332 157.582 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . 0.729 ' H ' HG22 ' A' ' 73' ' ' ILE . 14.5 t-20 -75.78 -12.98 60.28 Favored 'General case' 0 CA--C 1.531 0.249 0 O-C-N 119.336 -2.103 . . . . 0.0 109.649 -176.32 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -156.85 -172.24 3.97 Favored 'General case' 0 N--CA 1.442 -0.843 0 C-N-CA 126.84 2.056 . . . . 0.0 106.839 -150.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 42.3 m0 -73.22 75.78 1.3 Allowed 'General case' 0 C--N 1.32 -0.7 0 C-N-CA 126.809 2.043 . . . . 0.0 111.034 -172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -126.34 -169.23 1.98 Allowed 'General case' 0 C--O 1.237 0.409 0 C-N-CA 124.786 1.235 . . . . 0.0 110.83 -177.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -131.98 166.39 21.8 Favored 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 125.721 1.608 . . . . 0.0 107.499 168.835 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 17.0 tt -126.81 161.78 32.77 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.215 0 N-CA-C 107.045 -1.465 . . . . 0.0 107.045 165.795 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.585 ' CD1' HD11 ' A' ' 113' ' ' LEU . 16.1 p90 -105.89 145.54 31.12 Favored 'General case' 0 N--CA 1.444 -0.763 0 C-N-CA 126.964 2.105 . . . . 0.0 108.196 177.266 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 137.06 15.3 0.81 Allowed Glycine 0 CA--C 1.527 0.828 0 CA-C-O 118.757 -1.024 . . . . 0.0 112.787 -168.594 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.562 HG22 ' HB2' ' A' ' 111' ' ' ALA . 3.7 m -104.18 160.21 4.91 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 CA-C-N 119.356 1.578 . . . . 0.0 108.881 172.423 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.6 m -94.78 162.44 2.43 Favored 'Isoleucine or valine' 0 CA--C 1.516 -0.355 0 N-CA-C 107.825 -1.176 . . . . 0.0 107.825 -173.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -140.43 -177.16 15.73 Favored Glycine 0 N--CA 1.45 -0.407 0 O-C-N 123.385 0.428 . . . . 0.0 112.686 177.451 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 54.5 t -126.01 150.81 31.73 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 C-N-CA 126.91 2.084 . . . . 0.0 106.251 178.911 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -123.32 155.4 17.44 Favored Glycine 0 C--O 1.24 0.482 0 N-CA-C 109.824 -1.31 . . . . 0.0 109.824 169.696 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 53.6 p90 -96.44 150.01 21.09 Favored 'General case' 0 CA--C 1.538 0.503 0 C-N-CA 125.552 1.541 . . . . 0.0 111.375 -170.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -175.25 116.88 0.59 Allowed Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.184 0.897 . . . . 0.0 111.615 173.418 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 31.0 mtpp -93.14 -74.91 0.51 Allowed 'General case' 0 C--O 1.217 -0.614 0 C-N-CA 124.148 0.979 . . . . 0.0 109.084 162.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 95.8 m-85 -146.67 -37.75 0.23 Allowed 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 119.272 0.942 . . . . 0.0 112.269 -177.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 4.9 mp0 70.18 -39.94 0.45 Allowed 'General case' 0 N--CA 1.474 0.763 0 C-N-CA 128.285 2.634 . . . . 0.0 114.174 175.312 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . 0.67 HG22 ' H ' ' A' ' 94' ' ' GLU . 20.9 m -96.89 150.63 20.52 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 104.196 -2.52 . . . . 0.0 104.196 163.081 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . 0.285 0.7 OUTLIER -120.91 23.78 10.52 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.346 169.809 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . 0.67 ' H ' HG22 ' A' ' 92' ' ' THR . 4.1 tt0 66.81 74.31 0.34 Allowed 'General case' 0 C--N 1.346 0.423 0 C-N-CA 125.254 1.422 . . . . 0.0 108.507 173.769 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 175.46 -62.07 0.0 OUTLIER Pre-proline 0 CA--C 1.54 0.584 0 C-N-CA 130.899 3.68 . . . . 0.0 107.572 -170.404 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 66.0 Cg_endo -71.39 -3.43 12.98 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 121.846 1.697 . . . . 0.0 114.116 -174.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 11.1 m 52.16 49.56 20.34 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 125.953 1.701 . . . . 0.0 110.051 170.285 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -98.4 -63.84 1.09 Allowed 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 108.758 -0.83 . . . . 0.0 108.758 -175.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 8.4 tptt -142.44 -63.13 0.43 Allowed 'General case' 0 N--CA 1.463 0.188 0 C-N-CA 124.534 1.134 . . . . 0.0 108.507 176.386 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 51.2 t30 63.13 98.95 0.03 OUTLIER 'General case' 0 C--O 1.233 0.195 0 C-N-CA 126.442 1.897 . . . . 0.0 109.083 -157.109 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -135.37 168.41 19.24 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 108.045 -1.094 . . . . 0.0 108.045 171.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 16.5 p -86.75 164.36 16.76 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.732 0.813 . . . . 0.0 111.666 -166.026 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.1 p -63.41 109.57 1.65 Allowed 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 170.91 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 44.4 t0 -154.44 167.75 28.99 Favored 'General case' 0 C--N 1.327 -0.393 0 C-N-CA 123.368 0.667 . . . . 0.0 109.463 -159.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 95.6 m-85 -124.07 163.2 21.94 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 125.487 1.515 . . . . 0.0 110.386 -170.016 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -154.05 170.22 32.62 Favored Glycine 0 CA--C 1.522 0.469 0 N-CA-C 108.373 -1.891 . . . . 0.0 108.373 172.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 6.2 p90 -105.59 148.65 27.07 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.71 1.204 . . . . 0.0 109.16 -170.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.42 158.33 18.05 Favored 'General case' 0 C--N 1.328 -0.331 0 N-CA-C 107.076 -1.453 . . . . 0.0 107.076 166.193 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 12.3 t80 -151.69 108.34 3.49 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 -169.623 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 150.2 -150.2 22.21 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 108.37 -1.892 . . . . 0.0 108.37 -179.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.562 ' HB2' HG22 ' A' ' 82' ' ' VAL . . . -178.57 -38.28 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.486 0 C-N-CA 126.073 1.749 . . . . 0.0 109.026 159.066 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 102.26 174.9 27.54 Favored Glycine 0 C--N 1.335 0.517 0 N-CA-C 110.989 -0.844 . . . . 0.0 110.989 -176.672 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.585 HD11 ' CD1' ' A' ' 80' ' ' TYR . 3.3 mp -146.85 140.38 25.69 Favored 'General case' 0 C--O 1.233 0.225 0 N-CA-C 108.068 -1.086 . . . . 0.0 108.068 -171.907 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.41 145.4 31.78 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 125.526 1.53 . . . . 0.0 108.33 -174.147 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -96.06 171.9 8.33 Favored 'General case' 0 N--CA 1.469 0.519 0 C-N-CA 127.441 2.296 . . . . 0.0 110.73 -178.247 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 64.9 t-20 -56.33 111.7 3.54 Favored Pre-proline 0 N--CA 1.471 0.596 0 CA-C-O 117.999 -1.001 . . . . 0.0 109.916 -179.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -81.62 143.2 13.33 Favored 'Trans proline' 0 N--CA 1.454 -0.848 0 C-N-CA 122.187 1.925 . . . . 0.0 110.13 -176.766 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 8.4 ptt? 163.66 138.41 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 128.491 2.717 . . . . 0.0 108.463 -173.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 19.9 tt0 103.38 45.56 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.243 0 C-N-CA 129.33 3.052 . . . . 0.0 108.94 164.023 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.2 t-20 58.52 19.39 6.55 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 126.264 1.826 . . . . 0.0 111.702 -168.861 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 34.5 m -139.41 152.65 23.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.339 0 O-C-N 120.654 -1.279 . . . . 0.0 109.207 -178.891 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -129.61 119.17 23.15 Favored 'General case' 0 N--CA 1.449 -0.51 0 N-CA-C 106.348 -1.723 . . . . 0.0 106.348 165.233 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -86.29 115.28 23.73 Favored 'General case' 0 C--O 1.236 0.371 0 N-CA-C 105.672 -1.973 . . . . 0.0 105.672 -165.649 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 5.1 t0 -113.29 159.22 19.6 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 122.538 0.335 . . . . 0.0 110.884 -175.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 24.4 t80 -150.25 140.51 22.23 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 124.745 1.218 . . . . 0.0 108.273 173.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 96.3 p -146.32 154.98 42.29 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 125.981 1.712 . . . . 0.0 106.775 154.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 5.8 t80 -150.97 103.76 3.09 Favored 'General case' 0 C--O 1.236 0.362 0 N-CA-C 104.581 -2.377 . . . . 0.0 104.581 171.816 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -127.08 153.07 46.45 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 123.583 0.753 . . . . 0.0 109.385 -178.746 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 19.5 tm0? -132.23 151.05 52.01 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 125.192 1.397 . . . . 0.0 108.377 -170.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 69.8 p -140.29 158.68 43.66 Favored 'General case' 0 C--O 1.233 0.204 0 CA-C-N 119.341 0.973 . . . . 0.0 112.513 175.671 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 25.8 ttp-105 -134.71 97.84 3.89 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 125.703 1.601 . . . . 0.0 108.245 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.2 mt -95.11 81.88 1.37 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.514 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 173.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 26.4 ttt85 57.21 77.59 0.26 Allowed 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.726 1.61 . . . . 0.0 113.102 -178.657 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 2.2 t 52.23 23.13 2.22 Favored 'General case' 0 CA--C 1.538 0.499 0 C-N-CA 125.95 1.7 . . . . 0.0 114.434 -176.685 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 2.7 t -80.97 148.54 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 N-CA-C 104.476 -2.416 . . . . 0.0 104.476 162.162 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 -132.1 109.15 9.78 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 104.263 -2.495 . . . . 0.0 104.263 179.938 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 57.5 t -139.66 157.06 26.62 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.436 0 N-CA-C 107.245 -1.391 . . . . 0.0 107.245 178.587 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 151.8 22.75 Favored Glycine 0 CA--C 1.519 0.316 0 N-CA-C 108.571 -1.812 . . . . 0.0 108.571 176.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 80.4 p -133.74 120.27 20.34 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 0.6 OUTLIER -113.63 157.63 21.88 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.949 1.699 . . . . 0.0 108.479 176.354 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.3 pt -132.67 136.64 55.56 Favored 'Isoleucine or valine' 0 N--CA 1.469 0.508 0 N-CA-C 107.808 -1.182 . . . . 0.0 107.808 167.682 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -144.92 117.18 8.43 Favored 'General case' 0 CA--C 1.516 -0.331 0 N-CA-C 107.083 -1.451 . . . . 0.0 107.083 169.267 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -146.95 -178.77 22.53 Favored Glycine 0 N--CA 1.451 -0.332 0 N-CA-C 114.26 0.464 . . . . 0.0 114.26 -168.409 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.8 m -144.11 169.98 9.15 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.633 0 C-N-CA 130.352 3.461 . . . . 0.0 106.596 175.655 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 175.29 -98.08 0.12 Allowed Glycine 0 C--N 1.337 0.625 0 CA-C-N 120.344 1.429 . . . . 0.0 112.703 -165.144 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 27.9 t80 -164.17 165.43 22.12 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.051 1.426 . . . . 0.0 109.194 172.335 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -119.21 109.88 16.37 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 127.521 2.328 . . . . 0.0 106.041 170.12 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 C--O 1.247 0.971 0 N-CA-C 108.488 -0.93 . . . . 0.0 108.488 175.169 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.712 0 CA-C-O 120.487 0.184 . . . . 0.0 110.563 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 15.1 m -115.81 138.79 50.81 Favored 'General case' 0 C--O 1.241 0.654 0 N-CA-C 108.272 -1.011 . . . . 0.0 108.272 -166.755 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -113.05 122.45 47.64 Favored 'General case' 0 N--CA 1.45 -0.429 0 N-CA-C 107.463 -1.31 . . . . 0.0 107.463 -179.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 12.0 m -148.92 124.73 10.54 Favored 'General case' 0 C--O 1.237 0.399 0 O-C-N 120.076 -1.64 . . . . 0.0 107.185 168.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 7.5 p -119.18 132.02 70.23 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 N-CA-C 108.822 -0.807 . . . . 0.0 108.822 175.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.449 ' OG1' ' HE2' ' A' ' 27' ' ' LYS . 6.7 m -139.48 163.46 32.47 Favored 'General case' 0 N--CA 1.451 -0.413 0 N-CA-C 108.08 -1.081 . . . . 0.0 108.08 177.013 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -167.02 163.39 37.08 Favored Glycine 0 N--CA 1.443 -0.892 0 C-N-CA 125.96 1.743 . . . . 0.0 108.746 172.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 162.64 140.47 2.88 Favored Glycine 0 CA--C 1.521 0.427 0 N-CA-C 108.534 -1.826 . . . . 0.0 108.534 -176.533 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 3.6 t80 -152.61 159.24 43.24 Favored 'General case' 0 C--N 1.326 -0.453 0 C-N-CA 126.3 1.84 . . . . 0.0 107.248 -177.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -153.5 174.78 13.96 Favored 'General case' 0 C--N 1.324 -0.537 0 C-N-CA 124.292 1.037 . . . . 0.0 108.874 174.235 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.408 ' NE2' ' H ' ' A' ' 11' ' ' GLN . 1.9 pm0 -99.77 133.44 44.11 Favored 'General case' 0 N--CA 1.447 -0.6 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -165.554 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 6.8 p -84.16 129.73 34.88 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 108.36 -0.978 . . . . 0.0 108.36 -176.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -102.73 106.75 17.44 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 106.263 -1.754 . . . . 0.0 106.263 -179.328 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -72.93 116.65 13.7 Favored 'General case' 0 C--O 1.237 0.429 0 CA-C-N 114.682 -1.145 . . . . 0.0 109.107 172.989 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.9 tt0 57.01 -50.63 0.03 OUTLIER 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.625 2.77 . . . . 0.0 114.914 -168.528 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 172.39 -38.62 0.16 Allowed Glycine 0 C--N 1.334 0.434 0 O-C-N 121.254 -0.904 . . . . 0.0 112.824 179.194 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.83 111.61 4.01 Favored 'General case' 0 N--CA 1.454 -0.267 0 CA-C-N 118.372 1.086 . . . . 0.0 108.609 158.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 9.7 ttt -149.59 -65.82 0.22 Allowed 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 105.464 -2.05 . . . . 0.0 105.464 172.281 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 53.6 m-80 -137.18 141.91 42.15 Favored 'General case' 0 CA--C 1.518 -0.268 0 C-N-CA 125.186 1.395 . . . . 0.0 107.596 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 1.3 mtmp? -132.33 95.47 3.65 Favored 'General case' 0 CA--C 1.518 -0.266 0 C-N-CA 125.61 1.564 . . . . 0.0 108.716 -178.096 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -93.85 111.77 23.52 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 106.242 -1.762 . . . . 0.0 106.242 173.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -135.08 155.94 22.3 Favored Glycine 0 CA--C 1.528 0.885 0 N-CA-C 109.448 -1.461 . . . . 0.0 109.448 175.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -163.61 -121.2 0.55 Allowed Glycine 0 CA--C 1.527 0.784 0 CA-C-O 118.744 -1.031 . . . . 0.0 112.371 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.0 OUTLIER -151.09 148.58 28.49 Favored 'General case' 0 N--CA 1.47 0.548 0 C-N-CA 126.773 2.029 . . . . 0.0 109.087 174.684 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -126.34 156.56 40.25 Favored 'General case' 0 N--CA 1.465 0.303 0 C-N-CA 127.361 2.264 . . . . 0.0 106.961 173.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 31.8 mt -146.86 139.93 25.35 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 125.737 1.615 . . . . 0.0 109.303 -178.006 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.449 ' HE2' ' OG1' ' A' ' 6' ' ' THR . 0.0 OUTLIER -125.07 154.79 40.82 Favored 'General case' 0 C--O 1.235 0.306 0 C-N-CA 124.542 1.137 . . . . 0.0 109.97 174.227 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -144.09 127.07 16.41 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 162.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 58.3 ttt-85 -93.77 143.59 26.19 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.5 t80 -99.77 149.4 23.39 Favored 'General case' 0 CA--C 1.522 -0.119 0 N-CA-C 107.056 -1.461 . . . . 0.0 107.056 166.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -130.46 118.9 21.83 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 105.254 -2.128 . . . . 0.0 105.254 163.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -73.9 173.64 9.66 Favored 'General case' 0 C--O 1.235 0.308 0 CA-C-O 121.486 0.66 . . . . 0.0 109.411 -179.529 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.8 t70 -60.46 -53.76 53.74 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.382 0.673 . . . . 0.0 111.382 -176.484 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 8.3 m-80 -139.94 60.52 1.55 Allowed 'General case' 0 C--O 1.236 0.345 0 CA-C-O 122.415 1.102 . . . . 0.0 108.18 -178.095 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -144.13 110.56 5.09 Favored Pre-proline 0 C--O 1.238 0.488 0 N-CA-C 104.966 -2.235 . . . . 0.0 104.966 166.662 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 98.1 Cg_endo -77.55 68.66 7.52 Favored 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 123.049 2.499 . . . . 0.0 109.121 -175.088 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.9 tp -140.96 156.21 46.1 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 127.386 2.275 . . . . 0.0 108.151 -170.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -150.53 178.91 27.68 Favored Glycine 0 N--CA 1.445 -0.719 0 N-CA-C 108.995 -1.642 . . . . 0.0 108.995 148.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 34.6 m -141.03 165.31 19.66 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.502 0 C-N-CA 126.474 1.91 . . . . 0.0 106.705 175.813 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 1.8 pp -136.38 155.86 35.12 Favored 'Isoleucine or valine' 0 C--O 1.238 0.457 0 N-CA-C 106.955 -1.498 . . . . 0.0 106.955 156.071 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -97.28 150.28 19.49 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 107.424 -2.27 . . . . 0.0 107.424 155.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.4 t -122.43 137.81 54.75 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 107.014 -1.476 . . . . 0.0 107.014 178.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.5 m-85 -120.6 134.97 55.23 Favored 'General case' 0 CA--C 1.519 -0.234 0 CA-C-O 122.381 1.086 . . . . 0.0 111.905 -172.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -93.13 132.63 37.1 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 127.156 2.182 . . . . 0.0 107.345 173.508 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 20.1 t80 -143.75 145.63 32.54 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 105.794 -1.928 . . . . 0.0 105.794 172.386 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -138.49 152.01 47.89 Favored 'General case' 0 C--O 1.236 0.348 0 CA-C-N 119.744 1.156 . . . . 0.0 110.427 168.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -151.37 97.02 2.36 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 105.878 -1.897 . . . . 0.0 105.878 177.387 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 5.1 tptp -156.47 143.45 18.81 Favored 'General case' 0 N--CA 1.466 0.356 0 C-N-CA 123.005 0.522 . . . . 0.0 109.623 175.915 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 24.1 m -74.38 150.47 40.04 Favored 'General case' 0 C--O 1.239 0.522 0 CA-C-O 121.367 0.603 . . . . 0.0 110.515 175.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.9 tpm_? -99.31 116.36 31.3 Favored 'General case' 0 N--CA 1.456 -0.171 0 N-CA-C 105.267 -2.123 . . . . 0.0 105.267 160.477 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 23.1 m 35.07 -101.34 0.02 OUTLIER 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 127.472 2.309 . . . . 0.0 109.808 -161.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -122.99 -5.47 8.47 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 125.069 1.348 . . . . 0.0 112.28 -175.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.3 m 65.49 3.52 2.4 Favored 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 126.207 1.803 . . . . 0.0 114.344 -162.584 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 93.9 p -76.09 -14.18 60.2 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 124.572 1.149 . . . . 0.0 113.975 -179.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -160.21 -66.39 0.01 OUTLIER Glycine 0 C--N 1.337 0.618 0 N-CA-C 108.136 -1.986 . . . . 0.0 108.136 179.52 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -70.74 108.69 4.55 Favored 'General case' 0 CA--C 1.51 -0.568 0 N-CA-C 102.363 -3.199 . . . . 0.0 102.363 160.368 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 16.3 p90 -117.14 157.9 25.15 Favored 'General case' 0 C--N 1.315 -0.895 0 CA-C-N 114.372 -1.286 . . . . 0.0 108.552 145.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 42.3 t-20 -112.18 161.58 16.4 Favored 'General case' 0 C--O 1.237 0.447 0 N-CA-C 105.018 -2.215 . . . . 0.0 105.018 152.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.502 ' H ' ' HB2' ' A' ' 91' ' ' GLN . 30.9 mttt -131.63 114.92 15.4 Favored 'General case' 0 N--CA 1.445 -0.68 0 N-CA-C 104.903 -2.258 . . . . 0.0 104.903 154.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -161.03 167.64 26.04 Favored 'General case' 0 C--N 1.324 -0.538 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 160.304 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -112.24 176.68 4.92 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.944 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -107.16 137.27 45.54 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.074 -1.454 . . . . 0.0 107.074 172.994 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -138.14 128.75 26.54 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 102.82 -3.03 . . . . 0.0 102.82 178.424 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -152.33 88.76 0.13 Allowed Glycine 0 N--CA 1.444 -0.803 0 N-CA-C 107.02 -2.432 . . . . 0.0 107.02 -169.127 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 39.7 mm -79.55 109.87 14.62 Favored 'Isoleucine or valine' 0 C--O 1.236 0.352 0 CA-C-N 118.407 1.103 . . . . 0.0 108.465 -164.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 2.0 p -121.03 129.94 53.58 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 127.118 2.167 . . . . 0.0 110.941 -165.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.19 178.65 4.95 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.545 1.538 . . . . 0.0 110.795 169.546 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -165.46 46.37 0.28 Allowed Glycine 0 CA--C 1.53 0.97 0 CA-C-O 117.236 -1.869 . . . . 0.0 113.536 171.37 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 62.1 Cg_endo -63.07 137.14 60.17 Favored 'Trans proline' 0 N--CA 1.456 -0.718 0 CA-C-N 122.157 2.978 . . . . 0.0 108.85 -179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . 0.442 ' HA ' ' CD1' ' A' ' 80' ' ' TYR . . . -90.67 117.64 29.48 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 176.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.69 101.55 11.06 Favored 'General case' 0 C--O 1.237 0.404 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.209 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 12.3 ttt180 -81.28 121.65 26.44 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 106.637 -1.616 . . . . 0.0 106.637 177.221 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 8.4 pt -139.46 -3.32 0.57 Allowed 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 C-N-CA 126.265 1.826 . . . . 0.0 111.699 -178.772 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -146.41 172.87 12.87 Favored 'General case' 0 C--O 1.235 0.3 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 168.507 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -77.66 -15.39 59.21 Favored 'General case' 0 N--CA 1.47 0.55 0 O-C-N 121.146 -0.971 . . . . 0.0 111.91 174.756 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 11.6 p90 -123.17 -67.42 0.95 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.898 1.679 . . . . 0.0 111.268 -164.956 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -83.69 151.62 25.17 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 178.767 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 69.0 m -137.17 168.58 19.34 Favored 'General case' 0 C--O 1.237 0.435 0 C-N-CA 125.023 1.329 . . . . 0.0 107.885 171.65 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 34.7 pt -126.2 152.68 33.81 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 106.369 -1.715 . . . . 0.0 106.369 165.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.442 ' CD1' ' HA ' ' A' ' 70' ' ' ALA . 9.3 m-85 -116.85 164.51 14.56 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 106.467 -1.679 . . . . 0.0 106.467 167.086 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -145.06 89.52 0.16 Allowed Glycine 0 N--CA 1.447 -0.605 0 N-CA-C 105.467 -3.053 . . . . 0.0 105.467 -175.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 11.1 m -109.69 -175.94 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 C-N-CA 123.879 0.872 . . . . 0.0 109.534 -176.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 9.4 m -140.11 166.19 20.45 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.566 0 C-N-CA 127.294 2.238 . . . . 0.0 107.045 170.307 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -141.02 162.62 26.74 Favored Glycine 0 CA--C 1.523 0.591 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 164.414 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.2 p -144.9 117.73 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.128 0 N-CA-C 107.914 -1.143 . . . . 0.0 107.914 168.224 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -114.51 116.7 3.87 Favored Glycine 0 N--CA 1.446 -0.661 0 N-CA-C 108.99 -1.644 . . . . 0.0 108.99 -175.696 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 7.3 t80 -138.95 154.58 48.33 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.079 1.352 . . . . 0.0 108.121 178.068 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 161.65 -159.75 31.64 Favored Glycine 0 CA--C 1.52 0.379 0 N-CA-C 107.91 -2.076 . . . . 0.0 107.91 -176.532 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 29.7 ttpt 79.63 119.14 0.05 Allowed 'General case' 0 N--CA 1.473 0.712 0 C-N-CA 128.34 2.656 . . . . 0.0 108.767 176.637 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 11.5 t80 -139.56 -60.75 0.55 Allowed 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.977 -0.452 . . . . 0.0 109.796 -179.402 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . 0.502 ' HB2' ' H ' ' A' ' 59' ' ' LYS . 8.3 mp0 -66.57 95.47 0.34 Allowed 'General case' 0 CA--C 1.529 0.169 0 C-N-CA 124.52 1.128 . . . . 0.0 109.327 179.173 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.5 m -106.39 105.4 15.42 Favored 'General case' 0 N--CA 1.444 -0.775 0 N-CA-C 105.52 -2.03 . . . . 0.0 105.52 163.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 85.7 m -113.06 80.23 1.33 Allowed 'General case' 0 N--CA 1.445 -0.681 0 N-CA-C 104.738 -2.319 . . . . 0.0 104.738 162.321 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 49.3 tt0 -148.65 -53.73 0.18 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 103.935 -2.617 . . . . 0.0 103.935 175.079 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 5.7 m-30 -91.11 142.87 27.69 Favored Pre-proline 0 CA--C 1.535 0.387 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 179.294 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 53.0 Cg_endo -69.72 -11.86 31.77 Favored 'Trans proline' 0 CA--C 1.535 0.566 0 C-N-CA 122.824 2.349 . . . . 0.0 114.119 -168.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 1.2 t -76.62 -12.9 60.08 Favored 'General case' 0 CA--C 1.548 0.87 0 O-C-N 121.358 -0.839 . . . . 0.0 111.494 -177.17 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 57.34 12.71 1.49 Allowed 'General case' 0 CA--C 1.544 0.738 0 C-N-CA 126.819 2.047 . . . . 0.0 115.324 169.682 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 6.7 mptt -142.55 109.59 5.54 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 105.493 -2.04 . . . . 0.0 105.493 -176.099 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -71.68 -65.56 0.74 Allowed 'General case' 0 N--CA 1.463 0.208 0 N-CA-C 108.747 -0.834 . . . . 0.0 108.747 -178.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 38.9 m-20 55.64 39.55 30.91 Favored 'General case' 0 N--CA 1.47 0.537 0 C-N-CA 127.022 2.129 . . . . 0.0 112.882 173.815 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 34.1 m -101.68 99.04 9.26 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 173.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 19.6 m -48.68 119.69 3.28 Favored 'General case' 0 C--O 1.239 0.535 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 161.125 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -120.01 144.69 47.39 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 107.147 -1.427 . . . . 0.0 107.147 176.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -142.35 99.51 3.52 Favored 'General case' 0 C--O 1.233 0.227 0 N-CA-C 108.085 -1.08 . . . . 0.0 108.085 -176.602 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -88.17 158.41 29.04 Favored Glycine 0 CA--C 1.523 0.561 0 N-CA-C 109.932 -1.267 . . . . 0.0 109.932 176.381 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 56.4 t80 -138.47 107.53 6.03 Favored 'General case' 0 N--CA 1.45 -0.465 0 N-CA-C 105.904 -1.888 . . . . 0.0 105.904 169.205 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 68.7 m -93.13 164.73 13.15 Favored 'General case' 0 C--O 1.235 0.34 0 N-CA-C 108.29 -1.004 . . . . 0.0 108.29 158.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 29.9 p90 -146.69 175.85 10.3 Favored 'General case' 0 CA--C 1.534 0.361 0 C-N-CA 124.914 1.286 . . . . 0.0 110.732 -179.503 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 70.72 -90.41 0.39 Allowed Glycine 0 C--N 1.337 0.622 0 C-N-CA 126.386 1.946 . . . . 0.0 111.613 164.687 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 23.95 84.19 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.5 0 C-N-CA 130.035 3.334 . . . . 0.0 116.157 173.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . 172.89 105.47 0.18 Allowed Glycine 0 C--N 1.335 0.491 0 C-N-CA 119.293 -1.432 . . . . 0.0 111.947 149.499 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -121.76 138.51 54.33 Favored 'General case' 0 CA--C 1.53 0.201 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.182 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -118.68 130.55 55.9 Favored 'General case' 0 C--O 1.238 0.453 0 C-N-CA 125.537 1.535 . . . . 0.0 108.014 177.865 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.12 172.03 8.56 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.779 1.632 . . . . 0.0 107.709 172.485 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -58.89 120.71 48.82 Favored Pre-proline 0 CA--C 1.547 0.843 0 N-CA-C 108.163 -1.051 . . . . 0.0 108.163 178.511 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 86.6 Cg_endo -78.95 164.94 24.73 Favored 'Trans proline' 0 CA--C 1.54 0.789 0 C-N-CA 123.055 2.503 . . . . 0.0 111.494 -173.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -136.08 154.99 50.85 Favored 'General case' 0 N--CA 1.465 0.287 0 O-C-N 121.162 -0.961 . . . . 0.0 109.236 -178.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 49.1 mt-10 -76.06 19.24 0.23 Allowed 'General case' 0 N--CA 1.467 0.394 0 C-N-CA 128.018 2.527 . . . . 0.0 112.066 -169.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -140.96 -37.39 0.44 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 118.58 -0.724 . . . . 0.0 110.933 165.553 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 21.7 m -139.4 116.74 10.92 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.394 0 N-CA-C 109.095 -0.705 . . . . 0.0 109.095 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -66.03 169.42 6.87 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 164.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.4 mm? -132.99 115.12 14.8 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 104.734 -2.321 . . . . 0.0 104.734 162.146 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG21 ' A' ' 6' ' ' THR . 4.5 m-20 -123.65 168.33 12.8 Favored 'General case' 0 CA--C 1.535 0.38 0 N-CA-C 107.081 -1.452 . . . . 0.0 107.081 164.596 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -149.55 130.32 14.16 Favored 'General case' 0 C--O 1.235 0.302 0 C-N-CA 125.16 1.384 . . . . 0.0 107.682 -176.008 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.8 m -142.69 166.35 24.89 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.957 0.903 . . . . 0.0 109.627 174.974 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.1 p90 -145.04 108.8 4.7 Favored 'General case' 0 N--CA 1.446 -0.649 0 N-CA-C 106.104 -1.813 . . . . 0.0 106.104 175.992 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.4 mt-10 -97.91 118.52 34.67 Favored 'General case' 0 C--O 1.236 0.373 0 N-CA-C 104.0 -2.593 . . . . 0.0 104.0 168.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 3.4 pt20 -132.49 107.64 8.61 Favored 'General case' 0 N--CA 1.449 -0.523 0 C-N-CA 123.737 0.815 . . . . 0.0 109.325 -177.388 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 50.2 m -109.88 160.72 16.13 Favored 'General case' 0 C--O 1.238 0.47 0 C-N-CA 124.386 1.074 . . . . 0.0 111.624 -177.215 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.7 ttt85 -122.49 123.98 42.52 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.883 -1.525 . . . . 0.0 106.883 164.07 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 11.0 pt -137.91 113.41 10.25 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.251 0 C-N-CA 123.901 0.88 . . . . 0.0 108.77 -175.06 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 3.7 ttm-85 55.49 41.09 31.19 Favored 'General case' 0 N--CA 1.468 0.459 0 C-N-CA 124.254 1.022 . . . . 0.0 110.413 -167.037 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 15.1 m 66.44 -3.26 0.87 Allowed 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 125.053 1.341 . . . . 0.0 113.919 -171.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 16.8 t -81.16 128.54 38.63 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.443 0 N-CA-C 105.828 -1.915 . . . . 0.0 105.828 -172.435 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 6.8 p-10 -69.08 105.86 2.59 Favored 'General case' 0 N--CA 1.44 -0.963 0 C-N-CA 127.013 2.125 . . . . 0.0 107.297 170.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 8.5 t -138.24 101.62 1.9 Allowed 'Isoleucine or valine' 0 CA--C 1.53 0.197 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 177.712 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -126.73 148.49 17.27 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 108.797 -1.721 . . . . 0.0 108.797 171.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 3.6 p -106.95 142.76 36.06 Favored 'General case' 0 C--O 1.236 0.351 0 C-N-CA 125.095 1.358 . . . . 0.0 108.006 178.606 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 3.6 m95 -90.09 110.8 21.78 Favored 'General case' 0 CA--C 1.54 0.578 0 N-CA-C 107.733 -1.21 . . . . 0.0 107.733 -178.489 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.1 mp -102.58 111.57 32.81 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.572 0 CA-C-N 121.299 1.863 . . . . 0.0 106.545 -175.563 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.17 170.86 10.25 Favored 'General case' 0 N--CA 1.451 -0.425 0 C-N-CA 124.867 1.267 . . . . 0.0 109.854 174.778 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -130.66 130.53 6.17 Favored Glycine 0 N--CA 1.446 -0.679 0 N-CA-C 110.198 -1.161 . . . . 0.0 110.198 162.734 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -146.29 167.44 7.42 Favored 'Isoleucine or valine' 0 CA--C 1.546 0.805 0 C-N-CA 129.392 3.077 . . . . 0.0 106.46 156.502 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 172.04 -102.76 0.18 Allowed Glycine 0 N--CA 1.472 1.079 0 CA-C-N 121.809 2.095 . . . . 0.0 115.873 -176.762 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 1.6 t80 -164.0 174.86 10.88 Favored 'General case' 0 N--CA 1.471 0.599 0 C-N-CA 125.379 1.472 . . . . 0.0 110.138 174.029 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.412 HH21 ' C ' ' A' ' 148' ' ' PHE . 5.2 ttp180 -139.35 155.88 47.38 Favored 'General case' 0 N--CA 1.472 0.657 0 O-C-N 120.735 -1.228 . . . . 0.0 108.95 163.711 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.412 ' C ' HH21 ' A' ' 147' ' ' ARG . 12.9 p90 . . . . . 0 C--O 1.241 0.656 0 N-CA-C 107.35 -1.352 . . . . 0.0 107.35 160.458 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 0.785 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 1.5 m -132.63 109.14 9.52 Favored 'General case' 0 C--O 1.234 0.241 0 O-C-N 121.335 -0.853 . . . . 0.0 108.86 177.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -95.24 115.53 27.56 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 125.546 1.539 . . . . 0.0 107.0 173.302 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 18.6 p -125.79 125.57 43.15 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 107.933 -1.136 . . . . 0.0 107.933 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.602 HG11 ' H ' ' A' ' 146' ' ' TYR . 10.7 m -90.95 156.14 3.03 Favored 'Isoleucine or valine' 0 C--O 1.24 0.603 0 CA-C-O 121.254 0.549 . . . . 0.0 112.02 177.923 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 19.3 m -152.57 142.52 22.16 Favored 'General case' 0 CA--C 1.541 0.613 0 C-N-CA 125.031 1.332 . . . . 0.0 109.127 161.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.583 ' H ' ' HA2' ' A' ' 143' ' ' GLY . . . 80.42 -167.71 50.86 Favored Glycine 0 CA--C 1.528 0.852 0 C-N-CA 125.611 1.577 . . . . 0.0 114.075 167.848 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 176.53 -61.99 0.1 OUTLIER Glycine 0 CA--C 1.53 0.982 0 CA-C-O 118.551 -1.139 . . . . 0.0 112.421 -170.696 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -139.83 125.96 19.88 Favored 'General case' 0 N--CA 1.467 0.406 0 C-N-CA 126.17 1.788 . . . . 0.0 108.874 -169.727 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.2 164.84 11.6 Favored 'General case' 0 C--O 1.24 0.554 0 C-N-CA 123.468 0.707 . . . . 0.0 111.449 173.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.05 106.18 4.36 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.457 1.503 . . . . 0.0 108.517 165.283 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.0 m -85.03 125.02 32.39 Favored 'General case' 0 N--CA 1.448 -0.525 0 N-CA-C 107.943 -1.132 . . . . 0.0 107.943 174.707 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -103.16 172.27 6.91 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 124.992 1.317 . . . . 0.0 109.579 177.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -125.63 93.51 3.87 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 109.002 -0.74 . . . . 0.0 109.002 174.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.1 tt0 52.76 32.99 13.08 Favored 'General case' 0 CA--C 1.544 0.718 0 C-N-CA 125.537 1.535 . . . . 0.0 112.477 174.542 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 154.98 111.46 0.4 Allowed Glycine 0 N--CA 1.449 -0.446 0 C-N-CA 125.704 1.621 . . . . 0.0 109.7 -178.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 1.2 pt20 -57.1 94.37 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.498 0 C-N-CA 124.942 1.297 . . . . 0.0 111.779 -178.158 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 3.4 ttp -152.41 9.22 0.48 Allowed 'General case' 0 CA--C 1.539 0.531 0 C-N-CA 126.76 2.024 . . . . 0.0 110.161 -174.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -122.31 167.24 13.49 Favored 'General case' 0 N--CA 1.448 -0.566 0 C-N-CA 126.417 1.887 . . . . 0.0 109.97 -165.198 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.2 mttm -137.56 83.61 2.0 Allowed 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.504 1.122 . . . . 0.0 111.207 177.603 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 24.0 mmt -128.52 96.41 4.4 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 124.799 1.24 . . . . 0.0 108.672 179.04 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 166.01 157.46 10.12 Favored Glycine 0 C--N 1.337 0.587 0 N-CA-C 111.074 -0.81 . . . . 0.0 111.074 173.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -132.42 -83.93 0.25 Allowed Glycine 0 CA--C 1.523 0.545 0 C-N-CA 124.992 1.282 . . . . 0.0 110.878 -163.472 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 31.7 p90 -148.36 164.65 33.43 Favored 'General case' 0 C--O 1.233 0.219 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 162.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 15.2 m120 -138.51 111.55 7.87 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 107.208 -1.405 . . . . 0.0 107.208 170.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.3 tm? -91.07 134.75 34.25 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 106.509 -1.663 . . . . 0.0 106.509 166.745 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.2 mttp -129.45 121.25 26.91 Favored 'General case' 0 CA--C 1.515 -0.377 0 N-CA-C 107.794 -1.187 . . . . 0.0 107.794 171.555 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.1 p90 -122.48 140.01 53.22 Favored 'General case' 0 C--O 1.237 0.444 0 C-N-CA 123.799 0.84 . . . . 0.0 109.331 -176.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 11.8 ttm180 -93.34 163.06 13.75 Favored 'General case' 0 C--O 1.236 0.366 0 N-CA-C 108.162 -1.051 . . . . 0.0 108.162 172.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -134.72 157.73 45.93 Favored 'General case' 0 C--N 1.322 -0.59 0 N-CA-C 106.651 -1.611 . . . . 0.0 106.651 163.639 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 40.4 tt0 -116.42 131.28 56.99 Favored 'General case' 0 N--CA 1.448 -0.55 0 N-CA-C 104.313 -2.477 . . . . 0.0 104.313 163.575 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -144.23 126.04 15.23 Favored 'General case' 0 N--CA 1.443 -0.782 0 N-CA-C 106.076 -1.824 . . . . 0.0 106.076 -172.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER 51.9 34.61 13.86 Favored 'General case' 0 CA--C 1.537 0.474 0 C-N-CA 124.931 1.293 . . . . 0.0 112.329 -178.112 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 13.5 m120 59.23 11.71 2.22 Favored 'General case' 0 N--CA 1.47 0.528 0 C-N-CA 126.085 1.754 . . . . 0.0 115.02 179.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.3 t -64.76 125.1 88.17 Favored Pre-proline 0 CA--C 1.538 0.491 0 CA-C-N 119.096 0.862 . . . . 0.0 108.787 -175.771 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -79.12 46.11 2.11 Favored 'Trans proline' 0 CA--C 1.541 0.875 0 C-N-CA 123.562 2.841 . . . . 0.0 111.388 -179.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 48.9 tp -104.98 154.93 19.45 Favored 'General case' 0 C--O 1.236 0.38 0 C-N-CA 126.105 1.762 . . . . 0.0 107.745 173.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -119.57 148.8 18.06 Favored Glycine 0 C--N 1.333 0.362 0 N-CA-C 108.957 -1.657 . . . . 0.0 108.957 172.411 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 13.3 m -135.43 146.36 30.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 C-N-CA 124.979 1.312 . . . . 0.0 108.774 -176.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.542 ' H ' ' HA3' ' A' ' 68' ' ' GLY . 21.9 pt -140.55 160.68 24.63 Favored 'Isoleucine or valine' 0 C--O 1.234 0.283 0 C-N-CA 129.023 2.929 . . . . 0.0 106.899 167.354 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -134.21 118.15 1.96 Allowed Glycine 0 N--CA 1.447 -0.623 0 N-CA-C 108.276 -1.93 . . . . 0.0 108.276 157.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 32.1 m -67.16 101.48 0.9 Allowed 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.154 0.977 . . . . 0.0 108.523 161.735 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 66.0 t80 -88.32 134.27 33.86 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 106.029 -1.841 . . . . 0.0 106.029 158.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 34.5 p -128.06 149.67 50.28 Favored 'General case' 0 CA--C 1.54 0.559 0 C-N-CA 123.518 0.727 . . . . 0.0 110.675 -172.197 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.6 t80 -143.16 155.23 44.51 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 123.978 0.911 . . . . 0.0 110.053 178.435 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 14.0 p -138.73 141.48 38.9 Favored 'General case' 0 N--CA 1.473 0.682 0 C-N-CA 124.527 1.131 . . . . 0.0 110.51 162.646 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -145.92 3.48 0.94 Allowed 'General case' 0 N--CA 1.48 1.055 0 N-CA-C 115.778 1.77 . . . . 0.0 115.778 176.111 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 11.6 mmtt -101.68 147.19 26.74 Favored 'General case' 0 C--O 1.236 0.379 0 C-N-CA 125.419 1.488 . . . . 0.0 110.737 -178.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 60.9 p -116.25 150.9 36.81 Favored 'General case' 0 C--O 1.24 0.595 0 C-N-CA 125.665 1.586 . . . . 0.0 109.199 169.701 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 19.0 ttt-85 -134.79 100.44 4.61 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 119.54 1.064 . . . . 0.0 112.163 -179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.9 t -146.41 165.57 28.96 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 119.257 0.935 . . . . 0.0 109.047 156.189 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 178.97 -1.64 0.0 OUTLIER 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 127.668 2.387 . . . . 0.0 112.96 177.286 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 55.2 m -141.19 21.78 2.24 Favored 'General case' 0 CA--C 1.53 0.197 0 O-C-N 120.17 -1.581 . . . . 0.0 111.41 -179.14 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 14.3 m -150.49 -58.13 0.18 Allowed 'General case' 0 CA--C 1.53 0.196 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 166.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 114.02 7.54 19.16 Favored Glycine 0 CA--C 1.527 0.826 0 CA-C-O 118.761 -1.022 . . . . 0.0 111.87 -168.107 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 20.5 t0 -71.23 91.25 0.94 Allowed 'General case' 0 C--O 1.236 0.362 0 C-N-CA 126.568 1.947 . . . . 0.0 107.572 -179.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 22.4 t80 -83.8 85.84 7.24 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 124.992 1.317 . . . . 0.0 110.614 -162.636 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -74.34 130.21 39.25 Favored 'General case' 0 N--CA 1.465 0.282 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.781 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 55.0 tttm -157.59 114.38 2.95 Favored 'General case' 0 N--CA 1.464 0.251 0 N-CA-C 106.099 -1.815 . . . . 0.0 106.099 163.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -168.45 174.59 6.8 Favored 'General case' 0 N--CA 1.481 1.117 0 CA-C-N 120.867 1.667 . . . . 0.0 108.843 179.771 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -112.98 129.7 56.39 Favored 'General case' 0 N--CA 1.463 0.195 0 N-CA-C 108.59 -0.893 . . . . 0.0 108.59 -176.697 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 3.7 m-85 -95.83 138.9 32.83 Favored 'General case' 0 C--O 1.235 0.332 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 172.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 65.2 m-85 -134.0 143.07 47.9 Favored 'General case' 0 N--CA 1.452 -0.351 0 N-CA-C 106.943 -1.503 . . . . 0.0 106.943 171.459 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -162.84 123.82 1.23 Allowed Glycine 0 N--CA 1.444 -0.812 0 N-CA-C 106.907 -2.477 . . . . 0.0 106.907 178.447 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.7 mp -128.62 112.36 26.08 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.544 0 N-CA-C 104.726 -2.324 . . . . 0.0 104.726 -172.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 24.3 p -104.41 158.84 16.19 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 108.054 -1.091 . . . . 0.0 108.054 172.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -74.52 178.42 5.33 Favored 'General case' 0 C--O 1.234 0.277 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 166.351 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . 0.542 ' HA3' ' H ' ' A' ' 40' ' ' ILE . . . -127.99 34.46 2.97 Favored Glycine 0 CA--C 1.526 0.75 0 CA-C-O 115.825 -2.653 . . . . 0.0 117.647 178.193 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 80.0 Cg_endo -71.91 80.33 1.52 Allowed 'Trans proline' 0 CA--C 1.539 0.743 0 CA-C-N 122.187 2.994 . . . . 0.0 112.48 -168.48 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.18 147.07 23.8 Favored 'General case' 0 C--O 1.235 0.309 0 O-C-N 121.267 -0.895 . . . . 0.0 109.501 -176.657 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -90.74 133.14 35.39 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 108.486 -0.931 . . . . 0.0 108.486 -175.392 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.9 ttm180 -87.02 106.08 17.59 Favored 'General case' 0 N--CA 1.469 0.52 0 N-CA-C 106.336 -1.727 . . . . 0.0 106.336 177.762 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' H ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -110.32 -158.48 0.13 Allowed 'Isoleucine or valine' 0 CA--C 1.538 0.511 0 C-N-CA 124.953 1.301 . . . . 0.0 109.032 -179.131 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 63.5 m-20 -54.07 156.0 3.26 Favored 'General case' 0 N--CA 1.47 0.542 0 CA-C-N 119.724 1.147 . . . . 0.0 110.346 176.357 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 57.22 13.08 1.52 Allowed 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 126.608 1.963 . . . . 0.0 113.04 -172.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . 0.277 7.4 p90 40.93 46.92 2.5 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 126.506 1.922 . . . . 0.0 111.141 -162.494 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.17 172.17 12.85 Favored 'General case' 0 N--CA 1.448 -0.555 0 C-N-CA 125.061 1.344 . . . . 0.0 112.837 -169.232 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -83.84 158.53 21.63 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.572 2.349 . . . . 0.0 109.978 168.303 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.3 tt -153.63 153.01 9.24 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.344 0 C-N-CA 124.49 1.116 . . . . 0.0 108.503 175.717 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.764 ' HA ' ' HB3' ' A' ' 111' ' ' ALA . 19.1 p90 -104.4 126.1 51.2 Favored 'General case' 0 N--CA 1.451 -0.4 0 C-N-CA 124.945 1.298 . . . . 0.0 108.871 -172.059 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 168.98 33.22 0.02 OUTLIER Glycine 0 CA--C 1.534 1.259 0 CA-C-O 117.883 -1.51 . . . . 0.0 114.3 -170.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 4.3 m -105.04 167.91 2.76 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.739 0 CA-C-N 120.72 2.26 . . . . 0.0 111.207 179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 35.9 m -150.21 166.17 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.39 0 C-N-CA 126.187 1.795 . . . . 0.0 110.961 -168.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 171.5 -117.9 0.71 Allowed Glycine 0 C--N 1.338 0.675 0 CA-C-O 118.76 -1.022 . . . . 0.0 110.715 173.166 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.8 p -156.57 150.75 9.68 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.513 0 CA-C-N 118.389 1.094 . . . . 0.0 109.227 174.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -129.87 147.47 18.03 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 126.459 1.98 . . . . 0.0 111.288 170.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 16.1 t80 -132.63 117.68 18.22 Favored 'General case' 0 N--CA 1.454 -0.237 0 C-N-CA 129.27 3.028 . . . . 0.0 106.199 -174.108 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -140.32 75.04 0.36 Allowed Glycine 0 C--N 1.333 0.372 0 CA-C-O 119.354 -0.692 . . . . 0.0 112.093 -172.184 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -65.09 101.6 0.54 Allowed 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 117.36 0.58 . . . . 0.0 110.48 -173.548 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 4.2 t80 -69.94 121.03 16.57 Favored 'General case' 0 CA--C 1.531 0.216 0 N-CA-C 107.745 -1.205 . . . . 0.0 107.745 167.58 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.3 mm-40 -96.59 138.27 34.41 Favored 'General case' 0 C--N 1.339 0.111 0 N-CA-C 107.288 -1.375 . . . . 0.0 107.288 159.935 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.4 m -134.04 134.72 42.72 Favored 'General case' 0 C--O 1.24 0.583 0 N-CA-C 106.181 -1.785 . . . . 0.0 106.181 -175.59 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 5.2 m -144.72 66.63 1.26 Allowed 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 -170.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.5 tm-20 -151.52 -63.74 0.18 Allowed 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 179.412 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 50.9 m-85 -64.4 140.1 97.88 Favored Pre-proline 0 C--O 1.239 0.541 0 C-N-CA 123.531 0.732 . . . . 0.0 111.701 -177.533 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 87.0 Cg_endo -73.97 69.7 4.6 Favored 'Trans proline' 0 C--N 1.351 0.666 0 C-N-CA 124.849 3.699 . . . . 0.0 110.59 178.203 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 3.6 m -162.03 -37.1 0.04 OUTLIER 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 128.098 2.559 . . . . 0.0 107.301 176.369 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 4.2 p90 40.02 33.81 0.16 Allowed 'General case' 0 CA--C 1.54 0.584 0 C-N-CA 128.402 2.681 . . . . 0.0 115.31 165.234 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 54.2 mtpt -138.95 101.32 4.26 Favored 'General case' 0 CA--C 1.514 -0.417 0 N-CA-C 103.789 -2.671 . . . . 0.0 103.789 163.734 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 6.8 t30 -104.34 -27.82 11.75 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 111.999 0.37 . . . . 0.0 111.999 174.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 28.3 t0 28.08 71.59 0.05 Allowed 'General case' 0 C--O 1.233 0.194 0 C-N-CA 129.191 2.996 . . . . 0.0 114.045 155.69 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 13.1 m -122.37 109.37 14.33 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 127.217 2.207 . . . . 0.0 105.738 -174.428 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 72.3 p -163.09 74.66 0.37 Allowed 'General case' 0 CA--C 1.535 0.375 0 CA-C-N 119.438 1.017 . . . . 0.0 110.266 178.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 2.6 p30 -167.54 170.13 11.45 Favored 'General case' 0 N--CA 1.466 0.336 0 C-N-CA 124.526 1.131 . . . . 0.0 110.498 179.317 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 58.8 m-85 52.88 17.99 0.98 Allowed 'General case' 0 CA--C 1.539 0.552 0 C-N-CA 128.057 2.543 . . . . 0.0 116.768 170.061 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -73.58 78.75 0.85 Allowed Glycine 0 CA--C 1.524 0.636 0 CA-C-N 119.881 1.219 . . . . 0.0 111.728 179.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -73.55 93.31 2.0 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.227 -1.397 . . . . 0.0 107.227 175.001 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -69.94 141.39 53.07 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 123.702 0.801 . . . . 0.0 108.935 -177.383 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 58.8 t80 -143.02 116.86 9.32 Favored 'General case' 0 CA--C 1.53 0.203 0 CA-C-N 118.707 0.685 . . . . 0.0 110.002 -168.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 151.14 -172.22 30.75 Favored Glycine 0 CA--C 1.532 1.1 0 C-N-CA 126.375 1.941 . . . . 0.0 109.124 -174.988 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . 0.764 ' HB3' ' HA ' ' A' ' 80' ' ' TYR . . . -166.15 -61.28 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.569 0 CA-C-N 119.276 1.538 . . . . 0.0 110.862 156.537 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.498 ' C ' HD22 ' A' ' 113' ' ' LEU . . . 134.62 168.43 11.7 Favored Glycine 0 C--N 1.342 0.916 0 CA-C-N 118.965 0.802 . . . . 0.0 113.115 177.459 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.535 HD21 ' CD1' ' A' ' 80' ' ' TYR . 1.6 mm? -127.25 -178.46 4.45 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 125.777 1.631 . . . . 0.0 109.006 -175.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -146.05 105.51 3.94 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 125.711 1.604 . . . . 0.0 108.727 176.515 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 14.3 m-85 -135.41 108.19 7.53 Favored 'General case' 0 N--CA 1.463 0.206 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 172.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 57.3 t30 -159.19 131.6 4.36 Favored Pre-proline 0 C--O 1.233 0.194 0 CA-C-O 117.102 -1.428 . . . . 0.0 107.95 170.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_endo -75.3 9.31 2.17 Favored 'Trans proline' 0 CA--C 1.54 0.807 0 C-N-CA 122.582 2.188 . . . . 0.0 114.489 -172.279 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -176.34 2.88 Favored 'General case' 0 CA--C 1.531 0.247 0 CA-C-O 122.18 0.991 . . . . 0.0 109.514 -178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 11.5 mt-10 -132.31 16.11 4.53 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 127.424 2.289 . . . . 0.0 108.495 -169.927 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.404 ' O ' ' HA ' ' A' ' 146' ' ' TYR . 46.9 t30 -169.07 10.67 0.02 OUTLIER 'General case' 0 C--O 1.213 -0.822 0 C-N-CA 126.209 1.804 . . . . 0.0 110.175 -176.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 89.7 t -149.85 137.88 14.28 Favored 'Isoleucine or valine' 0 C--O 1.24 0.572 0 CA-C-N 123.241 2.746 . . . . 0.0 108.983 -170.804 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -109.96 151.01 27.66 Favored 'General case' 0 C--N 1.341 0.213 0 N-CA-C 108.771 -0.825 . . . . 0.0 108.771 171.375 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.33 146.76 51.16 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 105.0 -2.222 . . . . 0.0 105.0 164.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -177.48 -177.86 0.71 Allowed 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 129.009 2.924 . . . . 0.0 106.086 167.468 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 76.7 m-85 -142.78 114.39 8.01 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 104.758 -2.312 . . . . 0.0 104.758 164.448 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 60.3 p -80.15 166.29 21.61 Favored 'General case' 0 N--CA 1.449 -0.524 0 CA-C-O 122.327 1.06 . . . . 0.0 108.165 174.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 8.4 t80 -139.03 121.14 15.72 Favored 'General case' 0 N--CA 1.436 -1.147 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 -177.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.2 mp0 -120.98 124.66 45.43 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 107.427 -1.323 . . . . 0.0 107.427 173.178 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -99.52 151.91 20.61 Favored 'General case' 0 C--O 1.238 0.469 0 C-N-CA 126.066 1.747 . . . . 0.0 107.656 -178.971 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 49.6 m -140.43 159.26 42.59 Favored 'General case' 0 C--N 1.326 -0.432 0 O-C-N 121.277 -0.889 . . . . 0.0 108.969 161.354 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 23.8 ttm180 -126.33 129.58 49.13 Favored 'General case' 0 C--O 1.235 0.317 0 N-CA-C 104.627 -2.36 . . . . 0.0 104.627 161.359 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.8 mp -127.42 101.95 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.467 0 N-CA-C 105.179 -2.156 . . . . 0.0 105.179 172.601 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 59.8 ttt180 66.69 -80.54 0.03 OUTLIER 'General case' 0 C--N 1.332 -0.18 0 C-N-CA 128.581 2.752 . . . . 0.0 109.476 175.761 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -147.75 39.1 0.94 Allowed 'General case' 0 CA--C 1.538 0.487 0 C-N-CA 123.456 0.703 . . . . 0.0 110.377 170.971 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 15.1 m -125.56 141.43 45.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.415 0 O-C-N 121.935 -0.478 . . . . 0.0 110.192 166.629 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 76.9 m-20 -80.46 145.24 32.01 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 106.869 -1.53 . . . . 0.0 106.869 168.664 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 73.3 t -141.81 84.26 0.33 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.335 0 N-CA-C 105.141 -2.17 . . . . 0.0 105.141 174.004 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -109.46 125.51 7.68 Favored Glycine 0 CA--C 1.522 0.505 0 C-N-CA 124.402 1.001 . . . . 0.0 111.111 -167.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 9.5 t -117.65 153.75 32.78 Favored 'General case' 0 C--O 1.234 0.285 0 CA-C-N 117.703 0.752 . . . . 0.0 109.006 178.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 28.7 m95 -127.63 136.48 51.68 Favored 'General case' 0 N--CA 1.445 -0.676 0 N-CA-C 105.113 -2.18 . . . . 0.0 105.113 173.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 4.3 mp -132.29 131.71 60.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 N-CA-C 105.844 -1.91 . . . . 0.0 105.844 -175.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -89.36 127.91 35.85 Favored 'General case' 0 C--O 1.233 0.196 0 N-CA-C 109.276 -0.638 . . . . 0.0 109.276 -175.652 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.583 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -65.9 119.08 12.48 Favored Glycine 0 N--CA 1.448 -0.564 0 C-N-CA 124.783 1.182 . . . . 0.0 110.263 174.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -151.52 176.64 0.64 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.418 0 C-N-CA 125.141 1.376 . . . . 0.0 107.551 165.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 129.03 -150.88 18.94 Favored Glycine 0 N--CA 1.448 -0.513 0 N-CA-C 108.25 -1.94 . . . . 0.0 108.25 -173.597 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.602 ' H ' HG11 ' A' ' 5' ' ' VAL . 25.2 m-85 -134.5 169.38 17.36 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 108.332 -0.988 . . . . 0.0 108.332 -174.583 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . 0.468 ' HG2' ' CD1' ' A' ' 148' ' ' PHE . 38.6 ttp180 -128.07 152.17 48.29 Favored 'General case' 0 C--N 1.326 -0.417 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 -172.239 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . 0.468 ' CD1' ' HG2' ' A' ' 147' ' ' ARG . 41.7 p90 . . . . . 0 C--O 1.254 1.326 0 CA-C-O 115.709 -2.091 . . . . 0.0 109.119 152.661 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.469 0.498 0 N-CA-C 108.857 -0.794 . . . . 0.0 108.857 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 45.9 m -150.78 145.52 25.79 Favored 'General case' 0 C--O 1.235 0.313 0 N-CA-C 106.67 -1.604 . . . . 0.0 106.67 165.363 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 69.0 m -110.0 158.87 17.8 Favored 'General case' 0 N--CA 1.444 -0.736 0 C-N-CA 125.879 1.672 . . . . 0.0 108.274 168.11 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.2 t -120.34 149.19 42.72 Favored 'General case' 0 N--CA 1.446 -0.651 0 N-CA-C 107.266 -1.383 . . . . 0.0 107.266 168.224 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.449 HG11 ' H ' ' A' ' 146' ' ' TYR . 15.5 m -91.13 145.92 6.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 122.052 0.929 . . . . 0.0 109.264 170.686 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.413 HG23 ' CG ' ' A' ' 124' ' ' ASP . 30.7 m -158.15 117.23 3.16 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.324 -2.473 . . . . 0.0 104.324 -170.729 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.433 ' HA2' HG22 ' A' ' 141' ' ' ILE . . . 74.79 160.36 7.68 Favored Glycine 0 CA--C 1.525 0.683 0 C-N-CA 124.865 1.221 . . . . 0.0 114.594 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -174.23 -70.49 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.409 0 N-CA-C 109.5 -1.44 . . . . 0.0 109.5 -170.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -109.55 147.53 32.82 Favored 'General case' 0 N--CA 1.467 0.4 0 CA-C-N 118.809 1.304 . . . . 0.0 108.556 -165.653 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -111.72 148.28 33.79 Favored 'General case' 0 CA--C 1.513 -0.458 0 C-N-CA 124.108 0.963 . . . . 0.0 111.212 -171.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 31.3 mt-30 -136.84 141.89 42.85 Favored 'General case' 0 N--CA 1.447 -0.622 0 N-CA-C 105.465 -2.05 . . . . 0.0 105.465 154.09 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 73.7 m -115.97 149.26 39.07 Favored 'General case' 0 N--CA 1.45 -0.472 0 N-CA-C 106.849 -1.537 . . . . 0.0 106.849 152.897 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -110.08 170.45 8.07 Favored 'General case' 0 C--N 1.327 -0.388 0 C-N-CA 124.696 1.198 . . . . 0.0 109.904 170.587 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.57 137.79 20.6 Favored 'General case' 0 N--CA 1.442 -0.828 0 N-CA-C 105.093 -2.188 . . . . 0.0 105.093 165.404 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 tm0? -56.89 96.86 0.02 OUTLIER 'General case' 0 C--O 1.238 0.459 0 N-CA-C 104.668 -2.345 . . . . 0.0 104.668 156.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 144.34 -51.72 0.62 Allowed Glycine 0 N--CA 1.444 -0.815 0 CA-C-O 118.072 -1.404 . . . . 0.0 110.289 -176.277 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 3.2 mp0 -149.75 97.89 2.67 Favored 'General case' 0 CA--C 1.531 0.232 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 172.319 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 21.2 ptt? -70.84 8.23 0.95 Allowed 'General case' 0 CA--C 1.54 0.577 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 -172.563 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 29.4 m-80 -126.87 93.18 3.7 Favored 'General case' 0 N--CA 1.473 0.707 0 CA-C-N 119.547 1.067 . . . . 0.0 111.536 -166.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.1 77.15 1.64 Allowed 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 125.505 1.522 . . . . 0.0 107.621 174.42 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 20.1 ptm -92.78 113.42 25.69 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.536 1.135 . . . . 0.0 108.002 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.16 77.28 0.06 OUTLIER Glycine 0 CA--C 1.522 0.501 0 N-CA-C 109.595 -1.402 . . . . 0.0 109.595 172.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -175.08 164.62 35.3 Favored Glycine 0 C--O 1.238 0.37 0 CA-C-N 118.099 0.949 . . . . 0.0 110.944 173.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -135.52 109.42 8.15 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -175.042 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 27.1 m-20 -137.47 110.83 7.93 Favored 'General case' 0 N--CA 1.451 -0.389 0 N-CA-C 105.079 -2.193 . . . . 0.0 105.079 -158.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.2 pp -140.66 171.56 13.94 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 123.846 0.858 . . . . 0.0 110.754 -173.138 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -131.41 169.42 16.06 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 107.64 -1.244 . . . . 0.0 107.64 171.398 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 26.0 p90 -155.43 139.37 16.32 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 126.91 2.084 . . . . 0.0 106.335 -169.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -140.81 120.31 13.2 Favored 'General case' 0 CA--C 1.516 -0.332 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 -166.463 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -101.52 151.18 22.27 Favored 'General case' 0 C--O 1.234 0.285 0 N-CA-C 107.55 -1.278 . . . . 0.0 107.55 175.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -137.76 115.68 11.55 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 170.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -85.65 149.01 25.62 Favored 'General case' 0 C--N 1.324 -0.514 0 N-CA-C 107.42 -1.326 . . . . 0.0 107.42 155.398 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 96.8 m-20 18.76 71.57 0.02 OUTLIER 'General case' 0 N--CA 1.465 0.314 0 C-N-CA 130.26 3.424 . . . . 0.0 114.09 168.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 5.2 m-80 49.48 39.4 16.62 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 125.605 1.562 . . . . 0.0 111.892 174.362 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 31.1 t -63.56 137.22 97.02 Favored Pre-proline 0 C--O 1.24 0.585 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 -164.288 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . 0.436 ' HA ' ' CZ ' ' A' ' 72' ' ' ARG . 36.5 Cg_endo -67.97 -61.16 0.08 OUTLIER 'Trans proline' 0 N--CA 1.448 -1.16 0 C-N-CA 122.634 2.223 . . . . 0.0 111.235 -176.726 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 8.0 tp -70.41 138.33 51.18 Favored 'General case' 0 C--O 1.239 0.518 0 N-CA-C 107.952 -1.129 . . . . 0.0 107.952 174.92 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -116.37 -169.36 15.33 Favored Glycine 0 CA--C 1.527 0.808 0 N-CA-C 109.248 -1.541 . . . . 0.0 109.248 168.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 48.5 t -130.15 140.8 47.99 Favored 'Isoleucine or valine' 0 C--O 1.233 0.206 0 C-N-CA 124.184 0.993 . . . . 0.0 108.742 -172.676 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 38.4 mm -134.89 113.38 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.272 0 N-CA-C 105.797 -1.927 . . . . 0.0 105.797 169.618 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -142.25 115.2 0.94 Allowed Glycine 0 CA--C 1.519 0.337 0 N-CA-C 108.274 -1.93 . . . . 0.0 108.274 177.091 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -125.29 153.51 43.14 Favored 'General case' 0 C--O 1.237 0.399 0 CA-C-O 122.172 0.987 . . . . 0.0 111.152 -178.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 16.6 t80 -114.8 131.8 56.69 Favored 'General case' 0 N--CA 1.447 -0.597 0 C-N-CA 127.585 2.354 . . . . 0.0 104.703 166.934 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 33.4 m -125.71 116.29 21.42 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 107.12 -1.437 . . . . 0.0 107.12 -177.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 72.1 t80 -118.77 148.32 42.94 Favored 'General case' 0 C--O 1.241 0.656 0 C-N-CA 125.635 1.574 . . . . 0.0 108.914 -171.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.612 HG22 ' H ' ' A' ' 62' ' ' TYR . 1.5 t -129.58 153.94 47.57 Favored 'General case' 0 C--O 1.239 0.514 0 CA-C-O 121.995 0.903 . . . . 0.0 108.889 164.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -146.79 114.94 6.6 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 105.353 -2.091 . . . . 0.0 105.353 170.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 6.7 tttt -106.6 112.5 25.51 Favored 'General case' 0 CA--C 1.509 -0.629 0 N-CA-C 105.281 -2.118 . . . . 0.0 105.281 171.862 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.3 m -75.1 105.07 5.93 Favored 'General case' 0 C--N 1.319 -0.756 0 N-CA-C 105.913 -1.884 . . . . 0.0 105.913 176.625 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.84 132.72 38.95 Favored 'General case' 0 CA--C 1.511 -0.55 0 CA-C-N 120.934 1.697 . . . . 0.0 107.423 173.872 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -141.29 134.58 29.56 Favored 'General case' 0 C--N 1.322 -0.597 0 N-CA-C 105.546 -2.02 . . . . 0.0 105.546 163.815 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -66.83 -70.44 0.25 Allowed 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 107.348 -1.353 . . . . 0.0 107.348 162.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 8.9 t -153.16 13.49 0.5 Allowed 'General case' 0 CA--C 1.539 0.548 0 CA-C-N 120.302 1.41 . . . . 0.0 113.839 179.018 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.5 t 121.53 85.35 0.0 OUTLIER 'General case' 0 C--O 1.237 0.432 0 C-N-CA 130.331 3.452 . . . . 0.0 106.786 179.722 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . -175.62 -87.55 0.07 OUTLIER Glycine 0 N--CA 1.444 -0.788 0 N-CA-C 110.547 -1.021 . . . . 0.0 110.547 179.986 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 15.9 p-10 -72.6 90.65 1.37 Allowed 'General case' 0 C--N 1.321 -0.632 0 C-N-CA 125.85 1.66 . . . . 0.0 107.72 -177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 7.6 t80 -130.29 145.06 51.72 Favored 'General case' 0 C--N 1.319 -0.743 0 C-N-CA 123.703 0.801 . . . . 0.0 110.223 -176.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 19.3 t-20 74.63 -35.36 0.29 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 126.462 1.905 . . . . 0.0 113.689 169.648 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.65 167.1 0.15 Allowed 'General case' 0 N--CA 1.464 0.226 0 C-N-CA 125.194 1.398 . . . . 0.0 112.199 169.267 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 73.17 71.83 0.13 Allowed 'General case' 0 N--CA 1.465 0.29 0 C-N-CA 126.421 1.888 . . . . 0.0 108.226 176.607 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 34.1 mt-30 -137.77 171.72 14.01 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 123.19 0.596 . . . . 0.0 109.703 -177.688 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.612 ' H ' HG22 ' A' ' 46' ' ' THR . 4.5 t80 -144.87 152.7 40.67 Favored 'General case' 0 N--CA 1.438 -1.037 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 177.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 t80 -136.11 118.28 15.5 Favored 'General case' 0 N--CA 1.442 -0.826 0 N-CA-C 102.473 -3.158 . . . . 0.0 102.473 176.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -118.16 136.8 12.56 Favored Glycine 0 N--CA 1.443 -0.866 0 N-CA-C 107.767 -2.133 . . . . 0.0 107.767 178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.45 138.75 52.39 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 104.542 -2.392 . . . . 0.0 104.542 171.182 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . 0.424 ' HA ' ' O ' ' A' ' 83' ' ' VAL . 1.9 p -140.16 128.09 22.07 Favored 'General case' 0 N--CA 1.445 -0.701 0 C-N-CA 127.587 2.355 . . . . 0.0 105.655 178.705 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -142.6 144.62 32.92 Favored 'General case' 0 C--O 1.236 0.392 0 CA-C-N 118.656 0.662 . . . . 0.0 110.148 -170.079 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 160.01 -167.07 35.32 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 116.264 1.266 . . . . 0.0 116.264 174.353 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 33.7 Cg_endo -81.12 179.8 5.65 Favored 'Trans proline' 0 N--CA 1.445 -1.358 0 C-N-CA 123.611 2.874 . . . . 0.0 110.331 174.01 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -113.5 159.73 19.23 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.502 1.121 . . . . 0.0 108.442 152.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 8.7 t80 -134.02 154.71 50.96 Favored 'General case' 0 C--O 1.237 0.399 0 C-N-CA 125.604 1.561 . . . . 0.0 107.637 -168.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . 0.436 ' CZ ' ' HA ' ' A' ' 36' ' ' PRO . 0.0 OUTLIER -118.62 148.99 42.13 Favored 'General case' 0 CA--C 1.515 -0.392 0 C-N-CA 123.378 0.671 . . . . 0.0 111.895 178.657 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 79' ' ' ILE . 13.0 mt -73.35 -56.69 8.7 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.35 0 N-CA-C 107.016 -1.476 . . . . 0.0 107.016 166.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 1.5 m120 -131.1 -65.28 0.78 Allowed 'General case' 0 C--N 1.341 0.205 0 N-CA-C 107.669 -1.234 . . . . 0.0 107.669 173.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 38.7 m-20 -150.68 -78.2 0.13 Allowed 'General case' 0 C--O 1.233 0.234 0 N-CA-C 107.249 -1.389 . . . . 0.0 107.249 -176.876 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 38.1 m95 -82.54 94.22 7.45 Favored 'General case' 0 N--CA 1.449 -0.5 0 N-CA-C 108.13 -1.063 . . . . 0.0 108.13 -175.531 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . 173.54 161.41 0.15 Allowed 'General case' 0 C--O 1.235 0.334 0 C-N-CA 129.048 2.939 . . . . 0.0 107.937 161.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -113.97 136.34 53.01 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.538 1.535 . . . . 0.0 107.111 -178.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.665 HD11 HD11 ' A' ' 73' ' ' ILE . 38.9 mm -130.38 169.52 21.08 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.489 0 C-N-CA 125.797 1.639 . . . . 0.0 107.397 174.512 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 9.0 p90 -105.69 175.25 5.56 Favored 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 127.519 2.327 . . . . 0.0 109.841 -175.686 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 150.23 43.47 0.03 OUTLIER Glycine 0 CA--C 1.525 0.696 0 O-C-N 121.261 -0.899 . . . . 0.0 112.024 -170.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 29.6 m -104.58 -175.38 0.46 Allowed 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 172.981 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . 0.424 ' O ' ' HA ' ' A' ' 66' ' ' THR . 35.1 m -126.83 165.46 25.27 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.757 0 N-CA-C 105.582 -2.007 . . . . 0.0 105.582 149.183 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -135.55 175.12 20.95 Favored Glycine 0 N--CA 1.435 -1.408 0 O-C-N 124.157 0.911 . . . . 0.0 110.995 158.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 7.1 p -138.05 150.09 24.85 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.734 0 N-CA-C 106.268 -1.753 . . . . 0.0 106.268 175.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -119.25 141.89 16.14 Favored Glycine 0 N--CA 1.45 -0.417 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 172.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 31.8 t80 -132.92 132.19 41.73 Favored 'General case' 0 C--O 1.235 0.326 0 C-N-CA 126.245 1.818 . . . . 0.0 107.133 179.762 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -99.86 163.51 19.46 Favored Glycine 0 CA--C 1.528 0.88 0 C-N-CA 124.384 0.992 . . . . 0.0 112.583 -176.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -149.51 107.66 3.74 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 124.805 1.242 . . . . 0.0 109.81 -166.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 m-85 -114.36 97.93 6.62 Favored 'General case' 0 N--CA 1.452 -0.326 0 C-N-CA 123.628 0.771 . . . . 0.0 109.026 168.054 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -67.81 164.8 18.78 Favored 'General case' 0 CA--C 1.537 0.462 0 C-N-CA 123.085 0.554 . . . . 0.0 109.839 161.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -137.67 144.02 41.61 Favored 'General case' 0 CA--C 1.519 -0.242 0 O-C-N 120.594 -1.316 . . . . 0.0 112.227 161.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.79 -20.05 19.82 Favored 'General case' 0 CA--C 1.542 0.655 0 O-C-N 124.255 0.972 . . . . 0.0 111.39 179.854 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 4.6 mp0 -94.62 -84.03 0.33 Allowed 'General case' 0 N--CA 1.467 0.418 0 N-CA-C 107.824 -1.176 . . . . 0.0 107.824 -176.545 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER 166.98 -56.67 0.0 OUTLIER Pre-proline 0 CA--C 1.537 0.468 0 C-N-CA 131.533 3.933 . . . . 0.0 108.023 -178.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 46.1 Cg_exo -59.0 -44.71 32.95 Favored 'Trans proline' 0 C--N 1.353 0.795 0 C-N-CA 122.258 1.972 . . . . 0.0 113.427 179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 32.3 m -42.96 -61.88 1.17 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 127.166 2.186 . . . . 0.0 112.129 -163.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -168.11 71.9 0.1 Allowed 'General case' 0 CA--C 1.539 0.553 0 CA-C-O 122.16 0.981 . . . . 0.0 108.59 -171.215 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 3.1 ttpp -71.67 81.03 0.84 Allowed 'General case' 0 CA--C 1.537 0.471 0 O-C-N 120.642 -1.286 . . . . 0.0 112.437 -165.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER 47.58 84.48 0.03 OUTLIER 'General case' 0 N--CA 1.47 0.539 0 C-N-CA 126.791 2.036 . . . . 0.0 111.945 -172.004 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -61.49 166.45 4.05 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 114.614 1.339 . . . . 0.0 114.614 -175.048 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 1.5 m -63.61 131.32 47.65 Favored 'General case' 0 N--CA 1.451 -0.407 0 C-N-CA 125.287 1.435 . . . . 0.0 108.722 175.101 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 15.5 p -62.66 141.92 58.31 Favored 'General case' 0 N--CA 1.447 -0.605 0 N-CA-C 109.273 -0.64 . . . . 0.0 109.273 170.459 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 30.0 m-20 -110.58 167.34 10.3 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 106.693 -1.595 . . . . 0.0 106.693 166.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -134.33 142.29 47.2 Favored 'General case' 0 C--O 1.235 0.298 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 169.727 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -152.84 160.42 29.02 Favored Glycine 0 N--CA 1.451 -0.316 0 N-CA-C 108.388 -1.885 . . . . 0.0 108.388 174.279 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 83.8 m-85 -89.92 149.03 22.78 Favored 'General case' 0 CA--C 1.517 -0.302 0 C-N-CA 124.121 0.969 . . . . 0.0 109.406 -173.476 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 14.7 m -133.01 159.73 39.19 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.903 -1.147 . . . . 0.0 107.903 162.719 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 74.4 m-85 -140.4 115.89 10.07 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 105.92 -1.882 . . . . 0.0 105.92 177.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -77.96 171.27 55.13 Favored Glycine 0 C--N 1.334 0.465 0 N-CA-C 109.422 -1.471 . . . . 0.0 109.422 -175.047 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -135.69 136.09 40.61 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 172.589 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -142.98 95.16 0.18 Allowed Glycine 0 C--N 1.331 0.286 0 N-CA-C 107.075 -2.41 . . . . 0.0 107.075 -177.572 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -115.51 -179.45 3.65 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 125.579 1.552 . . . . 0.0 108.55 -177.51 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 30.0 tt0 -132.16 119.58 21.1 Favored 'General case' 0 N--CA 1.462 0.133 0 O-C-N 121.058 -1.026 . . . . 0.0 109.101 -173.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -93.55 173.78 7.53 Favored 'General case' 0 CA--C 1.535 0.374 0 C-N-CA 125.316 1.447 . . . . 0.0 111.188 178.956 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.7 m-20 -56.18 166.31 1.2 Allowed Pre-proline 0 CA--C 1.548 0.901 0 C-N-CA 125.544 1.538 . . . . 0.0 110.493 170.744 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 92.9 Cg_endo -71.25 159.63 51.32 Favored 'Trans proline' 0 C--N 1.35 0.629 0 C-N-CA 122.062 1.841 . . . . 0.0 109.554 177.659 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 4.7 tpt -148.76 -176.98 5.54 Favored 'General case' 0 N--CA 1.447 -0.618 0 N-CA-C 107.66 -1.237 . . . . 0.0 107.66 -172.967 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 93.4 mt-10 -78.4 83.41 4.62 Favored 'General case' 0 CA--C 1.515 -0.385 0 O-C-N 120.353 -1.467 . . . . 0.0 107.522 -173.695 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER 46.9 58.66 4.55 Favored 'General case' 0 C--O 1.22 -0.49 0 C-N-CA 128.011 2.524 . . . . 0.0 111.58 178.816 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . 0.428 HG12 ' H ' ' A' ' 145' ' ' GLY . 35.2 m -145.72 161.69 11.78 Favored 'Isoleucine or valine' 0 C--O 1.243 0.72 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 166.061 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -91.49 161.74 14.84 Favored 'General case' 0 N--CA 1.469 0.487 0 N-CA-C 107.886 -1.153 . . . . 0.0 107.886 148.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.9 mm? -117.96 133.94 55.43 Favored 'General case' 0 C--O 1.236 0.38 0 N-CA-C 105.562 -2.014 . . . . 0.0 105.562 169.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.413 ' CG ' HG23 ' A' ' 6' ' ' THR . 0.0 OUTLIER -141.11 153.36 45.38 Favored 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.055 2.142 . . . . 0.0 106.601 171.95 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 14.3 t80 -126.89 113.26 16.31 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.463 -1.68 . . . . 0.0 106.463 -175.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 5.9 t -121.16 135.66 55.12 Favored 'General case' 0 C--O 1.24 0.57 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 178.723 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 26.6 t80 -149.73 113.44 5.05 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 104.761 -2.311 . . . . 0.0 104.761 -175.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 52.1 mt-10 -111.25 137.51 48.88 Favored 'General case' 0 C--O 1.236 0.345 0 N-CA-C 106.189 -1.782 . . . . 0.0 106.189 177.58 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 9.7 tp60 -131.89 114.64 14.9 Favored 'General case' 0 N--CA 1.452 -0.372 0 N-CA-C 106.503 -1.666 . . . . 0.0 106.503 176.511 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 1.1 m -131.71 154.69 48.75 Favored 'General case' 0 C--N 1.322 -0.588 0 C-N-CA 127.153 2.181 . . . . 0.0 106.765 -176.861 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 45.0 ttp85 -146.86 136.31 22.84 Favored 'General case' 0 CA--C 1.51 -0.573 0 CA-C-N 119.644 1.111 . . . . 0.0 108.727 179.989 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -130.45 104.17 9.41 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.727 0 N-CA-C 107.02 -1.474 . . . . 0.0 107.02 172.478 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 54.7 ttt180 73.5 -76.55 0.06 Allowed 'General case' 0 N--CA 1.467 0.383 0 C-N-CA 128.191 2.596 . . . . 0.0 111.627 174.387 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 4.0 m -146.74 5.04 0.88 Allowed 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 126.875 2.07 . . . . 0.0 109.764 177.179 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 69.9 t -96.22 104.51 15.93 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.557 0 N-CA-C 104.399 -2.445 . . . . 0.0 104.399 178.348 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 17.7 p-10 -72.15 151.82 42.72 Favored 'General case' 0 N--CA 1.444 -0.764 0 C-N-CA 125.782 1.633 . . . . 0.0 107.1 154.004 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 4.9 t -143.04 60.71 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 N-CA-C 105.717 -1.957 . . . . 0.0 105.717 170.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -63.5 146.09 50.22 Favored Glycine 0 CA--C 1.521 0.466 0 N-CA-C 109.064 -1.615 . . . . 0.0 109.064 -175.32 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 44.2 p -137.51 154.09 49.92 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 178.784 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 15.7 p-90 -136.06 155.74 49.77 Favored 'General case' 0 N--CA 1.451 -0.407 0 N-CA-C 107.046 -1.465 . . . . 0.0 107.046 157.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . 0.433 HG22 ' HA2' ' A' ' 7' ' ' GLY . 4.0 mp -138.74 146.82 25.72 Favored 'Isoleucine or valine' 0 C--O 1.241 0.657 0 N-CA-C 105.459 -2.052 . . . . 0.0 105.459 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -124.28 131.44 53.52 Favored 'General case' 0 N--CA 1.467 0.383 0 CA-C-N 119.312 0.96 . . . . 0.0 111.715 -177.46 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . 0.412 ' HA2' ' H ' ' A' ' 7' ' ' GLY . . . -69.65 112.53 4.51 Favored Glycine 0 C--O 1.22 -0.747 0 N-CA-C 108.982 -1.647 . . . . 0.0 108.982 169.602 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 16.4 m -145.01 169.99 7.27 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.393 0 N-CA-C 106.644 -1.613 . . . . 0.0 106.644 155.094 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . 0.428 ' H ' HG12 ' A' ' 121' ' ' VAL . . . 156.2 -95.04 0.14 Allowed Glycine 0 CA--C 1.529 0.928 0 CA-C-O 118.895 -0.947 . . . . 0.0 110.736 173.187 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.449 ' H ' HG11 ' A' ' 5' ' ' VAL . 30.6 t80 -155.27 175.31 14.03 Favored 'General case' 0 CA--C 1.543 0.693 0 C-N-CA 125.709 1.604 . . . . 0.0 109.415 177.885 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 7.5 ppt_? -125.21 119.59 28.94 Favored 'General case' 0 N--CA 1.474 0.763 0 O-C-N 120.352 -1.468 . . . . 0.0 109.367 170.631 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 43.9 p90 . . . . . 0 C--O 1.255 1.348 0 CA-C-O 116.871 -1.538 . . . . 0.0 113.014 -168.593 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.597 0 N-CA-C 109.245 -0.65 . . . . 0.0 109.245 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 58.0 p -139.18 157.77 45.36 Favored 'General case' 0 C--O 1.239 0.51 0 CA-C-O 118.311 -0.852 . . . . 0.0 109.039 170.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 3.7 t -106.16 107.14 18.0 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 120.234 1.379 . . . . 0.0 108.776 175.702 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 96.0 m -90.5 116.78 28.69 Favored 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 107.682 -1.229 . . . . 0.0 107.682 176.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 10.5 m -123.56 99.21 6.26 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.406 0 N-CA-C 107.854 -1.165 . . . . 0.0 107.854 175.518 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -119.49 152.54 36.77 Favored 'General case' 0 CA--C 1.53 0.191 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 175.323 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -169.46 -175.35 38.57 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 109.634 -1.386 . . . . 0.0 109.634 179.742 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 155.37 -159.83 29.43 Favored Glycine 0 N--CA 1.449 -0.484 0 O-C-N 121.148 -1.207 . . . . 0.0 110.426 -172.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 18.2 m-85 -112.59 124.4 52.46 Favored 'General case' 0 N--CA 1.448 -0.563 0 N-CA-C 106.739 -1.578 . . . . 0.0 106.739 -175.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -95.7 138.83 32.8 Favored 'General case' 0 N--CA 1.449 -0.499 0 N-CA-C 105.651 -1.981 . . . . 0.0 105.651 154.41 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 36.0 mt-30 -133.15 127.13 33.21 Favored 'General case' 0 C--N 1.323 -0.567 0 N-CA-C 105.629 -1.989 . . . . 0.0 105.629 176.191 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 1.4 t -123.72 144.26 49.77 Favored 'General case' 0 N--CA 1.448 -0.566 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 173.211 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 1.2 p-10 -140.02 172.27 13.0 Favored 'General case' 0 N--CA 1.446 -0.64 1 C-N-CA 133.754 4.821 . . . . 0.0 106.552 177.88 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.28 164.84 33.7 Favored 'General case' 0 C--O 1.239 0.551 0 C-N-CA 125.195 1.398 . . . . 0.0 108.756 174.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 5.0 tt0 -70.69 26.41 0.04 OUTLIER 'General case' 0 CA--C 1.552 1.032 0 C-N-CA 125.663 1.585 . . . . 0.0 113.762 -178.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -177.53 -13.23 0.02 OUTLIER Glycine 0 CA--C 1.532 1.131 0 C-N-CA 125.698 1.618 . . . . 0.0 111.387 176.495 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 87.8 mt-30 -133.08 95.07 3.47 Favored 'General case' 0 N--CA 1.453 -0.289 0 O-C-N 121.153 -1.204 . . . . 0.0 107.894 167.021 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 42.0 mtp -81.4 42.81 0.69 Allowed 'General case' 0 N--CA 1.465 0.298 0 CA-C-O 122.215 1.007 . . . . 0.0 109.185 165.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -68.74 113.61 6.36 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 105.224 -2.139 . . . . 0.0 105.224 -179.073 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 54.4 tttt -70.38 81.44 0.55 Allowed 'General case' 0 N--CA 1.451 -0.408 0 C-N-CA 127.103 2.161 . . . . 0.0 109.816 -162.386 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . 0.402 ' HG3' ' CE2' ' A' ' 62' ' ' TYR . 1.9 tmt? -66.05 143.15 57.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.15 -1.056 . . . . 0.0 108.15 165.799 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . 0.557 ' H ' HG23 ' A' ' 46' ' ' THR . . . 162.85 170.9 28.38 Favored Glycine 0 N--CA 1.44 -1.048 0 C-N-CA 126.239 1.876 . . . . 0.0 109.073 164.303 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -179.73 -100.19 0.13 Allowed Glycine 0 N--CA 1.448 -0.543 0 N-CA-C 105.09 -3.204 . . . . 0.0 105.09 -179.329 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -140.87 174.18 10.77 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.635 1.174 . . . . 0.0 108.701 172.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 86.6 m-20 -120.98 154.27 36.21 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 106.036 -1.838 . . . . 0.0 106.036 162.804 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 4.3 mt -151.55 122.45 7.57 Favored 'General case' 0 N--CA 1.468 0.429 0 C-N-CA 124.19 0.996 . . . . 0.0 109.126 173.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 51.3 mmtt -125.29 138.32 54.08 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 119.302 0.956 . . . . 0.0 109.298 -176.076 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 1.3 p90 -141.37 141.46 33.8 Favored 'General case' 0 C--O 1.236 0.379 0 N-CA-C 106.808 -1.553 . . . . 0.0 106.808 -169.724 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 25.4 mtm-85 -140.12 161.92 36.48 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.39 1.076 . . . . 0.0 109.888 -178.898 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -127.73 120.61 28.34 Favored 'General case' 0 C--O 1.234 0.243 0 C-N-CA 126.343 1.857 . . . . 0.0 107.52 173.21 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 38.3 tt0 -127.92 113.21 15.58 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 167.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -124.56 171.81 9.72 Favored 'General case' 0 C--N 1.323 -0.581 0 C-N-CA 127.827 2.451 . . . . 0.0 105.16 160.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -81.81 26.21 0.51 Allowed 'General case' 0 N--CA 1.468 0.463 0 C-N-CA 125.504 1.521 . . . . 0.0 110.053 -169.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 23.3 t-20 -158.11 -53.53 0.07 Allowed 'General case' 0 N--CA 1.447 -0.601 0 C-N-CA 125.493 1.517 . . . . 0.0 110.581 -146.821 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 43.9 p -70.44 156.49 91.82 Favored Pre-proline 0 C--O 1.238 0.492 0 C-N-CA 125.208 1.403 . . . . 0.0 112.349 -170.269 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 50.8 Cg_endo -62.33 122.04 10.3 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.382 2.721 . . . . 0.0 109.526 171.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.54 HD13 ' H ' ' A' ' 38' ' ' GLY . 0.2 OUTLIER -80.29 156.1 26.96 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 123.909 0.884 . . . . 0.0 109.241 -179.251 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . 0.54 ' H ' HD13 ' A' ' 37' ' ' LEU . . . 77.11 76.49 0.85 Allowed Glycine 0 N--CA 1.44 -1.072 0 N-CA-C 110.224 -1.151 . . . . 0.0 110.224 179.544 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 6.7 m -139.74 120.57 14.69 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.469 0 C-N-CA 125.315 1.446 . . . . 0.0 108.733 -179.559 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -137.94 158.35 33.08 Favored 'Isoleucine or valine' 0 C--O 1.238 0.477 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 159.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -116.61 128.2 7.82 Favored Glycine 0 C--O 1.237 0.322 0 N-CA-C 105.959 -2.857 . . . . 0.0 105.959 164.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 1.3 t -66.85 150.12 49.62 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.756 -1.202 . . . . 0.0 107.756 174.023 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 27.6 t80 -144.24 103.0 3.94 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.66 -1.978 . . . . 0.0 105.66 156.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 54.0 m -104.28 133.44 49.19 Favored 'General case' 0 N--CA 1.451 -0.398 0 N-CA-C 106.023 -1.843 . . . . 0.0 106.023 167.23 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 12.5 t80 -138.12 147.01 43.53 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 170.88 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.557 HG23 ' H ' ' A' ' 22' ' ' GLY . 35.5 m -132.39 149.67 52.3 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 108.042 -1.095 . . . . 0.0 108.042 -176.349 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 10.2 tp10 -141.33 89.3 2.22 Favored 'General case' 0 N--CA 1.448 -0.53 0 N-CA-C 107.884 -1.154 . . . . 0.0 107.884 179.028 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 4.1 tptp -146.63 112.23 5.61 Favored 'General case' 0 C--N 1.343 0.284 0 CA-C-N 119.157 0.889 . . . . 0.0 111.253 167.584 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 70.5 p -83.92 155.97 22.6 Favored 'General case' 0 C--O 1.239 0.515 0 C-N-CA 125.966 1.706 . . . . 0.0 109.753 172.041 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 15.0 mtt85 -128.57 -179.71 5.2 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 106.733 -1.58 . . . . 0.0 106.733 160.031 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -67.4 -159.7 0.02 OUTLIER 'General case' 0 CA--C 1.542 0.635 0 C-N-CA 125.778 1.631 . . . . 0.0 106.896 165.27 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -138.66 105.05 5.27 Favored 'General case' 0 N--CA 1.443 -0.816 0 O-C-N 120.168 -1.582 . . . . 0.0 108.001 -174.465 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -60.11 -16.67 34.04 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 125.753 1.621 . . . . 0.0 113.164 -167.883 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 10.6 m -148.63 26.36 0.93 Allowed 'General case' 0 CA--C 1.538 0.493 0 C-N-CA 125.256 1.422 . . . . 0.0 109.197 168.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 78.5 -2.88 65.29 Favored Glycine 0 CA--C 1.539 1.55 0 O-C-N 121.282 -0.886 . . . . 0.0 112.259 -165.112 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -73.18 91.27 1.64 Allowed 'General case' 0 C--O 1.235 0.334 0 N-CA-C 105.704 -1.961 . . . . 0.0 105.704 160.075 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 97.1 m-85 -71.67 158.33 36.35 Favored 'General case' 0 C--O 1.237 0.402 0 C-N-CA 125.121 1.369 . . . . 0.0 108.286 169.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 68.1 m-20 -122.21 159.77 26.59 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 118.864 0.757 . . . . 0.0 109.824 179.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 11.3 mmtm -130.49 115.07 16.31 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 119.375 0.989 . . . . 0.0 108.451 177.779 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 3.9 m120 -84.63 108.84 17.58 Favored 'General case' 0 C--N 1.334 -0.086 0 N-CA-C 107.401 -1.333 . . . . 0.0 107.401 173.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 54.3 mt-30 -135.21 139.79 44.78 Favored 'General case' 0 N--CA 1.463 0.189 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 166.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . 0.497 ' CD2' ' HE3' ' A' ' 89' ' ' LYS . 7.3 m-85 -132.29 135.36 46.18 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 106.33 -1.73 . . . . 0.0 106.33 179.384 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.2 m-85 -139.25 147.36 41.6 Favored 'General case' 0 N--CA 1.446 -0.664 0 N-CA-C 106.58 -1.637 . . . . 0.0 106.58 175.322 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -155.66 164.78 32.28 Favored Glycine 0 N--CA 1.441 -1.003 0 N-CA-C 108.685 -1.766 . . . . 0.0 108.685 167.187 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 4.0 mp -107.0 132.41 54.43 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 103.256 -2.868 . . . . 0.0 103.256 174.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -130.51 127.97 40.23 Favored 'General case' 0 C--N 1.328 -0.34 0 N-CA-C 106.974 -1.491 . . . . 0.0 106.974 173.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -137.44 138.95 40.31 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.424 0.69 . . . . 0.0 110.127 -171.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 78.58 75.51 0.98 Allowed Glycine 0 CA--C 1.537 1.407 0 CA-C-O 119.143 -0.809 . . . . 0.0 113.56 174.877 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.45 ' HD2' ' C ' ' A' ' 38' ' ' GLY . 67.4 Cg_endo -81.42 -42.43 0.12 Allowed 'Trans proline' 0 N--CA 1.456 -0.697 0 C-N-CA 124.262 3.308 . . . . 0.0 114.053 177.029 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -146.79 103.42 3.64 Favored 'General case' 0 C--N 1.35 0.62 0 CA-C-N 121.115 1.779 . . . . 0.0 108.969 -178.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 43.3 t80 -85.79 130.41 34.56 Favored 'General case' 0 C--O 1.235 0.337 0 N-CA-C 106.474 -1.676 . . . . 0.0 106.474 173.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 46.6 ttt85 -63.87 115.41 4.82 Favored 'General case' 0 CA--C 1.529 0.147 0 N-CA-C 107.626 -1.249 . . . . 0.0 107.626 -176.524 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 95.6 mt -80.47 -69.81 0.44 Allowed 'Isoleucine or valine' 0 C--N 1.334 -0.109 0 N-CA-C 107.357 -1.349 . . . . 0.0 107.357 -169.35 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.3 t30 -168.14 -71.55 0.02 OUTLIER 'General case' 0 N--CA 1.454 -0.226 0 C-N-CA 125.429 1.491 . . . . 0.0 107.14 179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -169.04 129.91 1.14 Allowed 'General case' 0 C--O 1.234 0.28 0 C-N-CA 127.246 2.218 . . . . 0.0 106.034 -169.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 55.7 m95 126.68 -50.12 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.846 1 C-N-CA 132.033 4.133 . . . . 0.0 111.461 178.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -157.9 171.81 19.6 Favored 'General case' 0 N--CA 1.467 0.398 0 CA-C-N 119.988 1.267 . . . . 0.0 110.714 -175.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 59.4 m -140.54 104.84 4.83 Favored 'General case' 0 C--O 1.234 0.286 0 N-CA-C 106.689 -1.597 . . . . 0.0 106.689 -179.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 1.3 pp -143.74 170.08 9.81 Favored 'Isoleucine or valine' 0 C--O 1.237 0.426 0 C-N-CA 126.085 1.754 . . . . 0.0 107.811 -176.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -150.31 176.33 10.99 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 119.958 1.254 . . . . 0.0 111.436 165.87 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -93.78 131.71 10.88 Favored Glycine 0 N--CA 1.446 -0.696 0 N-CA-C 106.143 -2.783 . . . . 0.0 106.143 154.202 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.3 t -103.3 144.37 14.03 Favored 'Isoleucine or valine' 0 C--O 1.239 0.548 0 N-CA-C 104.078 -2.564 . . . . 0.0 104.078 -176.354 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 10.6 m -95.06 156.55 3.16 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 107.721 -1.214 . . . . 0.0 107.721 170.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -157.27 154.21 25.34 Favored Glycine 0 N--CA 1.444 -0.828 0 N-CA-C 111.322 -0.711 . . . . 0.0 111.322 -169.342 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 81.8 t -137.98 141.77 37.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 -173.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -131.72 105.08 0.6 Allowed Glycine 0 CA--C 1.526 0.735 0 CA-C-O 117.617 -1.657 . . . . 0.0 111.96 165.458 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -96.69 152.54 18.57 Favored 'General case' 0 N--CA 1.473 0.71 0 CA-C-N 119.537 1.668 . . . . 0.0 110.832 176.301 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . 91.4 -112.42 4.15 Favored Glycine 0 CA--C 1.527 0.829 0 C-N-CA 126.335 1.921 . . . . 0.0 114.987 159.755 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . 0.497 ' HE3' ' CD2' ' A' ' 62' ' ' TYR . 10.6 mptt 63.63 20.4 12.21 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 127.386 2.274 . . . . 0.0 112.531 -175.045 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -141.27 81.58 1.79 Allowed 'General case' 0 N--CA 1.448 -0.539 0 O-C-N 121.092 -1.005 . . . . 0.0 108.601 -173.256 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 34.3 mm-40 -124.91 118.06 25.46 Favored 'General case' 0 CA--C 1.511 -0.525 0 O-C-N 121.008 -1.058 . . . . 0.0 108.788 174.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 26.7 m -136.5 152.92 51.06 Favored 'General case' 0 N--CA 1.444 -0.76 0 C-N-CA 128.471 2.708 . . . . 0.0 105.711 -175.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 26.0 m -59.43 -28.8 67.27 Favored 'General case' 0 CA--C 1.539 0.54 0 CA-C-O 117.202 -1.38 . . . . 0.0 113.253 179.469 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 38.9 tt0 76.15 7.71 3.53 Favored 'General case' 0 CA--C 1.537 0.476 0 CA-C-N 120.202 1.365 . . . . 0.0 111.779 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -51.89 -48.27 88.43 Favored Pre-proline 0 CA--C 1.538 0.49 0 CA-C-O 117.929 -1.034 . . . . 0.0 113.463 176.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -80.56 7.62 4.69 Favored 'Trans proline' 0 CA--C 1.541 0.869 0 C-N-CA 121.995 1.796 . . . . 0.0 113.004 176.718 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 5.3 m 51.8 70.17 0.58 Allowed 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 127.325 2.25 . . . . 0.0 111.474 178.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 6.1 m-85 -139.63 -62.07 0.53 Allowed 'General case' 0 N--CA 1.464 0.234 0 CA-C-O 121.582 0.706 . . . . 0.0 110.602 178.716 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 13.2 mptt -81.39 -164.86 0.83 Allowed 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 124.175 0.99 . . . . 0.0 109.16 -177.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 45.0 t30 49.37 48.48 21.12 Favored 'General case' 0 N--CA 1.466 0.367 0 C-N-CA 126.516 1.926 . . . . 0.0 111.807 -176.62 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -127.74 -72.45 0.63 Allowed 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 107.261 -1.385 . . . . 0.0 107.261 172.647 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.2 t -79.47 149.05 31.65 Favored 'General case' 0 C--O 1.237 0.428 0 CA-C-O 121.992 0.901 . . . . 0.0 111.418 -164.38 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 36.8 m -159.86 161.8 34.5 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 127.829 2.451 . . . . 0.0 106.733 162.09 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 3.4 t0 -151.91 176.24 11.66 Favored 'General case' 0 N--CA 1.47 0.563 0 C-N-CA 123.688 0.795 . . . . 0.0 109.96 -172.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 57.1 m-85 -124.11 149.61 46.02 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 125.085 1.354 . . . . 0.0 111.382 -178.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -145.02 -167.15 12.04 Favored Glycine 0 CA--C 1.525 0.717 0 C-N-CA 125.052 1.31 . . . . 0.0 110.58 -175.628 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -103.96 143.54 32.72 Favored 'General case' 0 C--O 1.233 0.235 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 171.289 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 20.3 m -144.42 179.57 7.18 Favored 'General case' 0 CA--C 1.535 0.375 0 O-C-N 121.198 -0.939 . . . . 0.0 109.952 169.309 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 20.9 m-85 51.6 -145.55 0.52 Allowed 'General case' 0 CA--C 1.54 0.564 0 C-N-CA 124.006 0.922 . . . . 0.0 109.389 -162.466 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 127.25 -22.58 5.61 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 125.55 1.548 . . . . 0.0 112.336 -175.75 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -132.41 147.4 52.38 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-N 118.604 1.202 . . . . 0.0 109.613 -179.919 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -171.13 104.71 0.2 Allowed Glycine 0 CA--C 1.523 0.59 0 C-N-CA 125.798 1.666 . . . . 0.0 109.431 -173.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.39 171.24 7.74 Favored 'General case' 0 C--O 1.239 0.54 0 N-CA-C 106.903 -1.517 . . . . 0.0 106.903 -175.634 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -127.53 158.1 38.35 Favored 'General case' 0 N--CA 1.464 0.238 0 O-C-N 120.908 -1.12 . . . . 0.0 108.04 162.97 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -112.38 172.78 6.71 Favored 'General case' 0 N--CA 1.452 -0.327 0 C-N-CA 125.132 1.373 . . . . 0.0 109.698 172.537 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -56.41 145.63 57.6 Favored Pre-proline 0 C--O 1.237 0.427 0 CA-C-O 118.821 -0.609 . . . . 0.0 110.012 178.089 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 67.0 Cg_endo -67.71 113.15 2.87 Favored 'Trans proline' 0 N--CA 1.452 -0.959 0 C-N-CA 122.367 2.045 . . . . 0.0 108.119 169.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -178.56 6.48 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 158.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 65.0 tt0 -103.26 -20.16 14.22 Favored 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 123.614 0.766 . . . . 0.0 109.718 -176.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 54.5 t30 -141.1 17.24 2.27 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 126.266 1.826 . . . . 0.0 110.425 -179.384 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.5 t -145.87 149.09 16.68 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.348 0 N-CA-C 106.833 -1.543 . . . . 0.0 106.833 176.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -141.99 146.6 35.76 Favored 'General case' 0 C--O 1.237 0.407 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 168.255 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.5 mm? -129.75 121.59 27.17 Favored 'General case' 0 C--O 1.236 0.381 0 C-N-CA 124.543 1.137 . . . . 0.0 108.739 -173.801 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 17.3 p-10 -144.03 137.37 27.6 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.855 0.836 . . . . 0.0 108.967 152.802 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -108.46 152.02 25.27 Favored 'General case' 0 C--O 1.24 0.596 0 C-N-CA 127.057 2.143 . . . . 0.0 107.13 171.199 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 48.8 m -144.31 164.84 29.61 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 162.238 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 64.6 t80 -130.56 128.03 40.27 Favored 'General case' 0 N--CA 1.448 -0.57 0 N-CA-C 104.673 -2.343 . . . . 0.0 104.673 178.124 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -127.56 109.25 11.52 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.031 -1.099 . . . . 0.0 108.031 178.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -98.69 121.21 40.34 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 102.59 -3.115 . . . . 0.0 102.59 176.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 31.8 t -114.79 120.51 40.28 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 105.077 -2.194 . . . . 0.0 105.077 173.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 3.1 mpp_? -130.13 105.61 8.06 Favored 'General case' 0 CA--C 1.508 -0.648 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 176.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.56 150.06 25.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.475 0 N-CA-C 107.579 -1.267 . . . . 0.0 107.579 177.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 55.71 33.93 22.32 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 126.352 1.861 . . . . 0.0 111.656 173.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 18.7 m 52.27 41.14 30.24 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 123.465 0.706 . . . . 0.0 110.692 -172.944 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 48.6 t -128.48 125.67 64.19 Favored 'Isoleucine or valine' 0 C--O 1.234 0.28 0 N-CA-C 107.102 -1.444 . . . . 0.0 107.102 165.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.71 123.31 30.95 Favored 'General case' 0 N--CA 1.45 -0.437 0 N-CA-C 106.151 -1.796 . . . . 0.0 106.151 173.775 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 61.9 t -122.6 84.57 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 N-CA-C 103.9 -2.629 . . . . 0.0 103.9 174.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -90.81 134.61 12.41 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 108.735 -1.746 . . . . 0.0 108.735 179.058 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 6.8 t -141.43 155.09 45.91 Favored 'General case' 0 C--O 1.237 0.422 0 CA-C-N 118.827 1.314 . . . . 0.0 110.421 160.098 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 11.7 p90 -118.95 140.02 50.7 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 125.707 1.603 . . . . 0.0 107.131 175.071 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 14.7 mm -110.25 110.98 34.18 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.331 0 N-CA-C 106.087 -1.82 . . . . 0.0 106.087 -166.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.94 134.61 33.91 Favored 'General case' 0 N--CA 1.449 -0.498 0 N-CA-C 106.607 -1.627 . . . . 0.0 106.607 169.337 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -133.41 81.11 0.31 Allowed Glycine 0 N--CA 1.451 -0.31 0 N-CA-C 106.732 -2.547 . . . . 0.0 106.732 176.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 43.9 t -115.26 149.87 17.36 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.627 0 N-CA-C 104.467 -2.419 . . . . 0.0 104.467 173.908 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -179.42 -116.19 0.5 Allowed Glycine 0 CA--C 1.498 -0.992 0 N-CA-C 108.105 -1.998 . . . . 0.0 108.105 173.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -141.14 176.16 9.05 Favored 'General case' 0 N--CA 1.443 -0.778 0 O-C-N 125.496 1.351 . . . . 0.0 108.712 -166.13 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 10.4 ttt-85 -139.12 164.56 29.46 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 107.264 -1.384 . . . . 0.0 107.264 164.276 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 5.1 p90 . . . . . 0 N--CA 1.442 -0.868 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 161.019 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.467 0.418 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.1 m -135.56 158.13 45.15 Favored 'General case' 0 C--O 1.24 0.59 0 N-CA-C 104.937 -2.246 . . . . 0.0 104.937 158.606 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 1.7 p -128.85 105.65 8.38 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 106.98 -1.489 . . . . 0.0 106.98 164.402 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 1.8 m -106.97 124.53 49.76 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 106.97 -1.493 . . . . 0.0 106.97 -167.312 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 3.9 p -126.22 100.21 6.51 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.746 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 -150.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.453 HG21 ' HB2' ' A' ' 124' ' ' ASP . 59.2 p -134.86 129.48 34.5 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.752 0.786 . . . . 0.0 109.9 -155.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 179.32 -177.87 48.5 Favored Glycine 0 C--O 1.238 0.403 0 N-CA-C 110.102 -1.199 . . . . 0.0 110.102 -176.798 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 160.33 -163.9 34.16 Favored Glycine 0 N--CA 1.448 -0.517 0 N-CA-C 110.979 -0.849 . . . . 0.0 110.979 -174.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 6.7 m-85 -93.39 158.28 15.81 Favored 'General case' 0 C--O 1.236 0.363 0 C-N-CA 123.91 0.884 . . . . 0.0 109.749 179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -125.58 169.16 12.75 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.771 0.828 . . . . 0.0 109.698 167.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 21.6 tt0 -140.2 103.57 4.62 Favored 'General case' 0 N--CA 1.455 -0.21 0 N-CA-C 106.362 -1.718 . . . . 0.0 106.362 175.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 4.1 t -90.27 115.77 27.73 Favored 'General case' 0 N--CA 1.453 -0.315 0 N-CA-C 105.083 -2.192 . . . . 0.0 105.083 171.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 61.9 m-20 -103.1 161.27 13.91 Favored 'General case' 0 C--O 1.239 0.506 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 175.365 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -135.04 154.5 51.69 Favored 'General case' 0 C--O 1.234 0.276 0 C-N-CA 125.259 1.424 . . . . 0.0 109.136 171.381 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 47.0 mt-30 -61.49 79.95 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.581 0 C-N-CA 124.849 1.26 . . . . 0.0 110.155 165.296 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 152.83 -33.93 0.8 Allowed Glycine 0 CA--C 1.524 0.643 0 C-N-CA 125.436 1.493 . . . . 0.0 110.367 178.322 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 59.3 mt-30 -142.41 96.74 3.0 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 124.858 1.263 . . . . 0.0 107.648 174.907 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 7.6 mtt -88.64 67.97 8.55 Favored 'General case' 0 C--N 1.328 -0.36 0 N-CA-C 106.565 -1.642 . . . . 0.0 106.565 165.015 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 2.9 m-80 -113.43 165.88 12.03 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 105.867 -1.901 . . . . 0.0 105.867 169.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 7.4 ttpm? -71.59 98.6 1.91 Allowed 'General case' 0 CA--C 1.513 -0.443 0 N-CA-C 106.046 -1.835 . . . . 0.0 106.046 165.756 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 4.3 mpp? -83.06 117.85 23.13 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 105.722 -1.955 . . . . 0.0 105.722 146.343 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 179.15 -160.45 25.95 Favored Glycine 0 C--N 1.335 0.481 0 C-N-CA 120.965 -0.636 . . . . 0.0 113.622 -176.54 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -165.85 -119.2 0.47 Allowed Glycine 0 N--CA 1.447 -0.569 0 N-CA-C 107.49 -2.244 . . . . 0.0 107.49 -175.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 15.3 t80 -148.65 129.84 14.58 Favored 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 107.231 -1.396 . . . . 0.0 107.231 -176.558 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 25.5 t-20 -96.2 139.35 32.48 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.859 0.864 . . . . 0.0 109.13 -174.743 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -133.17 140.49 47.61 Favored 'General case' 0 C--O 1.238 0.483 0 N-CA-C 106.117 -1.808 . . . . 0.0 106.117 175.661 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -135.1 156.64 48.67 Favored 'General case' 0 C--O 1.236 0.375 0 C-N-CA 125.308 1.443 . . . . 0.0 107.503 174.051 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 22.7 p90 -128.45 139.11 52.52 Favored 'General case' 0 C--O 1.24 0.559 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 164.06 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -141.48 110.18 6.08 Favored 'General case' 0 C--O 1.233 0.226 0 N-CA-C 108.931 -0.766 . . . . 0.0 108.931 174.773 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.43 151.65 20.86 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 123.303 0.641 . . . . 0.0 109.438 176.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 8.1 pt-20 -90.54 161.53 15.43 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 125.655 1.582 . . . . 0.0 108.557 153.935 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 52.2 mt-10 -131.94 148.87 52.55 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 107.849 -1.167 . . . . 0.0 107.849 169.503 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.4 m-20 -81.3 -15.22 56.1 Favored 'General case' 0 N--CA 1.468 0.465 0 O-C-N 121.509 -0.744 . . . . 0.0 110.285 177.336 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -95.66 -9.55 31.72 Favored 'General case' 0 N--CA 1.453 -0.293 0 N-CA-C 113.823 1.046 . . . . 0.0 113.823 -157.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.32 163.27 18.72 Favored Pre-proline 0 CA--C 1.546 0.808 0 C-N-CA 127.767 2.427 . . . . 0.0 106.316 175.715 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 65.8 Cg_endo -79.36 21.69 0.75 Allowed 'Trans proline' 0 CA--C 1.546 1.101 0 C-N-CA 123.473 2.782 . . . . 0.0 113.517 -172.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 13.2 tp -107.53 156.19 19.27 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 126.872 2.069 . . . . 0.0 110.053 -162.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -134.67 160.23 24.17 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 109.999 -1.241 . . . . 0.0 109.999 159.841 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 56.8 t -101.2 147.58 8.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 176.754 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 5.1 mt -127.22 129.3 70.87 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 105.714 -1.958 . . . . 0.0 105.714 170.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -135.75 127.66 4.34 Favored Glycine 0 CA--C 1.521 0.43 0 N-CA-C 107.721 -2.151 . . . . 0.0 107.721 167.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 9.8 m -124.51 137.6 54.4 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 124.854 1.261 . . . . 0.0 108.087 -176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 29.3 m-85 -128.28 109.05 11.1 Favored 'General case' 0 N--CA 1.455 -0.177 0 C-N-CA 124.772 1.229 . . . . 0.0 108.653 -175.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 14.1 t -128.16 137.63 52.16 Favored 'General case' 0 CA--C 1.538 0.492 0 C-N-CA 126.203 1.801 . . . . 0.0 108.646 176.208 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 26.4 p90 -136.18 158.33 44.68 Favored 'General case' 0 N--CA 1.465 0.312 0 C-N-CA 125.665 1.586 . . . . 0.0 108.701 178.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -117.8 161.71 19.27 Favored 'General case' 0 CA--C 1.536 0.434 0 O-C-N 121.566 -0.709 . . . . 0.0 109.122 170.124 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 71.7 tt0 -147.2 165.4 30.16 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 127.763 2.425 . . . . 0.0 105.415 164.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 36.4 tttp -139.86 134.83 32.23 Favored 'General case' 0 C--O 1.236 0.388 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.805 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 69.6 m -72.93 112.87 9.36 Favored 'General case' 0 C--N 1.331 -0.198 0 C-N-CA 123.512 0.725 . . . . 0.0 111.301 -177.531 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 22.7 ptt180 -68.86 101.15 1.29 Allowed 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 105.697 -1.964 . . . . 0.0 105.697 158.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . 0.403 ' C ' ' H ' ' A' ' 53' ' ' SER . 0.2 OUTLIER -57.87 -40.17 79.56 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.864 -0.791 . . . . 0.0 108.864 174.49 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 55.73 -8.56 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.497 0 C-N-CA 128.063 2.545 . . . . 0.0 115.069 -175.213 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . 0.403 ' H ' ' C ' ' A' ' 51' ' ' THR . 23.0 t -79.8 71.19 6.45 Favored 'General case' 0 N--CA 1.448 -0.556 0 C-N-CA 128.967 2.907 . . . . 0.0 107.578 -179.195 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 19.0 m 122.17 0.7 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.599 1 C-N-CA 133.684 4.794 . . . . 0.0 111.395 -178.753 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 88.77 37.64 7.29 Favored Glycine 0 CA--C 1.526 0.734 0 CA-C-O 119.074 -0.848 . . . . 0.0 112.914 169.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -90.16 109.2 20.28 Favored 'General case' 0 C--O 1.238 0.46 0 N-CA-C 104.774 -2.306 . . . . 0.0 104.774 156.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 12.9 m-85 -85.44 123.97 31.5 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.038 -1.838 . . . . 0.0 106.038 164.245 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -116.23 124.93 51.46 Favored 'General case' 0 N--CA 1.447 -0.598 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 -179.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.6 142.4 29.06 Favored 'General case' 0 CA--C 1.509 -0.603 0 CA-C-N 119.356 0.98 . . . . 0.0 111.804 162.76 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 53.6 t30 -137.56 157.53 46.34 Favored 'General case' 0 N--CA 1.447 -0.612 0 N-CA-C 105.677 -1.972 . . . . 0.0 105.677 154.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 35.7 mt-30 -136.53 148.51 47.64 Favored 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 105.066 -2.198 . . . . 0.0 105.066 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 87.2 t80 -146.27 127.04 14.36 Favored 'General case' 0 C--O 1.234 0.251 0 N-CA-C 106.559 -1.645 . . . . 0.0 106.559 -174.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 19.1 m-85 -98.2 146.15 25.9 Favored 'General case' 0 N--CA 1.449 -0.478 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 145.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -127.51 89.42 0.34 Allowed Glycine 0 N--CA 1.451 -0.32 0 N-CA-C 105.578 -3.009 . . . . 0.0 105.578 167.506 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 31.5 mm -71.23 129.34 35.05 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.096 0 N-CA-C 106.366 -1.716 . . . . 0.0 106.366 -171.649 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 84.9 m -139.4 126.93 21.67 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 -177.291 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -157.57 156.24 31.59 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 123.436 0.695 . . . . 0.0 109.507 172.453 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 153.29 160.39 9.67 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 125.576 1.56 . . . . 0.0 110.653 173.955 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -81.79 151.95 16.89 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 122.153 1.902 . . . . 0.0 111.533 -173.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.93 161.99 14.95 Favored 'General case' 0 CA--C 1.532 0.272 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 158.222 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.1 t80 -140.44 140.55 35.42 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 107.216 -1.401 . . . . 0.0 107.216 179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.4 ptm180 -73.95 90.8 1.97 Allowed 'General case' 0 CA--C 1.534 0.36 0 O-C-N 121.927 -0.483 . . . . 0.0 110.689 179.122 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 90.7 mt -57.83 -38.36 65.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 172.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -124.9 -76.75 0.59 Allowed 'General case' 0 CA--C 1.518 -0.267 0 N-CA-C 106.295 -1.743 . . . . 0.0 106.295 160.838 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 66.7 m-20 -133.17 -69.27 0.56 Allowed 'General case' 0 N--CA 1.463 0.216 0 CA-C-O 121.546 0.689 . . . . 0.0 109.489 -177.367 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 5.6 p-90 -116.11 29.7 7.8 Favored 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 126.564 1.946 . . . . 0.0 110.19 -166.979 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.36 175.04 8.78 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 125.435 1.494 . . . . 0.0 109.598 163.777 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 44.0 t -143.55 168.61 19.46 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 167.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 8.6 tp -145.65 169.59 6.67 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.433 0 N-CA-C 108.725 -0.843 . . . . 0.0 108.725 177.26 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 48.6 p90 -104.84 171.08 7.51 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 126.176 1.79 . . . . 0.0 109.464 -177.713 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 139.33 37.26 0.12 Allowed Glycine 0 CA--C 1.528 0.877 0 C-N-CA 125.448 1.499 . . . . 0.0 109.664 -168.072 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 25.9 m -118.4 142.8 31.42 Favored 'Isoleucine or valine' 0 C--O 1.235 0.296 0 CA-C-N 118.127 0.963 . . . . 0.0 108.933 -176.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 11.4 m -154.54 165.88 1.24 Allowed 'Isoleucine or valine' 0 C--O 1.238 0.469 0 C-N-CA 125.444 1.498 . . . . 0.0 109.701 -169.605 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . 166.54 -169.62 40.68 Favored Glycine 0 C--N 1.333 0.416 0 C-N-CA 123.467 0.556 . . . . 0.0 112.425 170.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 74.6 t -73.88 133.65 31.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 N-CA-C 108.809 -0.811 . . . . 0.0 108.809 174.131 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -109.3 147.54 16.93 Favored Glycine 0 CA--C 1.527 0.824 0 N-CA-C 106.03 -2.828 . . . . 0.0 106.03 150.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.4 t80 -147.0 140.4 25.51 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 108.082 -1.081 . . . . 0.0 108.082 -175.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -137.93 102.78 0.39 Allowed Glycine 0 C--N 1.332 0.32 0 N-CA-C 108.715 -1.754 . . . . 0.0 108.715 -177.717 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 2.4 tmtm? -70.11 -28.96 65.82 Favored 'General case' 0 C--O 1.218 -0.555 0 CA-C-O 117.66 -1.162 . . . . 0.0 111.866 176.683 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 34.1 t80 30.74 85.81 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.542 0 C-N-CA 128.38 2.672 . . . . 0.0 112.698 168.065 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -105.88 167.57 9.7 Favored 'General case' 0 N--CA 1.47 0.543 0 CA-C-N 118.672 0.669 . . . . 0.0 111.012 -178.557 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 25.5 p -137.03 142.55 42.47 Favored 'General case' 0 N--CA 1.452 -0.336 0 C-N-CA 126.544 1.938 . . . . 0.0 107.858 176.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -67.24 -76.58 0.08 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-N 119.927 1.239 . . . . 0.0 111.658 -173.957 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -154.29 -23.81 0.13 Allowed 'General case' 0 CA--C 1.538 0.519 0 CA-C-N 121.658 2.026 . . . . 0.0 113.71 170.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -42.65 -47.53 12.9 Favored Pre-proline 0 CA--C 1.537 0.475 0 C-N-CA 125.495 1.518 . . . . 0.0 115.08 179.167 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -76.26 44.07 1.29 Allowed 'Trans proline' 0 CA--C 1.54 0.819 0 C-N-CA 122.101 1.867 . . . . 0.0 112.509 179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 7.1 m 52.06 53.89 11.74 Favored 'General case' 0 CA--C 1.539 0.52 0 C-N-CA 125.549 1.539 . . . . 0.0 109.732 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 1.7 t80 72.09 -49.71 0.69 Allowed 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 127.793 2.437 . . . . 0.0 111.829 179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 56.0 mttt 46.85 -95.9 0.03 OUTLIER 'General case' 0 C--N 1.341 0.199 0 C-N-CA 126.365 1.866 . . . . 0.0 109.462 -162.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 48.3 t30 45.14 41.55 5.89 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 125.577 1.551 . . . . 0.0 111.441 -172.596 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 8.2 p-10 -117.33 0.97 12.36 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 126.446 1.898 . . . . 0.0 111.007 -172.601 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 25.8 m -118.84 130.47 55.78 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 125.661 1.584 . . . . 0.0 107.222 -179.637 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 3.2 p 164.53 100.58 0.0 OUTLIER 'General case' 0 N--CA 1.47 0.567 0 C-N-CA 128.592 2.757 . . . . 0.0 108.698 171.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 61.1 t0 -162.07 173.98 13.62 Favored 'General case' 0 N--CA 1.474 0.771 0 C-N-CA 125.511 1.524 . . . . 0.0 108.458 -169.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 7.3 p90 -83.13 -177.57 6.8 Favored 'General case' 0 CA--C 1.543 0.683 0 C-N-CA 125.905 1.682 . . . . 0.0 110.843 165.785 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -132.53 -150.93 6.59 Favored Glycine 0 CA--C 1.53 0.999 0 C-N-CA 127.535 2.493 . . . . 0.0 108.726 171.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -131.56 129.74 41.37 Favored 'General case' 0 N--CA 1.465 0.308 0 N-CA-C 105.496 -2.038 . . . . 0.0 105.496 153.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 19.5 m -129.69 131.63 46.42 Favored 'General case' 0 C--O 1.236 0.376 0 CA-C-N 119.226 0.921 . . . . 0.0 109.204 -168.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -131.7 149.21 52.56 Favored 'General case' 0 C--O 1.236 0.388 0 C-N-CA 127.355 2.262 . . . . 0.0 107.019 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . -150.27 -170.9 18.06 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.237 1.399 . . . . 0.0 109.766 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -138.39 174.6 10.37 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 123.471 0.708 . . . . 0.0 112.693 -168.177 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -153.2 83.23 0.16 Allowed Glycine 0 C--N 1.339 0.721 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 176.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 3.7 mm? -115.33 145.02 42.9 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -177.462 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -146.08 128.21 15.66 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.306 1.042 . . . . 0.0 110.266 -165.915 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 1.1 m-85 -96.68 159.32 14.99 Favored 'General case' 0 C--O 1.232 0.176 0 C-N-CA 123.353 0.661 . . . . 0.0 109.632 172.198 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 21.5 t-20 -58.94 112.37 4.96 Favored Pre-proline 0 CA--C 1.544 0.745 0 C-N-CA 125.19 1.396 . . . . 0.0 109.363 178.275 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 97.4 Cg_endo -83.37 131.83 5.77 Favored 'Trans proline' 0 C--N 1.348 0.519 0 C-N-CA 123.251 2.634 . . . . 0.0 111.175 -163.224 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 12.0 ttt -165.5 157.83 15.22 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 176.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 16.5 tt0 93.28 28.99 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.829 0 C-N-CA 127.231 2.213 . . . . 0.0 110.24 166.342 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER 49.26 37.07 10.5 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 126.823 2.049 . . . . 0.0 111.765 -170.798 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 24.0 m -135.59 126.71 44.54 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 127.057 2.143 . . . . 0.0 105.757 164.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.44 159.01 35.27 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 156.498 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -129.06 115.74 18.21 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 105.715 -1.957 . . . . 0.0 105.715 169.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.453 ' HB2' HG21 ' A' ' 6' ' ' THR . 2.4 t0 -142.23 155.88 45.28 Favored 'General case' 0 C--N 1.323 -0.565 0 C-N-CA 128.009 2.524 . . . . 0.0 106.004 175.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -149.9 124.37 9.65 Favored 'General case' 0 C--O 1.236 0.381 0 CA-C-N 118.504 0.593 . . . . 0.0 110.02 -175.739 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 9.0 t -134.36 165.97 23.91 Favored 'General case' 0 C--O 1.239 0.522 0 N-CA-C 108.31 -0.996 . . . . 0.0 108.31 166.568 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 1.9 t80 -149.52 126.45 11.19 Favored 'General case' 0 N--CA 1.44 -0.939 0 N-CA-C 102.745 -3.058 . . . . 0.0 102.745 168.749 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -113.38 133.29 55.24 Favored 'General case' 0 C--N 1.327 -0.393 0 N-CA-C 107.315 -1.365 . . . . 0.0 107.315 179.159 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -130.94 139.51 50.06 Favored 'General case' 0 C--O 1.237 0.409 0 C-N-CA 123.917 0.887 . . . . 0.0 111.06 179.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 8.2 t -132.21 159.38 39.2 Favored 'General case' 0 N--CA 1.443 -0.78 0 C-N-CA 127.148 2.179 . . . . 0.0 106.499 162.524 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 28.5 ttp180 -129.46 98.04 4.74 Favored 'General case' 0 CA--C 1.506 -0.74 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 168.163 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . 0.401 HD13 HG21 ' A' ' 137' ' ' VAL . 2.4 mp -75.33 98.88 1.52 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.789 0 N-CA-C 106.485 -1.672 . . . . 0.0 106.485 -179.393 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 24.0 ttt180 68.81 -84.38 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 127.81 2.444 . . . . 0.0 109.038 170.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -136.77 24.08 3.1 Favored 'General case' 0 N--CA 1.447 -0.581 0 C-N-CA 125.728 1.611 . . . . 0.0 110.215 -179.357 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -126.18 140.95 47.19 Favored 'Isoleucine or valine' 0 N--CA 1.467 0.423 0 N-CA-C 108.064 -1.087 . . . . 0.0 108.064 166.141 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -89.95 138.1 31.78 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . 0.401 HG21 HD13 ' A' ' 132' ' ' ILE . 31.9 t -138.55 84.81 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 105.914 -1.884 . . . . 0.0 105.914 -168.874 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -113.01 151.83 18.16 Favored Glycine 0 C--O 1.238 0.346 0 N-CA-C 109.833 -1.307 . . . . 0.0 109.833 -179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -140.44 120.47 13.69 Favored 'General case' 0 C--O 1.236 0.384 0 C-N-CA 124.473 1.109 . . . . 0.0 108.963 168.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 6.4 p-90 -84.09 150.85 25.29 Favored 'General case' 0 C--O 1.237 0.44 0 N-CA-C 107.475 -1.305 . . . . 0.0 107.475 160.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 18.5 pt -124.14 151.41 29.17 Favored 'Isoleucine or valine' 0 C--O 1.235 0.305 0 N-CA-C 107.77 -1.196 . . . . 0.0 107.77 172.028 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -88.11 155.51 19.75 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 106.645 -1.613 . . . . 0.0 106.645 165.552 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -128.51 51.25 0.86 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 109.603 -1.399 . . . . 0.0 109.603 -173.703 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.6 m -105.42 174.42 1.32 Allowed 'Isoleucine or valine' 0 C--O 1.233 0.231 0 C-N-CA 124.315 1.046 . . . . 0.0 110.091 -173.638 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 162.78 -112.11 0.5 Allowed Glycine 0 C--N 1.335 0.527 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -174.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 52.1 p90 -159.69 176.51 11.9 Favored 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 126.329 1.852 . . . . 0.0 108.617 -173.168 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -107.38 135.05 49.52 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 120.413 1.46 . . . . 0.0 109.959 170.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.245 0.865 0 C-N-CA 125.642 1.577 . . . . 0.0 109.242 162.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.516 -0.328 0 N-CA-C 108.62 -0.881 . . . . 0.0 108.62 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.5 m -136.49 165.58 25.51 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 104.622 -2.362 . . . . 0.0 104.622 168.532 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 20.5 m -103.44 105.56 15.86 Favored 'General case' 0 N--CA 1.446 -0.662 0 N-CA-C 106.309 -1.737 . . . . 0.0 106.309 172.164 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 8.9 m -117.25 99.99 7.4 Favored 'General case' 0 C--O 1.236 0.374 0 N-CA-C 107.002 -1.481 . . . . 0.0 107.002 174.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . 0.447 ' CG1' ' H ' ' A' ' 146' ' ' TYR . 12.5 p -92.72 166.24 1.8 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.028 -0.73 . . . . 0.0 109.028 171.759 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . 0.421 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.1 m -146.09 138.41 25.33 Favored 'General case' 0 N--CA 1.441 -0.892 0 N-CA-C 107.633 -1.247 . . . . 0.0 107.633 158.006 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -101.94 -168.1 27.2 Favored Glycine 0 N--CA 1.449 -0.468 0 C-N-CA 125.245 1.402 . . . . 0.0 110.237 175.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 164.99 163.03 17.32 Favored Glycine 0 N--CA 1.45 -0.381 0 O-C-N 121.929 -0.748 . . . . 0.0 112.327 163.686 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -112.55 143.56 43.51 Favored 'General case' 0 C--O 1.238 0.451 0 N-CA-C 106.522 -1.659 . . . . 0.0 106.522 176.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.68 153.42 17.82 Favored 'General case' 0 N--CA 1.451 -0.412 0 CA-C-O 122.073 0.939 . . . . 0.0 111.335 -168.594 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 12.0 pt20 -135.11 104.37 5.9 Favored 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 126.688 1.995 . . . . 0.0 105.618 156.142 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 8.2 m -85.98 125.79 33.65 Favored 'General case' 0 C--O 1.237 0.431 0 C-N-CA 126.332 1.853 . . . . 0.0 106.527 169.057 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 26.3 m-20 -138.44 157.82 45.46 Favored 'General case' 0 C--O 1.235 0.309 0 CA-C-N 119.779 1.172 . . . . 0.0 108.72 172.059 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -149.86 122.42 8.55 Favored 'General case' 0 C--O 1.236 0.377 0 C-N-CA 124.79 1.236 . . . . 0.0 108.744 -178.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER 58.7 -7.62 0.04 OUTLIER 'General case' 0 CA--C 1.547 0.851 0 C-N-CA 126.221 1.808 . . . . 0.0 113.177 -173.729 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . 132.09 -118.25 2.24 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 107.717 -2.153 . . . . 0.0 107.717 -166.27 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 35.5 tt0 -109.39 96.13 6.08 Favored 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 126.214 1.806 . . . . 0.0 111.067 -163.742 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -154.85 -22.76 0.12 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.335 1.454 . . . . 0.0 112.316 174.158 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 20.3 m-80 -74.14 168.96 18.52 Favored 'General case' 0 N--CA 1.448 -0.575 0 O-C-N 120.297 -1.502 . . . . 0.0 108.344 172.589 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . 0.537 ' HE2' ' HA ' ' A' ' 20' ' ' LYS . 5.9 mmpt? -132.49 89.42 2.65 Favored 'General case' 0 C--N 1.319 -0.754 0 C-N-CA 126.31 1.844 . . . . 0.0 106.089 165.941 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -57.48 145.94 31.46 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.851 177.781 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -175.02 72.57 0.08 OUTLIER Glycine 0 N--CA 1.443 -0.844 0 N-CA-C 105.165 -3.174 . . . . 0.0 105.165 172.066 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -148.32 173.12 28.42 Favored Glycine 0 N--CA 1.448 -0.514 0 N-CA-C 110.838 -0.905 . . . . 0.0 110.838 -166.732 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 5.5 p90 -148.67 170.56 17.88 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 125.91 1.684 . . . . 0.0 107.408 -179.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 3.1 p-10 -138.37 160.85 38.45 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.761 0.825 . . . . 0.0 109.181 168.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 1.5 tm? -141.82 119.67 11.91 Favored 'General case' 0 C--O 1.235 0.291 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 170.885 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -112.23 122.59 48.15 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 105.573 -2.01 . . . . 0.0 105.573 173.17 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 3.9 t80 -155.78 109.55 2.79 Favored 'General case' 0 CA--C 1.52 -0.207 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 179.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 10.8 mmm180 -140.58 164.62 29.67 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 119.487 1.04 . . . . 0.0 110.44 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -99.02 157.78 16.1 Favored 'General case' 0 C--O 1.237 0.425 0 C-N-CA 126.149 1.78 . . . . 0.0 108.574 -179.024 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -140.37 160.55 39.74 Favored 'General case' 0 C--O 1.239 0.542 0 C-N-CA 123.938 0.895 . . . . 0.0 109.997 167.029 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -98.99 168.46 10.08 Favored 'General case' 0 N--CA 1.452 -0.346 0 C-N-CA 125.021 1.329 . . . . 0.0 113.393 -153.015 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -75.93 -48.14 22.41 Favored 'General case' 0 N--CA 1.464 0.23 0 C-N-CA 126.046 1.738 . . . . 0.0 109.17 163.012 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -79.98 -29.71 39.6 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.195 -154.329 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 65.9 m -141.12 151.26 61.46 Favored Pre-proline 0 N--CA 1.449 -0.489 0 C-N-CA 124.073 0.949 . . . . 0.0 108.516 159.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 75.7 Cg_endo -71.78 83.98 1.07 Allowed 'Trans proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.801 3.001 . . . . 0.0 108.526 166.947 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 1.2 tm? -138.26 114.12 9.91 Favored 'General case' 0 C--O 1.237 0.405 0 N-CA-C 105.793 -1.929 . . . . 0.0 105.793 178.951 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -109.96 159.42 13.95 Favored Glycine 0 CA--C 1.521 0.466 0 C-N-CA 125.248 1.404 . . . . 0.0 109.885 177.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 90.8 t -103.28 160.87 4.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.499 0 N-CA-C 107.483 -1.303 . . . . 0.0 107.483 177.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.517 HG23 HG11 ' A' ' 82' ' ' VAL . 5.3 tt -135.59 111.18 12.21 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.233 0 N-CA-C 107.772 -1.196 . . . . 0.0 107.772 168.184 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -93.41 149.99 19.7 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 108.285 -1.926 . . . . 0.0 108.285 163.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.5 m -125.71 153.52 43.79 Favored 'General case' 0 C--O 1.241 0.616 0 N-CA-C 108.051 -1.092 . . . . 0.0 108.051 165.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -141.94 128.34 20.03 Favored 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 105.053 -2.203 . . . . 0.0 105.053 173.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 15.0 t -128.2 145.92 50.88 Favored 'General case' 0 C--O 1.238 0.486 0 C-N-CA 124.696 1.199 . . . . 0.0 108.61 -179.729 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -143.5 156.81 44.73 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 123.839 0.855 . . . . 0.0 109.609 172.219 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 96.0 m -128.61 132.61 48.17 Favored 'General case' 0 C--O 1.234 0.267 0 CA-C-N 119.225 0.92 . . . . 0.0 109.606 166.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 21.4 mt-10 -139.04 101.36 4.26 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 126.342 1.857 . . . . 0.0 107.577 178.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . 0.493 ' HE3' ' HA ' ' A' ' 48' ' ' LYS . 0.0 OUTLIER -169.93 147.67 3.35 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 127.621 2.369 . . . . 0.0 106.693 174.298 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 20.3 t -123.62 154.74 38.9 Favored 'General case' 0 C--O 1.239 0.518 0 C-N-CA 126.196 1.798 . . . . 0.0 107.319 171.163 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 68.6 mtt-85 -90.0 110.33 21.32 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 164.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 1.8 t -141.19 142.96 33.96 Favored 'General case' 0 C--N 1.32 -0.708 0 N-CA-C 103.62 -2.733 . . . . 0.0 103.62 167.895 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.74 65.58 1.25 Allowed 'General case' 0 CA--C 1.53 0.189 0 C-N-CA 125.488 1.515 . . . . 0.0 111.149 -171.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 4.7 t -157.45 -93.86 0.03 OUTLIER 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 108.213 -1.032 . . . . 0.0 108.213 164.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 7.1 p -84.23 -9.61 58.38 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-N 120.282 1.401 . . . . 0.0 112.362 172.522 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 56.16 57.85 17.11 Favored Glycine 0 C--N 1.344 0.998 0 CA-C-N 119.277 0.944 . . . . 0.0 110.824 -171.816 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 17.5 t0 -119.46 98.28 6.06 Favored 'General case' 0 C--N 1.327 -0.39 0 N-CA-C 105.087 -2.19 . . . . 0.0 105.087 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 92.1 m-85 -97.08 104.57 16.6 Favored 'General case' 0 C--O 1.235 0.295 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -161.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . 0.507 HD21 ' ND2' ' A' ' 60' ' ' ASN . 4.3 p-10 -146.65 -174.52 4.49 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.954 1.302 . . . . 0.0 110.081 -170.229 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -121.19 159.09 26.61 Favored 'General case' 0 C--O 1.238 0.463 0 N-CA-C 107.958 -1.127 . . . . 0.0 107.958 163.241 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.507 ' ND2' HD21 ' A' ' 58' ' ' ASN . 1.2 m-20 -141.88 91.84 2.39 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 105.673 -1.973 . . . . 0.0 105.673 -160.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -113.3 129.89 56.41 Favored 'General case' 0 C--O 1.236 0.376 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -161.118 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -134.53 112.81 11.18 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.248 -1.019 . . . . 0.0 108.248 174.897 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 7.7 m-85 -99.82 139.95 34.75 Favored 'General case' 0 C--O 1.236 0.369 0 N-CA-C 106.277 -1.749 . . . . 0.0 106.277 159.746 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -132.68 145.65 17.55 Favored Glycine 0 C--N 1.331 0.267 0 N-CA-C 108.077 -2.009 . . . . 0.0 108.077 162.433 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -131.49 109.82 16.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 -177.397 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.66 139.19 52.37 Favored 'General case' 0 C--O 1.244 0.767 0 C-N-CA 126.424 1.89 . . . . 0.0 107.481 -173.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.56 170.46 22.32 Favored 'General case' 0 C--O 1.234 0.259 0 C-N-CA 124.158 0.983 . . . . 0.0 109.637 174.492 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 143.33 164.83 10.45 Favored Glycine 0 CA--C 1.525 0.704 0 C-N-CA 123.712 0.672 . . . . 0.0 112.449 159.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -65.54 147.99 87.12 Favored 'Trans proline' 0 N--CA 1.448 -1.196 0 C-N-CA 121.703 1.602 . . . . 0.0 108.03 161.635 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.02 179.87 5.85 Favored 'General case' 0 C--O 1.24 0.553 0 N-CA-C 108.112 -1.069 . . . . 0.0 108.112 176.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -118.68 128.18 54.27 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.015 -1.476 . . . . 0.0 107.015 163.948 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.85 139.8 37.96 Favored 'General case' 0 N--CA 1.454 -0.266 0 N-CA-C 107.711 -1.218 . . . . 0.0 107.711 168.783 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -141.44 175.59 5.32 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 C-N-CA 124.454 1.101 . . . . 0.0 109.604 -179.427 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 25.3 t-20 72.88 -49.27 0.7 Allowed 'General case' 0 N--CA 1.466 0.373 0 C-N-CA 129.114 2.966 . . . . 0.0 112.124 162.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 54.2 t0 -139.95 -67.23 0.44 Allowed 'General case' 0 CA--C 1.532 0.27 0 N-CA-C 106.758 -1.571 . . . . 0.0 106.758 135.632 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.5 OUTLIER -143.22 49.53 1.44 Allowed 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.489 1.516 . . . . 0.0 109.585 169.073 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -75.58 132.11 40.45 Favored 'General case' 0 N--CA 1.452 -0.375 0 N-CA-C 106.24 -1.763 . . . . 0.0 106.24 163.052 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 36.3 t -94.22 142.89 26.89 Favored 'General case' 0 C--O 1.233 0.211 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 -177.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.45 ' HA ' HD13 ' A' ' 113' ' ' LEU . 7.5 tt -120.77 172.62 7.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.267 0 C-N-CA 125.062 1.345 . . . . 0.0 111.254 -179.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . 0.522 ' HB3' ' H ' ' A' ' 112' ' ' GLY . 6.6 p90 -103.47 157.63 16.91 Favored 'General case' 0 N--CA 1.44 -0.957 0 N-CA-C 106.848 -1.538 . . . . 0.0 106.848 179.139 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 152.04 40.06 0.03 OUTLIER Glycine 0 N--CA 1.448 -0.506 0 N-CA-C 109.092 -1.603 . . . . 0.0 109.092 -175.844 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . 0.517 HG11 HG23 ' A' ' 40' ' ' ILE . 3.5 m -104.8 168.21 2.61 Favored 'Isoleucine or valine' 0 CA--C 1.521 -0.139 0 O-C-N 122.237 -0.567 . . . . 0.0 109.766 175.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -94.95 141.69 14.66 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.635 0 N-CA-C 106.398 -1.704 . . . . 0.0 106.398 173.98 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -160.77 174.26 37.39 Favored Glycine 0 N--CA 1.434 -1.462 0 N-CA-C 110.293 -1.123 . . . . 0.0 110.293 156.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 45.4 t -124.11 150.55 28.7 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 125.697 1.599 . . . . 0.0 108.099 -176.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -124.79 145.65 15.83 Favored Glycine 0 N--CA 1.448 -0.511 0 N-CA-C 107.594 -2.202 . . . . 0.0 107.594 163.655 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -152.59 116.58 4.87 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 172.091 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -94.1 102.71 2.92 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 109.078 -1.609 . . . . 0.0 109.078 172.108 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 46.2 tttm -88.59 100.16 12.87 Favored 'General case' 0 N--CA 1.464 0.274 0 N-CA-C 107.553 -1.277 . . . . 0.0 107.553 166.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 44.0 p90 -119.15 165.49 14.12 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.077 0.951 . . . . 0.0 109.187 173.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 6.3 mt-30 -136.23 159.0 43.07 Favored 'General case' 0 C--N 1.329 -0.319 0 C-N-CA 125.242 1.417 . . . . 0.0 107.727 -177.893 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 10.9 m -134.34 130.15 36.53 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 107.676 -1.231 . . . . 0.0 107.676 179.596 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER 63.36 -68.15 0.08 Allowed 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 130.435 3.494 . . . . 0.0 111.694 -177.36 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 61.48 -3.28 0.21 Allowed 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.523 1.929 . . . . 0.0 112.968 -171.435 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 1.5 t80 -70.13 -59.74 4.02 Favored Pre-proline 0 CA--C 1.543 0.692 0 CA-C-N 119.402 1.001 . . . . 0.0 110.903 171.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -71.78 176.73 7.83 Favored 'Trans proline' 0 CA--C 1.539 0.77 0 CA-C-N 121.441 1.55 . . . . 0.0 111.457 173.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 9.6 t -74.8 8.39 2.46 Favored 'General case' 0 CA--C 1.546 0.795 0 N-CA-C 114.562 1.319 . . . . 0.0 114.562 -170.763 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -129.24 110.3 11.85 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.834 1.652 . . . . 0.0 107.652 -161.251 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -159.87 132.13 6.42 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 109.279 -0.637 . . . . 0.0 109.279 -171.798 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 2.5 t30 62.97 146.72 0.02 OUTLIER 'General case' 0 C--O 1.236 0.387 0 C-N-CA 127.742 2.417 . . . . 0.0 111.976 -169.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -143.51 -41.64 0.29 Allowed 'General case' 0 C--N 1.325 -0.484 0 C-N-CA 124.731 1.212 . . . . 0.0 110.382 175.498 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 85.5 m -119.5 134.6 55.15 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 125.224 1.41 . . . . 0.0 108.187 179.396 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.09 126.54 32.14 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 106.574 -1.639 . . . . 0.0 106.574 155.004 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -65.02 151.69 45.33 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 108.24 -1.022 . . . . 0.0 108.24 168.581 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -159.68 110.9 1.99 Allowed 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 106.966 -1.494 . . . . 0.0 106.966 167.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -99.36 152.7 19.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 108.98 -1.648 . . . . 0.0 108.98 166.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 30.3 t80 -138.39 93.38 2.73 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 125.742 1.617 . . . . 0.0 107.608 175.69 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 3.3 m -170.28 -73.36 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 126.308 1.843 . . . . 0.0 106.758 167.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 5.4 t80 63.46 -59.76 0.17 Allowed 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 128.285 2.634 . . . . 0.0 113.213 -176.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 60.66 -144.61 47.9 Favored Glycine 0 CA--C 1.531 1.034 0 CA-C-N 120.759 1.618 . . . . 0.0 111.222 177.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . -159.02 -88.87 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 107.708 -1.219 . . . . 0.0 107.708 -172.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . 0.522 ' H ' ' HB3' ' A' ' 80' ' ' TYR . . . 139.18 -169.34 24.53 Favored Glycine 0 N--CA 1.444 -0.781 0 N-CA-C 107.812 -2.115 . . . . 0.0 107.812 -156.843 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . 0.45 HD13 ' HA ' ' A' ' 79' ' ' ILE . 3.1 mm? -120.87 152.56 38.28 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 107.468 -1.308 . . . . 0.0 107.468 -167.379 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -104.56 136.06 44.82 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 109.058 -0.719 . . . . 0.0 109.058 -172.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -139.22 107.96 5.93 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 123.53 0.732 . . . . 0.0 109.313 -175.551 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -131.51 107.49 14.47 Favored Pre-proline 0 C--N 1.326 -0.45 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 -171.416 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 82.8 Cg_endo -80.13 -6.85 14.09 Favored 'Trans proline' 0 CA--C 1.539 0.762 0 C-N-CA 123.403 2.735 . . . . 0.0 112.141 172.148 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 2.5 tpt -159.15 -177.6 6.6 Favored 'General case' 0 CA--C 1.533 0.304 0 N-CA-C 104.71 -2.33 . . . . 0.0 104.71 160.144 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -77.52 -33.07 54.43 Favored 'General case' 0 CA--C 1.536 0.409 0 O-C-N 120.476 -1.39 . . . . 0.0 108.653 159.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.44 -26.31 30.16 Favored 'General case' 0 C--N 1.344 0.33 0 C-N-CA 125.286 1.434 . . . . 0.0 112.598 -178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 10.9 m -137.03 110.65 8.67 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.466 0 N-CA-C 105.748 -1.945 . . . . 0.0 105.748 166.757 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -120.35 124.16 44.86 Favored 'General case' 0 C--O 1.237 0.417 0 C-N-CA 124.148 0.979 . . . . 0.0 108.633 -177.887 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -136.79 134.44 37.03 Favored 'General case' 0 CA--C 1.519 -0.24 0 C-N-CA 123.39 0.676 . . . . 0.0 111.524 -170.704 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.421 ' HB2' HG21 ' A' ' 6' ' ' THR . 26.7 m-20 -123.31 139.16 54.33 Favored 'General case' 0 C--O 1.236 0.384 0 N-CA-C 106.782 -1.562 . . . . 0.0 106.782 170.391 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 22.1 m-85 -98.55 134.85 40.93 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.638 -2.356 . . . . 0.0 104.638 165.043 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 42.6 t -142.31 148.44 38.0 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.083 0.953 . . . . 0.0 108.473 -162.659 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 36.3 t80 -144.96 149.14 34.68 Favored 'General case' 0 C--O 1.238 0.483 0 C-N-CA 125.146 1.378 . . . . 0.0 107.724 -173.062 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 6.8 pt-20 -136.55 147.09 46.85 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 125.929 1.692 . . . . 0.0 106.678 165.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 40.1 tt0 -132.94 113.43 12.84 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 124.304 1.042 . . . . 0.0 108.405 176.063 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 28.8 m -110.55 159.53 17.46 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 125.638 1.575 . . . . 0.0 109.474 176.411 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 6.5 ptm180 -140.16 97.21 3.19 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 -172.712 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 4.1 mp -113.29 86.35 0.88 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.108 -1.441 . . . . 0.0 107.108 -171.451 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 1.7 tmm_? 76.24 -57.73 0.55 Allowed 'General case' 0 N--CA 1.469 0.511 0 C-N-CA 126.04 1.736 . . . . 0.0 111.157 168.395 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 6.5 t -152.48 2.4 0.33 Allowed 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 125.185 1.394 . . . . 0.0 111.504 157.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 83.1 t -82.87 116.53 27.24 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.421 0 N-CA-C 106.271 -1.751 . . . . 0.0 106.271 -179.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 39.3 m-20 -77.7 134.13 38.18 Favored 'General case' 0 C--O 1.236 0.363 0 N-CA-C 106.49 -1.67 . . . . 0.0 106.49 164.14 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 2.4 t -125.32 130.66 72.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 104.69 -2.337 . . . . 0.0 104.69 170.753 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.01 151.7 22.68 Favored Glycine 0 N--CA 1.44 -1.055 0 N-CA-C 106.654 -2.578 . . . . 0.0 106.654 173.199 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 4.9 p -128.85 155.64 44.9 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 106.43 -1.692 . . . . 0.0 106.43 172.234 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 53.7 t-105 -111.68 149.05 32.12 Favored 'General case' 0 C--O 1.238 0.493 0 N-CA-C 105.939 -1.874 . . . . 0.0 105.939 159.644 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 39.1 mt -135.32 134.28 52.51 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.53 0 N-CA-C 106.222 -1.77 . . . . 0.0 106.222 170.263 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -142.6 160.54 40.1 Favored 'General case' 0 C--O 1.236 0.389 0 N-CA-C 107.538 -1.282 . . . . 0.0 107.538 162.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -175.13 -173.26 40.76 Favored Glycine 0 CA--C 1.526 0.767 0 C-N-CA 125.367 1.461 . . . . 0.0 109.616 -179.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 10.1 m -138.07 174.18 11.2 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.583 0 C-N-CA 125.8 1.64 . . . . 0.0 108.621 178.519 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -148.48 -169.66 15.57 Favored Glycine 0 CA--C 1.524 0.653 0 C-N-CA 124.739 1.161 . . . . 0.0 111.252 -159.442 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . 0.447 ' H ' ' CG1' ' A' ' 5' ' ' VAL . 26.3 m-85 -155.95 164.89 37.9 Favored 'General case' 0 CA--C 1.536 0.417 0 C-N-CA 125.597 1.559 . . . . 0.0 109.134 174.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 1.8 ttp-105 -88.14 141.28 28.69 Favored 'General case' 0 C--O 1.24 0.572 0 N-CA-C 105.594 -2.002 . . . . 0.0 105.594 166.516 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 55.7 p90 . . . . . 0 C--O 1.251 1.149 0 N-CA-C 109.674 -0.491 . . . . 0.0 109.674 178.276 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.47 0.532 0 CA-C-O 118.993 -0.527 . . . . 0.0 110.411 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.3 t -150.71 166.46 30.32 Favored 'General case' 0 C--O 1.236 0.367 0 N-CA-C 107.894 -1.15 . . . . 0.0 107.894 161.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 66.2 m -129.9 149.97 51.39 Favored 'General case' 0 N--CA 1.448 -0.526 0 C-N-CA 124.23 1.012 . . . . 0.0 109.264 179.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.407 ' H ' ' CB ' ' A' ' 29' ' ' ARG . 81.1 p -128.02 116.75 20.51 Favored 'General case' 0 C--O 1.237 0.423 0 N-CA-C 108.371 -0.974 . . . . 0.0 108.371 175.334 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 18.7 m -115.44 121.11 66.54 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 106.305 -1.739 . . . . 0.0 106.305 -175.91 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 6.9 p -147.64 141.62 25.92 Favored 'General case' 0 C--N 1.327 -0.395 0 C-N-CA 125.514 1.525 . . . . 0.0 107.65 -170.201 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -161.75 163.2 34.55 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 109.313 -1.515 . . . . 0.0 109.313 178.407 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 179.87 -169.63 40.53 Favored Glycine 0 N--CA 1.453 -0.218 0 N-CA-C 110.913 -0.875 . . . . 0.0 110.913 -161.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -122.31 114.98 21.54 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.693 -0.854 . . . . 0.0 108.693 -172.265 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.67 153.6 17.74 Favored 'General case' 0 C--O 1.241 0.612 0 C-N-CA 123.945 0.898 . . . . 0.0 109.053 -175.577 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . 0.46 ' NE2' ' HE1' ' A' ' 140' ' ' TRP . 6.4 pt20 -153.49 104.73 2.77 Favored 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 123.856 0.862 . . . . 0.0 108.788 -168.634 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 26.4 t -83.43 146.65 28.3 Favored 'General case' 0 C--O 1.238 0.474 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 32.5 m-20 -131.64 105.23 7.39 Favored 'General case' 0 C--O 1.234 0.284 0 N-CA-C 108.121 -1.066 . . . . 0.0 108.121 -177.92 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . 0.576 ' HB2' ' H ' ' A' ' 136' ' ' ASP . . . -99.05 143.64 29.1 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 179.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 28.3 tp60 -74.2 57.19 0.65 Allowed 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 124.725 1.21 . . . . 0.0 110.537 176.652 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -179.57 -45.23 0.08 OUTLIER Glycine 0 CA--C 1.525 0.683 0 C-N-CA 125.988 1.756 . . . . 0.0 109.284 -173.295 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 9.2 mp0 -147.01 97.86 2.95 Favored 'General case' 0 CA--C 1.541 0.607 0 C-N-CA 126.427 1.891 . . . . 0.0 107.71 -176.26 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 34.8 mtt -69.65 61.36 0.16 Allowed 'General case' 0 N--CA 1.474 0.729 0 C-N-CA 126.753 2.021 . . . . 0.0 109.031 170.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.9 m120 -103.18 108.3 19.45 Favored 'General case' 0 C--N 1.323 -0.548 0 C-N-CA 125.669 1.588 . . . . 0.0 107.477 -171.153 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 2.2 mptt -71.14 87.44 0.78 Allowed 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.915 1.286 . . . . 0.0 109.441 -164.097 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 26.7 mtt -63.94 90.2 0.06 Allowed 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 124.224 1.01 . . . . 0.0 109.037 175.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -140.05 -168.43 11.33 Favored Glycine 0 CA--C 1.524 0.613 0 C-N-CA 124.815 1.198 . . . . 0.0 111.049 179.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . 153.13 -81.02 0.18 Allowed Glycine 0 CA--C 1.521 0.443 0 N-CA-C 108.294 -1.922 . . . . 0.0 108.294 -178.709 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -139.35 143.17 37.65 Favored 'General case' 0 C--O 1.234 0.25 0 C-N-CA 123.317 0.647 . . . . 0.0 111.034 -177.684 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -137.18 125.58 23.4 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 126.773 2.029 . . . . 0.0 106.291 176.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 96.4 mt -142.25 165.8 26.43 Favored 'General case' 0 C--O 1.236 0.372 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 166.7 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -121.3 168.84 11.2 Favored 'General case' 0 C--O 1.24 0.588 0 C-N-CA 123.841 0.857 . . . . 0.0 111.264 170.312 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -88.59 127.44 35.56 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 105.774 -1.935 . . . . 0.0 105.774 156.757 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . 0.407 ' CB ' ' H ' ' A' ' 4' ' ' THR . 0.0 OUTLIER -93.94 135.9 34.8 Favored 'General case' 0 N--CA 1.447 -0.586 0 C-N-CA 126.308 1.843 . . . . 0.0 108.05 169.201 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -139.54 145.85 39.17 Favored 'General case' 0 C--O 1.237 0.397 0 N-CA-C 107.424 -1.324 . . . . 0.0 107.424 166.167 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -136.68 160.14 39.72 Favored 'General case' 0 C--O 1.238 0.497 0 C-N-CA 125.365 1.466 . . . . 0.0 107.547 160.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -137.99 168.42 19.74 Favored 'General case' 0 N--CA 1.453 -0.296 0 C-N-CA 126.669 1.987 . . . . 0.0 107.619 172.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -91.88 -15.83 27.56 Favored 'General case' 0 N--CA 1.469 0.523 0 C-N-CA 124.897 1.279 . . . . 0.0 110.491 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 14.7 p30 -131.59 1.29 4.05 Favored 'General case' 0 CA--C 1.533 0.296 0 C-N-CA 126.392 1.877 . . . . 0.0 112.504 -161.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.5 t -124.67 96.38 40.94 Favored Pre-proline 0 C--O 1.237 0.402 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 -179.946 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 76.0 Cg_endo -71.45 -14.43 30.83 Favored 'Trans proline' 0 CA--C 1.538 0.69 0 C-N-CA 122.448 2.099 . . . . 0.0 112.69 -174.396 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . 0.418 HD11 ' HB2' ' A' ' 69' ' ' PRO . 0.6 OUTLIER -73.78 135.87 43.55 Favored 'General case' 0 C--O 1.236 0.362 0 C-N-CA 123.741 0.817 . . . . 0.0 109.184 167.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -93.05 160.34 24.92 Favored Glycine 0 CA--C 1.526 0.736 0 CA-C-O 121.566 0.537 . . . . 0.0 112.423 173.662 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 53.8 t -117.56 132.43 67.38 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.694 1.598 . . . . 0.0 107.176 -179.217 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 42.7 pt -137.21 151.23 26.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 C-N-CA 124.215 1.006 . . . . 0.0 109.223 163.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -159.03 128.36 2.02 Favored Glycine 0 N--CA 1.449 -0.493 0 N-CA-C 104.633 -3.387 . . . . 0.0 104.633 165.655 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 2.6 t -124.79 151.49 45.09 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 107.361 -1.348 . . . . 0.0 107.361 -176.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 4.4 t80 -113.11 152.35 29.71 Favored 'General case' 0 C--O 1.238 0.447 0 N-CA-C 106.787 -1.561 . . . . 0.0 106.787 169.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 1.4 p -127.9 140.78 51.8 Favored 'General case' 0 C--O 1.239 0.513 0 N-CA-C 105.519 -2.03 . . . . 0.0 105.519 165.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 2.7 t80 -142.33 127.59 18.71 Favored 'General case' 0 C--O 1.236 0.393 0 CA-C-N 119.736 1.153 . . . . 0.0 109.056 -172.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 98.2 m -97.86 137.38 36.79 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 109.283 -0.636 . . . . 0.0 109.283 -170.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -133.08 101.64 5.29 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 105.01 -2.219 . . . . 0.0 105.01 165.177 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 1.4 tptp -156.63 146.87 21.28 Favored 'General case' 0 N--CA 1.468 0.456 0 C-N-CA 123.221 0.608 . . . . 0.0 110.086 -178.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 46.4 t -125.37 153.47 43.33 Favored 'General case' 0 C--O 1.236 0.369 0 C-N-CA 125.095 1.358 . . . . 0.0 108.882 -179.038 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -134.31 151.44 51.25 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 106.256 -1.757 . . . . 0.0 106.256 160.131 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.3 t -176.44 57.76 0.01 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 N-CA-C 108.027 -1.101 . . . . 0.0 108.027 -168.596 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . -149.1 8.14 0.73 Allowed 'General case' 0 N--CA 1.468 0.471 0 O-C-N 120.515 -1.365 . . . . 0.0 114.25 -164.089 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 7.5 t -143.57 66.08 1.31 Allowed 'General case' 0 CA--C 1.531 0.235 0 N-CA-C 107.228 -1.397 . . . . 0.0 107.228 173.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 3.6 m 50.85 75.29 0.19 Allowed 'General case' 0 C--O 1.225 -0.221 0 C-N-CA 125.05 1.34 . . . . 0.0 112.365 -170.727 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 67.96 22.82 74.23 Favored Glycine 0 CA--C 1.531 1.05 0 C-N-CA 120.612 -0.804 . . . . 0.0 111.734 166.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 10.3 t70 -71.34 90.91 0.96 Allowed 'General case' 0 N--CA 1.446 -0.67 0 C-N-CA 126.662 1.985 . . . . 0.0 106.718 177.143 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 53.7 t80 -118.88 94.13 4.34 Favored 'General case' 0 N--CA 1.455 -0.216 0 C-N-CA 125.861 1.664 . . . . 0.0 108.22 -170.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 10.5 m120 -88.71 21.37 3.03 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 113.811 1.041 . . . . 0.0 113.811 -162.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 17.4 mmtm -136.25 163.62 29.98 Favored 'General case' 0 CA--C 1.513 -0.47 0 O-C-N 120.866 -1.146 . . . . 0.0 111.391 -166.57 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -158.76 -62.99 0.08 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 128.639 2.776 . . . . 0.0 103.613 168.655 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 10.6 pt20 -147.22 147.7 30.73 Favored 'General case' 0 N--CA 1.45 -0.455 0 C-N-CA 124.776 1.23 . . . . 0.0 108.921 -179.279 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -150.28 134.31 16.96 Favored 'General case' 0 C--O 1.24 0.596 0 N-CA-C 106.007 -1.849 . . . . 0.0 106.007 162.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.1 p90 -136.94 162.89 32.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.399 1.079 . . . . 0.0 108.865 170.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -120.36 110.31 1.75 Allowed Glycine 0 CA--C 1.518 0.256 0 N-CA-C 107.707 -2.157 . . . . 0.0 107.707 172.014 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 22.3 mm -93.72 109.44 21.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.454 0 N-CA-C 105.391 -2.077 . . . . 0.0 105.391 172.983 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 15.6 m -140.53 125.16 17.99 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.252 1.421 . . . . 0.0 109.305 -170.882 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -166.83 168.05 14.46 Favored 'General case' 0 N--CA 1.47 0.543 0 O-C-N 120.375 -1.453 . . . . 0.0 110.996 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . 165.01 174.85 35.16 Favored Glycine 0 CA--C 1.53 0.991 0 CA-C-O 119.564 -0.576 . . . . 0.0 112.828 173.599 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . 0.418 ' HB2' HD11 ' A' ' 37' ' ' LEU . 60.3 Cg_endo -70.85 133.4 23.5 Favored 'Trans proline' 0 N--CA 1.457 -0.631 0 C-N-CA 124.246 3.297 . . . . 0.0 110.169 178.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -90.78 152.31 20.85 Favored 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 123.568 0.747 . . . . 0.0 109.881 -179.965 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -133.49 105.05 6.69 Favored 'General case' 0 C--O 1.235 0.329 0 C-N-CA 125.708 1.603 . . . . 0.0 108.297 -176.715 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 55.3 ttm-85 -88.27 95.07 10.04 Favored 'General case' 0 CA--C 1.514 -0.41 0 N-CA-C 107.488 -1.301 . . . . 0.0 107.488 172.247 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.478 ' H ' HD13 ' A' ' 73' ' ' ILE . 0.2 OUTLIER -112.06 15.49 8.27 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.439 0 C-N-CA 123.623 0.769 . . . . 0.0 111.305 -177.061 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -150.64 -179.77 7.53 Favored 'General case' 0 CA--C 1.535 0.384 0 C-N-CA 124.737 1.215 . . . . 0.0 107.929 173.128 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 1.6 t0 -75.02 -65.82 0.83 Allowed 'General case' 0 C--O 1.237 0.445 0 C-N-CA 125.549 1.54 . . . . 0.0 109.469 -179.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 0.3 OUTLIER -111.99 11.3 20.58 Favored 'General case' 0 CA--C 1.539 0.537 0 C-N-CA 126.178 1.791 . . . . 0.0 111.555 -172.017 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -124.13 152.96 42.18 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.805 1.242 . . . . 0.0 108.581 168.092 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 4.5 m -149.81 157.83 43.57 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 107.167 -1.42 . . . . 0.0 107.167 164.781 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 4.8 mp -134.72 146.73 30.29 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 104.545 -2.391 . . . . 0.0 104.545 172.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -136.38 124.41 22.89 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 107.131 -1.433 . . . . 0.0 107.131 -171.37 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . -90.0 96.69 2.23 Favored Glycine 0 CA--C 1.524 0.629 0 C-N-CA 124.816 1.198 . . . . 0.0 110.247 -177.199 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 12.2 m -104.46 155.46 5.99 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.255 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 -179.664 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 5.9 m -95.87 134.15 34.44 Favored 'Isoleucine or valine' 0 CA--C 1.519 -0.221 0 N-CA-C 106.508 -1.664 . . . . 0.0 106.508 161.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -127.39 149.91 17.99 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.813 -1.715 . . . . 0.0 108.813 173.105 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 5.8 p -140.89 127.0 20.16 Favored 'Isoleucine or valine' 0 C--O 1.236 0.346 0 C-N-CA 124.907 1.283 . . . . 0.0 108.289 179.788 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -116.37 115.0 3.21 Favored Glycine 0 CA--C 1.527 0.83 0 C-N-CA 125.953 1.739 . . . . 0.0 108.784 177.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 57.0 t80 -129.66 116.37 18.74 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-N 118.362 1.081 . . . . 0.0 109.784 -177.066 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -86.95 170.25 41.35 Favored Glycine 0 CA--C 1.526 0.751 0 C-N-CA 123.23 0.443 . . . . 0.0 113.951 -175.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 20.4 tptt -151.08 154.12 36.38 Favored 'General case' 0 C--O 1.238 0.481 0 C-N-CA 123.705 0.802 . . . . 0.0 111.693 -178.123 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 1.8 t80 64.91 -75.13 0.05 OUTLIER 'General case' 0 N--CA 1.471 0.588 0 C-N-CA 129.77 3.228 . . . . 0.0 112.424 178.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 33.8 mt-30 63.5 -64.83 0.12 Allowed 'General case' 0 CA--C 1.536 0.41 0 C-N-CA 127.693 2.397 . . . . 0.0 116.866 166.547 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 81.8 p -127.16 101.18 6.41 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 122.05 2.204 . . . . 0.0 106.623 172.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 7.5 m -63.78 -99.73 0.0 OUTLIER 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 127.217 2.207 . . . . 0.0 110.716 -169.789 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 37.4 tt0 -163.13 68.4 0.21 Allowed 'General case' 0 C--O 1.234 0.259 0 N-CA-C 106.025 -1.843 . . . . 0.0 106.025 -175.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -168.27 -57.04 0.01 OUTLIER Pre-proline 0 CA--C 1.535 0.383 0 C-N-CA 127.181 2.193 . . . . 0.0 108.371 171.564 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -73.49 -60.94 0.04 OUTLIER 'Trans proline' 0 C--N 1.356 0.95 0 CA-C-N 121.219 1.471 . . . . 0.0 112.227 -174.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -160.7 27.21 0.15 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 125.191 1.397 . . . . 0.0 110.539 -159.524 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 20.0 p90 -1.1 111.21 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.727 0 C-N-CA 129.096 2.958 . . . . 0.0 116.002 170.784 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 16.0 ttmm 61.02 45.34 9.39 Favored 'General case' 0 N--CA 1.471 0.589 0 C-N-CA 124.585 1.154 . . . . 0.0 111.663 173.398 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 26.6 t-20 -76.5 92.85 3.46 Favored 'General case' 0 C--O 1.224 -0.263 0 C-N-CA 125.272 1.429 . . . . 0.0 107.484 175.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 51.7 m-20 60.35 102.11 0.02 OUTLIER 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 127.148 2.179 . . . . 0.0 111.83 178.745 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.5 t -62.04 130.67 46.6 Favored 'General case' 0 C--O 1.238 0.479 0 N-CA-C 107.051 -1.463 . . . . 0.0 107.051 177.042 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 1.1 m -62.07 159.7 14.0 Favored 'General case' 0 CA--C 1.536 0.416 0 C-N-CA 125.098 1.359 . . . . 0.0 110.414 -165.271 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 1.2 t70 -137.09 168.6 19.28 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.707 0.685 . . . . 0.0 110.325 -174.22 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 74.0 m-85 -72.95 115.25 12.02 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 123.83 0.852 . . . . 0.0 110.185 -175.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -66.3 152.8 52.18 Favored Glycine 0 CA--C 1.534 1.221 0 N-CA-C 109.823 -1.311 . . . . 0.0 109.823 165.36 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 53.6 m-85 -132.69 112.3 11.89 Favored 'General case' 0 N--CA 1.453 -0.3 0 N-CA-C 105.407 -2.072 . . . . 0.0 105.407 164.77 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 43.9 m -91.07 -179.75 5.53 Favored 'General case' 0 C--O 1.24 0.573 0 C-N-CA 123.908 0.883 . . . . 0.0 110.41 174.719 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 2.3 t80 -156.46 159.16 38.4 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 125.739 1.615 . . . . 0.0 108.172 175.69 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 71.17 -105.71 1.7 Allowed Glycine 0 C--O 1.223 -0.568 0 N-CA-C 108.933 -1.667 . . . . 0.0 108.933 173.25 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 53.42 5.06 0.05 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 C-N-CA 127.832 2.453 . . . . 0.0 117.441 167.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -118.31 84.17 0.36 Allowed Glycine 0 N--CA 1.446 -0.634 0 N-CA-C 108.503 -1.839 . . . . 0.0 108.503 176.809 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -117.58 149.62 40.35 Favored 'General case' 0 C--O 1.226 -0.143 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 169.032 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -146.16 160.14 42.35 Favored 'General case' 0 C--N 1.322 -0.596 0 N-CA-C 106.501 -1.666 . . . . 0.0 106.501 172.542 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 3.9 m-85 -102.96 170.24 8.09 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 171.068 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -56.76 109.57 1.79 Allowed Pre-proline 0 CA--C 1.541 0.63 0 C-N-CA 126.562 1.945 . . . . 0.0 109.14 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 48.8 Cg_endo -72.43 134.28 22.31 Favored 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.878 1.719 . . . . 0.0 110.921 -179.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 28.5 ttm -75.45 -177.06 3.42 Favored 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 125.05 1.34 . . . . 0.0 108.014 168.016 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 40.8 mt-10 -96.82 5.12 51.19 Favored 'General case' 0 CA--C 1.541 0.598 0 C-N-CA 125.239 1.416 . . . . 0.0 110.608 175.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 16.1 t-20 -138.13 -21.57 1.07 Allowed 'General case' 0 N--CA 1.466 0.347 0 N-CA-C 113.745 1.017 . . . . 0.0 113.745 176.604 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 3.2 m -140.93 111.06 3.28 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 125.139 1.376 . . . . 0.0 108.786 177.225 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -100.01 146.18 27.02 Favored 'General case' 0 C--O 1.236 0.375 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 173.714 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 4.6 mm? -124.31 115.39 20.93 Favored 'General case' 0 C--O 1.237 0.406 0 N-CA-C 106.105 -1.813 . . . . 0.0 106.105 -170.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -115.25 143.39 45.32 Favored 'General case' 0 N--CA 1.468 0.468 0 C-N-CA 125.997 1.719 . . . . 0.0 106.824 175.306 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 70.2 m-85 -139.04 114.7 9.91 Favored 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.638 -0.875 . . . . 0.0 108.638 -177.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 43.1 t -126.39 128.98 47.88 Favored 'General case' 0 C--N 1.329 -0.315 0 N-CA-C 106.374 -1.713 . . . . 0.0 106.374 -175.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 31.2 p90 -137.46 110.33 7.66 Favored 'General case' 0 N--CA 1.455 -0.221 0 N-CA-C 107.064 -1.458 . . . . 0.0 107.064 167.164 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 12.4 pt-20 -121.32 135.21 55.13 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 105.229 -2.138 . . . . 0.0 105.229 -177.218 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 8.4 pt20 -131.29 155.22 47.55 Favored 'General case' 0 C--O 1.237 0.401 0 O-C-N 123.436 0.46 . . . . 0.0 111.141 -176.569 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 20.3 m -138.19 119.32 14.5 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 126.59 1.956 . . . . 0.0 106.579 -166.591 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 22.0 mtp85 -90.36 97.61 11.28 Favored 'General case' 0 N--CA 1.468 0.43 0 CA-C-N 119.484 1.038 . . . . 0.0 110.555 -177.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 2.1 mp -143.66 113.92 2.26 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.498 0 N-CA-C 105.324 -2.102 . . . . 0.0 105.324 173.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 58.31 11.2 1.52 Allowed 'General case' 0 N--CA 1.473 0.714 0 C-N-CA 126.435 1.894 . . . . 0.0 114.415 171.942 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 16.1 m 54.06 24.99 5.14 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.565 1.146 . . . . 0.0 112.432 -162.653 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . . . . . . . . . 31.1 m -100.73 149.41 6.2 Favored 'Isoleucine or valine' 0 C--O 1.234 0.247 0 C-N-CA 123.33 0.652 . . . . 0.0 110.127 169.053 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . 0.576 ' H ' ' HB2' ' A' ' 14' ' ' ALA . 4.2 t70 67.84 -59.24 0.43 Allowed 'General case' 0 N--CA 1.469 0.488 0 C-N-CA 128.797 2.839 . . . . 0.0 110.495 -174.156 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 12.9 t 60.95 -112.55 0.03 OUTLIER 'Isoleucine or valine' 0 N--CA 1.441 -0.9 0 N-CA-C 105.309 -2.108 . . . . 0.0 105.309 175.584 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -141.02 149.29 20.9 Favored Glycine 0 N--CA 1.441 -0.971 0 CA-C-N 119.853 1.206 . . . . 0.0 112.114 177.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 1.2 t -77.2 155.1 32.45 Favored 'General case' 0 N--CA 1.442 -0.868 0 C-N-CA 126.113 1.765 . . . . 0.0 108.782 167.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . 0.46 ' HE1' ' NE2' ' A' ' 11' ' ' GLN . 0.8 OUTLIER -94.54 157.87 15.79 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 117.27 -1.772 . . . . 0.0 108.088 131.172 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 2.5 mt -131.25 118.09 39.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.568 0 N-CA-C 103.485 -2.783 . . . . 0.0 103.485 175.226 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -146.17 157.97 43.86 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 123.594 0.758 . . . . 0.0 108.967 165.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -167.18 -117.42 0.4 Allowed Glycine 0 N--CA 1.451 -0.359 0 N-CA-C 108.827 -1.709 . . . . 0.0 108.827 163.253 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 2.0 m -142.57 -175.27 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 128.042 2.537 . . . . 0.0 107.626 -176.072 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . -162.96 -165.32 19.85 Favored Glycine 0 N--CA 1.438 -1.183 0 N-CA-C 108.683 -1.767 . . . . 0.0 108.683 -173.581 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -151.56 177.27 10.5 Favored 'General case' 0 C--O 1.241 0.619 0 C-N-CA 127.61 2.364 . . . . 0.0 107.182 -177.476 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.15 165.93 19.46 Favored 'General case' 0 N--CA 1.47 0.544 0 O-C-N 120.786 -1.196 . . . . 0.0 110.521 169.868 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--O 1.241 0.653 0 C-N-CA 124.521 1.128 . . . . 0.0 109.416 -179.525 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.471 0.619 0 N-CA-C 107.621 -1.251 . . . . 0.0 107.621 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -145.43 166.5 25.44 Favored 'General case' 0 C--O 1.235 0.327 0 CA-C-N 118.297 0.499 . . . . 0.0 111.173 -164.544 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' SER . . . . . . . . . . . . . 53.0 m -123.93 105.99 10.06 Favored 'General case' 0 N--CA 1.452 -0.357 0 CA-C-O 122.626 1.203 . . . . 0.0 108.794 162.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 4.7 m -119.24 126.76 52.27 Favored 'General case' 0 N--CA 1.447 -0.621 0 C-N-CA 125.677 1.591 . . . . 0.0 107.008 174.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' VAL . . . . . . . . . . . . . 1.5 p -112.42 131.35 64.15 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.714 0 N-CA-C 105.955 -1.868 . . . . 0.0 105.955 -178.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -150.32 163.48 38.21 Favored 'General case' 0 C--O 1.235 0.298 0 CA-C-N 119.337 0.971 . . . . 0.0 110.66 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 141.58 165.42 10.4 Favored Glycine 0 CA--C 1.526 0.775 0 C-N-CA 125.625 1.583 . . . . 0.0 109.837 174.891 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -152.92 -153.08 6.19 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 109.642 -1.383 . . . . 0.0 109.642 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -90.53 154.09 19.87 Favored 'General case' 0 C--O 1.233 0.231 0 N-CA-C 107.032 -1.47 . . . . 0.0 107.032 173.441 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -123.04 147.25 46.91 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 107.726 -1.213 . . . . 0.0 107.726 170.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' GLN . . . . . . . . . . . . . 55.4 mt-30 -138.21 104.51 5.22 Favored 'General case' 0 C--O 1.232 0.153 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 -165.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' SER . . . . . . . . . . . . . 21.5 m -118.26 150.8 38.84 Favored 'General case' 0 CA--C 1.529 0.172 0 C-N-CA 125.79 1.636 . . . . 0.0 108.389 179.201 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ASP . . . . . . . . . . . . . 10.0 t0 -139.04 172.62 12.57 Favored 'General case' 0 N--CA 1.468 0.435 0 N-CA-C 107.111 -1.441 . . . . 0.0 107.111 165.843 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ALA . . . . . . . . . . . . . . . -119.32 164.76 15.2 Favored 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.625 1.17 . . . . 0.0 110.848 174.187 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.499 ' H ' HG13 ' A' ' 135' ' ' VAL . 5.3 tt0 -52.23 -27.97 16.79 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 125.279 1.432 . . . . 0.0 113.014 -178.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -128.13 -102.01 1.1 Allowed Glycine 0 C--O 1.225 -0.461 0 N-CA-C 107.028 -2.429 . . . . 0.0 107.028 174.338 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -137.32 128.41 27.67 Favored 'General case' 0 N--CA 1.445 -0.685 0 N-CA-C 105.561 -2.015 . . . . 0.0 105.561 168.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' MET . . . . . . . . . . . . . 1.7 mpt? -144.59 -53.99 0.32 Allowed 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.95 1.3 . . . . 0.0 108.878 169.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -130.91 142.3 50.35 Favored 'General case' 0 CA--C 1.528 0.107 0 C-N-CA 125.893 1.677 . . . . 0.0 107.561 -179.492 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' LYS . . . . . . . . . . . . . 21.3 mttm -85.19 157.26 20.68 Favored 'General case' 0 C--O 1.237 0.423 0 C-N-CA 123.223 0.609 . . . . 0.0 109.774 171.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -56.83 104.11 0.14 Allowed 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 160.938 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . -160.41 79.08 0.16 Allowed Glycine 0 N--CA 1.445 -0.731 0 N-CA-C 105.841 -2.904 . . . . 0.0 105.841 171.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLY . . . . . . . . . . . . . . . -129.17 152.45 19.47 Favored Glycine 0 N--CA 1.44 -1.083 0 N-CA-C 108.721 -1.752 . . . . 0.0 108.721 -171.798 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PHE . . . . . . . . . . . . . 6.2 m-85 -145.37 158.67 43.79 Favored 'General case' 0 C--N 1.323 -0.562 0 N-CA-C 105.424 -2.065 . . . . 0.0 105.424 172.11 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' ASN . . . . . . . . . . . . . 46.3 t30 -136.34 143.08 43.91 Favored 'General case' 0 N--CA 1.442 -0.849 0 N-CA-C 105.54 -2.022 . . . . 0.0 105.54 152.985 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -158.73 119.22 3.26 Favored 'General case' 0 C--N 1.324 -0.525 0 N-CA-C 102.4 -3.185 . . . . 0.0 102.4 177.214 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.4 tptt -148.71 176.25 10.52 Favored 'General case' 0 C--O 1.234 0.268 0 N-CA-C 108.683 -0.858 . . . . 0.0 108.683 167.684 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -104.72 131.92 51.59 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 106.086 -1.82 . . . . 0.0 106.086 -171.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -94.46 108.91 20.82 Favored 'General case' 0 CA--C 1.516 -0.336 0 N-CA-C 107.736 -1.209 . . . . 0.0 107.736 177.341 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' TYR . . . . . . . . . . . . . 14.7 t80 -99.56 147.5 25.27 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 107.118 -1.438 . . . . 0.0 107.118 177.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLU . . . . . . . . . . . . . 31.5 tt0 -134.47 141.38 46.75 Favored 'General case' 0 C--O 1.24 0.582 0 C-N-CA 123.364 0.666 . . . . 0.0 109.605 172.884 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -63.66 165.16 8.6 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.153 1.381 . . . . 0.0 109.362 172.406 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -132.18 66.29 1.55 Allowed 'General case' 0 CA--C 1.518 -0.254 0 N-CA-C 106.522 -1.658 . . . . 0.0 106.522 173.022 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -159.22 -47.19 0.06 Allowed 'General case' 0 C--N 1.333 -0.119 0 C-N-CA 127.118 2.167 . . . . 0.0 107.752 175.298 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 66.7 m -132.16 157.63 77.74 Favored Pre-proline 0 C--O 1.237 0.425 0 C-N-CA 124.721 1.208 . . . . 0.0 110.623 177.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -76.39 83.36 2.05 Favored 'Trans proline' 0 N--CA 1.456 -0.694 0 C-N-CA 123.917 3.078 . . . . 0.0 109.278 176.272 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' LEU . . . . . . . . . . . . . 19.2 tp -139.9 116.57 10.82 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 108.119 -1.067 . . . . 0.0 108.119 172.124 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLY . . . . . . . . . . . . . . . -96.48 164.24 23.13 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 110.7 -0.96 . . . . 0.0 110.7 171.18 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' VAL . . . . . . . . . . . . . 4.1 t -132.19 119.09 38.97 Favored 'Isoleucine or valine' 0 C--O 1.239 0.546 0 N-CA-C 106.128 -1.805 . . . . 0.0 106.128 174.2 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -127.5 123.42 61.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.31 0 N-CA-C 104.975 -2.231 . . . . 0.0 104.975 171.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . -84.04 158.52 34.87 Favored Glycine 0 CA--C 1.519 0.323 0 N-CA-C 107.197 -2.361 . . . . 0.0 107.197 163.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' SER . . . . . . . . . . . . . 29.0 m -118.54 153.5 34.1 Favored 'General case' 0 C--N 1.324 -0.524 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 159.765 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -124.16 157.36 34.88 Favored 'General case' 0 N--CA 1.447 -0.612 0 C-N-CA 126.659 1.984 . . . . 0.0 107.408 174.16 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' THR . . . . . . . . . . . . . 77.2 m -120.16 151.68 38.75 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 125.804 1.642 . . . . 0.0 107.622 175.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' TYR . . . . . . . . . . . . . 10.7 t80 -122.31 154.69 37.27 Favored 'General case' 0 CA--C 1.533 0.308 0 N-CA-C 107.107 -1.442 . . . . 0.0 107.107 169.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.7 m -130.25 137.97 50.28 Favored 'General case' 0 C--O 1.235 0.292 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.64 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -53.88 146.79 13.32 Favored 'General case' 0 CA--C 1.536 0.441 0 CA-C-O 121.556 0.693 . . . . 0.0 110.632 178.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LYS . . . . . . . . . . . . . 47.1 mtpt -66.22 147.02 53.95 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 124.826 1.251 . . . . 0.0 108.207 173.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' SER . . . . . . . . . . . . . 6.4 p -64.23 151.31 43.9 Favored 'General case' 0 C--O 1.243 0.762 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 174.28 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.2 mtt85 -72.31 100.34 2.61 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 104.253 -2.499 . . . . 0.0 104.253 162.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' THR . . . . . . . . . . . . . 3.8 t -105.25 124.96 50.42 Favored 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 103.957 -2.609 . . . . 0.0 103.957 176.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ALA . . . . . . . . . . . . . . . 47.03 62.62 2.29 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 126.799 2.039 . . . . 0.0 112.288 -174.787 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' SER . . . . . . . . . . . . . 3.7 t -129.94 -67.82 0.73 Allowed 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 125.494 1.518 . . . . 0.0 107.683 172.398 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' SER . . . . . . . . . . . . . 16.3 m -139.13 12.29 2.61 Favored 'General case' 0 CA--C 1.545 0.783 0 C-N-CA 124.939 1.296 . . . . 0.0 113.374 176.621 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLY . . . . . . . . . . . . . . . 74.78 62.55 2.8 Favored Glycine 0 CA--C 1.527 0.813 0 CA-C-N 119.718 1.144 . . . . 0.0 112.56 178.004 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ASP . . . . . . . . . . . . . 63.0 t0 -120.37 91.74 3.61 Favored 'General case' 0 N--CA 1.471 0.577 0 N-CA-C 106.921 -1.511 . . . . 0.0 106.921 169.758 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -83.39 77.69 9.76 Favored 'General case' 0 CA--C 1.534 0.328 0 O-C-N 121.725 -0.609 . . . . 0.0 109.366 -167.258 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ASN . . . . . . . . . . . . . 20.0 m120 -87.79 68.33 9.36 Favored 'General case' 0 N--CA 1.467 0.412 0 O-C-N 120.617 -1.302 . . . . 0.0 109.415 177.505 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -68.39 115.39 7.76 Favored 'General case' 0 C--O 1.235 0.302 0 N-CA-C 107.232 -1.395 . . . . 0.0 107.232 176.38 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 24.8 p30 -179.71 159.62 0.87 Allowed 'General case' 0 C--O 1.239 0.529 0 C-N-CA 128.442 2.697 . . . . 0.0 107.101 179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -144.34 162.8 35.51 Favored 'General case' 0 C--O 1.236 0.346 0 N-CA-C 106.591 -1.633 . . . . 0.0 106.591 170.39 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' TYR . . . . . . . . . . . . . 7.4 p90 -73.16 139.69 46.52 Favored 'General case' 0 C--O 1.241 0.652 0 N-CA-C 108.449 -0.945 . . . . 0.0 108.449 174.738 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -143.43 117.1 9.23 Favored 'General case' 0 C--O 1.234 0.252 0 O-C-N 121.416 -0.802 . . . . 0.0 109.613 153.128 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' GLY . . . . . . . . . . . . . . . -144.0 115.58 0.9 Allowed Glycine 0 C--N 1.331 0.297 0 N-CA-C 109.177 -1.569 . . . . 0.0 109.177 -175.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ILE . . . . . . . . . . . . . 1.5 mp -105.19 116.59 49.29 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 103.239 -2.874 . . . . 0.0 103.239 175.185 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' THR . . . . . . . . . . . . . 51.1 m -137.16 128.0 27.3 Favored 'General case' 0 C--O 1.239 0.543 0 C-N-CA 127.061 2.144 . . . . 0.0 107.455 -169.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -84.39 178.3 7.8 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.974 1.309 . . . . 0.0 111.332 -174.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLY . . . . . . . . . . . . . . . -169.79 76.99 0.1 Allowed Glycine 0 C--N 1.334 0.46 0 CA-C-O 118.673 -1.07 . . . . 0.0 111.279 166.146 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' PRO . . . . . . . . . . . . . 64.1 Cg_endo -65.2 119.35 6.36 Favored 'Trans proline' 0 N--CA 1.452 -0.916 0 C-N-CA 122.308 2.005 . . . . 0.0 108.181 160.424 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . -110.71 115.93 30.43 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.211 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -132.88 154.75 50.07 Favored 'General case' 0 N--CA 1.467 0.403 0 C-N-CA 126.406 1.882 . . . . 0.0 107.72 -174.123 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.5 mpt_? -97.98 129.34 44.87 Favored 'General case' 0 N--CA 1.472 0.629 0 CA-C-N 120.516 1.507 . . . . 0.0 107.466 166.57 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.489 HD11 HG13 ' A' ' 79' ' ' ILE . 0.1 OUTLIER -144.86 -39.83 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.47 0.569 0 C-N-CA 123.911 0.884 . . . . 0.0 110.787 -177.061 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -63.58 -6.78 5.71 Favored 'General case' 0 N--CA 1.469 0.497 0 C-N-CA 124.858 1.263 . . . . 0.0 111.828 171.826 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASP . . . . . . . . . . . . . 24.7 t0 86.81 114.6 0.04 OUTLIER 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 131.442 3.897 . . . . 0.0 107.842 178.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' TRP . . . . . . . . . . . . . 23.0 m95 59.78 -6.85 0.07 Allowed 'General case' 0 N--CA 1.468 0.457 0 C-N-CA 127.38 2.272 . . . . 0.0 115.256 -169.583 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ALA . . . . . . . . . . . . . . . -129.47 154.62 46.8 Favored 'General case' 0 C--O 1.242 0.662 0 C-N-CA 125.265 1.426 . . . . 0.0 110.466 -179.099 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' SER . . . . . . . . . . . . . 43.6 p -101.8 168.86 9.17 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 126.735 2.014 . . . . 0.0 110.908 -179.68 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.489 HG13 HD11 ' A' ' 73' ' ' ILE . 2.2 pp -136.88 166.66 25.39 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.167 0 C-N-CA 124.958 1.303 . . . . 0.0 108.062 -178.797 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' TYR . . . . . . . . . . . . . 49.5 p90 -104.43 156.55 17.84 Favored 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 125.532 1.533 . . . . 0.0 110.084 -173.049 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLY . . . . . . . . . . . . . . . 153.26 42.38 0.02 OUTLIER Glycine 0 N--CA 1.447 -0.621 0 CA-C-N 114.991 -1.004 . . . . 0.0 110.851 -165.849 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' VAL . . . . . . . . . . . . . 2.1 m -102.98 152.58 5.82 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.871 -1.9 . . . . 0.0 105.871 175.698 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' VAL . . . . . . . . . . . . . 33.9 m -95.39 159.52 2.87 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.462 0 N-CA-C 108.379 -0.971 . . . . 0.0 108.379 171.007 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLY . . . . . . . . . . . . . . . -150.54 -176.72 23.79 Favored Glycine 0 N--CA 1.445 -0.744 0 N-CA-C 108.822 -1.711 . . . . 0.0 108.822 162.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' VAL . . . . . . . . . . . . . 34.3 m -134.28 151.07 31.52 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 161.053 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLY . . . . . . . . . . . . . . . -120.09 158.72 15.28 Favored Glycine 0 CA--C 1.52 0.363 0 N-CA-C 108.35 -1.9 . . . . 0.0 108.35 162.612 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -128.1 158.66 37.39 Favored 'General case' 0 C--O 1.237 0.441 0 C-N-CA 125.031 1.332 . . . . 0.0 108.777 173.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' GLY . . . . . . . . . . . . . . . -161.28 69.98 0.23 Allowed Glycine 0 C--O 1.225 -0.441 0 N-CA-C 108.079 -2.008 . . . . 0.0 108.079 176.355 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LYS . . . . . . . . . . . . . 5.6 mptp? -53.48 -25.98 18.69 Favored 'General case' 0 N--CA 1.469 0.52 0 CA-C-O 116.252 -1.833 . . . . 0.0 114.67 -164.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' PHE . . . . . . . . . . . . . 39.2 t80 26.45 88.25 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.47 0 C-N-CA 128.395 2.678 . . . . 0.0 113.862 -176.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -102.67 170.23 8.15 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 109.134 -0.691 . . . . 0.0 109.134 164.075 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' THR . . . . . . . . . . . . . 4.2 t -135.6 151.97 50.79 Favored 'General case' 0 C--O 1.239 0.503 0 C-N-CA 127.539 2.336 . . . . 0.0 105.708 177.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' THR . . . . . . . . . . . . . 60.1 m -132.58 60.1 1.7 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 125.243 1.417 . . . . 0.0 107.399 178.085 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' GLU . . . . . . . . . . . . . 8.4 pt-20 -158.43 -60.64 0.08 Allowed 'General case' 0 N--CA 1.462 0.146 0 N-CA-C 109.172 -0.677 . . . . 0.0 109.172 177.836 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' TYR . . . . . . . . . . . . . 10.6 m-85 -58.0 138.63 83.51 Favored Pre-proline 0 C--O 1.239 0.519 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 176.444 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 41.0 Cg_endo -61.53 149.67 88.7 Favored 'Trans proline' 0 N--CA 1.455 -0.751 0 C-N-CA 122.876 2.384 . . . . 0.0 110.594 -171.352 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' THR . . . . . . . . . . . . . 2.7 m 48.41 68.8 0.63 Allowed 'General case' 0 CA--C 1.538 0.5 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -165.632 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' TYR . . . . . . . . . . . . . 14.6 m-85 -37.25 162.39 0.0 OUTLIER 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 128.14 2.576 . . . . 0.0 113.207 170.853 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 56.26 70.38 0.65 Allowed 'General case' 0 N--CA 1.471 0.587 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -176.555 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -86.68 -56.56 3.35 Favored 'General case' 0 C--N 1.334 -0.079 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.119 -167.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ASP . . . . . . . . . . . . . 30.0 t0 -67.26 129.03 38.59 Favored 'General case' 0 C--O 1.239 0.545 0 C-N-CA 123.192 0.597 . . . . 0.0 110.756 -170.652 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' THR . . . . . . . . . . . . . 5.0 t -64.13 164.59 10.54 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 124.242 1.017 . . . . 0.0 110.694 -178.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' SER . . . . . . . . . . . . . 6.3 m -46.9 126.52 8.89 Favored 'General case' 0 C--O 1.236 0.354 0 C-N-CA 125.439 1.496 . . . . 0.0 112.129 -169.216 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -75.46 128.63 35.76 Favored 'General case' 0 N--CA 1.443 -0.819 0 N-CA-C 107.132 -1.433 . . . . 0.0 107.132 167.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' TYR . . . . . . . . . . . . . 36.4 p90 -150.26 136.19 18.5 Favored 'General case' 0 C--O 1.239 0.519 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 174.869 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -155.18 164.17 31.79 Favored Glycine 0 N--CA 1.445 -0.727 0 N-CA-C 111.041 -0.824 . . . . 0.0 111.041 178.713 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -128.51 117.11 20.73 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 108.457 -0.942 . . . . 0.0 108.457 -171.473 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -84.43 142.27 30.23 Favored 'General case' 0 C--O 1.239 0.538 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 179.115 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -147.91 103.22 3.47 Favored 'General case' 0 C--O 1.235 0.333 0 N-CA-C 107.683 -1.228 . . . . 0.0 107.683 178.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' GLY . . . . . . . . . . . . . . . 171.36 -150.46 13.64 Favored Glycine 0 C--N 1.333 0.412 0 CA-C-N 119.875 1.216 . . . . 0.0 113.272 -175.256 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' ALA . . . . . . . . . . . . . . . 36.61 71.56 0.13 Allowed 'General case' 0 CA--C 1.538 0.485 0 C-N-CA 130.414 3.485 . . . . 0.0 115.697 160.642 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' GLY . . . . . . . . . . . . . . . -133.72 30.41 2.98 Favored Glycine 0 C--N 1.346 1.096 0 CA-C-O 118.155 -1.359 . . . . 0.0 113.868 169.752 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -114.95 140.72 48.79 Favored 'General case' 0 N--CA 1.469 0.511 0 CA-C-N 120.362 2.081 . . . . 0.0 109.493 -172.599 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' GLN . . . . . . . . . . . . . 2.2 tt0 -125.13 159.63 31.03 Favored 'General case' 0 C--O 1.235 0.337 0 C-N-CA 125.397 1.479 . . . . 0.0 109.302 -178.106 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' PHE . . . . . . . . . . . . . 20.2 m-85 -116.8 170.94 8.22 Favored 'General case' 0 C--O 1.236 0.391 0 N-CA-C 109.149 -0.686 . . . . 0.0 109.149 158.016 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -67.68 124.62 89.77 Favored Pre-proline 0 CA--C 1.537 0.48 0 N-CA-C 107.008 -1.479 . . . . 0.0 107.008 166.401 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -83.89 147.13 11.88 Favored 'Trans proline' 0 CA--C 1.537 0.627 0 C-N-CA 122.108 1.872 . . . . 0.0 110.857 -175.808 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' MET . . . . . . . . . . . . . 3.9 ttt -159.56 166.84 29.96 Favored 'General case' 0 C--O 1.223 -0.34 0 O-C-N 121.484 -0.76 . . . . 0.0 109.149 177.278 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLU . . . . . . . . . . . . . 2.8 tm-20 79.75 16.14 0.84 Allowed 'General case' 0 N--CA 1.477 0.884 0 O-C-N 120.734 -1.229 . . . . 0.0 111.026 152.227 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 65.83 21.99 11.45 Favored 'General case' 0 C--O 1.223 -0.326 0 C-N-CA 124.294 1.037 . . . . 0.0 111.683 -169.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' VAL . . . . . . . . . . . . . 9.0 m -131.04 110.71 18.49 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.619 0 C-N-CA 124.921 1.289 . . . . 0.0 109.834 163.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -71.77 157.62 37.58 Favored 'General case' 0 N--CA 1.464 0.271 0 O-C-N 119.219 -2.176 . . . . 0.0 107.681 162.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -121.78 130.38 53.37 Favored 'General case' 0 C--O 1.242 0.695 0 N-CA-C 107.573 -1.269 . . . . 0.0 107.573 179.697 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.8 t0 -135.68 166.91 22.16 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 125.004 1.322 . . . . 0.0 108.161 173.597 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -136.32 114.54 11.57 Favored 'General case' 0 C--O 1.235 0.303 0 N-CA-C 107.591 -1.263 . . . . 0.0 107.591 174.386 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' SER . . . . . . . . . . . . . 1.1 m -119.41 113.94 21.55 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 106.032 -1.84 . . . . 0.0 106.032 172.37 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' TYR . . . . . . . . . . . . . 30.1 t80 -138.0 103.93 5.11 Favored 'General case' 0 N--CA 1.447 -0.576 0 N-CA-C 106.176 -1.787 . . . . 0.0 106.176 -178.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 61.6 mt-10 -131.29 144.78 51.53 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.289 -1.004 . . . . 0.0 108.289 -159.225 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLN . . . . . . . . . . . . . 26.2 tt0 -131.45 122.12 25.69 Favored 'General case' 0 C--O 1.235 0.309 0 N-CA-C 106.274 -1.75 . . . . 0.0 106.274 -171.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -132.19 128.83 38.82 Favored 'General case' 0 CA--C 1.516 -0.35 0 CA-C-N 118.308 0.504 . . . . 0.0 109.887 -176.847 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ARG . . . . . . . . . . . . . 21.1 mtm180 -136.9 96.77 3.37 Favored 'General case' 0 N--CA 1.47 0.561 0 CA-C-O 121.813 0.816 . . . . 0.0 110.683 -173.565 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' ILE . . . . . . . . . . . . . 3.6 mp -89.06 96.05 5.85 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.629 0 N-CA-C 105.919 -1.882 . . . . 0.0 105.919 -175.329 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ARG . . . . . . . . . . . . . 39.4 ttt-85 50.79 51.02 17.85 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 123.673 0.789 . . . . 0.0 112.141 171.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' SER . . . . . . . . . . . . . 1.2 t 77.09 -1.95 2.72 Favored 'General case' 0 N--CA 1.464 0.233 0 C-N-CA 127.024 2.13 . . . . 0.0 113.89 -179.553 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' VAL . . . . . 0.499 HG13 ' H ' ' A' ' 15' ' ' GLN . 21.6 t -82.31 111.28 18.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.309 0 N-CA-C 105.767 -1.938 . . . . 0.0 105.767 168.05 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -60.08 122.77 15.19 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 125.126 1.37 . . . . 0.0 107.923 166.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' VAL . . . . . . . . . . . . . 23.8 t -138.28 65.82 0.23 Allowed 'Isoleucine or valine' 0 CA--C 1.54 0.573 0 N-CA-C 106.84 -1.541 . . . . 0.0 106.84 173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' GLY . . . . . . . . . . . . . . . -91.54 145.23 17.63 Favored Glycine 0 C--N 1.336 0.543 0 N-CA-C 110.409 -1.077 . . . . 0.0 110.409 -172.429 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' THR . . . . . . . . . . . . . 15.1 t -141.13 154.15 45.74 Favored 'General case' 0 C--O 1.235 0.321 0 CA-C-N 118.129 0.965 . . . . 0.0 110.526 -173.063 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' TRP . . . . . . . . . . . . . 48.3 p-90 -141.23 157.44 45.24 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 106.174 -1.787 . . . . 0.0 106.174 170.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' ILE . . . . . . . . . . . . . 5.3 mt -127.05 148.48 31.86 Favored 'Isoleucine or valine' 0 N--CA 1.466 0.366 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 171.52 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' ALA . . . . . . . . . . . . . . . -87.56 110.46 20.37 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.468 -2.049 . . . . 0.0 105.468 176.721 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' GLY . . . . . . . . . . . . . . . -81.38 80.55 1.72 Allowed Glycine 0 N--CA 1.438 -1.198 0 N-CA-C 107.218 -2.353 . . . . 0.0 107.218 -179.587 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 18.5 m -112.49 -176.33 0.74 Allowed 'Isoleucine or valine' 0 C--O 1.239 0.504 0 C-N-CA 125.601 1.561 . . . . 0.0 106.832 166.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' GLY . . . . . . . . . . . . . . . 159.35 -143.06 8.79 Favored Glycine 0 C--O 1.22 -0.734 0 N-CA-C 108.761 -1.736 . . . . 0.0 108.761 -173.36 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' TYR . . . . . . . . . . . . . 62.8 m-85 -152.2 175.94 12.08 Favored 'General case' 0 CA--C 1.545 0.771 0 C-N-CA 127.54 2.336 . . . . 0.0 107.691 177.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.16 155.28 47.96 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 120.302 -1.499 . . . . 0.0 110.174 163.637 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' PHE . . . . . . . . . . . . . 6.4 p90 . . . . . 0 C--O 1.247 0.95 0 N-CA-C 107.607 -1.257 . . . . 0.0 107.607 174.907 . . . . . . . . 0 0 . 1 stop_ save_